Surgery for epilepsy by West, Siobhan et al.
Cochrane Database of Systematic Reviews
Surgery for epilepsy (Review)
West S, Nevitt SJ, Cotton J, Gandhi S, Weston J, Sudan A, Ramirez R, Newton R
West S, Nevitt SJ, Cotton J, Gandhi S, Weston J, Sudan A, Ramirez R, Newton R.
Surgery for epilepsy.
Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD010541.
DOI: 10.1002/14651858.CD010541.pub3.
www.cochranelibrary.com
Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
6BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Figure 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Figure 4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
42ADDITIONAL SUMMARY OF FINDINGS . . . . . . . . . . . . . . . . . . . . . . . . . .
47DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
51AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
51ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
52REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
67CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
126DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Surgery versus medical treatment (randomised evidence), Outcome 1 Proportion free from
seizures at 1 year. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
Analysis 1.2. Comparison 1 Surgery versus medical treatment (randomised evidence), Outcome 2 Proportion free from all
seizures (including auras) at 1 year. . . . . . . . . . . . . . . . . . . . . . . . . . . 131
Analysis 2.1. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 1 Parahippocampectomy
(PHC) or anterior temporal lobectomy (ATL): Proportion free from seizures (Engel Class Scale). . . . . . 132
Analysis 2.2. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 2 Parahippocampectomy
(PHC) or Selective Amygdalohippocampectomy (SAH): Proportion free from seizures (Engel Class Scale). . . 133
Analysis 2.3. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 3 Selective
Amygdalohippocampectomy (SAH) or Anterior Temporal Lobectomy (ATL): Proportion free from seizures (Engel
Class Scale). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
Analysis 2.4. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 4 Stereotactic radiosurgery
(SRS) or anterior temporal lobectomy (ATL): proportion with remission of seizures (at least Engel Class IB) between
25 and 36 months. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
Analysis 2.5. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 5 Resection with or
without corpus callosotomy (CCT): Proportion free from seizures (Engel Class 1). . . . . . . . . . . 136
Analysis 2.6. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 6 Anterior temporal
lobectomy (ATL) with or without corpus callosotomy (CCT): Proportion free from seizures (Engel Class 1) at 2
years. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
Analysis 2.7. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 7 Subtemporal or
transsylvian selective amygdalohippocampectomy (SAH): Proportion free from all seizures (including auras, ILAE 1a)
at 1 year. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
Analysis 2.8. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 8 Total or partial
hippocampectomy: Proportion free from all seizures (including auras) at 1 year. . . . . . . . . . . . 138
Analysis 2.9. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 9 Length of resection (2.5
or 3.5 cm): Proportion free from seizures (Engel Class 1) at 1 year. . . . . . . . . . . . . . . . . 138
Analysis 3.1. Comparison 3 Surgery for epilepsy (randomised and non-randomised evidence), Outcome 1 Proportion with
a good outcome of surgery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
Analysis 4.1. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 1 Good outcome by MRI results. . . . . . . . . . . . . . . . . . . . . . . . 145
Analysis 4.2. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 2 Good outcome by use of intracranial monitoring (IM). . . . . . . . . . . . . . . . 148
iSurgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.3. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 3 Good outcome by presence of mesial temporal sclerosis (MTS). . . . . . . . . . . . . 150
Analysis 4.4. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 4 Good outcome by concordance of pre-op MRI and EEG. . . . . . . . . . . . . . . 152
Analysis 4.5. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 5 Good outcome by history of febrile seizures (FS). . . . . . . . . . . . . . . . . . 154
Analysis 4.6. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 6 Good outcome by history of head injury (HI). . . . . . . . . . . . . . . . . . . 155
Analysis 4.7. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 7 Good outcome by presence of encephalomalacia. . . . . . . . . . . . . . . . . . 157
Analysis 4.8. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 8 Good outcome by presence of focal cortical dysplasia (FCD)/malformation of cortical development
(MCD). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
Analysis 4.9. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 9 Good outcome by presence of tumour. . . . . . . . . . . . . . . . . . . . . . 160
Analysis 4.10. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 10 Good outcome by presence of vascular malformation. . . . . . . . . . . . . . . . 163
Analysis 4.11. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 11 Good outcome by unilateral or bilateral interictal spikes. . . . . . . . . . . . . . . 165
Analysis 4.12. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 12 Good outcome by extent of resection. . . . . . . . . . . . . . . . . . . . . . 166
Analysis 4.13. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 13 Good outcome by extent of resection. . . . . . . . . . . . . . . . . . . . . . 169
Analysis 4.14. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 14 Good outcome by side of surgical resection. . . . . . . . . . . . . . . . . . . . 171
Analysis 4.15. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 15 Good outcome by side of surgical resection. . . . . . . . . . . . . . . . . . . . 173
Analysis 4.16. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 16 Good outcome by presence of postoperative discharges. . . . . . . . . . . . . . . . 175
Analysis 4.17. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence),
Outcome 17 Good outcome by presence of postoperative discharges. . . . . . . . . . . . . . . . 176
176ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iiSurgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Surgery for epilepsy
SiobhanWest1, Sarah J Nevitt2, Jennifer Cotton3 , Sacha Gandhi4, JenniferWeston5, Ajay Sudan1 , Roberto Ramirez6 , Richard Newton
1
1Department of Paediatric Neurology, Royal Manchester Children’sHospital,Manchester, UK. 2Department of Biostatistics, University
of Liverpool, Liverpool, UK. 3The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. 4Department of General Surgery,
NHS Ayrshire and Arran, Ayr, UK. 5Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine,
University of Liverpool, Liverpool, UK. 6Royal Manchester Children’s Hospital, Manchester, UK
Contact address: SiobhanWest, Department of Paediatric Neurology, Royal Manchester Children’sHospital, Hathersage Road,Manch-
ester, M13 0JH, UK. siobhan.west@cmft.nhs.uk, Siobhan.wykes@doctors.net.uk.
Editorial group: Cochrane Epilepsy Group.
Publication status and date: New search for studies and content updated (no change to conclusions), published in Issue 6, 2019.
Citation: West S, Nevitt SJ, Cotton J, Gandhi S, Weston J, Sudan A, Ramirez R, Newton R. Surgery for epilepsy. Cochrane Database
of Systematic Reviews 2019, Issue 6. Art. No.: CD010541. DOI: 10.1002/14651858.CD010541.pub3.
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
This is an updated version of the original Cochrane review, published in 2015.
Focal epilepsies are caused by a malfunction of nerve cells localised in one part of one cerebral hemisphere. In studies, estimates of the
number of individuals with focal epilepsy who do not become seizure-free despite optimal drug therapy vary between at least 20%
and up to 70%. If the epileptogenic zone can be located, surgical resection offers the chance of a cure with a corresponding increase in
quality of life.
Objectives
The primary objective is to assess the overall outcome of epilepsy surgery according to evidence from randomised controlled trials.
Secondary objectives are to assess the overall outcome of epilepsy surgery according to non-randomised evidence, and to identify the
factors that correlate with remission of seizures postoperatively.
Search methods
For the latest update, we searched the following databases on 11March 2019: Cochrane Register of Studies (CRSWeb), which includes
the Cochrane Epilepsy Group Specialized Register and the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE
(Ovid, 1946 to March 08, 2019), ClinicalTrials.gov, and theWorld Health Organization (WHO) International Clinical Trials Registry
Platform (ICTRP).
Selection criteria
Eligible studies were randomised controlled trials (RCTs) that included at least 30 participants in a well-defined population (age, sex,
seizure type/frequency, duration of epilepsy, aetiology, magnetic resonance imaging (MRI) diagnosis, surgical findings), with an MRI
performed in at least 90% of cases and an expected duration of follow-up of at least one year, and reporting an outcome related to
postoperative seizure control. Cohort studies or case series were included in the previous version of this review.
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Data collection and analysis
Three groups of two review authors independently screened all references for eligibility, assessed study quality and risk of bias, and
extracted data. Outcomes were proportions of participants achieving a good outcome according to the presence or absence of each
prognostic factor of interest. We intended to combine data with risk ratios (RRs) and 95% confidence intervals (95% CIs).
Main results
We identified 182 studies with a total of 16,855 included participants investigating outcomes of surgery for epilepsy. Nine studies were
RCTs (including two that randomised participants to surgery or medical treatment (99 participants included in the two trials received
medical treatment)). Risk of bias in these RCTs was unclear or high. Most of the remaining 173 non-randomised studies followed a
retrospective design. We assessed study quality using the Effective Public Health Practice Project (EPHPP) tool and determined that
most studies provided moderate or weak evidence. For 29 studies reporting multivariate analyses, we used the Quality in Prognostic
Studies (QUIPS) tool and determined that very few studies were at low risk of bias across domains.
In terms of freedom from seizures, two RCTs found surgery (n = 97) to be superior to medical treatment (n = 99); four found
no statistically significant differences between anterior temporal lobectomy (ATL) with or without corpus callosotomy (n = 60),
between subtemporal or transsylvian approach to selective amygdalohippocampectomy (SAH) (n = 47); between ATL, SAH and
parahippocampectomy (n = 43) or between 2.5 cm and 3.5 cm ATL resection (n = 207). One RCT found total hippocampectomy to
be superior to partial hippocampectomy (n = 70) and one found ATL to be superior to stereotactic radiosurgery (n = 58); and another
provided data to show that for Lennox-Gastaut syndrome, no significant differences in seizure outcomes were evident between those
treated with resection of the epileptogenic zone and those treated with resection of the epileptogenic zone plus corpus callosotomy (n
= 43). We judged evidence from the nine RCTs to be of moderate to very low quality due to lack of information reported about the
randomised trial design and the restricted study populations.
Of the 16,756 participants included in this review who underwent a surgical procedure, 10,696 (64%) achieved a good outcome from
surgery; this ranged across studies from 13.5% to 92.5%. Overall, we found the quality of data in relation to recording of adverse events
to be very poor.
In total, 120 studies examined between one and eight prognostic factors in univariate analysis. We found the following prognostic factors
to be associated with a better post-surgical seizure outcome: abnormal pre-operative MRI, no use of intracranial monitoring, complete
surgical resection, presence of mesial temporal sclerosis, concordance of pre-operative MRI and electroencephalography, history of
febrile seizures, absence of focal cortical dysplasia/malformation of cortical development, presence of tumour, right-sided resection,
and presence of unilateral interictal spikes. We found no evidence that history of head injury, presence of encephalomalacia, presence
of vascular malformation, and presence of postoperative discharges were prognostic factors of outcome.Twenty-nine studies reported
multi-variable models of prognostic factors, and showed that the direction of association of factors with outcomes was generally the
same as that found in univariate analyses.
We observed variability in many of our analyses, likely due to small study sizes with unbalanced group sizes and variation in the
definition of seizure outcome, the definition of prognostic factors, and the influence of the site of surgery
Authors’ conclusions
Study design issues and limited information presented in the included studies mean that our results provide limited evidence to aid
patient selection for surgery and prediction of likely surgical outcomes. Future research should be of high quality, follow a prospective
design, be appropriately powered, and focus on specific issues related to diagnostic tools, the site-specific surgical approach, and other
issues such as extent of resection. Researchers should investigate prognostic factors related to the outcome of surgery via multi-variable
statistical regression modelling, where variables are selected for modelling according to clinical relevance, and all numerical results of
the prognostic models are fully reported. Journal editors should not accept papers for which study authors did not record adverse events
from a medical intervention. Researchers have achieved improvements in cancer care over the past three to four decades by answering
well-defined questions through the conduct of focused RCTs in a step-wise fashion. The same approach to surgery for epilepsy is
required.
P L A I N L A N G U A G E S U M M A R Y
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Background
Focal epilepsies are caused by abnormal electrical discharges in specific (localised) parts of the brain. In up to 30% of people, these
seizures are not controlled bymedication. If the site of origin of these signals (the epileptogenic zone) can be located from the description
of the seizures, or via findings of magnetic resonance imaging (MRI) (a medical imaging scan that uses strong magnetic fields and radio
waves to produce detailed images of the inside of the body) and electroencephalography (EEG) (recording of electrical activity along
the scalp), the person should be offered the chance of having the epileptogenic zone removed. We studied characteristics of people
undergoing surgery and details of surgery type that might be linked to the best chance of surgical cure of epileptic seizures.
Study characteristics
We examined evidence from 182 included studies reporting the experience of 16,855 people of all ages. The evidence is current to
March 2019.
Key results
In total, 10,696 people (64% of the total who had surgery in all studies) experienced a good outcome from surgery, defined as freedom
from epileptic seizures.
Two randomised controlled trials (RCTs) established the superiority of surgery over use of different antiepileptic medications. Seven
RCTs compared different types of surgery. Three trials found no difference in seizure outcomes; one removed 2.5cm or 3.5cm of the
anterior temporal lobe (ATL - the part of the brain in which the epileptogenic zone is often located) or surgically removed the ATL with
or without an additional procedure to sever the nerves that connect the two halves of the brain. The third trial found that completely
removing the hippocampus (the part of the brain in which the epileptogenic zone is often located) was superior to removing only part
of the hippocampus. A fourth trial showed that removing the ATL was superior to a surgical procedure using radiation therapy, Two
trials showed no difference between different types of surgical procedures to remove the ATL or hippocampus and the final trial showed
that for Lennox-Gastaut syndrome, results show no significant differences in seizure outcomes between those undergoing resection of
the epileptogenic zone and those with resection plus corpus callosotomy.
We identified some factors associated with a better outcome from surgery, including a well-defined abnormality on the MRI scan
corresponding with what was expected from the description of seizures and EEG findings, complete surgical removal of the lesion, and
a history of febrile seizures (seizures associated with fever in a young child) often associated with mesial temporal sclerosis (scarring in
the inner portions of the temporal lobe of the brain).
More spread out brain abnormalities that might be associated with brain injury or an abnormality of brain development were not
associated with a good outcome. The presence of such abnormalities is often associated with a need to embark on more detailed pre-
operative investigations including intracranial (inside the skull) EEG monitoring. We would have liked to examine the collective effect
of these factors (i.e. the effect on outcome if a person has a history of febrile seizures, brain injury, and anMRI abnormality altogether);
however, studies did not report enough information to allow this.
Quality of the evidence
Most studies included in this review were of poor quality and had a retrospective design (whereby individuals are recruited after the
result of surgery has been recorded, which looks back for the existence of factors related to the results of surgery). Researchers used
variable surgical approaches for different sites of the brain, different processes to select candidates for surgery, and different definitions
of freedom from seizures after surgery, and they measured these outcomes at varying points. Fewer than half the studies gave details of
complications and deaths associated with surgery.
Conclusions
We encourage researchers that future studies should have a prospective design (a design whereby individuals are recruited before surgery
has taken place, which identifies factors of interest before surgery and follows up with individuals after surgery to record outcomes).
Studies should use appropriate statistical methods to examine the collective effect of factors that may predict the outcome of surgery.
Study authors should clearly record death during or after surgery, as well as complications and side effects from surgery.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Surgery compared with medical treatment for epilepsy
Patient or population: adults and children with drug-resistant epilepsy suitable for surgical intervent ion
Settings: outpat ients (following surgery in hospital)
Intervention: surgery
Comparison: medical treatment
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Assumed risk Corresponding risk
Medical treatment Surgery
Proportion free from
seizures at 1 year
71 per 1000 692 per 1000
(334 to 1000 per 1000)
a
RR 9.78
(4.73 to 20.21)
196 (2 studies) ⊕⊕©©
lowb,c
RR > 1 indicates advan-
tage for surgery
One study measured
f reedom f rom seizures
as ’all seizures impair-
ing awareness’, and an-
other study measured
f reedom f rom seizures
as ILAE Class 1
Proportion free from
all seizures (including
auras) at 1 year
25 per 1000 375 per 1000
(52 to 1000 per 1000)a
RR 15.00
(2.08 to 108.23)
80 (1 study) ⊕©©©
very lowb,c,d
RR > 1 indicates advan-
tage for surgery
* The basis for the assumed risk is the event rate in the control group (medical treatment). The corresponding risk (and its 95% conf idence interval) is based on the assumed
risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; ILAE: Internat ional League Against Epilepsy; RR: risk rat io
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GRADE Working Group grades of evidence.
High certainty (quality): f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate certainty (quality): f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low certainty (quality): f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low certainty (quality): we are very uncertain about the est imate.
aUpper bounds of the corresponding risk interval revised to their maximum to align with the upper bound of the conf idence
interval of the relat ive ef fect.
bLarge but imprecise ef fect size shown in favour of surgical treatment (downgraded due to imprecision as relat ively small
studies and low event rates in control groups).
cDowngraded due to insuf f icient information regarding methods of randomisat ion and allocat ion concealment provided by
one of the studies.
dDowngraded for indirectness: results are applicable to adults (over 16 years only), with children excluded f rom the study.
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B A C K G R O U N D
This review is an update of a review that was previously published
in the Cochrane Database of Systematic Reviews (Issue 7, 2015) on
“Surgery for epilepsy” (West 2015).
Description of the condition
Epilepsy has been redefined very recently by the International
League Against Epilepsy (ILAE) as “a disease of the brain defined
by any of the following conditions: (1) at least two unprovoked
(or reflex) seizures occurring > 24 h apart; (2) one unprovoked
(or reflex) seizure and a probability of further seizures similar to
the general recurrence risk (at least 60%) after two unprovoked
seizures, occurring over the next 10 years; (3) diagnosis of an
epilepsy syndrome” (Fisher 2014). Epilepsy is a common condi-
tion with a prevalence of around 1 in 200 people. Despite optimal
pharmacotherapy, about 20% to 30% of individuals do not be-
come seizure-free (Annegers 1979; Collaborative 1992; Cockerell
1995; Kwan 2000). For some of these people, surgery is a thera-
peutic option.
Description of the intervention
The intervention involves localisation of the epileptogenic focus
and then, if the potential benefit is assessed to outweigh the risk,
surgical resection. Feindel 2009 has thoroughly reviewed the his-
tory of the development of surgery for epilepsy. This work was
pioneered by Victor Horsley when, in 1886, he operated on a
22-year-old man who had developed a focal epilepsy following
a head injury. A highly vascular scar associated with an old de-
pressed comminuted skull fracture was excised along with a bor-
der of cortex. The presence of a discrete cortical vascular scar and
the arrest of focal motor seizures following its excision provided
direct support for Hughlings Jackson’s concept of the aetiology
of focal epilepsy. It subsequently became evident that a variety of
pathologies could give rise to the focal epilepsies. Techniques of
cortical stimulation along with the advent of electroencephalog-
raphy in the 1930s aided localisation. Until the 1940s, surgery
was directed mainly to the convexity of the cerebral hemispheres,
most often for removal of traumatic scars or tumours. The work
of Frederic Gibbs and William Lennox from 1936 promoted elec-
troencephalography (EEG) into a strategic position for diagnosis
and early classification of the epilepsies. Herbert Jasper, working
with Wilder Penfield, used EEG to develop new approaches for
surgery for epilepsy, particularly in the temporal lobe and mesial
temporal structures. A major obstacle to removal of these struc-
tures was lack of knowledge about their function (Feindel 2009).
Penfield considered EEG and emerging techniques for electro-
corticography (ECoG) useful if they could disclose pathological
areas in the brain. If a visible lesion was not found at the place
indicated by the recording of epileptic activity, Penfield usually
would decline to perform a resection. A success rate of just over
50% indicated that resection limited to the anterolateral temporal
cortex did not eliminate all epileptogenic tissue in many people.
Researchers then provided greater focus on mesial temporal struc-
tures. Jasper noted that a cure could be effected even when no ab-
normality was visible in the excised material, and added, “it seems
clear, therefore, that the pathophysiological state of spike foci may
not always be associated with structural alterations which can be
seen by present methods of microscopic examination” (Feindel
2009). This led to more detailed pathological study of excised ma-
terial - an approach led by Murray Falconer with Alfred Meyer.
More sophisticated EEG study, cortical stimulation, and detailed
descriptions of seizure semiology revealed the importance of the
human claustroamygdaloid complex in short-term memory, con-
sciousness, and emotions. As resection of anteromesial structures
became the accepted treatment for temporal lobe epilepsy, the
hippocampus was elucidated as important for short-term recent
memory function. This observation led to the inclusion of a neu-
ropsychologist in most surgery selection teams. Temporary and
partial suppression of one cerebral hemisphere by injection of in-
tracarotid sodium amytal, a technique introduced by Wada, be-
came a useful test for determining the laterality of speech function
and for evaluating memory responses in people with bitemporal
seizure activity. Functional magnetic resonance imaging (fMRI),
along with neuropsychometry, is now superseding this initial ap-
proach.
Other sophisticated technological developments followed: the ad-
vent of computerised tomography in the 1970s; magnetic reso-
nance imaging (MRI) in the 1990s; computerised analysis of ictal
and inter-ictal EEG activity; fMRI with psychometric analysis and
ever more sophisticated stereotaxis guiding the placement of deep
electrodes for long-term EEG analysis; and surgical intervention.
These techniques have been complemented by the co-registration
of single-photon emission computed tomography (SPECT) and
positron emission tomography (PET) findings (Feindel 2009),
and, most recently, by improved co-registration and simultane-
ous review of both structural and functional data from PET/MRI
(Shin 2015). These developments are now leading to more precise
localisation of epileptogenic foci and a reduction in the risk of re-
moving eloquent cortex. This approach has led to greater oppor-
tunity for accurate assessment for a surgical cure for any person
with drug-resistant focal epilepsy.However, sophisticated technol-
ogy has a place only in the setting of a good interdisciplinary team
working in harmony and incorporating the skills of a neurolo-
gist, a neurophysiologist, a psychiatrist, a neuropsychologist, and
a neurosurgeon with postoperative help from remedial therapists
who have good scope for liaison with educational, vocational, and
social services for good postoperative rehabilitation.
Success rates for resective epilepsy surgery are estimated to have
increased from 43% to 85% during the period from 1986 to
1999 (Engel 1993a; Engel 2003; National 1990a). Data from
multiple sources suggest that 55% to 70% of individuals un-
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dergoing temporal resection and 30% to 50% of those under-
going extratemporal resection become completely seizure-free. A
prospective randomised controlled trial of surgery for tempo-
ral lobe epilepsy showed that 58% of individuals randomised to
surgery were seizure-free compared to 8% of those in the medical
group (Wiebe 2001). Surgery is considered a valuable option for
medically intractable epilepsy, even in the absence of proven drug
resistance (Engel 1993b).
How the intervention might work
The rationale for the intervention is initial localisation of the
epileptogenic focus followed by its surgical resection. The main-
stay for investigation is MRI. Concordance between an MRI scan
and EEG findings along with seizure semiology is sought. Key is
accurate localisation of the epileptogenic focus to an area of the
brain that might safely be removed without inducing neurological
impairment. If the lesion is not well defined, further imaging via
PET, SPECT, or PET/MRI may supplement accurate placement
of indwelling EEG electrodes to achieve this aim (see Description
of the intervention).When the epileptogenic focus can be removed
safely, epilepsy may be cured with a corresponding improvement
in quality of life.
Why it is important to do this review
Surgical outcomes may be greatly influenced by the presence of
selected prognostic indicators (Berg 1998; Tonini 1997). How-
ever, uncertainties remain about which patients are most likely to
achieve good surgical outcomes. Good surgical outcomes appear
to be associatedwith various factors (i.e. hippocampal sclerosis, an-
terior temporal localisation of interictal epileptiform activity, ab-
sence of pre-operative generalised seizures, and absence of seizures
in the first postoperative week) (McIntosh 2001). However, pub-
lished trial results are frequently confusing and contradictory, thus
preventing inferences for clinical practice. The initial version of
this Cochrane review (West 2015) was the first to investigate the
association between specific prognostic factors and surgical out-
comes. It complemented and updated the only systematic review
to date to examine factors predictive of the outcome of epilepsy
surgery (Tonini 2004). This review informs the surgical selection
process and allows refinement of the risk/benefit analysis for sur-
gical intervention.
O B J E C T I V E S
The primary objective is to assess the overall outcome of epilepsy
surgery according to evidence from randomised controlled trials.
Secondary objectives are to assess the overall outcome of epilepsy
surgery according to non-randomised evidence, and to identify the
factors that correlate with remission of seizures postoperatively.
M E T H O D S
Criteria for considering studies for this review
Types of studies
In the original review (West 2015), we included studies if they
satisfied the following criteria.
• Randomised controlled trial (RCT), cohort study, or case
series, prospective and/or retrospective.
• A sample size of at least 30 participants undergoing surgery.
• A well-defined population (age, sex, seizure type and
frequency, duration of epilepsy, aetiology, MRI diagnosis,
surgical findings).
• MRI performed in at least 90% of cases.
• Expected duration of follow-up of at least one year.
• A reported outcome related to postoperative seizure control.
We excluded reports if they were provided in abstract form or in
book chapters, or if they did not present sufficiently clear details
about their methods; if they were written in languages other than
English, Italian, French, German, or Spanish (due to the availabil-
ity of translators for detailed data extraction); or if they did not
meet all of the above inclusion criteria. We also excluded repeated
publications from the same institution (among which we retained
only the most recent for review) unless they dealt with different
prognostic factors.
For this update, to provide the most clinically relevant and high-
quality updated evidence, we included only new RCTs meeting
the other inclusion criteria. We did not include in this updated
review new studies using a non-randomised design.
Types of participants
We included children, adolescents, and adults who were consid-
ered surgical candidates and had drug-resistant focal seizures and
secondarily generalised seizures of temporal or extratemporal ori-
gin (i.e. seizures that continue despite treatment with anticonvul-
sant medication).
Types of interventions
We included studies that provided surgical treatment for drug-
resistant focal seizures and secondarily generalised seizures of tem-
poral or extratemporal origin. For RCTs, we considered all control
groups for comparison, including those givenmedical treatment or
no treatment and those undergoing different surgical techniques.
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In the original version of this review (West 2015), we considered
non-randomised studies with or without control groups (i.e. case
series) for inclusion.
Types of outcome measures
Primary outcomes
Seizure outcome (proportion achieving a good outcome from
surgery)
The outcome of seizures after epilepsy surgery is classified ac-
cording to Engel’s four categories with subcategories (Engel 1987;
Engel 1993b), or it is reported as such when different definitions
are used (see the Table below).
Engel class Description (subclasses)
Class 1: free of disabling seizures 1A: completely seizure-free since surgery
1B: non-disabling simple focal seizures only since surgery
1C: some disabling seizures after surgery, but free of disabling seizures for at
least 2 years
1D: generalised convulsion with antiepileptic drug withdrawal only Class 2
(rare disabling seizures; ’almost seizure-free’)
Class 2: almost seizure-free (rare disabling seizures) 2A: initially free of disabling seizures, but rare seizures now
2B: rare disabling seizures since surgery
2C: more than rare disabling seizures after surgery, but rare seizures for at least
2 years
2D: nocturnal seizures only
Class 3: worthwhile improvement 3A: worthwhile seizure reduction
3B: prolonged seizure-free intervals amounting to greater than half the follow-
up period, but not less than 2 years
Class 4: no worthwhile improvement 4A: no significant seizure reduction
4B: no appreciable change
4C: seizures worse
Sources: Engel 1987; Engel 1993b.
We considered:
• ’good outcome’ as seizure control or seizure-free status for
at least one year, or Engel Class 1 (when individual study data
quality did not allow further refinement);
• ’improved outcome’ as near complete control or moderate
improvement, or Engel Classes 2 and 3; and
• ’worse outcome’ as slightly reduced or unchanged or
worsened seizure frequency, or Engel Class 4.
We also considered, when data for these time points were available,
results at 12 and 24 months. Reporting of this primary outcome
using the outcome scales described above was not an eligibility
requirement for inclusion in this review. However, we excluded
studies that did not report an outcome related to seizure control
following surgery. We considered other outcome scales that sat-
isfied our above definitions. We divided studies into subgroups
based on seizure outcomes defined by the Engel Class Scale, more
than one year seizure-free, or another scale (see Subgroup analysis
and investigation of heterogeneity).
For the purposes of this review, we compared a ’good outcome’
(seizure remission as defined above) versus a ’poor outcome’, with a
poor outcome defined as improved and worse outcome categories
as combined above (i.e. Engel Classes 2 to 4, or not seizure-free
for at least one year). We did not consider other combinations
of outcome scales. For trials that reported other combinations of
outcome scales, and for studies that used a scale that did not clearly
satisfy our definitions, when possible we contacted the trial authors
to request further information about seizure outcome data. When
further information could not be provided, we excluded studies
from analysis in the review (see Data synthesis), but we retained
them in the narrative section of the review.
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Secondary outcomes
Seizure outcome according to prognostic factors of interest
We considered the proportion of individuals with a good outcome
from surgery (see Primary outcomes) according to the following
prognostic factors, which we considered to be of clinical relevance.
Pre-operative factors
• Results of pre-operative MRI: normal (i.e. no abnormality
visible on MRI) or abnormal (i.e. abnormality visible on MRI).
We included studies in which study authors referred to MRI re-
sults only as ’abnormal’, as well as studies that reported specific
abnormalities.
• Use of pre-operative intracranial (invasive) monitoring: yes
or no.
• Mesial temporal sclerosis (MTS) on MRI or pathology:
present or absent.
• Concordance of pre-operative MRI and EEG: yes or no.
Concordance relates to whether EEG discharges arise from the
area of the brain identified as abnormal on MRI scan (i.e. the
surgically targeted area).
• History of febrile seizures: yes or no.
• History of head injury: yes or no.
• Encephalomalacia on pathology: present or absent.
• Focal cortical dysplasia/malformation of cortical
development on pathology: present or absent.
• Tumour on pathology: present or absent.
We included studies that referred to pathological results of ’tu-
mour’ and studies that reported specific tumour types.
• Vascular malformation on pathology: present or absent.
We included studies that referred to pathological results of ’vascular
malformation’ and studies that reported specific types of vascular
malformations.
• Distribution of interictal spikes: unilateral or bilateral.
We were interested in determining whether interictal spikes
(epileptiformEEGdischarges noted between seizures) were related
to the area to be excised at surgery, or whether they were more
widespread. Terms also used in the included studies are ’lateralis-
ing versus non-lateralising spikes’ (i.e. discharges on the side to be
operated or on both sides of the brain) and ’focal versus non-focal
spikes’ or ’localising versus non-localising spikes’ (i.e. discharges
seen only related to the surgical site or seen to bemore widespread).
Operative factors
• Extent of surgical resection: complete or incomplete.
We anticipated that the definition of a ’complete’ or ’less com-
plete’ resection would be variable across studies. Most researchers
based this definition on the type of surgery performed (e.g. an-
terior temporal lobectomy or extended resection is complete re-
section, selective amygdalohippocampectomy or lesionectomy is
less complete resection). When study authors provided other clear
descriptions, we included those studies (e.g. postoperative MRI
appearance; intraoperative subdural EEG findings; intraoperative
surgical description; dimensions of resected areas).
• Side of surgical resection: left-sided or right-sided resection.
Postoperative factors
• Postoperative discharges: presence or absence of EEG
epileptiform discharges in the postoperative period.
We dichotomised all factors for analysis according to the defini-
tions presented above.We included data reported according to our
definitions above, as well as data reported in a way that allowed
us to categorise using the above definitions (e.g. if specific MRI
results were reported for all individuals, we categorised them into
’normal’ and ’abnormal’, or ’concordant’ and ’discordant’ with
EEG results). We considered other definitions reported in the in-
cluded studies if equivalent (or approximately equivalent) to our
pre-specified definitions.
Search methods for identification of studies
Review authors carried out a MEDLINE (OVID) search for
Tonini 2004, to identify relevant studies published between 1984
and 2001 (noting that 1984 coincides with the introduction of
MRI). We used the results provided in that review and carried out
searches to cover the time from 2001 onwards.
Electronic searches
We ran searches for the original review on 4 July 2013, and we ran
subsequent searches on 14 December 2017. For the latest update,
we searched the following databases on 11 March 2019.
1. Cochrane Register of Studies (CRS Web), which includes
the Cochrane Epilepsy Group Specialized Register and the
Cochrane Central Register of Controlled Trials (CENTRAL),
using the search strategy outlined in Appendix 1
2. MEDLINE (Ovid, 1946 to March 08, 2019), using the
search strategy outlined in Appendix 2
3. ClinicalTrials.gov, using the search strategy outlined in
Appendix 3
4. World Health Organization (WHO) International Clinical
Trials Registry Platform (ICTRP), using the search strategy
outlined in Appendix 4.
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We imposed language restrictions due to the availability of trans-
lators for extensive data extraction (English, Italian, French, Ger-
man, or Spanish). For the latest update, we searched only for ran-
domised controlled studies, whereas for the original review, we
searched for non-randomised studies as well (West 2015). No
Cochrane approved or recommended search filter is available for
non-randomised studies, so for the MEDLINE search, the In-
formation Specialist for the Cochrane Epilepsy Group chose the
terms to be used for required types of non-randomised studies. We
did not subject the resulting search filter to any systematic testing
before use.
Searching other resources
We also examined the reference lists of included studies for further
relevant studies for inclusion in this review.
Data collection and analysis
Selection of studies
Two review authors (SW and RN) independently assessed trials
for inclusion. We resolved disagreements through mutual discus-
sion and sought the opinion of a third review author (SN) when
necessary.
Data extraction and management
We implemented a database search for identification and inclusion
of relevant articles (i.e. those that fulfil the inclusion criteria and
provide complete information about the outcome of epilepsy and
prognostic factors).
SW,RN, JC, AS, and SG collected the data using a semi-structured
form via a Microsoft Access database (created by SN) for each
study. RR joined RN to extract data from the Spanish papers.
We considered the following variables.
• Methods of assessment of eligible studies.
• Demographic and clinical characteristics (number of
patients selected for surgery, age (with special attention to
patients younger and older than 12 years), sex, disease duration,
history of febrile seizures or relevant central nervous system
(CNS) disorder).
• MRI pre-operative diagnosis (MTS, tumours, other CNS
abnormalities, normal).
• Surgical findings (age at surgery, side of resection, surgical
procedure (temporal or extratemporal), extent of resection).
• Histopathological diagnosis (same categories as MRI);
duration of follow-up; post-surgery findings (dropouts, adverse
events).
• Prognostic indicators: different indicators are described as
factors affecting the outcome of epilepsy surgery in terms of
seizure remission (specifically, focal cortical dysplasia/
malformation of cortical developments, febrile seizures, tumours,
vascular disorders, CNS infections, MTS, abnormal MRI, EEG/
MRI concordance, interictal spikes, intracranial monitoring,
extent of resection, postoperative discharges, other factors
studied). Mesial temporal sclerosis and tumours require
pathological confirmation. We also recorded details of statistical
analysis of prognostic indicators and multi-variable prognostic
models (if reported).
We limited this review to prognostic factors that are clinically
relevant (detailed in Secondary outcomes) and/or were reported
by at least two studies.
Consensus is required for each variable reported on the data col-
lection form; any disagreement led to a discussion of the issue by
the two review authors and resolution of persisting disagreement
by an independent third review author. In selected cases, an inde-
pendent evaluator (SN) resolved conflicting data.
Assessment of risk of bias in included studies
Two review authors (SW and RN) assessed risk of bias, and two
review authors (SN and JW) independently checked these judge-
ments.
For RCT evidence, we assessed all domains of the current
Cochrane ’Risk of bias’ tool (Higgins 2011).
For the original review (West 2015), for non-randomised evi-
dence, we employed the Effective Public Health Practice Project
(EPHPP) tool, which is appropriate for case series study designs
(see Appendix 5). In a post hoc review of a multi-variable prog-
nostic model, SN assessed risk of bias according to the Quality in
Prognosis Studies (QUIPS) tool (Hayden 2006).
We planned to incorporate ’Risk of bias’ assessments into the anal-
ysis if deemed appropriate, using sensitivity analysis, because a
secondary analysis of the data would include only studies rated
as low in quality, with results presented in the Results section of
the review. However, upon using the EPHPP tool, we found this
tool to be inadequate to judge the relative quality of the included
studies, so we concluded that incorporation of quality assessment
into the analysis would be inappropriate (see Sensitivity analysis
and Risk of bias in included studies for further details).
Measures of treatment effect
We measured the outcome of seizures after epilepsy surgery as
good compared to poor overall, and according to the presence or
absence of prognostic factors of interest in univariate analysis (see
Types of outcome measures and Data synthesis). We analysed all
outcomes as dichotomous outcomes summarised with risk ratios
(RRs) and 95% confidence intervals (95% CIs). We considered
multi-variable prognostic models narratively, as reported in the
original study publications.
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Unit of analysis issues
We did not encounter any unit of analysis issues. The unit of in-
tervention and analysis was the individual for all included studies,
and no studies were of a repeated measures (longitudinal) nature
or used a cross-over design.
Dealing with missing data
We attempted to seek missing statistics from studies through con-
tact with the study authors. In cases of missing data, we attempted
to clarify the reasons for missing data to determine whether data
were missing at random. We analysed all data according to the
intention-to-treat principle.
Assessment of heterogeneity
We assessed the existence of clinical heterogeneity by examining
differences in study characteristics and in participant demographic
factors, to inform decisions regarding the combination of study
data. We assessed statistical heterogeneity by visually inspecting
forest plots and using a Chi² test for heterogeneity (with a P value
of 0.10 for significance) and the I² statistic as a measure of incon-
sistency across studies, with an I² value of 50% to 75% or higher
representing substantial heterogeneity (Higgins 2011). When we
found considerable statistical heterogeneity according to the I²
statistic value (> 50%), we performed meta-analysis using a ran-
dom-effects rather than a fixed-effect model, in addition to sub-
group and sensitivity analyses, to investigate differences in study
characteristics and participant factors.
Assessment of reporting biases
To enable comparison of outcomes of interest, wewould require all
protocols from study authors. However, due to the large number
of included studies in this review, obtaining all protocols was im-
practical and impossible, so we made a judgement on the existence
of reporting bias. If we suspected reporting bias, we investigated
further using the ORBIT classification system (Kirkham 2010).
We examined publication bias by identifying unpublished data
by carrying out a comprehensive search of multiple sources and
requesting unpublished data from study authors. We looked for
small-study effects to establish the likelihood of publication bias,
and we examined asymmetry of funnel plots.
Data synthesis
For each prognostic factor of interest individually (see point six
of Data extraction and management), we performed a univariate
aggregate data fixed-effect meta-analysis using the Mantel-Haen-
szel method to assess the presence or absence of that factor as an
independent predictor of the outcome of surgery (good or poor
outcome), analysed as a dichotomous outcome and presented as a
pooled risk ratio with 95% confidence interval.
For post hoc analysis in the original review (West 2015), we also
investigated whether effects of other prognostic factors on any in-
dividual prognostic factor had been adjusted for (e.g. inmulti-vari-
able regression models). In this case, we hoped to perform separate
meta-analyses of adjusted and unadjusted estimates and to com-
pare results. However, adjusted data presented were insufficient to
allow us to perform meta-analysis of adjusted results from multi-
variable prognostic models; therefore we summarised all multi-
variable models narratively and provided narrative comparisons of
multi-variable adjustments to univariate analyses.
Whenwe found considerable statistical heterogeneity to be present
(Chi² test for heterogeneity P < 0.1 and/or I² > 50%), we used
a random-effects meta-analysis and performed subgroup and sen-
sitivity analyses to investigate differences in study characteristics
and participant factors.
Subgroup analysis and investigation of heterogeneity
When we noted a substantial amount of heterogeneity across uni-
variate prognostic factors, we performed further analyses such as
stratification, subgroup analyses, and sensitivity analyses to exam-
ine differences in study characteristics (such as outcome and prog-
nostic factor definition, study design, and study quality) and par-
ticipant demographic factors.
Researchers measured good and poor outcomes using varying def-
initions across studies (e.g. a good outcome can be defined as
seizure-free status for at least one year, Engel Class 1, or other
equivalent definitions). We defined these scales as Engel Class
Scale, more than one year seizure-free scale, and some ’other’ scale
(see Primary outcomes for further details). We planned to exam-
ine the effect of variation in outcome definitions by performing
subgroup analysis.
Due to differences in surgical technique and/or associated pathol-
ogy with location of surgery (temporal or extratemporal lobe),
when applicable we also performed stratified analyses, grouping
studies into the following categories: all participants in the study
had temporal lobe surgery (temporal lobe); all participants in the
study had extratemporal lobe surgery (extratemporal lobe); or the
study included a combination of participants with temporal lobe
and extratemporal lobe surgery (combination).
Sensitivity analysis
We intended to perform sensitivity or subgroup analyses to exam-
ine the effect of study quality based on ’Risk of bias’ and quality
assessment tools. However, due to inadequacy of the quality as-
sessment tool used in the original review in separating studies of
generally poor methodological design (majority retrospective case
series) (West 2015), we decided that sensitivity or subgroup analy-
sis according to ’quality assessment’ would not be informative and
would not be appropriate (see Risk of bias in included studies for
more information).
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Instead, as described under Subgroup analysis and investigation of
heterogeneity, we considered differences in study characteristics
and participant demographic factors as sources of heterogeneity in
analyses. Further, in the case of a study reporting an extreme result
(a particularly large effect in favour of the presence of absence
of a prognostic factor), we double-checked extracted data on this
factor from the study publication and investigated study-related
or participant-related characteristics that could have contributed
to the large effect.
’Summary of findings’ and certainty of the evidence
We presented the primary outcome (seizure outcome) for studies
with a randomised controlled design in ’Summary of findings’ ta-
bles (Summary of findings for the main comparison; Summary of
findings 2), and we judged the certainty of the evidence contribut-
ing to these outcomes according to GRADE (Grading of Rec-
ommendations Assessment, Development and Evaluation) crite-
ria (Guyatt 2008; Hultcrantz 2017).
R E S U L T S
Description of studies
Results of the search
AMEDLINE search conducted over the years from 1984 to 2001
identified 1051 records, 619 of which we excluded as ’prognosis of
seizures after surgery was notmeasured’ (in other words, no seizure
outcome data were recorded); 383 met other exclusion criteria of
the review (see Tonini 2004 for further details). The Tonini 2004
review included 47 studies; we screened these studies for inclusion
in our review as ’records found from other sources’.
From searches conducted by the Cochrane Epilepsy Group be-
tween 2001 and 2010, we identified 833 records. From searches
conducted after the initiation of this review in 2010, we identified
575 records. We used the search strategies outlined in Electronic
searches to conduct database searches from 2001. We removed 96
duplicate records from those identified between 2010 and 2013
and screened 1395 records (title and abstract) for inclusion in the
review. We excluded 1089 records based on title and abstract and
assessed 270 full-text articles for inclusion in the review. We ex-
cluded 93 studies from the review (see Excluded studies below)
and included 177 studies from the original review (West 2015).
See Figure 1 for the PRISMA study flow diagram for the original
version of this review, including RCTs and non-randomised stud-
ies.
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Figure 1. Study flow diagram (original review: randomised controlled trials (RCTs) and non-randomised
studies (NRSs) included).
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For this latest update, only RCTs were eligible for inclusion (see
Types of studies). We identified 410 records from the databases
and search strategies outlined in Electronic searches. We removed
70 duplicate records and screened 340 records (title and abstract)
for inclusion in the review. We excluded 325 records that were
clearly irrelevant and screened the full-text articles of 15 records.
We included five studies (reported in seven full-text articles) and
excluded eight full-text articles that did not report a seizure out-
come, recruited less than 30 surgical participants or did not ran-
domise surgical interventions.
See Figure 2 for the PRISMA study flow diagram for inclusion of
RCTs from the original version and this updated version of the
review.
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Figure 2. Study flow diagram (2019 update: randomised controlled trials (RCTs) only included).
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Therefore in total, we included 182 studies within this updated
review: 173 non-randomised studies from the original version of
the review (West 2015), and nine RCTs (four RCTs from the
original review and five new RCTs in this update).
Included studies
We included 182 studies in this review (Aaberg 2012; Adam 1996;
Adelson 1992; Alfstad 2011;Alonso-Vanegas 2018; Althausen
2013; Arruda 1996; Awad 1991; Babini 2013; Barbaro 2018;
Battaglia 2006; Baumann 2007; Bautista 2003; Bell 2009; Benifla
2006; Berkovic 1995; Blount 2004; Blume2004; Boesebeck 2007;
Boshuisen 2010; Brainer-Lima 1996; Britton 1994; Caraballo
2011; Cascino 1995; Chabardes 2005; Chang 2009; Chee 1993;
Chkhenkeli 2007; Choi 2004a; Chung 2005; Cossu 2005; Cossu
2008; Costello 2009; Cukiert 2002; Dagar 2011; Dalmagro
2005; Delbeke 1996; Dellabadia 2002; de Tisi 2011; Devlin
2003; Ding 2016; Donadio 2011; Dorward 2011; Duchowny
1998; Dunkley 2011; Dunlea 2010; Dwivedi 2017; Elsharkawy
2008a; Elsharkawy 2009a; Elsharkawy 2011a; Engman 2004;
Erba 1992; Erickson 2005; Fauser 2004; Fujiwara 2012; Garcia
1991; Garcia 1994; Gelinas 2011; Georgakoulias 2008; Gilliam
1997a; Gilliam 1997b; Goldstein 1996; Greiner 2011; Grivas
2006; Gyimesi 2007; Hader 2004; Hajek 2009; Hallbook 2010;
Hamiwka 2005; Hartley 2002; Hartzfield 2008; Hemb 2010;
Holmes 1997; Holmes 2000; Jack 1992; Janszky 2003a; Janszky
2003b; Jaramillo-Betancur 2009; Jayakar 2008; Jayalakshmi2011;
Jeha 2006; Jehi 2012; Jennum 1993; Jeong 1999; Kan 2008;
Kang 2009; Kanner 2009; Kilpatrick 1997; Kim 2009; Kim
2010a; Kim 2010b; Kloss 2002; Knowlton 2008; Kral 2007;
Krsek 2013; Kuzniecky 1993; Kwan 2010; Lackmayer 2013;
Lee 2006; Lee 2008; Lee 2010a; Lee 2011; Lei 2008; Li 1997;
Li 1999; Liang 2010; Liang 2012; Liava 2012; Lopez-Gonzalez
2012; Lorenzo 1995; Madhavan 2007; Mani 2006; Mathern
1999; McIntosh 2012; Mihara 2004; Miserocchi 2013; Morino
2009; Morris 1998; O’Brien 1996; O’Brien 2000; Oertel 2005;
Paglioli 2006; Paolicchi 2000; Park 2002; Park 2006; Perego
2009; Perry 2010; Phi 2009; Phi 2010; Pinheiro-Martins 2012;
Prevedello2000;Raabe 2012;Radhakrishnan 1998;Rausch 2003;
Remi 2011; Roberti 2007; Rossi 1994; Russo 2003; Sagher
2012; Sakamoto 2009; Salanova 1994; Sarkis 2012; Schramm
2011; Seymour 2012; Sinclair 2003; Sindou 2006; Sola 2005;
Spencer 2005; Sperling 1992; Stavrou 2008; Suppiah 2009; Swartz
1992; Tanriverdi 2010; Tatum 2008; Terra-Bustamante 2005a;
Terra-Bustamante 2005b; Tezer 2008; Theodore 2012; Tigaran
2003; Tripathi 2008; Trottier 2008; Urbach 2007; Ure 2009;
Velasco 2011; Vogt 2018; Walz 2003; Weinand 1992; Wellmer
2012; Widdess-Walsh 2007; Wiebe 2001; Wieshmann 2008;
Wray 2012; Wyler 1995; Wyllie 1998; Yang 2011; Yeon 2009;
Yu 2009; Yu 2012a; Yu 2012b; Zangaladze 2008; Zentner 1995;
Zentner 1996).
We included nine studies of a randomised controlled design.
Six studies randomised the type of surgical intervention: ante-
rior temporal lobectomy (ATL) compared to selective amygdalo-
hipppocampectomy (SAH) compared to parahippocampectomy
(PHC) (Alonso-Vanegas 2018); stereotactic radiosurgery (SRS) or
ATL (Barbaro 2018), resective surgery or combined resection and
corpus callosotomy (CCT) (Ding 2016), ATLwith or without an-
terior CCT (Liang 2010), subtemporal of transsylvian SAH (Vogt
2018); partial versus total hippocampectomy (Wyler 1995) and
one study randomised length of surgical resection; 2.5-cm or 3.5-
cm tailored temporal lobe resection (Schramm2011). Two studies
(n = 196) randomised adults over the age of 16 and children and
adolescents under the age of 18, respectively, to immediate surgery
in Wiebe 2001 or to medical treatment (antiepileptic drugs) with
placement on a waiting list for surgery in Dwivedi 2017.
All other 173 studies were of a non-randomised design and did
not include a control group in the study design.
See Characteristics of included studies and Table 1 for detailed
study characteristics and participant demographics in all 182 in-
cluded studies. Below we provide a summary.
A total of 16,756 participants in the 182 studies underwent a sur-
gical procedure for intractable epileptic seizures, and 99 partici-
pants from two RCTs received medical treatment. Therefore in
total 16,855 participants were included in the review.
In terms of the participants undergoing a surgical procedure, study
authors reported gender for 13,608 participants from 154 studies
(7714male (57%) and 5894 female (43%)), and dataweremissing
for 3148 participants from 28 studies (19% of total participants).
A measure of the age of participants at surgery (see Table 1) was
available for 157 studies (86% of total studies), ranging from 0
years to 86 years at surgery. Age at surgery was not available for
2707 participants from 25 studies (14% of total studies). Given
that adults are classified as over the age of 18 years, 31 studies
included adults only (17% of total studies; 2433 participants), 23
studies included children only (13% of total studies; 1247 partic-
ipants), and 103 studies included both adults and children (56%
of total studies; 10,374 participants). A measure of the duration
of epilepsy among participants (see Table 1) was available for 113
studies (62% of total studies; 10,553 participants), ranging from 0
years to 86 years. Duration of epilepsy was not available for 6203
participants from 69 studies (38% of total studies).
The type of surgical resection performed was available for 173
studies (95% of total studies). Researchers in 94 studies reported
a single-lobe surgery; 8090 participants from 79 studies (43% of
total studies) underwent temporal lobe resection only; 1058 from
15 studies (8% of total studies) underwent extratemporal lobe
resection only; and 79 studies (44% of total studies) including
6761 participants reported both temporal and extratemporal lobe
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resection.
A total of 144 studies identified 13,557 participants via a retro-
spective design (79% of 177 studies); 26 studies identified 2120
participants via a prospective design (14% of studies); three stud-
ies identified 342 participants via a combination of prospective
and retrospective designs (2% of studies); and nine studies did not
state the method of identification of the 670 participants and it
could not be deduced (5% of studies).
Follow-up in the 182 studies ranged from 0 to 366 months. We
specified in our inclusion criteria (see Criteria for considering
studies for this review) that studies must have an ’Expected dura-
tion of follow-up of at least one year’ for inclusion; therefore we
excluded studies that did not specify the duration of follow-up at
all, studies that reported the duration of follow-up as definitely
less than one year, and studies that provided unclear information
on howmany participants were followed up for at least one year. A
number of studies included participants with less than 12 months’
follow-up but did not include these participants in postoperative
seizure outcomes or made it possible for us to separate data for
participants followed up for less than or longer than 12 months.
We considered these studies to have an expected follow-up longer
than one year. Similarly, we considered studies that reported a
mean or median follow-up time greater than 12 months but no
expected minimum follow-up of at least 12 months. At least two
review authors closely examined follow-up information from all
studies before deciding whether to include or exclude the study.
We defined three types of outcome scales appropriate for the pri-
mary seizure outcome (see Primary outcomes). Forty-two stud-
ies reported seizure outcome according to a ’more than one year
seizure-free scale’ (23% of total studies; 3981 participants), 119
studies reported seizure outcome according to the ’Engel Class
Scale’ (65% of total studies; 10,705 participants), and 21 studies
reported seizure outcome according to some ’other scale’ (12% of
total studies; 2070 participants). Other scales we deemed to meet
our definition of a ’good outcome’ were as follows.
• Seven studies reported more than two years of seizure
freedom (Engman 2004; Goldstein 1996; Gyimesi 2007;
Holmes 2000; Jeong 1999; Lee 2006; Mathern 1999), one
reported more than three years of seizure freedom (Rossi 1994),
and one reported more than five years of seizure freedom
(McIntosh 2012).
• Seven studies reported seizure outcome according to the
classification proposed by the International League Against
Epilepsy (ILAE 2001) as follows.
◦ Class 1, completely seizure-free; Class 2, aura alone
with no seizure; Class 3, one to three seizure days/year; Class 4,
50% reduction in baseline number of seizure days; Class 5, less
than 50% reduction in baseline number of seizure days; and
Class 6, more than 100% increase in baseline number of seizure
days.
⋄ We considered ILAE Class 1 to correspond to
Engel Class 1A, and ILAE Classes 1 and 2 together to
correspond to Engel Class 1 (see Primary outcomes); therefore if
a study reported a ’good outcome’ to be ILAE Class 1 (poor
outcome classes 2 to 6) or ILAE Classes 1 and 2 (poor outcome
classes 3 to 6), we accepted this as a satisfactory ’other’ scale. Five
studies defined ILAE Class 1 as a good outcome (de Tisi 2011;
Dwivedi 2017; Kral 2007; Lackmayer 2013; Vogt 2018), and
two defined ILAE Classes 1 and 2 as a good outcome (Sakamoto
2009; Yang 2011). We did not accept any other combinations of
ILAE classes as an outcome that measured seizure freedom.
• Four studies reported seizure freedom by the Engel Class
Scale but not as our definition above, where a good outcome
corresponds to Engel Class 1 and a poor outcome corresponds to
Engel Classes 2 to 4 (see Primary outcomes); two studies defined
a good outcome as Engel Class 1A and a poor outcome as Engel
Classes 1B to 4 (Boshuisen 2010; Phi 2010), one study defined a
good outcome as Engel Class 1A to B and a poor outcome as
Engel Classes 1C to 4 (Boesebeck 2007) and one study defined a
good outcome (seizure remission) as at least Engel Class IB
between 25 and 36 months of follow-up (Barbaro 2018). As the
definitions in these studies did not match our definition of the
Engel Class Scale, but these definitions do measure seizure
freedom, we deemed these three studies to report a satisfactory
’other’ scale.
Four of the 182 included studies (255 participants) did not report
an outcome scale that we deemed satisfactory formeasuring seizure
freedom; three studies defined a good outcome as Engel Classes 1
and 2 and a poor outcome as Engel Classes 3 and 4 (Krsek 2013;
Kwan 2010; Ure 2009), and one study defined a good ’other’
outcome as ’seizure free or rare seizures’ and a poor outcome as
’less than 80% reduction in seizures’ (Kuzniecky 1993). We did
not include these four studies in the meta-analysis (see Effects of
interventions).
Excluded studies
We excluded a total of 101 studies from the review. We excluded
30 studies with insufficient follow-up (in other words, follow-up
was not defined, follow-up was less than a year, or an unknown
proportion of participants were followed up for less than a year)
(Acar 2008; Alpherts 2008; Binder 2009; Busch 2011; Chang
2007;Choi 2004b;Cohen-Gadol 2003;Colonnelli 2012;Coutin-
Churchman 2012; D’Angelo 2006; da Costa-Neves 2012; Dulay
2006; Dulay 2009; Ferrari-Marinho 2012; Ferroli 2006; Freitag
2005; Ghacibeh 2009;Harvey 2008;Hellwig 2012;Helmstaedter
2004; Hu 2012; Junna 2013; Limbrick 2009; Ogiwara 2010;
Roth 2011; Smyth 2007; Stefan 2004; Vachrajani 2012; Vadera
2012; Zupanc 2010). We excluded 23 studies with fewer than 30
participants (Bauer 2007; Bindu 2018; Bourgeois 2007; Caicoya
2007; Cukiert 2009;Danielsson 2009;Datta 2009; Engel Jr 2012;
Haegelen 2013; Lee 2010; Lodenkemper 2007; Mikati 2004;
Moien-Afshari 2009; Negishi 2011; Nikase 2007; Placantonakis
2010; Rocamora 2009; Sakuta 2005; Soeder 2009; Teutonico
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2008;Upchurch2010;Wetjen2009; Yasuda 2010b).We excluded
24 studies that did not report any seizure outcome data (Alemany-
Rosales 2011; Andersson-Roswall 2010; Baxendale 2005; Bell
2010; Carne 2004; D’Argenzio 2011; Elsharkawy 2009b; Fauser
2008; Griffin 2007; Hervas-Navidad 2002; Hildebrandt 2005;
Lutz 2004; McClelland 2007; McClelland 2011; Oertel 2004;
Park 2010; Schatlo 2015; Stavem 2005; Stavem 2008; Tong
2015; Vogt 2016; Wang 2016; Wetjen 2006; Yasuda 2010a).
We excluded eight studies in which the inclusion criteria were
based on seizure outcome (i.e. only participants with postopera-
tive seizures or who were seizure-free were included) (Boshuisen
2012; Buckingham 2010; Elsharkawy 2011b; Jehi 2010; Lach
2010; Schwartz 2006; Stefan 2008; Vadlamudi 2004). We ex-
cluded eight duplicate studies and retained the primary reference
in the review (Boesebeck 2002; Cascino 1996; Elsharkawy 2008b;
Helmstaedter 2011; Kuzniecky 1996; Lachhwani 2003; Malla
1998; Weinand 2001). We found no papers from the same in-
stitutions reporting different factors (all reported either the same
factors or factors outside the scope of our review). Characteristics
of excluded studies tables present the relevant details. We excluded
three studies in which fewer than 90% of participants had anMRI
(Mohammed 2012; Wieser 2003a; Wieser 2003b), we excluded
three studies which did not randomise surgical interventions
(CTRI/2018/07/015007; NCT03643016; NCT03790280) and
we excluded two studies that were not studies of surgery for
epilepsy (one was a study of surgery for tumours (Grunert 2003),
and the other was a study of the outcome of taking antiepileptic
drugs after epilepsy surgery (Asadi-Pooya 2008)).
Risk of bias in included studies
As most of the studies in this review were not of a randomised de-
sign, we believe it would not be appropriate to judge the quality of
each study on criteria of selection bias, performance and detection
bias, attrition bias, and reporting bias. Instead, we employed the
Effective Public Health Practice Project (EPHPP) tool, which is
appropriate for the study designs included in this review (mostly
retrospective case series). See Appendix 5 for the full tool, Table 2
for quality assessments for each study for each criterion of the tool
(A to F) and an overall grading of quality for each study, and Table
3 for a summary of all components of the tool (A to G). We also
note that the EPHPP tool is a tool for quality assessment rather
than risk of bias, so we refer to ’quality assessment of included
studies’ throughout this section.
A. Selection bias
We judged that 129 of 182 studies (71%) recruited a sample of
individuals that was ’very likely’ to be representative of the target
population. We made this judgement if the participants recruited
were ’consecutive’, or if all eligible participants undergoing surgery
over a specific period of time were included. We also checked how
reasonable inclusion criteria, exclusion criteria, and participant
demographics in the study were for recruiting a sample very likely
to be representative of the target population.
We judged that the remaining 53 studies (29%) recruited sam-
ples of individuals that were ’somewhat likely’ to be representative
of the target population. We made this judgement if participants
were not consecutive, or if apparently eligible participants had
been excluded. We also made this judgement if we were uncer-
tain about where participants had been recruited from, if we were
uncertain regarding inclusion or exclusion criteria, if we judged
that inclusion and exclusion criteria were too specific or restrictive
to recruit a sample representative of the target population (e.g. all
participants had a very specific pathology for inclusion), or if we
judged that the demographics of recruited participants were not
representative of the target population.
We judged that if the sample recruitedwas based in anyway onout-
come (e.g. included only individuals with recurrence of seizures),
then the study had recruited a sample of individuals ’not likely’
to be representative of the target population. Such a study design
met the exclusion criteria for this review (see Excluded studies).
Therefore we judged all included studies in the review to have a
sample of individuals ’very likely’ or ’somewhat likely’ to be rep-
resentative of the target population.
For the 144 studies of a retrospective design, we were unable to
judge the percentage of participants who agreed to take part in the
study. Nine studies of a prospective design reported the percentage
of eligible participants who agreed to take part in the study as 80%
to 100% and one study reported that less than 60% of eligible
participants had agreed to take part. For the remaining 28 studies,
we could not tell how many participants agreed to take part in the
study.
Overall we judged that 118 studies (65%) were of ’strong’ quality
in their selection criteria (i.e. the sample selected was very likely
to be representative of the target population and the study was
of a retrospective design, or 80% to 100% of participants agreed
to take part for studies of a prospective design). We judged the
remaining 64 studies (35%) to be of ’moderate’ quality in their
selection criteria (i.e. the sample selected was somewhat likely to
be representative of the target population or the sample selected
was very likely to be representative of the target population, but
a large number of eligible participants had declined to participate
in the study or we could not tell how many eligible participants
had agreed to participate in the study).
B. Study design
Most of the included studies (144 of 182 studies; 79%) were of the
design of a retrospective review of the clinical notes of a number
of participants meeting specific inclusion criteria at a given centre
over a specified time period (e.g. a clinical audit). We refer to this
design in Table 2, in Table 3, and throughout this review as a
’retrospective case series’ (one group before and after intervention),
and we considered this design to be of ’moderate’ quality as it is not
18Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
specifically referred to in the EPHPP tool.Wemade the judgement
to avoid the design of the study alone dictating the overall quality
rating (i.e. all retrospective designs are weak) to separate out the
144 retrospective studies based on other quality criteria.
We included nine studies of a randomised controlled design - a
design judged by the EPHPP tool to be strong (Alonso-Vanegas
2018; Barbaro 2018; Ding 2016; Dwivedi 2017; Liang 2010;
Schramm 2011; Vogt 2018; Wiebe 2001; Wyler 1995; see
Included studies for additional details).We also used theCochrane
’Risk of bias’ tool for these six studies (Higgins 2011); see Table
4 for more information on the ’Risk of bias’ criteria for these six
studies. We preferred to present quality assessment data in Addi-
tional tables rather than in ’Risk of bias’ tables in Characteristics
of included studies, as the domains considered in these tables are
not appropriate for most of the included studies.
Table 4 shows that only four of the nine RCTs described an ade-
quate method of randomisation; Alonso-Vanegas 2018; Dwivedi
2017; Schramm 2011 and Vogt 2018 randomised participants by
using a computer-generated randomisation list. Researchers de-
scribed three studies as randomised but provided no details about
themethod used to generate the random list (Barbaro 2018;Wiebe
2001; Wyler 1995). Two studies described an inadequate method
of quasi-randomisation (no allocation concealment in quasi-ran-
domised studies); we judged these studies to be at high risk of bias
(Ding 2016; Liang 2010). Three studies did not provide any infor-
mation on concealment of treatment allocation (Alonso-Vanegas
2018; Barbaro 2018; Wyler 1995), and three studies described
adequate methods of allocation concealment: sealed, opaque, and
sequentially numbered envelopes prepared outside the treatment
centre (Dwivedi 2017; Schramm 2011; Vogt 2018; Wiebe 2001).
Three studies did not provide any information on blinding of
participants, personnel, and outcome assessors (Ding 2016; Liang
2010; Vogt 2018); and for two studies that randomised partic-
ipants to surgical or medical treatment, blinding was not possi-
ble by design (Dwivedi 2017; Wiebe 2001). One of these stud-
ies reported that outcome assessors were blinded (Dwivedi 2017),
and for the other study, it is unclear if outcomes were affected
by this design (Wiebe 2001). Two studies reported blinding of
participants and outcome assessors, with only the surgeon re-
maining unblinded to allocation of treatment (Schramm 2011;
Wyler 1995), one study reported that outcome assessors only were
blinded (Barbaro 2018) and one study reported that there was
no blinding (Alonso-Vanegas 2018). Five studies reported that
no losses to follow-up occurred and/or included all randomised
participants in the analysis (Alonso-Vanegas 2018; Barbaro 2018;
Liang 2010; Schramm 2011;Wyler 1995). Three studies reported
complete attrition rates and followed an intention-to-treat ap-
proach (Ding 2016; Dwivedi 2017; Wiebe 2001), so we judged
these studies to be at low risk of attrition bias. One study reported
excluded 13% of randomised participants from analysis who did
not complete neuropsychological assessments at one year (Vogt
2018); this is not an intention-to-treat approach so we judged this
study to be at high risk of attrition bias A protocol available as
an online supplement for one study reported all pre-specified out-
comes (Dwivedi 2017). We did not have access to study protocols
for comparison of outcomes defined a priori for the remaining
eight studies, but all eight studies reported outcomes defined well
in the methods section and consistently in the results section, so
we judged all of the studies to be at low risk of reporting bias. We
detected no other biases in any studies.
Two studies described a randomised design: Oertel 2005 ran-
domised participants to waterjet dissection or ultrasonic aspira-
tor during surgery, and Velasco 2011 randomised participants to
presurgical evaluation with or without SPECT. As neither of these
designs randomised the intervention, for the purposes of this re-
view, we refer to these designs as ’cohort analytic’ (two groups be-
fore and after intervention), and we considered this design to be
of ’strong’ quality according to the EPHPP tool.
We considered the remaining 27 studies (15 of a prospective de-
sign, three of a combination design, and nine with the method of
identification of participants not stated) to be of a ’cohort’ design
(one group before and after intervention), and this design is con-
sidered to be of ’moderate’ quality according to the EPHPP tool.
Therefore, we judged that 11 of 182 studies (6%) used a ’strong’
design, and 171 of 182 (94%) used a ’moderate’ design.
C. Confounders
Given that the aim of our review was to identify prognostic fac-
tors associated with the outcome of surgery (essentially factors that
confound the results of surgery), it was difficult to make a judge-
ment on the presence of confounders. Therefore we did not class
any of the pre-operative prognostic factors of interest in our review
as confounders (see Data extraction and management). Further-
more, most studies (171 of 182 studies; 94%) were of a design that
followed up one group of participants before and after the inter-
vention (retrospectively or prospectively), rather than two groups
that may differ in terms of demographics, so by this single-sam-
ple design, we deemed it more appropriate to judge the methods
of selection of the sample (see “A. Selection bias”) than to assess
’confounders’. For this reason, we judged these 171 studies to be
of ’strong’ quality, in the absence of confounding variables.
For the nine studies of a randomised controlled design (Alonso-
Vanegas 2018; Barbaro 2018; Ding 2016; Dwivedi 2017; Liang
2010; Schramm 2011; Vogt 2018; Wiebe 2001; Wyler 1995),
as well as the two studies of a cohort analytic design (Oertel
2005; Velasco 2011), with two groups before and after in-
tervention (randomised and non-randomised, respectively), we
made a judgement regarding potential confounding factors (other
than prognostic factors) in the two groups. Ten of these stud-
ies presented demographics for the two participant groups and/
or tested whether any significant differences were present between
the groups (Alonso-Vanegas 2018; Barbaro 2018; Ding 2016;
Dwivedi 2017; Liang 2010; Schramm 2011; Velasco 2011; Vogt
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2018; Wiebe 2001; Wyler 1995). We found no significant dif-
ferences in any of these studies; therefore we judged that groups
were balanced and there was no evidence of confounders. One
study reported very limited information on the demographics of
the two groups, and it did not appear that the groups had been
compared for differences that may have influenced the results of
analysis (Oertel 2005); for this study, we could not tell if any con-
founders were present, or if any adjustments had been made to
the analysis to account for confounders.
Therefore we judged that for 181 studies (99%), the quality of
evidencewas ’strong’ (i.e. no confounders thatmay have influenced
the results of analysis were present). For one study of a cohort
analytic design (1% of total studies), the quality of evidence was
’moderate’ (i.e. we were unable to judge whether any confounders
that may have influenced the analysis were present) (Oertel 2005).
D. Blinding
In the context of surgical treatment, blinding is very difficult, as
the operating surgeon is required to know the procedure being
carried out and the participant will be aware that he/she is under-
going surgery. It may be possible, however, to blind participants
and outcome assessors (other than the surgeon) to the specific sur-
gical procedure being carried out, and researchers often blinded
outcome assessors to pre-operative evaluation details while mak-
ing judgements regarding outcomes following surgery. We believe
that in the context of surgical treatment, where blinding usually is
not feasible, study outcomes would not necessarily be influenced
by this. However, for the purposes of this quality assessment, we
followed the criteria specified by the EPHPP tool related to blind-
ing of the intervention.
Question 2 of the EPHPP tool for the blinding component (see
Appendix 5) is stated as follows: “Were the study participants aware
of the research question?” We interpreted this to mean ’Were the
study participants aware of the intervention allocated?’ as we be-
lieve that awareness of the research question is not the same as
blinding to allocation of the intervention, and it would be impos-
sible to determine awareness of participants of a research question
in a study of retrospective design.
For 176 of 182 studies (97%), we judged that outcome assessors
and participants were aware of the intervention, and that these
studies provided evidence of ’weak’ quality due to high risk of bias
from lack of blinding. The remaining six studies were randomised
controlled trials. Four studies (2%) blinded participants (if pos-
sible), and all studies blinded outcome assessors; we considered
these studies to provide evidence of ’strong’ quality (Barbaro 2018;
Dwivedi 2017; Schramm 2011; Wyler 1995). Two studies (1%)
did not provide any information on blinding of participants or
outcome assessors, so we judged this study to provide evidence of
’moderate’ quality (Liang 2010; Vogt 2018).
E. Data collection methods
Our outcome of interest in this review was seizure freedom fol-
lowing surgery; therefore the data required for the outcome would
include details of recurrence of participant seizures after surgery.
Given that such data are recorded from participant reports, which
may be prone to recall error, and that no validated tools (e.g. qual-
ity of life assessment tools) are available to record such data, for
each study, given the information reported on outcome data col-
lection, we made a judgement on whether methods used were ad-
equate and reliable.
Overall, we accepted any method of seizure data collection that
seemed reasonable (participant seizure diaries, clinical notes, in-
terviews with participants and/or family members at clinic visits
or over the phone, postoperative MRI or EEG) to be valid. We
judged all these methods to be ’reliable’, given that all methods
are likely prone to error, as the outcome is somewhat subjective.
Ninety-five of 182 studies (52%) reported a ’valid and reliable’
data collection method, and we judged these studies to provide
evidence of ’strong’ quality.
The remaining 87 studies (48%) either did not provide any in-
formation at all on data collection methods or did not provide
sufficiently clear information on data collection methods for us
to judge whether they were valid and/or reliable. We judged these
studies to provide evidence of ’weak’ quality.
F. Withdrawals and dropouts
This criterion was not applicable to the 144 studies (79%) of a ret-
rospective design. For the remaining 35 studies, we made a judge-
ment on whether study authors adequately reported withdrawal
information.
Seventeen studies (9%), all of a prospective design, reported the
numbers of withdrawals/losses to follow-up in the study with rea-
sons when applicable; at least 80% of participants in all 17 studies
completed the study, and less than 20% withdrew from the study.
We judged these studies to provide evidence of ’strong’ quality (8%
of total studies). The remaining 21 studies (nine of a prospective
design, three of a combination design, and nine with design not
stated) provided no information regarding participant withdrawal
nor losses to follow-up; therefore we could not tell how many par-
ticipants completed the study. We judged these studies to provide
evidence of ’weak’ quality (12% of total studies).
G. Intervention integrity
In the context of a surgical intervention, we judged that it was
’highly unlikely’ that any participant received an unintended in-
tervention. Within all 182 included studies, 80% to 100% of
included participants received the surgical intervention. Several
studies (particularly those aiming to identify criteria in presurgi-
cal evaluation that may be associated with outcome) specified the
numbers of participants who underwent presurgical evaluation
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andwere not recommended for surgical intervention; however this
proportion of participants was less than 20% for all studies, and
we included in the results of this review only participants who
underwent surgery.
We judged that researchers had measured ’consistency’ of the in-
tervention if a study reported at least details of all surgical tech-
niques used for all participants; it was not necessary for the surgical
intervention to be exactly the same for all participants in a study
for the intervention to be considered consistent, as many partici-
pants required tailored resections based on pathology or aetiology
of seizures. We also considered the intervention to be ’consistent’
if investigators used the same surgical technique for all partici-
pants or used the same surgical protocol or if the same surgeon(s)
performed all surgeries, and if any study authors reported specific
differences in surgical technique. We judged that researchers had
not measured the ’consistency’ of the intervention if the details
of surgical techniques were not reported or were not reported for
all participants, or if the types of interventions performed were
unclear. We judged that the intervention was ’consistent’ for 164
studies (90%) and was ’inconsistent’ for 18 studies (10%).
H. Analyses
All 182 studies included individual units of allocation and analysis
by design; in other words, all studies performed a surgical interven-
tion on each individual and analysed each individual for the seizure
outcome. We identified no studies of a cluster (randomised) de-
sign for this review. We judged that all studies performed analysis
by intervention allocation status (intention-to-treat) rather than
by the actual intervention received; for studies of a retrospective
design, it was difficult to discern whether a different type of sur-
gical intervention had been ’allocated’, as the only information
provided by a retrospective study is the intervention received. We
judged that all studies of a prospective or combination design had
taken an intention-to-treat approach to analysis.
Of 182 studies, 159 (87%) performed statistical analysis, and the
remaining 23 studies (13%) reported only observational results
without performing analysis. The statistical author of this review
(SN) judged that all statistical analyses performed in the 156 stud-
ies were appropriate for the study design.
Overall rating
The global quality rating is based on components A to F of the
EPHPP tool. We judged a study that had no components judged
as ’weak’ was ’strong’ overall, a study with one ’weak’ component
was ’moderate’ overall, and a study that had two or more ’weak’
components was ’weak’ overall.
We judged the global quality rating to be ’strong’ for five studies
(3% of total studies; all randomised controlled trials; Dwivedi
2017; Liang 2010; Wyler 1995), ’moderate’ for 79 studies (43%
of total studies), and ’weak’ for 98 studies (54% of total studies).
Adequacy of EPHPP quality assessment tool
Based on the work of Tonini 2004 related to this review, we knew
that most studies identified via searches for this review were likely
to be of a non-randomised and retrospective design. At the initi-
ation of the protocol for this review in 2012, a ’Risk of bias’ tool
for assessment of randomised controlled trials had been developed
and was recommended by the Cochrane Handbook for Systematic
Reviews of Interventions (Chapter 8, Higgins 2011); however we
were not aware of a specific tool for assessment of studies of a non-
randomised and/or retrospective design as recommended by the
Cochrane Handbook for Systematic Reviews of Interventions (Chap-
ter 13, Higgins 2011). Therefore two review authors (SN and JW)
withmethodological experience in quality assessment reviewed the
existing literature at this time for a quality assessment tool and
judged that the EPHPP tool, intended for the quality assessment
of all study designs including non-randomised and retrospective,
would be the most appropriate tool to use for this review.
Given that the tool was used by five authors of the 182 included
studies, we now believe that this tool has not provided a fully
accurate assessment of the quality of included studies. It is assumed
that a randomised controlled trial provides evidence of the highest
quality for the efficacy of an intervention (Mann 1996); 79%of the
studies included in this review were of a retrospective, single-group
design, which could be considered as providing evidence of the
poorest quality in the hierarchy of evidence about an intervention.
Therefore we needed a tool to separate the different levels of ’poor’
evidence, and the EPHPP tool did not do this.
Despite the described applicability of this tool to all quantitative
study designs, many criteria are not appropriate for studies of a
retrospective design (e.g. withdrawals from the study, proportion
of participants agreeing to take part in the study) nor for stud-
ies of a single-group design (confounders). Also in the context of
surgical studies for epilepsy, where blinding of participants and
outcome assessors is often impossible and only objective, non-val-
idated methods for collection of seizure outcome data exist, the
global quality rating of the study was influenced by two compo-
nents (D and E) for most studies. Only five of the RCTs included
in this review attempted blinding; therefore we automatically as-
signed the judgement for 175 of 182 studies (97%) as ’weak’ ac-
cording to the definition provided in the tool. On the basis of
global rating, this meant that we could judge 97% at the most to
be of ’moderate’ quality due to lack of blinding alone. Then the
difference between a ’moderate’ and a ’weak’ global rating was dic-
tated by component E (’strong’ or ’weak’). Essentially, the global
rating reflects the quality of data collection methods rather than
overall quality.
Furthermore, for the component “B. Study design”, we made an
assumption that the study design of 144 ’retrospective case series’
(one group before and after intervention) not specifically referred
to in the EPHPP tool was of ’moderate’ quality - the same quality
assigned to a prospective cohort study. We made this judgement
to avoid the design of the study alone dictating the overall quality
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rating (i.e. all retrospective designs are ’weak’) to separate out the
144 studies based on other quality criteria. If instead, more fitting
with National Institute for Health and Care Excellence (NICE)
guidelines (Mann 1996), we had assumed all retrospective designs
to be of ’weak’ quality, the global rating would have been as fol-
lows: ’strong’: five studies; ’moderate’: six studies; and ’weak’: 171
studies. Such ratings would not have provided us with any useful
information regarding the relative quality of included studies.
In hindsight, given the context of surgery for epilepsy and our
prior knowledge of the likely design of included studies based
on the Tonini 2004 review, it would have been more appropriate
for us to design our own quality assessment tool for the review
based on what we know to be clinically important in studies of
surgical interventions. Given our lack of confidence in the global
ratings assigned to included studies by the EPHPP tool, we believe
it would be inappropriate to conduct sensitivity analyses based
on the global quality assessments (see Effects of interventions for
subgroup and sensitivity analyses performed).
Assessment of risk of bias in studies reporting multi-
variable prognostic models according to the Quality
in Prognostic Studies (QUIPS) tool
Twenty-eight studies reported a multi-variable prognostic model
including one or more of the factors of interest to us (Althausen
2013; Boesebeck 2007; Cossu 2005; Cossu 2008; Elsharkawy
2008a; Elsharkawy 2009a; Gelinas 2011; Janszky 2003a; Jennum
1993; Kim 2009; Kim 2010a; Lopez-Gonzalez 2012; Madhavan
2007; McIntosh 2012; O’Brien 2000; Paolicchi 2000; Phi 2009;
Radhakrishnan 1998; Rossi 1994; Sagher 2012; Sarkis 2012;
Schramm 2011; Spencer 2005; Tezer 2008; Theodore 2012;Walz
2003; Wyler 1995; Yang 2011) (see “Multi-variable analyses” in
Effects of interventions below for additional details of these results
and reported results).
TheQUIPS tool considers six domains (see Table 5 for judgements
for each domain for each study).
1. Study participation: judge risk of selection bias (likelihood
that the relationship between prognostic factor (PF) and
outcome is different for participants and eligible non-
participants)
We judged 11 of 28 studies to be at ’low’ risk of selection bias; the
population of interest and the method of sample recruitment are
well described and the samples seem to match the characteristics
of the source population. We judged 15 of the 28 studies to be
at ’moderate’ risk of selection bias due to uncertainties or limited
information regarding the population of interest or the method of
sample recruitment, or both, to enable judgement on whether the
sample matched the source population. We judged two studies to
be at ’high’ risk of selection bias: one due to a selective sample that
is unlikely to represent the source population (Janszky 2003a), and
one due to very limited information regarding the population of
interest, themethod of sample recruitment, and the characteristics
of the sample (Rossi 1994).
2. Study attrition: judge risk of attrition bias (likelihood that
the relationship between PF and outcome is different for
completing and non-completing participants)
Twenty-two of the 28 studies were of a retrospective design, so
this domain was not applicable. Six studies were of a prospective
design. We judged that two of these studies were at ’low’ risk
of attrition bias, as intention-to-treat analyses were planned in
the case of withdrawals or losses to follow-up, so all participants
contributed to outcome assessment (Schramm 2011;Wyler 1995).
We judged three to be at ’moderate’ risk of attrition bias due to lack
of information reported about withdrawals and losses to follow-
up (Spencer 2005; Theodore 2012; Walz 2003), and one study to
be at ’high’ risk of attrition bias due to exclusion of participants
with missing data and uncertainty over whether participants were
recruited prospectively or retrospectively (Radhakrishnan 1998).
3. Prognostic factor measurement: judge risk of
measurement bias related to how PF was measured
(differential measurement of PF related to level of outcome)
We judged 22 of the 28 studies to be at ’moderate’ risk of measure-
ment bias due to unclear definitions of prognostic factors and lim-
ited information regarding how data were collected. Four studies
judged to be at ’low’ risk of measurement bias provided detailed
definitions of prognostic factors andmethods of measurement and
data collection (Cossu 2008; McIntosh 2012; Sagher 2012; Sarkis
2012). We judged two studies to be at ’high’ risk of measurement
bias; in one multi-centre study, it is likely that researchers collected
data using differentmethods across centres (Madhavan 2007), and
in the other study, a large proportion of prognostic factor data was
missing, which is likely to have had an impact on analyses (Rossi
1994).
4. Outcome measurement: judge risk of bias related to
measurement of outcome (differential measurement of
outcome related to baseline level of PF)
Recurrence of seizures in outpatients is generally patient-reported
and therefore difficult to measure in a valid and reliable way; vali-
dated scales such as the Engel Class Scale as described above exist
for assessment of post-surgical outcome.
We judged 18 of 28 studies to be at ’moderate’ risk of bias; it is
unclear exactly how and/or when outcome data had been collected
and/or how outcome was defined. We judged two studies to be
at ’high’ risk of bias: in Althausen 2013, researchers measured
outcome in variable ways (taken only from patient reports for
some participants, and using supplementary data from medical
records for other participants); Kim 2009 did not measure the
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outcome according to a known scale such as the Engel Class Scale
and provided no information on when study authors recorded
outcome. We judged the remaining eight studies to be at ’low’ risk
of bias: investigators reported clear information about how they
collected outcome data; they measured outcome according to a
known scale such as the Engel Class Scale; and they recorded this
information at the same time for all participants.
5. Study confounding: judge risk of bias due to confounding
(i.e. the effect of PF is distorted by another factor that is
related to PF and outcome)
Twenty of the 28 studies were of a single-group design, so this
domain was not applicable. We judged one RCT, Wyler 1995, to
be at ’low’ risk of bias due to confounding, as the randomised de-
sign should remove confounding and it is confirmed in the study
that groups were balanced at baseline. We judged seven studies
to be at ’moderate’ risk of bias of confounding: one study of an
RCT design did not demonstrate whether groups were balanced
at baseline and which variables of interest were prognostic fac-
tors and which were confounders (Schramm 2011); another study
made reference to confounders and interactions in a generalised
estimating equations model but did not specify which variables
of interest were prognostic factors and which were confounders
(Sagher 2012); and the remaining five studies made reference to
“confounders” but did not adequately define the variables and/
or did not specify which variables of interest were prognostic fac-
tors and which were confounders (Althausen 2013; Cossu 2008;
Elsharkawy 2008a; Gelinas 2011; Janszky 2003a).
6. Statistical analysis and reporting: judge risk of bias related
to statistical analysis and presentation of results
We judged only one study to be at ’low’ risk of bias because re-
searchers described statistical analysis well, performed modelling
based on clinical relevance, and did not selectively report results
(O’Brien 2000). We judged the other 27 studies to be at ’mod-
erate’ or ’high’ risk of bias (13 ’moderate’ and 14 ’high’) due to
use of unclear or inappropriate statistical methods, selection of
variables based on statistical significance, and selective reporting
of results. We have further discussed these issues and their likely
impact on the analyses under “Multi-variable analyses” in Effects
of interventions (below).
Overall, we judged one study to be at ’high’ risk of bias in three do-
mains (Rossi 1994), three studies to be at ’high’ risk of bias in two
domains (Althausen 2013; Janszky 2003a; Madhavan 2007), and
11 studies to be at ’high’ risk of bias in one domain (Cossu 2008;
Elsharkawy 2008a; Elsharkawy 2009a; Jennum 1993; Kim 2009;
Paolicchi 2000; Radhakrishnan 1998; Sarkis 2012; Spencer 2005;
Tezer 2008; Theodore 2012). The remaining 13 studies were not
judged to be at ’high’ risk of bias in any domain (Boesebeck 2007;
Cossu 2005; Gelinas 2011; Kim 2010a; Lopez-Gonzalez 2012;
McIntosh 2012; O’Brien 2000; Phi 2009; Sagher 2012; Schramm
2011; Walz 2003; Wyler 1995; Yang 2011).
Effects of interventions
See: Summary of findings for the main comparison; Summary
of findings 2
Overall outcome of surgery compared to medical
treatment
Two studies randomised participants to a surgical or control (med-
ical) intervention (Dwivedi 2017; Wiebe 2001).
Dwivedi 2017 randomised 116 participants aged 18 years or
younger to receive either appropriate brain surgery or continuing
medical therapy.
All 57 allocated to the surgical intervention completed 12-month
follow-up. One of the 59 allocated to continuing medical treat-
ment was lost to follow-up. Researchers used an intention-to-treat
approach to analysis and analysed all randomised participants in
the allocated groups, regardless of the intervention received. Se-
rious adverse events occurred in 19 participants (33%) in the
surgery group and in none in the medical therapy group. These
events included monoparesis in two participants (following tem-
poral lobectomy or resection of parietal focal cortical dysplasia);
hemiparesis in 15 (following hemispherotomy); and generalized
hypotonia and language deficits in one (following frontal lobec-
tomy). Study authors provided details on outcome at 12-month
follow-up. None of these events appears to have been transient.
Wiebe 2001 randomised 40 participants to each intervention
group and followed them up for 12 months for assessment of out-
come.
Four participants allocated to the surgery group did not undergo
surgical intervention (one declined surgery, two were deemed not
eligible for surgery based on pre-operative testing, and one did not
have seizures during pre-operative testing). Researchers took an in-
tention-to-treat approach to analysis and analysed all randomised
participants in the allocated groups, regardless of the intervention
received.
Four participants experienced adverse events from surgery: one
had a small thalamic infarct causing sensory abnormalities in the
thigh, one had a wound infection, and two had decline in verbal
memory that interfered with their occupations at one year. In ad-
dition, 22 participants in the surgery group experienced asymp-
tomatic, superior sub-quadrantic visual field defects; seven expe-
rienced depression; and one developed transient psychosis. The
only adverse event reported in the medical treatment group was
depression (eight participants).
Primary outcome: seizure outcome
(See also Summary of findings for the main comparison.)
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At one year, in Wiebe 2001, 23 of 40 (58%) participants in the
surgery group were free from seizures impairing awareness com-
pared to 3 of 40 (8%) in the medical treatment group (risk ra-
tio (RR) 7.67, 95% confidence interval (CI) 2.50 to 23.51; P =
0.0004; Analysis 1.1), and in Dwivedi 2017, 44 of 57 (77%) par-
ticipants in the surgery group were free from seizures (ILAE Class
1) compared to 4 of 59 (7%) in the medical treatment group (RR
11.33, 95% CI 4.37 to 29.64; P < 0.00001; Analysis 1.1). Pool-
ing of data from the two studies showed that the RR of seizure
freedom in the surgery group compared to the medical group was
9.78 (95% CI 4.73 to 20.21; P < 0.00001; Analysis 1.1; low-cer-
tainty evidence). No heterogeneity was present between studies (I²
= 0%).
Also at one year in Wiebe 2001, 15 of 40 (38%) participants
in the surgery group were free from all seizures including auras
compared to 1 of 40 (3%) in the medical treatment group (RR
15.00, 95% CI 2.08 to 108.23; P = 0.007; Analysis 1.2; very
low-certainty evidence). The median percentage improvement in
monthly seizure frequency impairing awareness was 100% in the
surgery group compared to 34% in the medical treatment group.
Secondary outcome: seizure outcome according to
prognostic factors of interest
Neither Dwivedi 2017 nor Wiebe 2001 reported any univariate
or multi-variable analyses that investigated the influence of any
prognostic factors on the seizure outcome (including prognostic
factors of interest to us).
Overall outcome according to surgical techniques
Six studies randomised the type of surgical intervention (Alonso-
Vanegas 2018; Barbaro 2018; Ding 2016; Liang 2010; Vogt 2018;
Wyler 1995) and one trial randomised the length of surgical in-
tervention (Schramm 2011).
One study randomised 43 adult participants to anterior temporal
lobectomy (ATL), selective amygdalohippocampectomy (SAH) or
parahippocampectomy (PHC) (Alonso-Vanegas 2018). No par-
ticipants died and in the PHC group, one participant had venous
thrombosis of the arm, which resolved, in the ATL group, two
participants developed mastoiditis, one had a transient oculomo-
tor nerve palsy, and one presented with an internal cerebral spinal
fluid fistula and in the SAHgroup, one participant developed acute
transient hypoacusia. Participants in the PHC group did not have
any postoperative visual field deficits whereas the outcome in the
ATL and SAH groups was 85.7% and 46.7%, respectively, which
was statistically significant (P <0.001).
One study randomised 63 adult participants who had been rec-
ommended for ATL to stereotactic radiosurgery (SRS) or ATL
(Barbaro 2018). Five participants withdrew before surgery and
were not included in analysis. Two participants withdrew from the
study, one in each group. The participant in the SRS group with-
drew early for ATL due to continued focal seizures and participant
in the ATL group was lost to follow-up. There were 14 adverse
events definitely related to treatment (5 serious and 9 non-seri-
ous) in 12 (39%) SRS patients and 5 events (2 serious and 3 non-
serious) in 3 (11%) ATL patients. Events were cerebral edema,
new neurological deficit, seizure exacerbation, pin-site infection,
subdural hematoma, deep venous thrombosis, wound dehiscence
and infection and psychiatric, with no overlap across treatment
groups. Twenty SRSparticipants (65%) and seven (26%)ATLpar-
ticipants were treated with steroids during follow-up, there were
no complications relating to steroids. 49 out of 54 participants
(91%) who completed visual field defect testing experienced some
visual field defects; 27 (93%) participants in the SRS group and
22 (88%) participants in the ATL group.
One study enrolled 68 children with Lennox-Gastaut syndrome
who had no focal lesion on brain MRI, 25 of whom were in a
continuing medical treatment group and 43 of whom underwent
surgery (Ding 2016). This group allocation was not randomised.
Within the surgery group, 20 had exclusively resective surgery and
23 had resective surgery combined with corpus callosotomy. Re-
searchers randomised children to either of these two surgical sub-
groups and followed up on all children for three to five years. No
postoperative death or permanent complications occurred. Inves-
tigators encountered transient complications in four participants,
including two with urinary incontinence, one of whom had hemi-
plegia; one with aphasia; and one with apraxia. All transient com-
plications resolved within three weeks.
One study randomised participants to anterior temporal lobec-
tomywith or without anterior corpus callosotomy (ATL vs aCCT)
(Liang 2010). Researchers randomised 30 participants to each
group and followed them up for two years for assessment of out-
come. Study authors reported transient complications of surgery
in nine participants in total. The aCCT group included two cases
of urinary incontinence, one case of aphasia, and two cases of
apraxia. The ATL group comprised two cases of aphasia and two
cases of apraxia.
One study randomised 54 adult participants who had been rec-
ommended for SAH to a subtemporal or transsylvian approach
to surgery (Vogt 2018). Seven participants who did not complete
neuropsychological follow-up at 12 months were excluded. One
year after surgery, there were no permanent neurological deficit
except for visual field defects; three participants in the transsylvian
group showed no visual field defects compared to 11 participants
in the subtemporal group. Severe deterioration of memory func-
tions was shown in three participants in the subtemporal group
and one participant in the transsylvian group. Postoperative MRIs
of six participants showed vascular events (infarctions in four par-
ticipants in the transsylvian group and transient postsurgical apha-
sia in one participant in each group).
One study randomised 34 participants to partial hippocampec-
tomy (removal of hippocampus en bloc to the anterior margin of
the cerebral peduncle) and 36 to total hippocampectomy (removal
of hippocampus en bloc to the level of the colliculi) and followed
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up participants for 12 months for assessment of outcome (Wyler
1995). Study authors reported complications in five participants:
two participants with partial hippocampectomy (one subgaleal
cerebrospinal fluid fistula and one temporary diplopia) and three
participants with total hippocampectomy (one temporary nerve
paresis and two cerebrospinal fluid subgaleal fistula).
One study randomised participants to a 2.5-cm or 3.5-cm tai-
lored temporal lobe resection (i.e. intended minimum resection
length of 25 vs 35 mm for hippocampus and parahippocampus)
(Schramm2011). Researchers randomised 104participants to 2.5-
cm resection and 103 to 3.5-cm resection and followed them up
for 12 months for assessment of outcome. Results show no sig-
nificant differences between 2.5-cm and 3.5-cm resection groups
concerning neurological complications (P < 0.605), visual field
defects (P < 0.856), or surgical complications (P < 0.875). Study
authors provided no details of surgical complications.
Primary outcome: seizure outcome
(See also Summary of findings 2.)
In Alonso-Vanegas 2018, at one year, 11 out of 14 (79%) partic-
ipants in the parahippocampectomy (PHC) group, 13 out of 14
(93%) in the anterior temporal lobectomy (ATL) group and 14
of 15 (93%) in the selective amygdalohippocampectomy (SAH)
group had a good outcome according to Engel Class Scale 1 and
6 out of 14 (43%) participants in the PHC group, 10 out of 14
(71%) in the ATL group and 9 of 15 (60%) in the SAH group
were seizure free according to Engel Class Scale 1A.
At 5 years, 50%, 64% and 67% of participants in the PHC, ATL
and SAH groups respectively were seizure free according to Engel
Class Scale 1 and 29%, 50% and 53% of participants in the PHC,
ATL and SAH groups respectively were seizure free according to
Engel Class Scale 1A. There were no statistically significant dif-
ferences between any of the pairs of treatments at 1 year or at 5
years, or according to either definition of the Engel Class Scale
(low-certainty evidence, Analysis 2.1, Analysis 2.2, Analysis 2.3).
In Barbaro 2018, between 25 and 36 months, 16 out of 31 (52%)
participants in the stereotactic radiosurgery group achieved remis-
sion of seizures (at least Engel Class IB) which was statistically
significantly less compared to 21 out of 27 (78%) participants in
the ATL group (RR 0.66, 95% CI 0.45 to 0.99; P = 0.04; low-
certainty evidence; Analysis 2.4).
In Ding 2016, at one year, 17 of 23 (74%) participants in the
resection with CCT group were free from seizures (Engel Class 1)
compared to 13 of 20 (65%) in the resection only group (RR 1.14,
95% CI 0.76 to 1.70; P = 0.53; low-certainty evidence; Analysis
2.5). The RR of seizure freedom for the resection with CCT group
compared to the resection only group at three years was 1.19 (95%
CI 0.72 to 1.95; P = 0.50; intention to treat approach; Analysis
2.5), and at five years was 1.09 (95% CI 0.53 to 2.21; P = 0.82;
intention-to-treat approach; Analysis 2.5).
In Liang 2010, at two years, 18 of 30 (60%) participants in the
ATL group were free from seizures (Engel Class 1) compared to
22 of 30 (73%) participants in the aCCT group (RR 1.22, 95%
CI 0.85 to 1.76; P = 0.28; moderate-certainty evidence; Analysis
2.6).
In Vogt 2018, at 1 year, 13 out of 22 (59%) participants in the
subtemporal SAHgroupwere free from all seizures including auras
(ILAE 1a) compared to 16 out of 25 (64%) participants in the
transsylvian group (RR 0.92, 95% CI 0.59 to 1.46; P = 0.73; low-
certainty evidence; Analysis 2.7).
In Wyler 1995, at one year, 25 of 36 (69%) participants in the to-
tal hippocampectomy group were free from all seizures including
auras compared to 13 of 34 (32%) participants in the partial hip-
pocampectomy group (RR 1.82, 95% CI 1.12 to 2.93; P = 0.01;
low-certainty evidence; Analysis 2.8). Wyler 1995 also reported
time to first seizure: seizure recurrence occurred earlier in the par-
tial hippocampectomy group than in the total hippocampectomy
group (at 1.3 vs 1.9 years, respectively).
In Schramm 2011, at one year, 77 of 104 (74%) participants in
the 2.5-cm resection group were free from seizures (Engel Class
1) compared to 75 of 103 (73%) participants in the 3.5-cm resec-
tion group (RR 1.02, 95% CI 0.86 to 1.20; P = 0.84; moderate-
certainty evidence; Analysis 2.9).
Secondary outcome: seizure outcome according to
prognostic factors of interest
Ding 2016 reported univariate analyses contributing to ’MRI
results’, ’Presence of encephalomalacia’, and ’Presence of focal
cortical dysplasia (FCD)/malformation of cortical development
(MCD)’.
Schramm 2011 reported univariate analyses contributing to ’Ex-
tent of resection’, ’Presence of mesial temporal sclerosis (MTS)’,
and ’Side of surgical resection’ (see below). Study authors pre-
sented results of these univariate analyses for all participants in
the study who underwent a surgical procedure and did not report
them separated by randomised group. They also reported a multi-
variable regression model of prognostic factors (see “Multi-vari-
able analyses” below).
The randomised comparison in Wyler 1995 (partial vs total hip-
pocampectomy) contributed to the univariate analysis of ’Extent
of resection’ (see Analysis 2.8 and “Extent of resection” below).
Study authors also reported a multi-variable regression model of
prognostic factors (see “Multi-variable analyses” below).
Alonso-Vanegas 2018, Barbaro 2018, Dwivedi 2017, Liang 2010,
Vogt 2018, andWiebe 2001 did not report any univariate or mul-
tivariable analyses that investigated the influence of any prognostic
factors of interest to us for the seizure outcome.
Overall outcome of surgery according to all
randomised and non-randomised evidence
Of 16,756 participants who underwent surgery for epilepsy in-
cluded in the 182 studies, satisfactory seizure outcome data were
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available for 16,501 from 178 studies. Among these 16,501 par-
ticipants, 10,696 achieved a good outcome (65%), defined as En-
gel Class 1 - more than one year seizure-free - or a good outcome
measured on another scale that satisfied our definition of a good
outcome (see Primary outcomes and Included studies). Figure 3
shows the proportion of participants with a good outcome in each
study (by outcome scale), ranging from 13.5% to 92.5% of par-
ticipants with a good outcome. We note that Figure 3 is for illus-
trative purposes only, and the proportion of participants with a
good outcome is not pooled in meta-analysis in Analysis 3.1 nor
Figure 3.
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Figure 3. Forest plot of comparison: 1 Surgery for Epilepsy, outcome: 1.1 Proportion with a good outcome
of surgery.
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See Figure 4 for the funnel plot of the outcome ’Proportion with
a good outcome of surgery’ for 178 included studies.
Figure 4. Funnel plot of comparison: 1 Surgery for epilepsy, outcome: 1.1 Proportion with a good outcome
of surgery.
Further examination of overall post-surgery seizure outcome ac-
cording to site of surgery (169 studies reported these data) revealed
that 722 of 1253 participants from 14 studies in which partici-
pants underwent extratemporal lobe surgery achieved a good out-
come of surgery (62%), 4558 of 6638 participants from 78 studies
in which participants underwent temporal lobe surgery achieved
a good outcome of surgery (69%), and 5016 of 7654 partici-
pants from 77 studies in which participants underwent temporal
or extratemporal lobe surgery achieved a good outcome of surgery
(66%). Data show a statistically significant association between
site of surgery and outcome of surgery (Chi² test P < 0.001).
For 255 participants from four studies (1.5% of the total 16,756
participants undergoing surgery), we did not deem the seizure out-
come scale to be satisfactory for the outcomes of this review, and
we did not include these participants in any meta-analyses (see
Primary outcomes and Included studies). Under the definition of
’good’ outcome in these four studies, 142 of 255 (56%) partici-
pants achieved a ’good outcome’. We did not consider these four
studies further in this review (Krsek 2013; Kuzniecky 1993; Kwan
2010; Ure 2009).
Recording of adverse events in all included studies
In all, 79 of the 182 (43%) included studies reported adverse
events or complications of surgery.Detailswere highly variable; the
RCTs reported the most details, see ’Overall outcome of surgery
compared to medical treatment’ and ’Overall outcome according
to surgical techniques’ for a summary of the surgical complications
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and adverse events in the RCTs.
In the non-randomised studies, some studies reported deaths only,
including those occurring many years later from unrelated causes.
Study authors often did not state the timing of events and provided
no clarity around what was perioperative, what was a transient
event (some included persistence of a feature up to 12 months as
transient), andwhat was a permanent deficit. The overall quality of
these data is therefore very poor. Few studies included any reference
to postoperative cognition or mental state.
Notwithstanding these constraints, study authors recorded adverse
events in 1331 of the 9599 (13.8%) participants involved in these
76 studies. By taking data from studies that specified the number
with transient adverse events (282 (21%)) and adding to this the
number of events that we can assume to be transient (i.e. short-
lived and treatable, to include infection/fever, cerebrospinal fluid
(CSF) leak/collection, haemorrhage, deep venous thrombosis, sta-
tus epilepticus, and cerebral oedema), we found that the total
number with a transient adverse event is 618 (6%). This leaves
us 713 of the 9599 (7.4%) participants with a permanent adverse
event. It is highly likely that this represents an overestimation of
a prevalence figure for permanent neurological deficit, as many
studies did not record which events were only transient, and more
than one event could be recorded in the same person.
Recorded adverse events include the following.
• Adverse events were undefined in 98 (7.5%) participants
and included infection/fever (difficult to differentiate infective
causes from autonomic dysfunction) in 251 (19.2%); motor
impairment (to include monofacial and hemifacial pareses, along
with cranial nerve involvement) in 220 (16.8%); visual field
defect in 173 (13.2%); haemorrhage in 56 (4.3%); language
impairment in 42 (3.2%); CSF leak or collection (e.g. sub-
galeal) in 36 (2.8%); cognitive impairment to include memory
loss in 34 (2.6); hydrocephalus in 24 (1.8%); and miscellaneous
(to include deep venous thrombosis (associated in three with
pulmonary embolism), status epilepticus, cerebral oedema, and
urinary incontinence in 10 (0.8%).
• Study authors recorded altered mental state in 118 (9%)
participants. They did not define duration. It is notable that one
study contributed 65 of this number as the result of a detailed
psychiatric assessment included in its post-surgery follow-up
protocol (Suppiah 2009). A new episode of psychological
symptoms occurred in 52% of 114 participants assessed in this
way during the first year after surgery. Sixty-six of these people
had a lifetime prevalence of anxiety or depression or another axis
I disorder. Supplementary publications sometimes reported on
mental state. For example, Cleary 2012 analysed psychiatric
diagnoses in 280 of 615 participants reported in de Tisi 2011,
showing that 38% of 280 had significant psychiatric problems
within four years following temporal lobe surgery.
The figures given here in parentheses are percentages of 1308 - the
overall number of recorded adverse events.
Prognostic factors of a good outcome of surgery in all
included studies
Univariate analyses
Of 175 studies reporting seizure outcome data on a satisfactory
scale, 119 contributed data towards at least one of our pre-specified
prognostic factors of interest for univariate analysis (i.e. the inde-
pendent, unadjusted effect of each of these factors on outcome; see
Data extraction and management). Twenty-nine studies reported
one prognostic factor, 20 reported two prognostic factors, 28 three
prognostic factors, 17 four prognostic factors, 12 five prognostic
factors, seven six prognostic factors, two seven prognostic factors,
and four nine prognostic factors. See Table 6 for full details of the
prognostic factors recorded in each study.
Analyses 4.1 to 4.14 show the univariate risk ratio (RR) and 95%
confidence interval (CI) of good outcome for each prognostic fac-
tor. All analyses are subgrouped according to the outcome scales
’more than one year seizure-free’, ’Engel Class Scale’, or ’other’
scale, and an overall pooled RR and 95% CI adjusted for outcome
scale are reported for each factor. All analyses were performed with
a fixed-effect model unless otherwise stated.
We intended to compare the results of pooling unadjusted univari-
ate analyses versus the results of pooling adjusted multi-variable
analyses for each prognostic factor, under the assumption that it
is likely that our pre-specified factors of interest do not act com-
pletely independently of outcome and do in fact interact with each
other as well as with the outcome. However, due to limited infor-
mation from adjustedmulti-variable analyses reported as aggregate
data, we were unable to perform any analyses in this review using
adjusted results, and we have described below the multi-variable
adjusted models including our pre-specified variables of interest
(see “Multi-variate analyses”).
We emphasise that the univariate RRs presented in Analyses 4.1
to 4.14 assume that each factor acts independently on seizure
outcome, which, in reality, is unlikely to be the case. Therefore
we have discussed only the direction of the analyses rather than
the numerical magnitude, and we do not encourage use of these
results in future research.
Pre-operative factors
Results of pre-operative MRI
Forty-three studies with 3999 participants reported pre-opera-
tive MRI results (normal vs abnormal, where abnormal is defined
within individual studies) as a prognostic factor for seizure out-
come of surgery. Seventeen studies reported seizure outcome ac-
cording to a more than one year seizure-free scale, 22 accord-
ing to the Engel Class Scale, and four according to ’other’ scales
29Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(see Included studies for definitions of ’other’ scales). A total of
1271 participants had normal MRI results, 700 of whom (55%)
achieved a good outcome of surgery; and 2728 participants had
abnormal MRI results, 1833 of whom (67%) achieved a good
outcome of surgery.
Analysis 4.1 shows that participants with abnormal pre-operative
MRI results are significantlymore likely to have a good outcome of
surgery than those with normal pre-operative MRI results (pooled
RR for normal vs abnormal MRI, 95% CI adjusted for outcome
scale 0.78 (0.73 to 0.83); P < 0.00001). Results according to out-
come scale are very similar: more than one year seizure-free pooled
RR for normal versus abnormal MRI 0.82 (95% CI 0.74 to 0.90;
P < 0.0001); Engel Class Scale pooled RR for normal versus ab-
normalMRI 0.76 (95%CI 0.69 to 0.81; P < 0.00001); and ’other’
scale pooled RR for normal versus abnormal MRI 0.84 (95% CI
0.53 to 1.32; P = 0.45). We found no evidence of a difference
between outcome scales for this prognostic factor (Chi² test for
subgroup differences P = 0.35).
A moderate amount of heterogeneity is present between studies in
each of the subgroups and in the overall analysis (I² value ranges
from20% to 65% in subgroup analyses and is 39%overall).When
the analysis is repeated for subgroups and overall analysis with a
random-effects model, pooled results are similar and conclusions
remain unchanged. The largest amount of heterogeneity is present
between studies using ’other’ scales; therefore the variability of re-
sults here is likely to be due to the different outcome scales used
(see Included studies). Also one study in this subgroup shows a
large effect in favour of an abnormal MRI for a good outcome of
surgery (RR 0.17, 95% CI 0.01 to 2.38), as only 4 of 36 partici-
pants in this study had a normal pre-operative MRI, and none of
these participants achieved a good outcome of surgery (Sakamoto
2009).
Further subgroup analysis separating site of surgery of participants
in the study (temporal only, extratemporal only, both temporal
and extratemporal) and study design (prospective or retrospective
identification of participants) shows no significant differences be-
tween these subgroups, and this could be contributing to hetero-
geneity (analyses not shown but available from study authors). We
therefore deduce that variability between studies may originate
from slightly different definitions of pre-operativeMRI abnormal-
ity across studies; for example, some studies defined only ’abnor-
malities’ on MRI, and other studies defined specific abnormali-
ties such as ’lesions on MRI’. Further, small participant numbers
and unbalanced participant numbers with normal and abnormal
MRIs leading to large, imprecise results may have contributed to
variability between studies (e.g. in Adam 1996, of 30 participants,
1 had an abnormal MRI and 29 had a normal MRI).
Use of pre-operative intracranial (invasive) monitoring
Twenty-one studies with 1547 participants reported data on use
of intracranial monitoring (used vs not used) as a prognostic factor
for seizure outcome of surgery. Six studies reported seizure out-
come according to a more than one year seizure-free scale, 14 stud-
ies according to the Engel Class Scale, and one study according to
some ’other’ scale (see Included studies for definitions of ’other’
scales). A total of 762 participants underwent intracranial moni-
toring, 448 of whom (59%) achieved a good outcome of surgery;
and 785 did not undergo intracranial monitoring, 564 of whom
(72%) achieved a good outcome of surgery.
Analysis 4.2 shows that participants who do not undergo intracra-
nial monitoring are significantly more likely to have a good out-
come of surgery than those who do undergo intracranial monitor-
ing (pooled RR for intracranial monitoring used vs not used 0.85,
95% CI adjusted for outcome scale 0.78 to 0.93; P = 0.0002). Re-
sults according to outcome scale include the following: more than
one year seizure-free pooled RR for intracranial monitoring used
versus not used 0.88 (95% CI 0.76 to 1.02; P = 0.10); Engel Class
Scale pooled RR for intracranial monitoring used versus not used
0.85 (95% CI 0.77 to 0.94; P = 0.004); and ’other’ scale pooled
RR for intracranial monitoring used versus not used 0.53 (95%
CI 0.28 to 0.98; P = 0.04). We found no evidence of a difference
between outcome scales for this prognostic factor (Chi² test for
subgroup differences P = 0.39).
A moderate amount of heterogeneity is present between studies
in each of the subgroups and in overall analysis (I² value ranging
from 37% to 46% in subgroup analyses and 37% overall). When
analysis is repeatedwith a random-effectsmodel, pooled results are
similar and conclusions remain unchanged. We assume it is likely
that the small amount of heterogeneity present between studies is
due to small participant numbers, unbalanced participant num-
bers, and using or not using intracranial monitoring, leading to
large, imprecise results that may have contributed to variability
between studies.
Mesial temporal sclerosis (MTS) on MRI or pathology
Forty-six studies with 4354 participants reported data on mesial
temporal sclerosis on pathology (present vs absent) as a prognostic
factor for seizure outcome of surgery. Nine studies reported seizure
outcome according to a more than one year seizure-free scale,
30 studies according to the Engel Class Scale, and seven studies
according to some ’other’ scale (see Included studies for definitions
of ’other’ scales). A total of 1735 participants had confirmedMTS
on pathology, 1287 of whom (74%) achieved a good outcome of
surgery; and 2619 participants did not show MTS on pathology,
1609 of whom (62%) achieved a good outcome of surgery.
Analysis 4.3 shows that patients withMTS onpathology are signif-
icantly more likely to have a good outcome of surgery than those
without MTS on pathology (pooled RR for presence vs absence
of MTS 1.18 (95% CI adjusted for outcome scale 1.13 to 1.24;
P < 0.00001). Results according to outcome scale include the fol-
lowing: more than one year seizure-free pooled RR for presence
versus absence of MTS 1.25 (95% CI 1.13 to 1.39; P < 0.0001);
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Engel Class Scale pooled RR for presence versus absence of MTS
1.13 (95%CI 1.07 to 1.20; P < 0.00001); and ’other’ scale pooled
RR for presence versus absence of MTS 1.31 (95% CI 1.14 to
1.51; P = 0.0002). We found no statistically significant evidence
of a difference between outcome scales (Chi² test for subgroup
differences P = 0.06).
Across subgroups, no heterogeneity was present between studies
classifying seizure outcome as more than one year seizure-free (I²
= 0%). Some heterogeneity was present between studies classi-
fying seizure outcome by Engel Class Scale (I² = 30%) and by
’other’ scales (I² = 17%), so overall heterogeneity between all in-
cluded studies was quite low (I² = 28%). As in previous examples,
it is likely that the small amount of heterogeneity present between
studies is due tomany studies having small sample sizes and unbal-
anced numbers of participants with and without MTS. This has
led to several large, imprecise results, which may have contributed
to variability between studies.
Concordance of pre-operative MRI and EEG
Concordance is seen when results of two investigations - usually
an MRI scan and an EEG - localise the likely source of epilepsy
to the same lobe. Twenty-three studies with 1778 participants re-
ported data on concordance of pre-operative MRI and EEG (con-
cordant vs discordant) as a prognostic factor for seizure outcome
of surgery. Eight studies reported seizure outcome according to a
more than one year seizure-free scale, 12 studies according to the
Engel Class Scale, and three studies according to some ’other’ scale
(see Included studies for definitions of ’other’ scales). A total of
1200 participants had concordant pre-operative MRI and EEG,
824 of whom (69%) achieved a good outcome of surgery; and 578
participants had discordant pre-operative MRI and EEG, 313 of
whom (54%) achieved a good outcome of surgery.
Analysis 4.4 shows that participants with concordant pre-opera-
tive MRI and EEG are significantly more likely to have a good
outcome of surgery than those with discordant pre-operative MRI
and EEG (pooled RR for concordant vs discordant 1.25, 95% CI
adjusted for outcome scale 1.15 to 1.37; P < 0.00001). Results
according to outcome scale include the following: more than one
year seizure-free pooled RR for concordant versus discordant 1.21
(95% CI 1.07 to 1.37; P = 0.003); Engel Class Scale pooled RR
for concordant versus discordant 1.27 (95% CI 1.11 to 1.46; P =
0.0005); and ’other’ scale pooled RR for concordant versus discor-
dant 1.40 (95%CI 1.02 to 1.93; P = 0.04). We found no evidence
of a difference between outcome scales for this prognostic factor
(Chi² test for subgroup differences P = 0.65).
Noheterogeneity is present between studies classifying seizure out-
come according to the Engel Class Scale (I² = 0%). A moderate
amount of heterogeneity is present between studies in other sub-
groups (I² = 50% to 56% and I² = 26% overall). When analysis is
repeated with a random-effects model, the pooled RR for concor-
dant versus discordant is no longer significant in the subgroups on
a more than one year seizure-free scale (RR 1.24, 95% CI 0.97 to
1.59; P = 0.08) and on another scale (RR 1.46, 95% CI 0.89 to
2.39; P = 0.14). However, overall pooled results adjusted for out-
come scale are similar and conclusions remain unchanged (pooled
RR for concordant vs discordant 1.20, 95% CI 1.08 to 1.34; P =
0.0009).
Heterogeneity present between three studies using ’other’ scales is
likely due to the different outcome scales used by the these stud-
ies (Holmes 2000; Rossi 1994; Yang 2011; see Included studies).
From inspection of studies that classified seizure outcome as more
than one year seizure-free, small participant numbers and unbal-
anced participant numbers with concordant and discordant pre-
operative MRI and EEG leading to large, imprecise results may
have contributed to variability between studies. Further, three
studies show particularly variable results. Tatum 2008 shows a
large significant effect in favour of concordance, with wide con-
fidence intervals; participants in this study had a normal MRI
for inclusion; therefore concordance with MRI was determined
operatively rather than pre-operatively. Kim 2010b also showed
a large effect in favour of concordance, with wide confidence in-
tervals; all participants in this study had dual pathology of MTS
and focal cortical dysplasia (FCD) for inclusion. Kim 2009 is the
only study to show an effect in favour of discordance; all partici-
pants in this study had FCD for inclusion. Other studies in this
subgroup, all showing moderate, non-significant effects in favour
of concordance, had no specific inclusion criteria based on imag-
ing or pathology. It is feasible that specific study inclusion criteria
based on how pathological lesions are sited may in turn influence
classification of the pre-operative MRI and therefore concordance
with the pre-operative EEG (see below for the apparent disadvan-
tage of retrospective design in this respect).
Further subgroup analysis separating the site of surgery of partic-
ipants in the study (temporal only, extratemporal only, both tem-
poral and extratemporal) shows no significant differences between
these subgroups that could be contributing to heterogeneity (anal-
yses not shown but available from study authors). Subgroup anal-
ysis according to study design (prospective or retrospective iden-
tification of participants) shows a larger advantage for concordant
pre-operative MRI and EEG in the three studies of a prospective
design than in the 20 studies of a retrospective design (prospective
pooled RR for concordant vs discordant 1.91, 95% CI 1.06 to
3.44; P = 0.03; retrospective pooled RR for concordant vs discor-
dant 1.21, 95% CI 1.10 to 1.33; P < 0.0001). We found no statis-
tically significant evidence of differences between subgroups (Chi²
test for subgroup differences P = 0.13); however, this trend may be
contributing towards the heterogeneity. For example, for studies
with a prospective design, determining concordance of tests per-
formed during the study may be easier and more reliable than de-
termining concordance of medical records of tests that have been
previously performed in a study of a retrospective design. In sum-
mary, it is likely that study characteristics such as design, inclusion
criteria, and outcome scale may have contributed to variability in
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this prognostic factor.
History of febrile seizures
Fifteen studies with 1368 participants reported data on history of
febrile seizures (history vs no history) as a prognostic factor for
post-surgery seizure outcome. Five studies reported seizure out-
come according to a more than one year seizure-free scale, nine
studies according to the Engel Class Scale, and one study according
to some ’other’ scale (see Included studies for definitions of ’other’
scales). A total of 440 participants had a history of febrile seizures,
343 of whom (78%) achieved a good outcome of surgery; and
928 participants had no history of febrile seizures, 615 of whom
(66%) achieved a good outcome of surgery.
Analysis 4.5 shows that participants with a history of febrile
seizures were significantly more likely to have a good outcome of
surgery than those without a history of febrile seizures (pooled RR
for history vs no history of febrile seizures 1.09, 95% CI adjusted
for outcome scale 1.01 to 1.17; P = 0.002). Results according to
outcome scale include the following: more than one year seizure-
free pooled RR for history versus no history of febrile seizures 1.18
(95% CI 1.05 to 1.32; P = 0.006); Engel Class Scale pooled RR
for history versus no history of febrile seizures 1.01 (95% CI 0.92
to 1.11; P = 0.83); and ’other’ scale (one study) RR for history
versus no history of febrile seizures 1.11 (95% CI 0.90 to 1.37; P
= 0.32). We found no evidence of a difference between outcome
scales for this prognostic factor (Chi² test for subgroup differences
P = 0.14).
A substantial amount of heterogeneity is present between studies
that classified seizure outcome according to more than one year
seizure-free (I² = 70%), and no heterogeneity is present between
the other outcome scales (I² = 0%), which leads to an overall mod-
erate amount of heterogeneity in the overall analysis (I² = 32%).
When analysis is repeatedwith a random-effectsmodel, the pooled
RR remains unchanged in subgroups without heterogeneity be-
tween studies, but in the subgroup more than one year seizure-
free, and now in the overall analysis, the advantage for participants
with a history of febrile seizures is no longer statistically signifi-
cant (more than one year seizure-free pooled RR for history vs no
history of febrile seizures 1.23, 95% CI 0.96 to 1.57; P = 0.10;
overall pooled RR for history vs no history of febrile seizures 1.07,
95% CI 0.98 to 1.17; P = 0.12).
From inspection of studies that classified seizure outcome as more
than one year seizure-free, small participant numbers and unbal-
anced participant numbers with and without a history of febrile
seizures, leading to large, imprecise results, may have contributed
to variability between studies as in previous analyses, particularly
the two smallest studies showing the two largest effects in favour
of a history of febrile seizures (Holmes 1997; Kim 2010b).
A potential association between febrile seizures and MTS, par-
ticularly whether prolonged febrile seizures are a risk factor for
febrile seizures, is well documented (Davis 1996; Maher 1995;
Sarkisian 1999; Scott 2002; Szabo 1999). Therefore as we have
already noted in this review a good outcome associated with the
presence ofMTS onpathological examination (see Analysis 4.3), it
is intuitive that we should also observe a good outcome of surgery
for participants with a history of febrile seizures. Seven studies
have recorded data on the presence of both MTS on pathological
examination and a history of febrile seizures: two show a signifi-
cant advantage for participants with MTS (Radhakrishnan 1998;
Spencer 2005), three show a non-significant advantage for MTS
(Jeong 1999; Perry 2010; Terra-Bustamante 2005a), and two show
a small non-significant advantage for no MTS on pathological ex-
amination (Chabardes 2005; Grivas 2006). The same trends are
evident in the analysis of febrile seizures as a prognostic factor: the
five studies that show an advantage for MTS on pathological ex-
amination (significant or non-significant) also show an advantage
for a history of febrile seizures in relation to a good post-surgery
outcome; and the two studies that show small advantages for no
MTS also show small advantages for no history of febrile seizures
(see Analysis 4.5).
Given this apparent association between febrile seizures and MTS
pathology, as in Analysis 4.4, specific inclusion criteria of studies
based on pathologymay be contributing to the variability observed
in the subgroup of studies that classified seizure outcome by amore
than one year seizure-free scale (see Analysis 4.5). Two studies
in this subgroup included only participants with a diagnosis of
MTS - in Walz 2003 - or a diagnosis of dual pathology MTS and
FCD - in Kim 2010b, and one study excluded participants with
any pathology other than FCD including MTS (Kim 2009). The
two remaining studies had no specific inclusion criteria based on
pathological findings (Holmes 1997; Spencer 2005).
History of head injury
Seven studies with 551 participants reported data on history of
head injury (history vs no history) as a prognostic factor for post-
surgery seizure outcome. Two studies reported seizure outcome
according to a more than one year seizure-free scale, three studies
according to the Engel Class Scale, and two studies according to
some ’other’ scale (see Included studies for definitions of ’other’
scales). A total of 159 participants had a history of head injury,
100 of whom (63%) achieved a good outcome of surgery, and 392
participants had no history of head injury, 242 of whom (62%)
achieved a good outcome of surgery.
Analysis 4.6 shows that there is no significant difference between
history and no history of head injury for the outcome of surgery
(pooled RR for history vs no history of head injury, 95% CI ad-
justed for outcome scale 0.99, 95% CI 0.86 to 1.13; P = 0.85).
Results according to outcome scale are as follows: more than one
year seizure-free pooled RR for history versus no history of head
injury 0.87 (95% CI 0.72 to 1.05; P = 0.14); Engel Class Scale
pooled RR for history versus no history of head injury 1.17 (95%
CI 0.99 to 1.37; P = 0.06); and ’other’ scale pooled RR for history
32Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
versus no history of head injury 0.83 (95% CI 0.51 to 1.33; P =
0.43).
Here, evidence shows a difference between outcome scales (Chi²
test for subgroup differences P = 0.05), revealing the trend that
studies classifying outcome on the Engel Class Scale favour a his-
tory of head injury for a good outcome of surgery, and studies
classifying outcome on a more than one year seizure-free scale or
’other’ scale favour no history of head injury. Heterogeneity is
present only between studies using ’other’ scales to classify seizure
outcome (I² = 71%), which is the source of moderate heterogene-
ity in the analysis overall (I² = 46%). When analysis is repeated for
subgroups and the overall analysis uses a random-effects model,
pooled results are similar and conclusions remain unchanged. It is
likely that this variation is due to the two different ’other’ scales
used by these studies. Holmes 2000 classified more than two years
seizure-free as a good outcome, and Yang 2011 categorised ILAE
Classes 1 and 2 as a good outcome.
Encephalomalacia on pathology
Five studies with 317 participants reported data on encephaloma-
lacia on pathological examination (present vs absent) as a prog-
nostic factor for seizure outcome of surgery. Four studies reported
seizure outcome according to the Engel Class Scale, and one study
according to some ’other’ scale (see Included studies for definitions
of ’other’ scales). A total of 45 participants had encephalomalacia,
16 of whom (36%) achieved a good outcome of surgery; and 272
participants did not have encephalomalacia, 113 of whom (42%)
achieved a good outcome of surgery.
Analysis 4.7 shows that there is no significant difference between
the presence or absence of encephalomalacia for the outcome of
surgery (pooled RR for presence vs absence of encephalomalacia
0.78, 95% CI adjusted for outcome scale 0.52 to 1.17; P = 0.23).
In other words, the presence of encephalomalacia on pathology
is not a significant independent predictor of seizure outcome of
surgery. Results according to outcome scale include the following:
Engel Class Scale pooled RR for presence versus absence of en-
cephalomalacia 0.89 (95% CI 0.60 to 1.33; P = 0.58); and ’other’
scale (one study) RR for presence versus absence of encephaloma-
lacia 0.28 (95%CI 0.04 to 1.87; P = 0.19). We found no evidence
of a difference between outcome scales for this prognostic factor
(Chi² test for subgroup differences P = 0.24), nor did we find
evidence of heterogeneity between studies in any of the subgroup
analyses or overall (I² = 0%).
Focal cortical dysplasia/malformation of cortical development
on pathology
Forty-six studies with 3572 participants reported data on FCD/
malformation of cortical development (MCD) on pathological ex-
amination (present vs absent, with defect generally defined as FCD
or MCD) as a prognostic factor for seizure outcome of surgery.
Nine studies reported seizure outcome according to a more than
one year seizure-free scale, 33 studies according to the Engel Class
Scale, and five studies according to some ’other’ scale (see Included
studies for definitions of ’other’ scales). A total of 1205 partici-
pants showed FCD/MCD, 687 of whom (57%) achieved a good
outcome of surgery; and 2367 participants did not show FCD/
MCD, 1599 of whom (68%) achieved a good outcome of surgery.
Analysis 4.8 shows that participants without FCD/MCD were
significantly more likely to have a good outcome of surgery than
those with FCD/MCD on pathology (pooled RR for presence vs
absence of FCD/MCD 0.90, 95% CI adjusted for outcome scale
0.85 to 0.95; P = 0.0005). Results according to outcome scale
include the following: more than one year seizure-free pooled RR
for presence versus absence of FCD/MCD 0.92 (95% CI 0.84 to
1.02; P = 0.11); Engel Class Scale pooled RR for presence versus
absence of FCD/MCD0.89 (95%CI0.82 to 0.96; P = 0.003); and
’other’ scale pooled RR for presence versus absence of FCD/MCD
0.91 (95% CI 0.73 to 1.13; P = 0.39). We found no evidence of a
difference between outcome scales for this prognostic factor (Chi²
test for subgroup differences P = 0.83).
A moderate amount of heterogeneity is present between studies in
each of the subgroups and in the overall analysis: I² value ranges
from 28% to 41% in subgroup analyses and is 28% overall.When
analysis is repeatedwith a random-effectsmodel, pooled results are
similar and conclusions remain unchanged. As in previous analy-
ses, we assume it is likely that the small amount of heterogeneity
present between studies is due to small participant numbers and
unbalanced participant numbers with and without FCD/MCD,
leading to large, imprecise results that may have contributed to
variability between studies. Furthermore, variability across studies
in the exact definition of FCD/MCD (focal cortical dysplasia or
malformation of cortical development of varying severities) may
have contributed to variability in study results.
Tumour on pathology
Forty-one studies with 3357 participants reported data on tumour
as a pathological finding (present vs absent, with specific tumour
types defined in some included studies) as a prognostic factor for
seizure outcome of surgery. Seven studies reported seizure outcome
according to a more than one year seizure-free scale, 28 studies ac-
cording to the Engel Class Scale, and six studies according to some
’other’ scale (see Included studies for definitions of ’other’ scales).
A total of 806 participants had a confirmed tumour, of whom 595
(74%) achieved a good outcome of surgery; and 2551 participants
did not show a tumour, of whom 1512 (59%) achieved a good
outcome of surgery.
Analysis 4.9 shows that participants with a tumour were signifi-
cantly more likely to have a good outcome of surgery than those
without a tumour (pooled RR for presence vs absence of tu-
mour 1.21, 95% CI adjusted for outcome scale 1.15 to 1.28; P
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< 0.00001). Results according to outcome scale are very similar:
more than one year seizure-free pooled RR for presence versus
absence of tumour 1.16 (95% CI 1.03 to 1.31; P = 0.02); Engel
Class Scale pooled RR for presence versus absence of tumour 1.20
(95% CI 1.13 to 1.29; P < 0.00001); and ’other’ scale pooled
RR for presence versus absence of tumour 1.34 (95% CI 1.12 to
1.60; P = 0.001). We found no evidence of a difference between
outcome scales for this prognostic factor (Chi² test for subgroup
differences P = 0.41).
A moderate amount of heterogeneity is present between studies in
each of the subgroups and in the overall analysis: I² value ranges
from 34% to 54% and is 41% overall. The largest amount of het-
erogeneity is present between studies classifying seizure outcome
by more than one year seizure-free (I² = 54%); however variabil-
ity is greatly influenced by a single study in this subgroup with
a large effect size due to all participants in this study with a tu-
mour achieving a good outcome of surgery (Duchowny 1998).
When analysis is repeated with a random-effects model in this
subgroup, the pooled RR for presence versus absence of tumour is
no longer statistically significant at 1.17 (95%CI 0.97 to 1.41; P =
0.10). Within other subgroups and in the overall analysis, pooled
results are similar and conclusions remain unchanged. As in the
previous analyses, we assume it is likely that the small amount of
heterogeneity present between studies is due to small participant
numbers and unbalanced participant numbers with and without
tumours, leading to large, imprecise results and contributing to
variability between studies. Furthermore, variability in the type of
tumour observed across studies (i.e. some studies recorded specific
types of tumours observed (e.g. dysembryoplastic neuroepithelial
tumour (DNET), ganglioglioma, oligodendroglioma), and other
studies reported that non-specific ’tumours’ were observed) may
have contributed to variability in study results.
Vascular malformation on pathology
Nineteen studies with 1488 participants reported data on vascu-
lar malformations (present vs absent, with specific malformations
defined in some included studies) as a prognostic factor for post-
surgery outcome. One study reported seizure outcome according
to a more than one year seizure-free scale, 13 studies according to
the Engel Class Scale, and five studies according to some ’other’
scale (see Included studies for definitions of ’other’ scales). A total
of 139 participants had a confirmed vascular malformation, 89 of
whom (64%) achieved a good outcome post surgery; and 1349
participants did not show a vascular malformation, 785 of whom
(58%) achieved a good post-surgery outcome.
Analysis 4.10 shows there is no significant difference between pres-
ence and absence of vascular malformation for the outcome of
surgery (pooled RR for presence vs absence of vascular malfor-
mation 1.07, 95% CI adjusted for outcome scale 0.94 to 1.21; P
= 0.34). In other words, the presence of a vascular malformation
on pathology is not a significant independent predictor of seizure
outcome of surgery. Results according to outcome scale are very
similar: more than one year seizure-free pooled RR for presence
versus absence of vascular malformation 1.06 (95% CI 0.62 to
1.79; P = 0.84); Engel Class Scale pooled RR for presence versus
absence of vascular malformation 1.14 (95% CI 0.98 to 1.34; P
= 0.09); and ’other’ scale pooled RR for presence versus absence
of vascular malformation 1.07 (95% CI 0.94 to 1.21; P = 0.64).
We found no evidence of a difference between outcome scales for
this prognostic factor (Chi² test for subgroup differences P = 0.42)
and no evidence of heterogeneity between studies in any subgroup
analyses or overall (I² = 0%).
Distribution of interictal spikes
Eighteen studies with 1404 participants reported data on distri-
bution of interictal spikes (unilateral vs bilateral spikes, also de-
fined as lateralising vs non-lateralising spikes, focal vs non-focal
spikes, or localising vs non-localising spikes) as a prognostic fac-
tor for seizure outcome of surgery. Seven studies reported seizure
outcome according to a more than one year seizure-free scale, six
studies according to the Engel Class Scale, and five studies accord-
ing to some ’other’ scale (see Included studies for definitions of
’other’ scales). A total of 722 participants had unilateral spikes, of
whom 504 (70%) achieved a good outcome of surgery; and 682
participants had bilateral spikes, of whom 406 (59%) achieved a
good outcome of surgery.
Analysis 4.11 shows that participants with unilateral interictal
spikes are significantly more likely to achieve a good outcome of
surgery than those with bilateral interictal spikes (pooled RR for
unilateral vs bilateral spikes 1.14, 95% CI adjusted for outcome
scale 1.05 to 1.24; P < 0.0001). Results according to outcome scale
include the following: more than one year seizure-free pooled RR
for unilateral versus bilateral spikes 1.08 (95% CI 0.94 to 1.24; P
= 0.72); Engel Class Scale pooled RR for unilateral versus bilateral
spikes 1.19 (95% CI 1.04 to 1.36; P = 0.009); and ’other’ scale
pooled RR for unilateral versus bilateral spikes 1.16 (95% CI 0.97
to 1.39; P = 0.11). We found no evidence of a difference between
outcome scales for this prognostic factor (Chi² test for subgroup
differences P = 0.58).
A substantial amount of heterogeneity is present in the analysis
overall (I² = 67%) and between studies that classified seizure out-
come according to the Engel Class Scale (I² = 84%) and ’other’
scales (I² = 82%). No heterogeneity is present between studies
that classified seizure outcome according to a more than one year
seizure-free scale (I² = 0%). When analyses were repeated with a
random-effects model for studies that classified seizure outcome
according to the Engel Class Scale, the pooled RR for unilateral
versus bilateral spikes was no longer statistically significant at 1.33
(95% CI 0.88 to 2.00; P = 0.17). Results for other subgroups
and for the overall analysis are similar, and conclusions remain
unchanged.
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As in previous analyses, a large amount of heterogeneity is present
between studies using ’other’ scales. Therefore the variability of re-
sults may be due to the different outcome scales used (see Included
studies). Small participant numbers and unbalanced participant
numbers with unilateral and bilateral spikes leading to large, im-
precise results may have contributed to variability between studies.
Further subgroup analysis separating the site of surgery for study
participants (temporal only, extratemporal only, both temporal
and extratemporal) and study design (all studies are of a retrospec-
tive design) shows no significant differences between these sub-
groups that could be contributing to heterogeneity (analyses not
shown but available from study authors).
We note that data on interictal spikes are defined in slightly dif-
ferent ways across studies: two studies defined lateralising versus
non-lateralising or contralateral spikes (Boshuisen 2010; Greiner
2011), three studies defined localised versus non-localised spikes
(Dalmagro 2005; Lee 2008; Tatum 2008), four studies defined fo-
cal versus non-focal spikes (Jayakar 2008; Kim 2010b; Kim 2009;
Rossi 1994), and nine studies defined unilateral versus bilateral
spikes (Chee 1993; Erickson 2005;Goldstein 1996;Holmes 2000;
Lee 2006; Madhavan 2007; Remi 2011; Walz 2003; Weinand
1992). Data based on these differing definitions as subgroups in-
clude the following: lateralising spikes pooled RR for lateralising
versus non-lateralising spikes 1.05 (95% CI 0.85 to 1.31; P =
0.65; I² = 11%); localising spikes pooled RR for localised versus
non-localised spikes 1.08 (95% CI 0.81 to 1.44; P = 0.59; I² =
0%); focal spikes pooled RR for focal versus non-focal spikes 1.05
(95% CI 0.85 to 1.30; P = 0.65; I² = 11%); and unilateral spikes
pooled RR for unilateral versus bilateral spikes 1.22 (95% CI 1.10
to 1.34; P < 0.00001; I² = 76%). We found no statistically signif-
icant evidence of a difference between these subgroups (Chi² test
for subgroup differences P = 0.39); however a trend is apparent
for a larger effect in favour of unilateral spikes when compared
with bilateral spikes as opposed to the other definitions of data
related to the distribution of interictal spikes. We deduced that the
definition of the prognostic factor was likely to have influenced
this analysis; therefore we recommend caution when results of this
analysis are interpreted.
Operative factors
Extent of surgical resection
Forty studies with 3013 participants reported data on ’Extent of
surgical resection’ (complete vs less complete, with completeness
defined in individual studies) as a prognostic factor for seizure out-
come of surgery. Nine studies reported seizure outcome according
to a more than one year seizure-free scale, 28 studies according to
the Engel Class Scale, and three studies according to some ’other’
scale (see Included studies for definitions of ’other’ scales). A to-
tal of 1716 participants underwent complete surgical resection,
of whom 1277 (74%) achieved a good outcome of surgery; and
1297 participants underwent a less complete surgical resection, of
whom 725 (56%) achieved a good outcome of surgery.
Analysis 4.12 shows that participants with complete surgical resec-
tion were significantly more likely to achieve a good outcome of
surgery than those with a less complete resection (pooled RR for
complete vs incomplete resection 1.41, 95% CI adjusted for out-
come scale 1.32 to 1.50; P < 0.00001). Results according to out-
come scale include the following: more than one year seizure-free
pooled RR for complete versus incomplete resection 2.00 (95%
CI 1.66 to 2.41; P < 0.00001); Engel Class Scale pooled RR for
complete versus incomplete resection 1.29 (95% CI 1.21 to 1.39;
P < 0.00001); and ’other’ scale pooled RR for complete versus
incomplete resection 1.59 (95% CI 1.15 to 2.20; P = 0.005). We
found highly significant evidence of a difference between outcome
scales for this prognostic factor (Chi² test for subgroup differences
P < 0.0001), and we noted a larger advantage for studies that clas-
sified studies using a more than one year seizure-free scale com-
pared with the other two outcome scales.
A substantial amount of heterogeneity is present between all sub-
groups and overall in the analysis (I² value ranges from 67% to
86% in subgroups and is 77% in the overall analysis). When anal-
yses were repeated with a random-effects model for studies that
classified seizure outcome according to ’other’ scales, the pooled
RR for complete versus incomplete resection was no longer statis-
tically significant at 1.15 (95% CI 0.44 to 3.00; P = 0.78). Results
for the ’other’ outcome scale and in the overall analysis are similar
and conclusions remain unchanged.
As in previous analyses, some of the variability evident between
studies using the Engel Class Scalemay be due to small participant
numbers and unbalanced participant numbers, with unilateral and
bilateral spikes leading to large, imprecise results. Also, some of
the heterogeneity between studies using ’other’ scales may be due
to the different outcome scales used (see Included studies): two
studies in this subgroup, which classified participants according
to the ILAE scale (Lackmayer 2013; Sakamoto 2009), show a
non-significant trend in favour of less complete resection, and the
other study shows a large effect in favour of complete resection,
classified according to more than three years of seizure freedom
(Rossi 1994).
We carried out further subgroup analysis by separating the site of
surgery of participants in the study (temporal only (13 studies),
extratemporal only (one study), both temporal and extratemporal
(24 studies); site of surgery not available for Dalmagro 2005 and
Raabe 2012) andobtained the following results (see Analysis 4.13):
extratemporal only RR 2.00 (95% CI 0.76 to 5.29; P = 0.16);
temporal only pooledRR for complete versus incomplete resection
1.11 (95% CI 1.03 to 1.20; P = 0.006; I² = 31%); temporal and
extratemporal pooledRR for complete versus incomplete resection
1.98 (95% CI 1.77 to 2.23; P < 0.00001; I² = 75%); and overall
pooled RR 1.48 (95% CI 1.38 to 1.58; P < 0.00001; I² = 78%).
We found highly significant evidence of a difference between the
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site of surgery and the outcome of surgery (Chi² test for subgroup
differences P < 0.00001) and less of an advantage for complete
surgical resection for studies in which participants had temporal
lobe surgery only compared to the study in which all participants
had extratemporal lobe surgery or studies in which participants
had either temporal or extratemporal lobe surgery.
Furthermore, most of the heterogeneity in this analysis can be seen
between studies in which participants had either temporal or ex-
tratemporal lobe surgery. This could be due to the association we
observed between site of surgery and seizure outcome of surgery
(see “Overall outcome of surgery” above). In other words, the dif-
ference in site of surgery across studies is confounding the analysis
of extent of resection. Analysis 4.13 could also suggest that there
may be a difference in the feasibility of performing a complete or
less complete resection for temporal or extratemporal lobes; there-
fore it would be expected that results would be variable between
studies that include a mixture of temporal lobe and extratemporal
lobe surgery candidates, and that outcomes may be dependent on
the proportion of participants receiving each type of surgery.
In addition, we noted that the definition of a ’complete’ or ’less
complete’ resection was variable across studies. Most studies de-
fined the extent of resection by the type of surgery performed
(e.g. anterior temporal lobectomy or extended resection is com-
plete resection, but selective amygdalohippocampectomy or le-
sionectomy is less complete resection; Lackmayer 2013; Sakamoto
2009). Other studies defined complete or incomplete resection
postoperatively by MRI (e.g. O’Brien 2000; Zentner 1996), or
operatively by subdural EEG (e.g. Widdess-Walsh 2007). Other
studies confirmed the completeness of tailored resection by the
surgical team at the time (e.g. Hamiwka 2005). These differences
in definition are also likely to have contributed to substantial vari-
ability in this analysis.
Side of surgical resection
Thirty-seven studies with 2976 participants reported data on side
of surgical resection (left- vs right-sided resection) as a prognos-
tic factor for post-surgery seizure outcome. Five studies reported
seizure outcome according to a more than one year seizure-free
scale, 27 studies according to the Engel Class Scale, and five studies
according to some ’other’ scale (see Included studies for definitions
of ’other’ scales). A total of 1749 participants underwent left-sided
surgical resection, of whom 1302 (67%) achieved a good outcome
of surgery; and 1476 participants underwent a right-sided surgi-
cal resection, of whom 1056 (72%) achieved a good outcome of
surgery.
Analysis 4.14 shows that participants with right-sided resection
are significantly more likely to achieve a good outcome of surgery
than those with left-sided resection (pooled RR for left- vs right-
sided resection 0.94, 95% CI adjusted for outcome scale 0.90
to 0.98; P = 0.008). Results according to outcome scale include
the following: more than one year seizure-free pooled RR for left
versus right-sided resection 1.01 (95% CI 0.90 to 1.13; P = 0.90);
Engel Class Scale pooled RR for left- versus right-sided resection
0.93 (95% CI 0.88 to 0.98; P = 0.01); and ’other’ scale pooled RR
for left- versus right-sided resection 0.92 (95% CI 0.79 to 1.07; P
= 0.27). We found no evidence of a difference between outcome
scales for this prognostic factor (Chi² test for subgroup differences
P = 0.47).
Noheterogeneity is evident between studies classifying seizure out-
come according to amore than one year seizure-free scale or ’other’
scales (I² = 0%); however some heterogeneity is present between
studies classifying seizure outcome according to the Engel Class
Scale (I² = 43%) and in the overall analysis (I² = 28%). When
analyses were repeated with a random-effects model for studies
that classified seizure outcome according to the Engel Class Scale,
the pooled RR and the overall pooled RR were no longer statisti-
cally significant: Engel Class Scale pooled RR for left- versus right-
sided resection was 0.96 (95% CI 0.89 to 1.02; P = 0.19); and
overall pooled RR for left- versus right-sided resection 0.96 (95%
CI 0.91 to 1.01; P = 0.14). We found no evidence of a difference
between outcome scales for this prognostic factor (Chi² test for
subgroup differences P = 0.60).
As in previous analyses, the heterogeneity that is evident between
studies using the Engel Class Scale may be due to small partici-
pant numbers and unbalanced participant numbers, with left- and
right-sided resections leading to large, imprecise results.
We carried out further subgroup analysis by separating the site of
surgery of participants in the study (temporal only (30 studies),
extratemporal only (two studies), both temporal and extratempo-
ral (four studies); site of surgery not available for Dalmagro 2005).
This approach yielded the following results (see Analysis 4.15):
extratemporal only pooled RR for left- versus right-sided resection
1.03 (95% CI 0.76 to 1.39; P = 0.84; I² = 85%); temporal only
pooled RR for left- versus right-sided resection 0.93 (95%CI 0.89
to 0.98; P = 0.006; I² = 30%); temporal and extratemporal pooled
RR for left- versus right-sided resection 0.98 (95% CI 0.84 to
1.14; P = 0.77; I² = 0%); and overall pooled RR for left- versus
right-sided resection 0.94 (95% CI 0.90 to 0.98; P = 0.009; I²
= 28%). We found no statistically significant difference between
sites of surgery for this prognostic factor (Chi² test for subgroup
differences P = 0.68); however this subgroup analysis shows that
the significant advantage of right-sided resection for good out-
come of surgery is found only in studies in which all participants
had temporal lobe surgery. Further, this subgroup analysis shows
that the two studies with the largest effects favouring left and right
resection, respectively (Lee 2008; Liava 2012), which contributed
to most of the variability in this analysis, are the only studies in
which all participants had extratemporal lobe surgery.
In summary, results of this analysis suggest that there is likely to
be an association between side of surgery and outcome of surgery
(right-sided resection is associated with good outcome); however
these results may have been confounded by the site of surgery,
and this association may exist only for participants undergoing
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temporal lobe surgery. We require more evidence on the side of
extratemporal surgery related to seizure outcome before we can
provide conclusions regarding side of resection as a prognostic
factor for outcome.
Postoperative factors
Postoperative discharge
Six studies with 542 participants reported data on postoperative
discharge (present vs absent) as a prognostic factor for post-surgery
seizure outcome. Two studies reported seizure outcome according
to a more than one year seizure-free scale, four studies according to
the Engel Class Scale, and one study according to some ’other’ scale
(see Included studies for definitions of ’other’ scales). A total of
200 participants had postoperative discharge, of whom 132 (66%)
achieved a good outcome of surgery; and 342 participants did not
have postoperative discharge, of whom262 (77%) achieved a good
outcome of surgery.
Analysis 4.16 shows that there is no significant difference between
presence or absence of postoperative discharge in the outcome
of surgery (pooled RR for presence vs absence of postoperative
discharges 0.91, 95% CI adjusted for outcome scale 0.79 to 1.04;
P = 0.16). In other words, the presence of postoperative discharge
is not a significant independent predictor of seizure outcome of
surgery. Results according to outcome scale include the following:
more than one year seizure-free pooled RR for presence versus
absence of postoperative discharge 1.19 (95% CI 0.82 to 1.73;
P = 0.36); and Engel Class Scale pooled RR for presence versus
absence of postoperative discharge 0.85 (95% CI 0.74 to 0.98; P
= 0.03). We found no evidence of a difference between outcome
scales for this prognostic factor (Chi² test for subgroup differences
P = 0.10).
A substantial amount of heterogeneity is present in the analysis
overall (I² = 73%) and between the two studies that classified
seizure outcome according to a more than one year seizure-free
scale (Jennum 1993; Widdess-Walsh 2007) (I² = 90%); these two
studies showed the largest effects in favour of discharges present
and absent, respectively. Further, some heterogeneity is present
between studies that classified seizure outcome according to the
Engel Class Scale (I² = 34%). Analyses repeated with a random-
effects model yielded the following results: overall pooled RR ad-
justed for outcome scale 0.91 (95% CI 0.68 to 1.22; P = 0.52);
more than one year seizure-free pooled RR for presence versus
absence of postoperative discharges 0.97 (95% CI 0.24 to 3.93;
P = 0.97); and Engel Class Scale pooled RR for presence versus
absence of postoperative discharge 0.85 (95% CI 0.70 to 1.03; P
= 0.09).
Further subgroup analysis separating the site of surgery for study
participants (temporal only in Janszky 2003b, Miserocchi 2013,
and Radhakrishnan 1998, vs both temporal and extratemporal in
Jennum 1993, Widdess-Walsh 2007, and Wray 2012) shows a
significant difference between these subgroups (Chi² test for sub-
group differences P = 0.02; see Analysis 4.17). Within the three
studies in which researchers performed temporal lobe surgery on
participants, the pooled RR for presence versus absence of post-
operative discharge was 0.81 (95% CI 0.70 to 0.94; P = 0.006; I²
= 0%), indicating that for temporal lobe surgery only, participants
without postoperative discharge were significantly more likely to
achieve a good outcome of surgery than those with postopera-
tive discharge. However, within the three studies that performed a
mixture of temporal and extratemporal lobe surgeries on partici-
pants, the pooled RR for presence versus absence of postoperative
discharge was 1.20 (95% CI 0.89 to 1.61; P = 0.23; I² = 81%).
This shows a non-significant trend in favour of the presence of
postoperative discharge for a good outcome of surgery, and all of
the heterogeneity noted in the analysis is seen between these three
studies. These three studies are the smallest in this analysis, and all
show large, imprecise effect sizes due to small participant numbers.
Further, themixture of participants undergoing temporal lobe and
extratemporal lobe surgery in these studies is likely to have con-
tributed to the variability. The difference between subgroups also
may suggest a difference between the presence of postoperative
discharge in participants undergoing temporal or extratemporal
surgery and in the prognosis of the two surgery types.
Results of these further analyses and our observation of an associa-
tion between site of surgery and outcome of surgery (see “Overall
outcome of surgery” above) show that absence of postoperative
discharge may be a predictor of good outcome of surgery. How-
ever, this analysis is likely to have been confounded by differing
sites of surgery across the included studies, and we require more
evidence on this prognostic factor specific to the site of surgery
before presenting any conclusions. We note the limitation in this
analysis that the factor ’postoperative discharge’ may be related to
and may be influenced by other pre-operative and postoperative
factors and potentially by outcome (e.g. whether or not a post-
operative EEG is obtained), which may be more likely if an indi-
vidual has experienced a possible postoperative seizure. Further-
more, clinicians may bemore likely to perform postoperative EEG
after a long interval following surgery to inform decisions such
as antiepileptic drug tapering. Selective use of postoperative EEG
and therefore selective participants contributing to this factor may
have introduced selection bias into this analysis; we recommend
extreme caution when results of this analysis are interpreted.
Multi-variable analyses
Summary of studies reporting multi-variable models
In an additional post hoc analysis, we screened all 174 studies re-
porting seizure outcome data on a satisfactory scale. This revealed
whether a multi-variable prognostic regression model had been
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fitted to assess the adjusted influence of independent prognostic
factors of interest in this review (see Secondary outcomes) on the
dependent variable of seizure outcome (defined as the proportion
of individuals experiencing a good outcome of surgery; see Primary
outcomes for further details on this definition).
Twenty-nine of 174 studies (17%) performed no statistical analysis
at all and reported only proportions/percentages. For 72 of 174
studies (41%), researchers described only univariate analyses. For
19 of 174 studies (11%), study authors did not report seizure
outcome according to our definitions of a ’good’ seizure outcome
for analyses involving prognostic factors. In 16 of 174 studies
(9%), investigators described a multi-variable model but did not
include any of our pre-specified factors.
In total, 29 studies described a multi-variable prognostic model
including one or more of the factors of interest to us (Althausen
2013; Boesebeck 2007; Cossu 2005; Cossu 2008; Elsharkawy
2008a; Elsharkawy 2009a; Gelinas 2011; Grivas 2006; Janszky
2003a; Jennum 1993; Kim 2009; Kim 2010a; Lopez-Gonzalez
2012; Madhavan 2007; McIntosh 2012; O’Brien 2000; Paolicchi
2000; Phi 2009; Radhakrishnan 1998; Rossi 1994; Sagher 2012;
Sarkis 2012; Schramm2011; Spencer 2005;Tezer 2008;Theodore
2012; Walz 2003; Wyler 1995; Yang 2011). The authors of two
studies described two separate multi-variate models for seizure
outcome, with different combinations of variables entered into the
two models (McIntosh 2012; O’Brien 2000).
We extracted data from all 29 studies regarding variables entered
into themulti-variable model, statistical methods used, and results
of multi-variable modelling; we performed an additional risk of
bias assessment of each of the 29 studies using a tool for prognostic
studies (see Risk of bias in included studies). Overall, we judged
one study to be at ’high’ risk of bias in three domains (Rossi 1994),
three studies to be at ’high’ risk of bias in two domains (Althausen
2013; Janszky 2003a; Madhavan 2007), and 11 studies to be at
’high’ risk of bias in one domain (Cossu 2008; Elsharkawy 2008a;
Elsharkawy 2009a; Jennum 1993; Kim 2009; Paolicchi 2000;
Radhakrishnan 1998; Sarkis 2012; Spencer 2005; Tezer 2008;
Theodore 2012); The remaining 13 studies were not judged to
be at ’high’ risk of bias in any domain (Boesebeck 2007; Cossu
2005;Gelinas 2011;Kim2010a; Lopez-Gonzalez 2012;McIntosh
2012; O’Brien 2000; Phi 2009; Sagher 2012; Schramm 2011;
Walz 2003; Wyler 1995; Yang 2011).
In the 29 studies, 2311of 3564 individualswhounderwent surgery
(65%) experienced a good outcome of surgery. Five studies identi-
fied participants according to a prospective design (Radhakrishnan
1998; Schramm 2011; Spencer 2005; Theodore 2012; Wyler
1995), two of which used a randomised design (Schramm 2011;
Wyler 1995). In one study, it was not clear if participants were
identified according to a prospective or retrospective design (Walz
2003); the remaining 23 studies identified participants according
to a retrospective design.
It is unclear from the information reported in one study whether
the dependent variable of seizure outcome was analysed as ’good’
(Engel Class 1) or ’favourable’ (Engel Classes 1 and 2) (Grivas
2006). Furthermore, it is unclear whether this study entered vari-
ables into the model, and study authors provided very little infor-
mation regarding the results of modelling. Due to these issues, we
have not considered this study any further in the narrative review
of multi-variable models.
Given the variability of statistical regression models used (logistic
regression, Cox proportional hazards regression, generalised esti-
mating equations, etc.) and the combinations of variables entered
into prognostic models, as well as the level of detail reported re-
garding results of prognostic models, combining adjusted results
in meta-analysis was impossible in this review. Instead we provide
below a narrative summary of the multi-variable models fitted.
Furthermore, we have identified several issues that arose when we
considered the multi-variable models reported in 28 studies (mi-
nus Grivas 2006; see “Adjusted results” below for further details).
• For 13 of 28 studies (46%), it is not clear exactly which
variables had been entered into the model.
• For 13 of 28 studies (46%), researchers seem to have
entered variables into the model according to statistical
significance rather than clinical relevance (i.e. only variables
showing a statistical association with outcome in univariate
analyses were considered for multi-variable modelling).
• For 13 of 28 studies (46%), study authors reported no
adjusted treatment effect sizes (revealed only P values or whether
results that were ’significant’ were reported).
• For 15 of 28 studies (54%), researchers selectively reported
results of the multi-variate model or did not report them fully
(e.g. numerical results reported only for variables shown to be
statistically significant in multi-variable analysis).
One study did not report adjusted results for the Cox proportional
hazards model fitted to a wide range of prognostic variables con-
sidered in the study (including extent of surgical resection, history
of febrile seizures, history of initial precipitating insult, distribu-
tion of interictal spikes, and side of surgery of interest to us); study
authors reported only ’crude’ unadjusted hazard ratios from the
model (Walz 2003).
One study described a multi-variable logistic regression analysis
for a wide range of prognostic variables (including extent of sur-
gical resection of interest to us); however, study authors referred
to ’univariate conditions’ when describing results of the model
(Paolicchi 2000). Therefore, it is unclear whether presented results
reflect adjusted or unadjusted values.
Adjusted results
The other 26 studies presented adjusted results for amulti-variable
model. We have summarised these results below according to the
level of detail reported (least detailed to most detailed) and the
type of regression model fitted.
Four studies reported only the significance of results (Cossu 2005;
Elsharkawy 2008a; Elsharkawy 2009a; Theodore 2012). For all
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four studies, it is clear which variables had been entered into the
model; however two studies - Elsharkawy 2008a and Elsharkawy
2009a - entered variables into the multi-variable model based on
statistical significance in univariate analyses, and all four studies
selectively reported ’significant’ and ’non-significant’ results.
• Cossu 2005 entered a large range of variables into a
stepwise multi-variable logistic regression analysis: discrete
numerical variables (age at seizure onset, illness duration before
surgery, monthly seizure frequency) and categorical variables
(sex, presence of lesion on MRI, presence of MTS on MRI, side
of stereoelectroencephalography, site of epileptogenic zone (EZ),
site of resection, type of resection, completeness of lesionectomy,
reason for incomplete lesionectomy, histological diagnosis,
presence of MTS at histological analysis on resected mesial
temporal specimens). Most variables are not mentioned in the
results (including presence of MTS on MRI and presence of
MTS at histological analysis of interest to us) and therefore are
assumed to be not significantly associated with seizure outcome.
It is stated that completeness of lesionectomy shows “statistically
significant association with outcome at univariate and
multivariate analysis”, but no P value, treatment effect size, or
direction of effect is mentioned.
• Elsharkawy 2008a entered the following variables
(significant in univariate analyses) into multi-variable logistic
regression analysis: well-circumscribed lesion on the pre-
operative MRI scan, short duration of epilepsy, early surgical
interference, a neoplasm in the resected specimen, a psychic aura,
versive seizures, tonic-clonic seizures, history of previous surgery,
and focal cortical dysplasia in the resected specimen. The only
variable of interest to us is “presence of focal cortical dysplasia in
the resected specimen”, which was “unable to provide predictive
value for the outcome”.
• Elsharkawy 2009a entered the following variables
(significant in univariate analyses) into multi-variable stepwise
Cox proportional hazards regression analysis: presence of regional
hippocampal atrophy on pre-operative MRI, history of febrile
seizure, EEG unilateral seizure onset, age under 30 years at
surgery, exclusively unilateral sharp waves, right-sided resection,
short epilepsy duration, family history of epilepsy, bilateral sharp
waves, seizure onset bilateral, versive seizures, somatosensory
aura, EEG at six months with interictal epileptiform discharges
(IEDs), and EEG at two years with IEDs. The variables of
interest to us (history of febrile seizures, EEG unilateral seizure
onset, EEG with IED at two years, and right-sided resection)
“did not retain significance in [the] stepwise model”.
• Theodore 2012 entered three variables into a multi-variable
stepwise logistic regression analysis: MRI, 18-
(fluorodeoxyglucose)F-trans-4-fluoro-N-2-[4-(2-
methoxyphenyl) piperazin-1-yl]ethyl-N-(2-pyridyl)cyclohexane
carboxamide (FCWAY) positron emission tomography (PET),
and 18F-FDG PET. The only variable of interest to us (MRI)
“was not selected as being predictive of outcome”.
Six studies reported only P values for results (Althausen 2013;
Jennum 1993; Madhavan 2007; Rossi 1994; Sarkis 2012;
Schramm 2011). Three studies entered variables into the multi-
variable model based on statistical significance in univariate anal-
yses (Madhavan 2007; Rossi 1994; Sarkis 2012), and four stud-
ies selectively reported multi-variable model results based on sta-
tistical significance (Althausen 2013; Jennum 1993; Sarkis 2012;
Schramm 2011).
• Althausen 2013 specified in the methods section that age at
surgery, side of surgery, aetiology (acquired, developmental,
progressive), pre-operative intelligence, age at epilepsy onset, and
duration of epilepsy would be entered into a stepwise logistic
regression, but reported results suggest that hemispherectomy
technique or completeness of hemispheric disconnection has also
been entered into the model. Among the variables of interest to
us, neither completeness of hemispheric disconnection nor side
of surgery showed “significant effect on postoperative outcome”
(P > 0.1). It is unclear if any other variables of interest to us were
included in the model.
• Jennum 1993 entered the following variables into multiple
regression analysis: age, sex, duration of epilepsy, MRI, structural
lesion (tumour, arteriovenous malformation, or hamartoma)
versus normal or localised atrophy, extent of temporal resection,
temporal versus extratemporal focus, ictal focus completely
resected, interictal focus completely resected, and presence of
post-resection spikes in operative electrocorticography. Among
the variables of interest to us, study authors did not report
structural lesions on MRI in the results of factors strongly
associated with good outcome. P values < 0.01 and < 0.04 were
reported for complete resection of ictal focus and presence of
post-resection spikes in operative electrocorticography,
respectively, with no further discussion of the association
between these variables and outcome.
• Madhavan 2007 entered the following variables (significant
in univariate analyses) into the multi-variate analysis (details of
multi-variate model not specified): age at seizure onset, presence/
prior history of infantile spasms, ictal and interictal focality
(unilateral vs bilateral), extent of surgical procedure (corpus
callosotomy, lesionectomy, lobar resection, lesionectomy, lobar
resection), and presence of residual dominant tube. Among the
variables of interest to us, “there was a trend toward better
seizure outcome in those patients that had more extensive
procedures (p = 0.86)”, and interictal focality was not associated
with seizure outcome (P = 0.42).
• Rossi 1994 entered the following variables (significant in
univariate analyses) into multi-variate logistic regression: spatial
arrangement of electrocerebral epileptiform interictal and ictal
activities, extent of resection of the structural lesion, and that of
the epileptogenic zone. Among the variables of interest to us,
extent of resection of the structural lesion and prevalence of
interictal epileptiform activity were ’significantly associated with
surgical outcome’ (P < 0.001 and P = 0.013, respectively);
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however researchers did not specify the direction of association
for either variable.
• Sarkis 2012 entered the following variables (significant in
univariate analyses) into multi-variate Cox proportional hazards
regression: type of resection, pre-operative auras, incomplete
resection, presence of postoperative spikes, age at seizure onset,
and prior epilepsy surgery. Among the variables of interest to us,
incomplete surgical resection and presence of postoperative
spikes are “correlated with seizure recurrence” (P = 0.03 and P =
0.0003, respectively).
• Schramm 2011 presented unclear information on which
variables from a list of “confounders” researchers entered into
multi-variable logistic regression analysis. Study authors stated,
“Extent of resection and surgery type interacted, as did extent of
resection and centre (p = 0.073)”; however they did not discuss
any association between extent of resection and seizure outcome.
It remains unclear whether any other variables of interest to us
were included in the model.
Three studies reported P values plus regression coefficients (
Boesebeck 2007; Kim 2010a; Sagher 2012). None of these studies
seemed to enter variables into the multi-variable model based on
statistical significance; however it is unclear for all three studies
exactly which variables researchers had entered into the models.
Regression coefficients could not be converted to treatment effects
(e.g. odds ratios) in any of the three studies.
• In Boesebeck 2007, details are unclear regarding which
’demographic’ and ’histological’ data had been entered into a
backward stepwise multi-variable logistic regression. Among the
variables of interest to us, tumour on histology was significantly
associated with a good outcome (regression coefficient 1.358;
standard error (SE) 0.67; P = 0.044), and vascular lesions and
malformation of cortical development (MCD) on histology were
not significantly associated with outcome (regression coefficient
0.40; SE 0.94; P = NS; and regression coefficient 0.39, SE 0.62;
P = NS, respectively).
• Kim 2010a entered extent of resection, EEG findings, MRI
findings, and pathology findings (not further defined) into
multi-variate logistic regression analysis. Among the variables of
interest to us, visible lesion on MRI and extent of resection of
electrodes were significantly associated with outcome (P < 0.001,
likelihood ratio 12.7; and P = 0.008, likelihood ratio 7.1,
respectively); however study authors did not specify the direction
of association. It also appears that researchers entered presence of
tumour and presence of cortical dysplasia on pathology into the
model, but they mentioned no numerical results for these
variables.
• Sagher 2012 analysed the following variables via generalised
estimating equations: type of operation, extent of resection of
mesial temporal structures, sex, participant age at operation,
handedness, pre-operative secondary generalisation, age at onset
of epilepsy, duration of epilepsy, dual pathology, complications,
and grid implantation. Among the variables of interest to us,
increasing percentage of various mesial temporal structures
(amygdala, hippocampus, entorhinal cortex, total) was
significantly associated with good outcome, and implantation of
grids and/or depth of electrodes was significantly associated with
poor outcome (coefficient 0.12; SE 0.06; P = 0.05).
Two studies reported a mixture of P values and treatment effect
sizes (Janszky 2003a; Spencer 2005).
• Janszky 2003a entered the following variables into stepwise
logistic regression analyses (variables not selected based on
statistical significance): complex febrile seizures (CFCs),
unilateral interictal epileptiform discharges, tonic-clonic seizures,
perinatal insult, or side of surgery. Researchers reported
numerical results only for variables that were significant in multi-
variable analysis; among the variables of interest to us, results
showed that history of CFC (odds ratio (OR) 5.9, 95% CI 1.26
to 27.7; P = 0.023), where OR > 1, was associated with a good
surgical outcome. Study authors also stated that history of
perinatal insult, unilateral epileptiform discharges concordant
with the operated side, and side of surgery had “no influence on
post-operative outcome”.
• For Spencer 2005, it is unclear which of the variables from
a long list of ’independent variables’ researchers had entered into
the multi-variable proportional hazards model; variables did not
seem to be entered based on statistical significance. Study
authors reported numerical results only for variables that were
significant in multi-variable analysis. Among the variables of
interest to us, results showed that presence of hippocampal
atrophy on MRI (RR 1.58, 95% CI 1.13 to 2.21; P = 0.007),
where RR > 1, is a predictor of two-year remission. Study
authors also stated that a history of febrile seizures did not
“approach significance”; it is unclear whether investigators
included in the model any other variables of interest to us.
Three studies reported risk ratios (RRs) or hazard ratios (HRs)
from multi-variable Cox proportional hazards models (Lopez-
Gonzalez 2012; McIntosh 2012; Phi 2009). All three studies en-
tered variables into multi-variable analysis based on statistical sig-
nificance at univariate analysis, but none of these studies seemed
to selectively report the results of multi-variable analysis based on
statistical significance.
• Lopez-Gonzalez 2012 entered the following variables
(significant in univariate analyses) into multi-variable analysis:
side of surgery (left), number of antiepileptic drug trials (more
than four), tumour aetiology, and extensive surgical resection
(lesionectomy plus cortico-amygdalohippocampectomy). Among
the variables of interest to us, tumour aetiology and right side of
resection were not significant predictors of seizure freedom (RR
0.72, 95% CI 0.30 to 1.48; and RR 1.59, 95% CI 0.92 to 2.76,
respectively), but extensive surgical resection was a significant
predictor of seizure freedom (RR 0.13, 95% CI 0.007 to 0.64; P
= 0.007).
• McIntosh 2012 conducted two multi-variable analyses.
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Study authors entered the following variables into the first
model: pathology (lesion (tumour), acquired insult, cortical
dysplasia, non-specific) and extent of resection. For the second
model, they entered the variables that were significant in the first
multi-variable analysis plus presence or absence of early
postoperative seizures. Among the variables of interest to us,
model one shows that incomplete resection was a significant risk
factor for seizure recurrence (HR 1.71, 95% CI 1.06 to 2.76; P =
0.028), but model two shows that incomplete resection was no
longer a significant risk factor (HR 0.98, 95% CI 0.59 to 1.63; P
= 0.95). Also, in both models one and two, pathology of FCD
compared to other pathologies is a significant risk factor for
seizure recurrence (model one: HR 1.90, 95% CI 1.08 to 3.34; P
= 0.025; model two: HR 1.54, 95% CI 0.87 to 2.42; P = 0.014).
• In Phi 2009, it is unclear which variables from a long list of
“patient-related factors” and “treatment-related factors” were
significant at univariate analysis and had been entered into
analysis. Among the variables of interest of us, failure of
macroscopic total resection was significantly associated with poor
outcome (RR 18.22, 95% CI 3.81 to 87.09; P < 0.001). It is
unclear if any other variables of interest to us were included in
the model.
The remaining eight studies reported odds ratios frommulti-vari-
able logistic regression models (Cossu 2008; Gelinas 2011; Kim
2009; O’Brien 2000; Radhakrishnan 1998; Tezer 2008; Wyler
1995; Yang 2011). Four studies entered variables into the multi-
variable model based on statistical significance in univariate anal-
yses (Cossu 2008; Kim 2009; Radhakrishnan 1998; Tezer 2008);
for five studies, it is not clear exactly which variables researchers
had entered intomulti-variable analysis (Gelinas 2011; Kim 2009;
Radhakrishnan 1998; Tezer 2008; Yang 2011); and three studies
selectively reported multi-variable model results based on statisti-
cal significance (Cossu 2008; Kim 2009; Tezer 2008).
• Cossu 2008 entered the following variables (significant in
univariate analysis) into multi-variable analysis: sex, neurological
status, age at seizure onset, duration of epilepsy, seizure
frequency, MRI findings, use of video EEG and
stereoelectroencephalography, age at surgery, type of surgery, side
and site of surgery, extent of lesion resection, histology of
resected tissue, length of follow-up. Among the variables of
interest to us, results show that complete lesionectomy and
histological diagnosis of neuronal/glial-neuronal tumour were
significantly associated with surgical outcome (OR 0.40, 95% CI
0.23 to 1.01; P = 0.05; and OR 0.19, 95% CI 0.05 to 0.53; P =
0.004, respectively).
• For Gelinas 2011, it is unclear which of the variables from
’clinical characteristics’ researchers had entered into analysis.
Among the variables of interest to us, use of ECoG (intracranial
monitoring) was not associated with seizure freedom at one year
or at most recent follow-up (OR 0.71, 95% CI 0.21 to 2.43; P =
0.59; and OR 0.44, 95% CI 0.14 to 1.34; P = 0.15,
respectively). It is unclear whether any other variables of interest
to us were included in the model.
• For Kim 2009, it is unclear which of the variables from a
long list of ’clinical characteristics’ and ’prognostic factors’ were
significant variables at univariate analysis and had been entered
into analysis. Among the variables of interest to us, results show
that complete resection of the epileptogenic area was associated
with seizure outcome (OR 4.94, 95% CI 2.41 to 10.14; P <
0.001). It is unclear whether any other variables of interest to us
were included in the model.
• O’Brien 2000 conducted two multi-variable analyses. For
the first model, researchers entered the following variables:
subtraction ictal SPECT co-registered with MRI (SISCOM)
regional localisation (concordant vs non-concordant/non-
localising), pre-operative MRI findings (lesional vs non-lesional),
and ictal scalp EEG findings (localising vs non-localising). For
the second model, researchers entered the following variables:
extent of excision of the SISCOM focus, pre-operative MRI
findings, and ictal scalp EEG findings. Neither model showed
the presence of focal structural lesions to be a significant
predictor of surgical outcome (OR 2.3, P = 0.32; and OR 4.7, P
= 0.28, respectively). The second model showed complete
excision of SISCOM focus to be a significant predictor of
surgical outcome (OR 201.0, P = 0.03).
• For Radhakrishnan 1998, it is unclear which of the
variables were significant variables at univariate analysis and had
been entered into analysis. Among the variables of interest to us,
results show that the presence of MRI-detected unilateral
hippocampal formation atrophy “is a predictor of excellent
seizure control” (OR 3.7, 95% CI 1.2 to 11.71; P = 0.024). It is
unclear whether any other variables of interest to us were
included in the model.
• For Tezer 2008, it is unclear which ’continuous’ and
’categorical’ variables were significant variables at univariate
analysis and had been entered into analysis. From the variables of
interest to us, results show that the presence of history of trauma
was “predictive for worsening of outcome” (OR 0.33, 95% CI
0.003 to 0.38; P = 0.05). It is unclear whether any other
variables of interest to us were included in the model.
• Wyler 1995 entered the following variables into multi-
variable analysis: extent of resection (partial vs total
hippocampectomy), age at surgery, age at onset of epilepsy,
laterality of surgery, gender, and presence/absence of
hippocampal sclerosis. Among the variables of interest to us,
results show that total hippocampectomy (compared to partial
hippocampectomy) was associated with seizure freedom (OR
4.2, P = 0.02), but the presence of hippocampal sclerosis was not
associated with seizure freedom (OR 2.0, P = 0.32).
• For Yang 2011, it is unclear which of the variables from
’data collected’ researchers had entered into analysis. Among the
variables of interest to us, results show that concordance of MRI
with EEG and presence of hippocampal sclerosis were
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significantly associated with outcome (OR 6.33, 95% CI 1.44 to
27.81; P = 0.015; and OR 18.06, 95% CI 4.48 to 72.88; P <
0.001, respectively), but complete resection and use of subdural
electrodes were not significantly associated with outcome (OR
0.60, 95% CI 0.06 to 5.76; P = 0.659; and OR 0.61, 95% CI
0.14 to 2.68; P = 0.52, respectively).
Summary of adjusted analyses
It is difficult to summarise the adjusted results of the 26 studies
described above due to different statistical methods used, different
variables entered into the models chosen according to different
criteria, and variable levels of detail in the reporting of multi-
variable results.
Overall, none of the reported prognostic models included en-
cephalomalacia as a factor; one included vascular malformations;
two included concordance of MRI and EEG, head injury, and
distribution of interictal spikes; three included focal cortical dys-
plasia, febrile seizures, and use of intracranial monitoring; four
included MRI results, tumour, and postoperative discharge; five
included side of resection; six included mesial temporal sclerosis;
and 18 included extent of resection.
Due to the different combinations of variables entered into multi-
variable models and therefore lack of adjustment of adjusted re-
sults for the same factors, direct comparison of the multi-variate
analysis versus the univariate meta-analysis reported in this review
is difficult.
Generally the direction of association of variables with outcome
was the same in multi-variable analyses as in univariate meta-anal-
yses. The only differences of note were that nomulti-variablemod-
els found an association between side of surgery and outcome (the
significant advantage for right-sided resection in Analysis 4.14),
or between distribution of interictal spikes and outcome (the sig-
nificant advantage for unilateral spikes in Analysis 4.11).
However, we note that for all but one study (O’Brien2000), we had
judged statistical analysis and reporting of multi-variable models
to be at moderate or high risk of bias; therefore we recommend
caution when any numerical results from multi-variable models
are interpreted. Many of the multi-variable models included only
variables that were significant at univariate analysis, or for which
some variables did not retain significance in adjusted analysis (in
other words, the aim of the model may have been to investigate
which variables would not retain significance). This approach to
multi-variable analysis may explain why no significant associa-
tion was found between certain variables and outcomes in some
studies, whereas a univariate association was shown in this review.
Furthermore, many studies reported results only for variables that
showed a statistically significant association with outcome. There-
fore, there might have been more instances in which a factor of
interest to us was shown not to be associated with outcome by a
multi-variable model, but this information is not provided in the
published study paper.
In several instances, researchers reported that variables were asso-
ciated with outcome (particularly extent of resection) but did not
specify the direction of the association (variably associated with
good or poor outcome); reporting an association without a direc-
tion is of little clinical utility for practice.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Comparison of surgical interventions for epilepsy
Patient or population: adults and children with drug-resistant epilepsy suitable for surgical intervent ion
Settings: outpat ients (following surgery in hospital)
Intervention: experimental surgical intervent ion (see comments)
Comparison: control surgical intervent ion (see comments)
Outcomes Illustrative comparative risks*
(95% CI)
Relative effect
(95% CI)
No. of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Assumed risk Corresponding risk
Control
surgical intervention
(see comments)
Experimental
surgical intervention
(see comments)
Proportion free from
seizures (Engel Class 1
or 1A) at 1 year and at
5 years
There were no clear dif f erences between the ATL,
SAH and PHC groups in terms of seizure f reedom
(by either Engel Class def init ion) at 1 year or at 5
years
NA 43
(1 study)
⊕⊕©©
low a,b
Interven-
t ions are anterior tem-
poral lobectomy (ATL),
select ive amygdalohip-
pocampectomy (SAH)
or parahippocampec-
tomy (PHC). All pairs
of intervent ions were
compared
P roportion with re-
mission of seizures (at
least Engel Class IB)
between 25 and 36
months
778 per 1000 513 per 1000
(350 to 770 per 1000)
RR 0.66 (0.45 to 0.99) 58
(1 study)
⊕⊕©©
lowb,c
Experimental Interven-
t ion is Stereotact ic ra-
diosurgery (SRS)
Control intervent ion is
anterior temporal
lobectomy (ATL)
RR > 1 indicates advan-
tage for SRS
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Proportion free from
seizures (Engel Class
1) at 1 year
650 per 1000 741 per 1000
(494 to 1000 per 1000)
d
RR 1.14
(0.76 to 1.70)
43
(1 study)
⊕⊕©©
lowe,f
Ex-
perimental Intervent ion
is resect ion with corpus
callosotomy (CCT)
Control intervent ion is
resect ion only
RR > 1 indicates advan-
tage for resect ion with
CCT
The RR of seizure f ree-
dom for the resect ion
with CCT group com-
pared to the resect ion
only group at 3 years
was 1.19 (95% CI 0.72
to 1.95; P = 0.50) and at
5 years was 1.09 (95%
CI 0.53 to 2.21; P = 0.
82)
Proportion free from
seizures (Engel Class
1) at 2 years
600 per 1000 732 per 1000
(510 to 1000 per 1000)
d
RR 1.22
(0.85 to 1.76)
60
(1 study)
⊕⊕⊕©
moderatee
Experimental Interven-
t ion is anterior temporal
lobectomy with corpus
callosotomy (aCCT)
Control intervent ion is
anterior temporal
lobectomy without cor-
pus callosotomy (ATL)
RR > 1 indicates advan-
tage for aCCT
Proportion free from
all seizures (including
auras, ILAE 1a) at 1
year
640 per 1000 589 per 1000
(378 to 934 per 1000)
RR 0.92 (0.59 to 1.46) 47
(1 study)
⊕⊕©©
lowb,g
Experimental interven-
t ion is Subtemporal
select ive amygdalohip-
pocampectomy (SAH)
Control intervent ion is
Transsylvian SAH4
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RR > 1 indicates ad-
vantage for Subtempo-
ral SAH
Proportion free from
all seizures (including
auras) at 1 year
382 per 1000 695 per 1000
(428 to 1000 per 1000)
d
RR 1.82
(1.12 to 2.93)
70
(1 study)
⊕⊕©©
lowb,c
Experimental interven-
t ion is total resect ion
Control intervent ion is
part ial resect ion
RR > 1 indicates advan-
tage for total resect ion
Proportion free from
seizures (Engel Class
1) at 1 year
728 per 1000 743 per 1000
(626 to 874 per 1000)
RR 1.02
(0.86 to 1.2)
207
(1 study)
⊕⊕⊕©
moderateb
Experimental Interven-
t ion is a 2.5-cm resec-
t ion
Control intervent ion is
3.5-cm resect ion
RR > 1 indicates advan-
tage for 2.5-cm resec-
t ion
* The basis for the assumed risk is the event rate in the control group (medical treatment). The corresponding risk (and its 95% conf idence interval) is based on the assumed
risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
aCCT: anterior temporal lobectomy with corpus callosotomy; ATL: anterior temporal lobectomy without corpus callosotomy; CCT: corpus callosotomy; CI: conf idence interval;
RR: risk rat io; parahippocampectomy (PHC); select ive amygdalohippocampectomy (SAH)
GRADE Working Group grades of evidence.
High certainty (quality): f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate certainty (quality): f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low certainty (quality): f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low certainty (quality): we are very uncertain about the est imate.
aDowngraded due to risk of bias: outcome assessors of the study were not blinded
bDowngraded for indirectness: results are applicable to adults (18 years and over only), with children excluded f rom the study.
cDowngraded due to insuf f icient information regarding methods of randomisat ion and allocat ion concealment in the study.
dUpper bounds of corresponding risk interval revised to their maximum to align with the upper bound of the conf idence
interval of the relat ive ef fect.
eDowngraded due to risk of bias: inadequate method of quasi-randomisat ion used (allocat ion based on odd and even
part icipant ID numbers) and unclear if part icipants/ personnel/ outcome assessors were blinded.4
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fDowngraded for indirectness: results are applicable to children and adolescents (under 18 years only), with adults excluded
f rom the study.
gDowngraded due to risk of bias: part icipants not complet ing one year of follow-up measures were excluded f rom the study
and an intent ion to treat approach was not taken
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D I S C U S S I O N
Summary of main results
We have identified 182 studies investigating the outcome of
surgery for epilepsy. These studies were of variable size and design,
were conducted in a range of countries, and recruited a wide range
of participants of different ages and with different durations of
epilepsy. These studies carried out a wide range of surgical tech-
niques and used different scales tomeasure the outcome of surgery.
Nineof the 182 studies used a randomised controlled trial (RCT)
design: two that randomised surgery and medical treatment, six
that randomised types of surgical technique (i.e. anterior temporal
lobectomy (ATL) with or without corpus callosotomy (CCT),
partial or total hippocampectomy, ; resection of the epileptogenic
region with or without CCT in children with Lennox-Gastaut
syndrome, stereotactic radiosurgery (SRS) or ATL, subtemporal
or transsylvian approach to selective amygdalohippocampectomy
(SAH), and ATL, SAH or parahippocampectomy (PHC)), and
one that randomised length of surgical resection (2.5-cm vs 3.5-
cm resection).
The two RCTs that randomised surgery and medical treatment
found surgery to be superior to medical treatment in terms of
freedom from seizures at one year (risk ratio (RR) 9.78, 95%
confidence interval (CI) 4.73 to 20.21; P < 0.00001), and one of
the these RCTs found surgery to be superior to medical treatment
in terms of freedom from all seizures including auras at one year
(RR 15.00, 95% CI 2.08 to 108.23; P = 0.007). Results show no
statistically significant differences between ATL with or without
CCT in terms of seizure freedom at two years (RR 1.22, 95% CI
0.85 to 1.76; P = 0.28), between subtemporal and transsylvian
SAH (RR 0.92, 95% CI 0.59 to 1.46; P = 0.73), or between 2.5-
cm and 3.5-cm ATL resection (RR 1.02, 95% CI 0.86 to 1.20; P
= 0.84) in terms of seizure freedom at one year, respectively. Data
also show no statistically significant differences between resection
with CCT and resection only at one year (RR 1.14, 95% CI 0.76
to 1.70; P = 0.53), at three years (RR 1.19, 95% CI 0.72 to 1.95;
P = 0.50), or at five years (RR 1.09, 95% CI 0.53 to 2.21; P =
0.82) or between any pair of ATL, SAH and PHC at 1 year or
at 5 years in terms of seizure freedom. Results show a statistically
significant advantage of total over partial hippocampectomy in
terms of seizure freedom at one year (RR 1.82, 95% CI 1.12 to
2.93; P = 0.01) and for ATL over SRS (RR 0.66, 95% CI 0.45 to
0.99; P = 0.04) in terms of seizure remission between 25 months
and 36 months after surgery.
The 182 studies included in this review included 16,501 partici-
pants with adequate data relating to outcomes of surgery, 10,696
(65%) of whom achieved a good outcome of surgery, ranging
across studies from 13.5% to 92.5% of participants. We found
reporting of related adverse events to be sparse and very poor;
less than half of included studies reported complications and/or
surgery-related deaths, often lacking specific details of the nature
and consequences of the event (transient or permanent) and event
timing. Few studies contained any reference to postoperative cog-
nition or mental state.
A total of 119 studies examined between one and nine factors of
interest for this review in univariate relation to outcome of surgery.
We found abnormal pre-operative magnetic resonance imaging
(MRI), no use of intracranial monitoring, complete surgical resec-
tion, presence of mesial temporal sclerosis, concordance of pre-op-
erative MRI and electroencephalography (EEG), history of febrile
seizures, absence of focal cortical dysplasia/malformation of cor-
tical development, presence of tumour, right-sided resection, and
presence of unilateral interictal spikes to be independently associ-
ated with a good outcome of surgery. We found no evidence that
history of head injury, presence of encephalomalacia, presence of
vascular malformation, and presence of postoperative discharges
were independent, univariate prognostic factors for outcome of
surgery. We observed variability between studies in many of our
analyses, likely due to small study sizes with unbalanced group
sizes, variation in the definition of the seizure outcome, definition
of the prognostic factor (e.g. the definition of a ’complete’ resec-
tion varied across studies), and the influence of the site of surgery,
which we have observed to be related to postoperative seizure out-
come.
Twenty-nine studies presented multi-variable prognostic models,
and 26 of these provided clear adjusted results for the association
of independent variables with the dependent variable of seizure
freedom. None of the studies included encephalomalacia as a fac-
tor; one included vascular malformations; two included concor-
dance of MRI and EEG, head injury, and distribution of interic-
tal spikes; three included focal cortical dysplasia, febrile seizures,
and use of intracranial monitoring; four included MRI results, tu-
mour, and postoperative discharge; five included side of resection;
six included mesial temporal sclerosis; and 18 included extent of
resection. Generally the direction of association of variables with
outcome was the same in multi-variable analyses as in univariate
meta-analyses. However, due to different combinations of vari-
ables entered into the multi-variable models, different (often in-
appropriate) statistical approaches used to modelling, and selec-
tive reporting of results, meaningful comparison of multi-variate
analysis versus the univariate meta-analysis reported in this review
is difficult. We recommend caution when results of the univariate
meta-analysis and the narratively reported multi-variable analyses
are interpreted.
Overall completeness and applicability of
evidence
Completeness of evidence
We were aware that most of the evidence for this review was
likely to be derived from non-randomised studies; however no
Cochrane-approved or -recommended search filter is available for
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non-randomised studies. The Trial Search Co-ordinators for the
Cochrane EpilepsyGroup chose the search strategies implemented
and did not subject the resulting search filters to any systematic
testing before use. We do believe that our systematic electronic
searches identified the vast majority of relevant evidence for this
review, and given the large number of studies included in this re-
view, it is unlikely that any evidence not identified by the elec-
tronic searches would change the review conclusions.
We were able to extract data for 16,756 participants from 182
eligible studies who had surgery, and the large number of partici-
pants that we included in this review is reflected in the precision
of our results. However, we believe that some of the studies we had
to exclude from the review (see Excluded studies) could possibly
have been included if additional information regarding follow-up
had been available, or if study authors had presented data in an ex-
tractable way. For example, several studies reported only percent-
ages, P values, or coefficients of regression models for prognostic
factors related to outcome, and we were unable to extract raw data
for the number of participants with and without the prognostic
factor achieving good or poor outcome of surgery for inclusion
in our univariate analyses; other researchers provided insufficient
detail regarding multi-variable analyses of prognostic factors to al-
low for meaningful comparison with univariate analyses.
Furthermore, several studies reported outcome as ’favourable’
(usually Engel Classes 1 and 2 combined) versus ’unfavourable’
(Engel Classes 3 and 4 combined) rather than as ’good’ versus
’poor’ (Engel Class 1 vs Engel Classes 2 to 4). We strongly be-
lieve there is a large difference between a ’good’ outcome and a
’favourable’ outcome of surgery for epilepsy. Therefore we believe
it was not appropriate to extract data on prognostic factors ex-
pressed as ’favourable’ versus ’unfavourable.’ However, if the data
had been presented in a different way, for example, if each Engel
Class 1 to 4 had been presented by the prognostic factor of inter-
est, we would have been able to include this information, further
improve the precision of our results, and possibly reduce variabil-
ity between studies in our results.
Applicability of our results
The potential efficacy of temporal and extratemporal resection for
people with a focal epilepsy uncontrolled by antiepileptic medi-
cation is undisputed (Engel 2003), and our review, which showed
that about two-thirds of patients have a good surgical outcome,
has confirmed this. For temporal resection, Engel’s practice pa-
rameter focuses on the single intention-to-treat RCT of surgery
for mesial temporal lobe epilepsy (Wiebe 2001), which found that
58% of participants randomised to be evaluated for surgical ther-
apy (64% of those who received surgery) were free of disabling
seizures at one year, compared with 8% free of disabling seizures
in the group randomised to continued medical therapy. The re-
cent consensus from the International League Against Epilepsy
proposes that treatment success should be defined by sustained
freedom from seizures (Kwan 2010b), as this is the only efficacy
outcome that is consistently associated with improved quality of
life (and in the UK, the only efficacy outcome that allows a patient
to drive legally). This justifies our focus in this review on at least
12 months of seizure freedom. Using this measure, Costa 2011
showed in a meta-analysis that the overall weighted pooled risk
difference in favour of newer antiepileptic drugs compared with
placebo for freedom from seizures during limited study periods
was only 6% (95% confidence interval (CI) 4% to 8%; num-
ber needed to treat in terms of freedom from seizures with newer
drugs as add-on therapy ranged from 9 to 19 (mean 11.3)). The
message for the clinician facing a person with intractable epilepsy
in consultation is therefore clear. The chance of helping with the
next antiepileptic drug is 1 in 11, and the chance of helping with
surgery is 2 in 3, if selection criteria are met.
Furthermore, we have observed that overall surgical procedures
have a low rate of complications, and this finding is consistent
with other reports showing that less than 5% of patients have per-
manent postoperative neurological deficits secondary to acciden-
tal damage of central nervous system (CNS) tissue (Engel 1996;
Engel 2003). As stated, the figure given here for adverse events of
7.3% is highly likely to represent an overestimation of prevalence
for permanent neurological deficit, as many studies did not record
which events were only transient, and more than one event could
be recorded in the same person. Having said this, very few studies
address the important issue of formally reassessing any postoper-
ative impairment of cognition, speech and language, and social
functioning or altered mental state (all linked to quality of life).
Researchers should write this aspect into research protocols.
The poor recording of adverse event data in the included studies
is lamentable. Most studies recorded no data at all. No signifi-
cant improvement has occurred over the past 10 years since the
Tonini 2004 review. When any intervention study is carried out,
researchers should provide detailed assessments of both risks and
benefits. We are surprised how journal editors continue to accept
papers for publication without requiring adverse event reporting.
The required standard should be to report how many events are
recorded in howmany participants, and to make it clear which are
postoperative complications, which are transient events (within a
set period), and which are permanent new impairments. Proto-
cols should include pre-operative and postoperative measures of
speech and language function, cognition, and social functioning,
along with a mental state assessment.
The criteria adopted to identify indications and applications of
epilepsy surgery are constantly evolving. Continuing attempts
must be made to define patient- and procedure-related prognostic
indicators. Our systematic review shows that the strongest predic-
tors of success of surgery include, in decreasing order, extent of
resection (especially for extratemporal surgery), an abnormal MRI
finding, concordance between neuroimaging and EEG findings,
tumour, mesial temporal sclerosis, unilateral EEG discharges espe-
cially when extratemporal, a history of febrile seizures, and vascu-
lar malformations. By contrast, adverse prognostic factors include
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the need for intracranial monitoring and the presence of postop-
erative discharges (particularly those seen extratemporally).
The extent of resection, particularly with extratemporal surgery,
was the strongest determinant of outcome in our review. The
dilemma for the surgeon is that larger areas of resection are likely
to be associated with a higher complication risk. The extent of re-
section is affected by the underlying pathology, the site of surgery,
and the development of investigational and surgical procedures.
It is clear that this is one area in which further RCTs may inform
future practice with good effect.We identified two trials using this
design - Schramm 2011 (with Helmstaedter 2011 reporting on a
sub-set from Schramm 2011) and Wyler 1995. The primary in-
tention-to-treat analysis did not show benefit for the seizure free-
dom rate in the more extensive resection group in Schramm 2011
but did demonstrate benefit in Wyler 1995.
Tumours carry a higher chance of seizure remission at 12 months
when compared with other CNS disorders (risk ratio (RR) present
vs absent for 12-month remission 1.23, 95% CI 1.14 to1.32).
This finding is readily understood in that the epileptogenic area is
more easily detectable and defined both on neuroimaging and at
operation.Non-tumoural lesions often have amore diffuse pathol-
ogy; many of these are less easily resectable, resulting in a poor
surgical outcome. In this heterogeneous group, we observed in-
ferior 12-month remission pooled risk ratios: encephalomalacia
RR for present versus absent 0.67 (95% CI 0.37 to 1.21); neu-
ronal migration disorders including focal cortical dysplasias RR
for present versus absent 0.90 (95%CI 0.85 to 0.95); and vascular
malformations RR for present versus absent 1.07 (95% CI 0.94
to 1.21). In these instances, the margin both on theMRI scan and
at operation is often difficult to define.
The good outcome associated with the presence of any abnor-
mal MRI findings is expected and probably largely reflects a vari-
ety of CNS conditions that we know are associated with a good
prognosis, such as tumour, mesial temporal sclerosis (MTS), and
many congenital malformations. These are discrete structural le-
sions that lend themselves to complete resection. We note mod-
erate heterogeneity between studies, in part accounted for by the
degree of definition of MRI abnormality in individual studies. So,
non-specific or ill-defined white matter abnormalities described
in one study may well dilute the benefit of a well-defined area of
MTS or tumour noted in another study. A reasonable prospect of
seizure freedom is not ruled out with a normal MRI. Bell 2009
reported an Engel Class 1 outcome at 12 months in 60% (24/
40) of people following anterior temporal lobectomy for medi-
cally refractory temporal lobe epilepsy, but it should be noted that
one of the inclusion criteria was subtle non-specific MRI findings
in the mesial temporal lobe concordant with the area of resec-
tion. Jayakar 2008 reported on a cohort (predominantly of chil-
dren) with non-lesional intractable focal epilepsy undergoing re-
sective surgery. At two years’ follow-up, 44 of 101 participants
were seizure-free. Outcomes correlated with good outcome in-
cluded the presence of convergent scalp EEG focal interictal spikes
(P < 0.005) and completeness of resection (P < 0.0005). Dorward
2011 studied children with extratemporal, non-lesional epilepsy.
Researchers classified outcome as Engel Class 1 or 2 in 54.5% of
the children who underwent resection of the lesion or multiple
sub-pial resections. Investigators obtained results by using invasive
monitoring with grid/strip electrodes.
The association between MTS and a history of febrile seizures
is strong. The term ’mesial temporal sclerosis’ as an alternative
to ’hippocampal sclerosis’ was introduced in recognition of the
frequent involvement of mesial limbic structures adjacent to the
hippocampus. Thom 2009 studied neocortical neuronal loss and
gliosis (temporal lobe sclerosis (TLS)). Investigators identifiedTLS
in 30 of 272 surgically treated cases of hippocampal sclerosis. A
history of a febrile seizure was an initial precipitating injury in
73% of patients with TLS compared with 36% without TLS. A
history of febrile status was noted in 27% of these cases. Changes
in TLSmay be due to enhanced vulnerability of superficial cortical
neurons to an early cerebral event in the maturing neocortex in
a small group of children. The good outcome associated with a
history of febrile seizures can be interpreted in the light of its
association with MTS.
Concordance of EEG/MRI findings is correlated with positive
surgical outcome. It is clear that results obtained from individual
studies will depend very much on the mix of associated patholo-
gies underlying the epilepsy seen among participants. Studies con-
taining a large number of participants with discrete lesions such
as tumours are likely to show more concordance and a better out-
come than studies with a predominance of less discrete lesions, as
can be the case with many neurodevelopmental abnormalities.
The need for intracranial monitoring itself implies that uncer-
tainty surrounds the location and extent of an epileptogenic zone,
often accompanied by indeterminate neuroimaging. The associa-
tion between the need for neuroimaging and a poor outcome is
therefore not surprising. In these cases, less than 50% of cases may
become seizure-free postoperatively. Poor localisation is also re-
flected in the fact that participants with unilateral interictal spikes
are significantly more likely to achieve a good outcome of surgery
than participants with bilateral interictal spikes. The persistence
of postoperative discharge is likely to reflect these very same issues.
Some units will re-operate very quickly when postoperative dis-
charges are identified. The heterogeneity of our results does not
allow us to support this approach. It is but one example of how
properly conducted research should in the future inform the cor-
rect care pathway (see below).
We have already referred to the limitations of this review. We can
summarise these as including the following: different criteria for
seizure outcome; variable length of follow-up; forced dichotomi-
sation of each putative prognostic predictor; retrospective design
for most studies that enhances the risk of bias in data collection
and presentation; and variables that were examined most often in
univariate analyses without consideration of the role of combined
effects of prognostic factors or of other (known or unknown) con-
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founders, which may be the true prognostic predictors. We min-
imised bias in part by using restrictive criteria for study inclusion
and by measuring the heterogeneity of study results. The predic-
tive value of prognostic factors was usually higher when hetero-
geneity of study results was lower.
Despite these limitations, our results provide some clinical guid-
ance for selection of the best surgical candidates. Engel 2003 iden-
tified major methodological deficiencies in the published studies
on epilepsy surgery, which included retrospective design, scarcity
of data on pre-operative seizures, and absence of blinding in seizure
outcome assessment.We have to report no quality improvement in
the vast majority of the body of literature reviewed here, published
since Engel’s comments 11 years ago. We would strongly advocate
such an improvement and identification of better standards for
assessment of surgical outcome in future studies. We would em-
phasise the need for a prospective design. Examples of this include
Helmstaedter 2011, Schramm 2011, and Wyler 1995, already
mentioned, which studied the extent of resection and the outcome
of temporal lobe surgery; Liang 2010, which reported benefit in
improved quality of life and performance IQ for anterior temporal
lobectomy combined with anterior corpus callosotomy in people
with temporal lobe epilepsy and mental retardation; Oertel 2005,
which demonstrated that a waterjet dissector enables a significant
reduction in intraoperative blood loss in epilepsy surgery; Velasco
2011, which showed that ictal-single-photon emission computed
tomography (SPECT) did not add localising value beyond that
provided by EEG-video telemetry and structural MRI that altered
the surgical decision and outcome for patients with mesial tem-
poral lob epilepsy with unilateral hippocampal sclerosis (MTLE-
HS); and the sentinel work ofWiebe 2001, already referred to. For
the future, the primary outcome measure for intervention studies
ought to be seizure freedom at set time points with a minimum of
one year of follow-up. Assessment should be blinded and linked to
quality of life measurement. The design should be a randomised
controlled trial, appropriately powered with a focus on specific
research questions that remain as unanswered today by this large
body of literature as they were when Victor Horsley helped the
young Scot in 1886.
Many questions remain to be answered, but researchers should
address the issues of extent of resection for temporal and ex-
tratemporal lesions, the definition of care pathways for the most
cost-efficient and effective pre-operative selection, non-lesional fo-
cal epilepsy, bilateral and postoperative spikes, and when to stop
antiepileptic drugs, among many others. Investigators should al-
ways record clear data on risks (adverse events, their nature and
timing) and benefits. We are pleased to note that since this review
was first published in 2015 (West 2015), RCTs are now being
conducted and results published, addressing some of these ques-
tions. Outcomes are still not addressing all the issues important in
a person’s life. We suggest that protocols should include pre-oper-
ative and postoperative measures of speech and language function,
cognition, and social functioning, along with a mental state as-
sessment. Methodological difficulties and adequate powering will
require multi-centre approaches. Researchers have achieved im-
provements in cancer care over the past three to four decades by
answering well-defined questions through the conduct of focused
RCTs in a step-wise fashion. The same approach to surgery for
epilepsy is required.
Quality of the evidence
Most of the evidence included in this review was of a non-ran-
domised, retrospective design. As detailed in Assessment of risk of
bias in included studies and Risk of bias in included studies, at the
time of initiation of this review, we did not know of a tool recom-
mended by Cochrane for assessment of the quality of studies using
this design. After extensive review of the literature related to qual-
ity assessment tools for studies of a non-randomised design, we
selected a tool that we believed to be appropriate a priori; however
we discovered that it was not effective in separating differences in
quality between studies. We also learned that several criteria were
not applicable for most of the studies we identified, and that the
overall quality rating was dictated by one or two criteria.
Currently, the certainty of evidence for outcomes addressing the
primary objective of the review is moderate to very low. We down-
graded the evidence due to indirectness, risk of bias, and impreci-
sion arising from small sample sizes in these studies (Summary of
findings for the main comparison; Summary of findings 2). Most
of the relevant evidence for this review addresses the secondary
objective of the review but comes from studies of a retrospective
design and has not enabled us to explore the effects of multiple
prognostic factors in a single analysis.
Surgical treatment for epilepsy is the only treatment option for a
substantial proportion of individuals. Designing randomised trials
in which participants could be randomised away from an effec-
tive treatment could be considered unethical (the two RCTs that
randomised participants to surgical or medical treatment showed
a large advantage for surgery over antiepileptic drugs - Dwivedi
2017;Wiebe 2001). Therefore, identifying prognostic factors that
are associated with a good outcome of surgery is a very important
goal of research.
Until higher-quality evidence becomes available, ideally from stud-
ies of a prospective cohort design that aim to examine differences
in surgical approaches and specific prognostic factors of interest,
it is important that we accurately judge differences in quality of
evidence that currently exists. We established from this review
that the Effective Public Health Practice Project (EPHPP) Qual-
ity Assessment Tool was not appropriate for assessing the qual-
ity of retrospective studies of surgery. After considering existing
tools developed for risk of bias assessment of studies of a non-
randomised design listed in Chapter 13 of the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011), along with
the ACROBAT-NRSI (A Cochrane Risk Of Bias Assessment Tool
for Non-Randomised Studies of Interventions) tool recently de-
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veloped by the methods groups at Cochrane (ACROBAT 2014),
we were not able to identify any tool that would be appropriate for
most of the studies of the design included in this review. Therefore
it is essential that an appropriate tool is developed for assessment
of non-randomised studies of all designs, including those without
comparator control groups.
Potential biases in the review process
As we have stated, use of a retrospective design in the vast major-
ity of the body of literature reviewed allows great scope for bias
in study results with lack of standardisation in data collection,
differing durations of follow-up, and lack of blinding for seizure
assessment, as reflected by the significant heterogeneity of study
results. We have also discussed at length in Overall completeness
and applicability of evidence the limitations associated with the
search strategy employed, the quality assessment tool used, and the
restricted analyses we were able to perform, particularly in terms
of multi-variable analyses.
Agreements and disagreements with other
studies or reviews
Our results broadly concur with those presented in the Tonini
2004 review (of which RN was a co-author). We have reviewed
a substantially larger body of literature. Often this led to identifi-
cation of greater heterogeneity for studies related to specific ocu-
tome predictors. Nonetheless, the general implications for clinical
practice remain the same. This observation serves to emphasise the
need for the clinical questions to be refined and for a new body
of research with prospective and randomised controlled design to
emerge, so that future clinical practice can be better informed by
evidence of improved quality.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The poor quality of the data presented in most of the body of
literature reviewed, for example, due to lack of uniformity regard-
ing definitions of outcomes, prognostic factors, and measurement
times; variable populations; retrospective designs; and inadequate
reporting of analysis results means that our results provide lim-
ited clinical guidance for selection of the best surgical candidates.
Assessment for surgical selection should be offered to all people
with a focal epilepsy wherein the first two antiepileptic drugs have
failed, and assessment for surgery must be tailored to the indi-
vidual, with co-morbidities and the whole patient context con-
sidered. Given the results of the univariate analysis conducted in
this review and supported by multi-variable analyses conducted
in the included studies, by which a discrete lesion is identified on
magnetic resonance imaging (MRI) and there is good concordance
with seizure semiology and ictal electroencephalography (EEG)
discharges, more sophisticated pre-operative investigation proba-
bly is not required. When one of these pointers is absent, more so-
phisticated imaging andEEG studies (whichmay include intracra-
nial electrodes) are needed. Pre-operative assessment of memory
function should be carried out on all candidates for temporal lobe
surgery. The technology must be used in a setting that includes
a good interdisciplinary team. Pre-operative and postoperative as-
sessments should include cognition and mental state; neuropsy-
chological and psychiatric evaluations are essential parts of pre-
surgical evaluation and should also be scheduled after surgery, at
a minimum at three to four months and at one year.
Implications for research
The case has already beenmade for surgical resection of the epilep-
togenic zone for intractable focal epilepsy in carefully selected
cases. Future research should have a prospective cohort or ran-
domised controlled trial (RCT) design, should be appropriately
powered, and should focus on specific issues related to diagnostic
tools, the site-specific surgical approach, and other issues such as
extent of resection. Researchers should investigate prognostic fac-
tors related to the outcome of surgery via multi-variable statisti-
cal regression modelling, whereby variables are selected for mod-
elling according to clinical relevance and all numerical results of
prognostic models are fully reported. Protocols should include
pre-operative and postoperative measures of speech and language
function, cognition, and social functioning, along with a mental
state assessment. Investigators must record adverse events; jour-
nal editors should not accept papers that report studies that did
not record adverse events from a medical intervention. We found
that the Effective Public Health Practice Project (EPHPP) Quality
Assessment Tool was not appropriate for assessing the quality of
retrospective studies of surgery, and to the best of the review au-
thors’ knowledge, an appropriate tool does not exist and needs to
be developed. Researchers have achieved improvements in cancer
care over the past three to four decades by answering well-defined
questions through the conduct of focused RCTs in a step-wise
fashion. The same approach to surgery for epilepsy is required.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Aaberg 2012
Methods Retrospective case series
Participants 54 children from a single Norwegian centre
Interventions Lesionectomy or hemispherotomy; 44 had resective surgery, temporal and extratemporal
Outcomes Assessed as Engel class at 12 and 24 months post surgery
Notes -
Adam 1996
Methods Prospective case series
Participants 30 adults aged 18 to 44 from a single French centre
Interventions Anteromedial temporal lobe resections
Outcomes Seizure outcome assessed by Engel class at a mean of 24 months and at least 12 months after surgery
Notes -
Adelson 1992
Methods Retrospective case series
Participants 33 children younger than 15 years of age at 1 American centre
Interventions Temporal or extended temporal lobe resections
Outcomes Seizure outcome assessed by the presence of seizure freedom at least 18 months after surgery
Notes -
Alfstad 2011
Methods Retrospective case series
Participants 48 patients - adults and children younger than 14 years old - who had had surgery for epilepsy
Interventions Type of surgery: temporal and extratemporal
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Alfstad 2011 (Continued)
Outcomes Seizure outcome assessed at 2 years post surgery using Engel’s classification
Notes -
Alonso-Vanegas 2018
Methods Pilot, unblinded randomised controlled trial conducted at a tertiary-care neurological center located in Mexico City,
Participants Adult participants, over the age of 18 years of age, with medically refractory mesial temporal lobe epilepsy and
hippocampal sclerosis (typical clinical seizures, mesial temporal lobe focalMRI findings, and concordant epileptiform
activity with ILAE pathologic confirmation of HS,failure to acceptably control seizures with 2 to 3 antiepileptic
drugs over 2 years)
Interventions Randomisation to anterior temporal lobectomy (ATL, n = 14), selective amygdalohippocampectomy (SAH, n = 15)
or parahippocampectomy (PHC, n = 14)
Outcomes Freedom from seizures according to the Engel Class Scale at 1 year and 5 years after surgery
Notes
Althausen 2013
Methods Retrospective case series
Participants 61 children (aged 6 years and older) and adults from a single German centre
Interventions Hemispherectomy
Outcomes Reported as seizure-free at least 12 months after surgery
Notes -
Arruda 1996
Methods Retrospective case series
Participants 74 adults from a single Canadian centre
Interventions Selective amygdalohippocampectomy or anterior temporal lobe resection
Outcomes Seizure outcome assessed by Engel class at a mean of 33.1 months
Notes Study of people with non-lesional temporal lobe epilepsy who had MRI volumetric studies
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Awad 1991
Methods Retrospective case series
Participants 47 children and adults from a single American centre
Interventions Surgical objectives included biopsy of the structural lesion and maximum resection of the lesion as defined on
neuroimaging studies and of the epileptogenic area when possible. Lesions were temporal and extratemporal
Outcomes Seizure outcome assessed as seizure-free at 12 months
Notes -
Babini 2013
Methods Retrospective case series
Participants 30 participants, 3 to 18 years of age, from a single Italian centre, who underwent surgery for histopathologically
confirmed low-grade tumours, in which seizures were the only clinical manifestation
Interventions Lesionectomy or tailored lesionectomy (i.e. tumour plus neighbouring epileptogenic region)
Outcomes Assessed as Engel class at least 12 months post surgery
Notes -
Barbaro 2018
Methods Randomised controlled trial conducted at 14 treatment centers based in the USA, UK, and India
Participants Participants over the age of 18 years who were eligible for anterior temporal lobectomy (ATL) to treat pharmaco-
resistant unilateral mesial temporal lobe epilepsy (MRI evidence of concordant unilateral hippocampal sclerosis
without significant secondary cortical lesions and at least 3 focal-onset seizures with impairment of consciousness
occurred during stable anticonvulsant administration documented over three months),
Interventions Randomisation to stereotactic radiosurgery (SRS, n = 31 analysed) or anterior temporal lobectomy (ATL, n = 27
analysed); a total of 63 participants were randomised and five withdrew before surgery
Outcomes Seizure remission outcome is defined by the seizure-free (defined as at least Engel scale IB) rate between 25 and 36
months
Adverse events
Verbal memory and quality of life (not relevant to this review)
Notes
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Battaglia 2006
Methods Case series; unclear whether prospective or retrospective
Participants 45 children with refractory epilepsy operated on before 7 years from 1 Italian centre
Interventions 19 had hemispherectomy, 9 had multi-lobar resection, 17 had focal resection - 9 temporal, 4 frontal, 4 parieto-
occipital
Outcomes Seizure outcome at least 2 years after the time of surgery
Notes Focus on neurocognitive outcome
Baumann 2007
Methods Multi-centre retrospective case series
Participants Participants were 168 consecutive children and adults with a single supratentorial cerebral cavernous malformation
and symptomatic epilepsy. Centres in Switzerland, Italy, Germany, USA, and Canada
Interventions Type of surgery: temporal and extratemporal
Outcomes Seizure outcome by Engel class was determined in the first, second, and third postoperative years
Notes -
Bautista 2003
Methods Retrospective case series
Participants 55 patients aged 17 to 57 years with a histopathological diagnosis of focal cortical dysplasia
Interventions Types of surgery - temporal and extratemporal
Outcomes Seizure outcome after at least 12 months of follow-up from the time of surgery
Notes -
Bell 2009
Methods Retrospective case series
Participants 44 patients, 13 to 62 years of age, with a non-lesional modern “seizure protocol” MRI, who underwent anterior
temporal lobectomy for treatment of medically refractory partial epilepsy
Interventions Temporal lobe surgery
Outcomes Seizure outcome measured using Engel’s classification at least 1 year post surgery
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Bell 2009 (Continued)
Notes Study of people with “non-lesional MRIs”
Benifla 2006
Methods Retrospective case series
Participants 126 children who had surgery at 1 Canadian centre over a 10-year period
Interventions Anterior temporal lobectomy (ATL) with resection of mesiotemporal structures. The resection margin extended
5 to 6 cm from the temporal pole of the non-dominant hemisphere (and included the superior temporal gyrus)
, and 4 to 5 cm in the dominant hemisphere, modified according to presentation, imaging findings, and lesion
localisation. Patients with dorsal temporal or basal temporal lesions underwent lesionectomy or ATL without removal
of mesiotemporal structures. Mesiotemporal structures were removed in certain cases, particularly if lesions impinged
upon or involved the hippocampus or the amygdala. Intraoperative ECoG was performed in 94 patients
Outcomes Seizure outcome assessed using Engel’s classification at follow-up at least 24 months after surgery
Notes -
Berkovic 1995
Methods Retrospective case series
Participants 135 children and adults from a single Australian centre
Interventions Standard anterior temporal lobectomy, including partial hippocampectomy, for dominant temporal lobe removal; 3.
5 cm of the lateral temporal lobe was excised; for non-dominant removals, 5.0 cm was excised. The hippocampus was
excised microsurgically, usually to the level of the posterior midbrain. Foreign tissue lesions were completely excised
when possible, and the anterior 2 cm of hippocampus was also removed. When the foreign tissue lesion was located
in the lateral temporal region, the hippocampus was not resected unless it appeared abnormal on MRI
Outcomes Seizure outcome assessed as Engel’s class at last follow-up (after at least 18 months of follow-up) or as at least 2 years
of seizure-free remission at last follow-up
Notes -
Blount 2004
Methods Retrospective case series
Participants 30 consecutive Canadian children from 1 centre followed for at least 30 months
Interventions Multiple subpial transections
Outcomes Seizure outcome by Engel class determined at mean follow-up of 3.5 years after surgery
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Blount 2004 (Continued)
Notes -
Blume 2004
Methods Retrospective case series
Participants 70 participants with intractable focal epilepsy and no specific lesion, as determined by both MRI and histopathology;
age ranged from 6 to 65 years, with a mean age of 31 years
Interventions Temporal and extratemporal
Outcomes Seizure outcome measured using Engel’s classification at least 2 years post surgery
Notes Study of non-lesional intractable epilepsy
Boesebeck 2007
Methods Retrospective case series
Participants 81 patients, aged 16 to 53 years at surgery, from a single German centre, with lesional focal epilepsies of the
extratemporal cortex with resistance to at least 2 antiepileptic drugs
Interventions Extratemporal surgery
Outcomes Seizure outcome measured using Engel’s classification at 2-year follow-up post surgery
Notes -
Boshuisen 2010
Methods Retrospective case series
Participants 43 children from a single Dutch centre who had hemispherectomy for intractable hemispheric epilepsy
Interventions Functional hemispherectomy
Outcomes Seizure outcome by Engel class determined at least 12 months after surgery
Notes -
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Brainer-Lima 1996
Methods Retrospective case series
Participants 32 children and adults from a single Brazilian centre with a tumour and intractable epilepsy
Interventions Temporal corticectomy with amygdalo-hippocampectomy, temporal corticectomy, extratemporal corticectomy, pos-
terior hippocampectomy, and lesionectomy with stereotactic guidance
Outcomes Seizure outcome assessed by Engel class at a mean of 26.3 months
Notes -
Britton 1994
Methods Retrospective case series
Participants 51 children and adults from a single American centre with a tumour and intractable epilepsy
Interventions Lesionectomy or lesion resection and corticectomy
Outcomes Seizure outcome assessed by Engel class at least 24 months postoperatively
Notes -
Caraballo 2011
Methods Retrospective case series
Participants 45 children, aged 2 months to 18 years, from a single Argentinian centre, with a medically refractory epilepsy and
hemispheric lesions
Interventions Extratemporal
Outcomes Seizure freedom assessed using Engel’s classification at least 1 year post surgery
Notes -
Cascino 1995
Methods Retrospective case series
Participants 165 children and adults from a single American centre with intractable temporal lobe epilepsy
Interventions Temporal lobe surgery
Outcomes Seizure freedom assessed using Engel’s classification at least 1 year post surgery
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Cascino 1995 (Continued)
Notes -
Chabardes 2005
Methods Retrospective case series
Participants 48 consecutive adults from France and Italy with drug-refractory temporal lobe epilepsy
Interventions All participants underwent tailored anterior temporal lobectomy that included the temporal pole, the hippocampus,
the parahippocampal gyrus, and the anterior part of the lateral temporal cortex
Outcomes Seizure outcome by Engel class determined at least 48 months after surgery and related to site relative to the pole of
temporal lobe seizure onset
Notes -
Chang 2009
Methods Retrospective case series
Participants Results on 57 of a total group of 164 American participants with cavernomas and epilepsy
Interventions Microsurgical resection of supratentorial cerebral cavernous malformations
Outcomes Seizure outcome by Engel class determined at 12 months after surgery
Notes -
Chee 1993
Methods Retrospective case series
Participants 40 adults from a single American centre with temporal lobe epilepsy
Interventions Temporal lobectomy
Outcomes Seizure outcome assessed by seizure freedom at least 12 months postoperatively
Notes This was a study of non-lesional epilepsy with FDG-PET scanning
75Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Chkhenkeli 2007
Methods Retrospective case series
Participants 129 adults and children from Georgia and the USA with bitemporal epileptiform abnormalities in multiple scalp
EEGs
Interventions Temporal lobectomies were performed in 85 of 129 participants. Temporal lobe resections included 2modifications of
the surgery, depending on hemispheric dominance. The “standard temporal lobe resection” in “en block”modification
was performed in the non-dominant hemispheres (29/67 participants). This resection usually included 6.0 to 6.5 cm
of lateral cortex, uncus, amygdala, and 2 to 4 cm of the anterior hippocampus. In the dominant hemisphere (38/67
participants), extension of cortical resection was reduced to 3 to 4 cm and usually was performed as a modification
named “anterior medial temporal lobectomy”. This modification includes incision of the temporal lobe cortex for 3
to 3.5 cm from the temporal pole along the inferior surface of the superior temporal gyrus
Outcomes Seizure outcome by Engel class determined at 24 months after surgery
Notes -
Choi 2004a
Methods Retrospective case series
Participants 35 Korean teenagers and adults with temporal lobe epilepsy associated with tumour
Interventions Resection of epileptogenic area and tumour (guided by ECoG as required)
Outcomes Seizure outcome by Engel class determined at a mean of 33 months and at least 15 months after surgery
Notes -
Chung 2005
Methods Retrospective case series
Participants 128 adults and children from a single Korean centre with epilepsy secondary to cortical dysplasia diagnosed postop-
eratively on histology
Interventions Types of surgery: temporal and extratemporal
Outcomes Seizure outcome by Engel class determined at least 48 months after surgery
Notes -
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Cossu 2005
Methods Retrospective case series
Participants 174 children and adults from 1 Canadian centre and 1 Italian centre operated on over a 7-year period
Interventions Temporal and extratemporal surgery: corticectomy, n = 58; corticectomy and lesionectomy, n = 112; lesionectomy,
n = 3
Outcomes Seizure outcome assessed using Engel’s classification at follow-up at least 12 months after surgery
Notes -
Cossu 2008
Methods Retrospective case series
Participants 113 children from 1 Italian centre
Interventions 72 had a complete lesionectomy. Resection sites were as follows: 43 temporal, 32 frontal, 20 posterior, and 9 including
central: 4 temporal plus and 5 wide multi-lobar
Outcomes Seizure outcome assessed using Engel’s classification at follow-up at least 24 months after surgery
Notes -
Costello 2009
Methods Retrospective case series
Participants 42 with disabling, medically refractory focal epilepsy operated on at 1 American centre
Interventions 11 participants underwent a standard left anterior-medial temporal lobectomy (including amygdalohippocampec-
tomy); 17 a standard right anterior-medial temporal lobectomy; 3 a limited left frontal resection; 3 a limited right
frontal resection; and 2 a left temporal lesionectomy (without removal of the amygdalohippocampal complex). The
following operations were performed in single patients: right temporal neocortical resection of extensive malforma-
tion of cortical development, right posterior temporal resection, left posterior temporal resection, right temporal
lesionectomy, corpus callosotomy, and left parietal lesionectomy. Intraoperative mapping of language was performed
in 2 participants
Outcomes Seizure outcome was assessed using Engel’s classification at between 1 and 14.4 years postoperatively
Notes Included only those 45 years of age or older
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Cukiert 2002
Methods Prospective case series
Participants 100 adults from a single Brazilian centre
Interventions Corticoamygdalohippocampectomy on the side of the mesial temporal sclerosis, consisting of cortical resection,
including superior, middle, and inferior temporal lobes; fusiform and parahippocampal gyri, with its posterior border
at the level of the central artery; total hippocampectomy; and resection of the intratemporal portion of the amygdala.
The central artery was used as the landmark for the posterior border of the cortical resection (a proportional method)
, instead of distances measured from the tip of the temporal lobe (a quantitative method)
Outcomes Seizure outcome assessed using Engel’s classification at follow-up from 18 to 48 months after surgery
Notes -
Dagar 2011
Methods Retrospective case series
Participants 118 children from a single Indian centre, aged 0.3 to 18 years at the time of surgery, with a medically refractory
epilepsy
Interventions Temporal and extratemporal
Outcomes Seizure outcome as measured using Engel’s classification at least 12 months after surgery
Notes -
Dalmagro 2005
Methods Retrospective case series
Participants 44 children and adults from a single Brazilian centre with posterior cortex epilepsy
Interventions Multi-lobar resection, lesionectomy, and lobectomy in 5 (11.63%). According to POMRI, surgeries were considered
complete in 16 (37.21%) and incomplete in 27 (62.79%) of 43 participants. However, completeness of the resection
had no influence on surgical outcome
Outcomes Assessed as Engel class at 12 months post surgery
Notes -
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de Tisi 2011
Methods Retrospective cohort study
Participants 615 people from a single UK centre, aged 16 to 63 years at surgery, who had undergone surgery for epilepsy
Interventions Temporal and extratemporal surgery
Outcomes Seizure freedom assessed using ILAE outcome score at follow-up, at least 12 months from surgery
Notes -
Delbeke 1996
Methods Retrospective case series
Participants 38 participants aged 15 to 59 years from a single American centre with temporal lobe epilepsy, who had FDG-PET
as part of their pre-operative assessment
Interventions Lesionectomy with or without neocortical resection
Outcomes Seizure outcome assessed by Engel class at least 18 months postoperatively
Notes -
Dellabadia 2002
Methods Retrospective case series
Participants Initially 99 children and adults from an American centre admitted for surgical selection with a temporal or extratem-
poral lobe epilepsy
Interventions Of 69 participants evaluated, 35 had a focal resection (33 temporal, 2 frontal)
Outcomes Assessed as Engel class at least 22 months post surgery
Notes Focus on which pre-operative tests are most discriminatory of good outcome
Devlin 2003
Methods Retrospective case series
Participants 33 children who underwent hemispherectomy at a single UK centre between 1991 and 1997
Interventions Functional hemispherectomy involving a modified approach with a limited suprasylvian window but a large temporal
lobectomy; the insular cortex was undercut
Outcomes Assessed as Engel class at least 12 months post surgery
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Devlin 2003 (Continued)
Notes -
Ding 2016
Methods Prospective study with participants “randomly allocated” to either surgical treatment group
Participants 43 Chinese children aged 4 to 18 with Lennox-Gastaut syndrome submitted to surgery with a localised epileptogenic
Interventions Randomisation to exclusive resective surgery (n = 20) or to resective surgery combined with CCT (n = 23)
Outcomes Seizure outcome by Engel class determined at 12 months after surgery
Notes Study conducted to compare the outcome of the 2 surgical approaches. 25 children recruited without a localised
epileptogenic zone were enrolled into a ’medical therapy’ group; however as this group was not randomised within
the study (2018 update), these 25 children are not included within the review
Donadio 2011
Methods Retrospective case series
Participants 110 participants, children and adults ranging in age from 1 year to 52 years, with a drug-resistant epilepsy
Interventions Extratemporal and temporal surgery including lesionectomies, lobectomies, callostomies, multiple subpial transec-
tions, hemispherectomies, and insertion of vagal nerve stimulators
Outcomes Assessed using Engel’s classification at follow-up at least 12 months after surgery
Notes -
Dorward 2011
Methods Retrospective case series
Participants 33 children, aged 3 to 19 years at surgery, with an intractable epilepsy and no lesion on MRI scan, who had invasive
EEG monitoring with subdural grid/strip electrodes
Interventions Extratemporal resections or multiple subpial resections
Outcomes Seizure outcome assessed using Engel’s classification at follow-up at least 12 months after surgery
Notes -
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Duchowny 1998
Methods Retrospective case series
Participants 31 young children from a single American centre
Interventions Temporal and extratemporal lesionectomy
Outcomes Seizure outcome assessed by seizure freedom at least 12 months postoperatively
Notes -
Dunkley 2011
Methods Retrospective case series
Participants 42 children younger than 36 months who had surgery for epilepsy
Interventions Temporal and extratemporal surgery and hemispherectomies
Outcomes Assessed using Engel’s classification at follow-up at least 12 months after surgery
Notes -
Dunlea 2010
Methods Retrospective case series
Participants 199 Irish participants with at least 1-year follow-up who underwent resective surgery for refractory epilepsy since
1975
Interventions Interventions included anterior temporal lobectomy, amygdalo-hippocampectomy, neocorticectomy, lesionectomy,
and frontal lobe resection
Outcomes Engel’s criteria were used to classify seizure outcome at 1, 2, 5, 10, 15, and > 15 years of follow-up
Notes -
Dwivedi 2017
Methods Randomised controlled trial conducted at the All India Institute of Medical Sciences in New Delhi
Participants Participants had to have “drug-resistant epilepsy”, defined as failure of adequate trials of 2 appropriately chosen
antiepileptic drug schedules with acceptable side effects and referred for surgery at the trial centre
Interventions Randomisation to a resection (n = 57) ORmedical therapy group (n = 59 remaining on the waiting list, with surgery
planned for 1 year or longer after randomisation)
Participants with concordance of video EEG localisation of the ictal-onset zone and location of the lesion on MRI
underwent resection of that region of cortex or of the lesion or malformed cortex
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Dwivedi 2017 (Continued)
Participants with multiple, subtle, or no lesions underwent resection of the region that was concordant between video
EEG results and localisation on PET, SPECT, or MEG
Participants who had multiple seizure types and multiple bilateral lesions and seizure foci underwent corpus calloso-
tomy
Participants who had extensive lesions confined to 1 hemisphere with significant weakness of limbs (weak pincer grip
or worse) opposite to the involved hemisphere underwent hemispherotomy
Outcomes Primary outcome was freedom from seizures according to the ILAE Scale at 12 months
Secondary outcomes were seizure severity scores and cognitive/quality of life measures (not relevant to this review)
Notes
Elsharkawy 2008a
Methods Retrospective case series
Participants 218 consecutive adults with extratemporal lesions from a single German centre who underwent resective surgical
treatment for intractable focal epilepsy between 1991 and 2005
Interventions Resection of epileptogenic zone: frontal lobe 95, posterior cortical 103, multi-lobar 20
Outcomes Assessed as Engel class at least 12 months post surgery
Notes -
Elsharkawy 2009a
Methods Retrospective case series
Participants 434 German adults from 1 centre
Interventions • Anterior temporal lobe resection included the pole of the temporal lobe. The laterodorsal resection line was
delineated by EEG and abnormalities noted by MRI. The size of the resection ws 2.5 to 4 cm in the language-
dominant hemisphere and 3 to 6 cm in the non-dominant hemisphere. The procedure included removal of the
parahippocampal gyrus, hippocampus, and amygdala
• Apical temporal resection: tailored resection of the lesion in the apex of the temporal lobe with amygdalectomy,
and maximal 4 cm laterodorsal cortex from the pole; extension of the resection was guided by ECoG
• Temporal lesionectomy included only a singular lesion resection as defined by EEG andMRI but saved the eloquent
cortex. In the case of dual pathology a lesionectomy and a selective amygdalohippocampectomy were performed, and
the dorsal resection was guided via intraoperative ECoG
• Selective amygdalohippocampectomy included only a resection of the hippocampus or mesial structures based on
MRI and intraoperative findings (5 people only)
Outcomes Seizure outcome by Engel class determined at 24 months and 5, 10, and 16 years after surgery
Notes -
82Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Elsharkawy 2011a
Methods Retrospective case series
Participants 61 patients ranging in age from 5 to 58 years at the time of surgery with a refractory temporal lobe epilepsy, with
MRI showing a lesion in the apex of the temporal lobe but normal hippocampus and intact memory function
Interventions All had apical temporal lobe resections
Outcomes Seizure outcomemeasured at 2 years and 5 years of follow-up post surgery, measured according to Engel’s classification
Notes -
Engman 2004
Methods Retrospective case series
Participants 54 patients
Interventions Temporal lobectomy
Outcomes Seizure outcome not the main focus but data show numbers of those who were seizure-free at 2 years of follow-up
Notes -
Erba 1992
Methods Retrospective case series
Participants 46 children and adults from a single American centre
Interventions Standard or modified en bloc anterior temporal lobectomy. Depending on hemispheric dominance, 4 to 7 cm of
lateral cortex of the temporal lobe was removed.Mesial structures (uncus, amygdala, hippocampus, and hippocampal
gyrus) were not removed when assessment suggested bilateral involvement
Outcomes Seizure outcome assessed by seizure freedom at least 24 months postoperatively
Notes -
Erickson 2005
Methods Retrospective case series
Participants 84 military beneficiaries at the only US military medical centre with a comprehensive epilepsy surgery programme
Interventions Standard temporal lobectomy in themajority, includingmesial temporal lobe structures; margins extended posteriorly
3.5 to 4.0 cm in the dominant lobe and 5 to 6 cm in the non-dominant lobes; 8 had amygdalohippocampectomies
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Erickson 2005 (Continued)
Outcomes Seizure outcome by Engel class determined at least 24 months after surgery
Notes -
Fauser 2004
Methods Retrospective case series
Participants 67 patients, aged 2 to 66 years, with histologically proven focal cortical dysplasias
Interventions Temporal lobe
Outcomes Seizure outcome measured using Engel’s classification at least 12 months post surgery, with a mean follow-up period
of 21.9 months
Notes -
Fujiwara 2012
Methods Retrospective case series
Participants 44 in 2 American centres operated after intracranial EEG over a 15-month period
Interventions Lesionectomies - temporal and extratemporal
Outcomes Reported as seizure-free at least 12 months after surgery
Notes Focus was outcome related retrospectively to the presence of high-frequency oscillations on ICEEG
Garcia 1991
Methods Retrospective case series
Participants 55 children and adults from a single American centre operated on over a 3-year period
Interventions Temporal lobectomy
Outcomes Seizure outcome assessed by seizure freedom at 12 months postoperatively and annually thereafter
Notes Focus on postoperative seizures and outcome
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Garcia 1994
Methods Prospective case series
Participants 51 participants from a single American centre operated on over a 3-year period
Interventions Anterotemporal resection including amygdala and hippocampus
Outcomes Seizure outcome assessed by seizure freedom at least 12 months postoperatively
Notes Focus on value of qualitative pre-operative MRI findings
Gelinas 2011
Methods Single-centre retrospective case series
Participants 67 children between 3 months and 16 years of age with recurrent seizures attributable to a discrete lesion on
neuroimaging
Interventions Site of surgery was temporal and extratemporal
Outcomes Seizure outcome was examined 1 year post surgery and at subsequent follow-ups using Engel’s classification
Notes -
Georgakoulias 2008
Methods Retrospective case series
Participants 50 adult patients from a single UK centre - mean age 34 years - with medically intractable medial temporal lobe
epilepsy
Interventions Temporal
Outcomes Seizure outcome measured using Engel’s classification; intermediate-term and long-term with mean follow-up of 6.
2 years
Notes -
Gilliam 1997a
Methods Prospective case series
Participants 78 children and adults from a single American centre with mesial-basal temporal lobe epilepsy
Interventions En bloc neocorticectomy of the anterior 4.5 to 5.5 cm of the temporal lobe, sparing the superior temporal gyrus
Outcomes Seizure outcome assessed by seizure freedom at least 12 months after surgery
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Gilliam 1997a (Continued)
Notes Study focuses on concordance of MRI and EEG findings and outcome
Gilliam 1997b
Methods Prospective case series
Participants 33 children from a single American centre
Interventions Extratemporal and temporal lobe cortical resection for children with intractable epilepsy
Outcomes Seizure outcome assessed by ILAE classification at a mean follow-up period of 2.7 years
Notes -
Goldstein 1996
Methods Retrospective case series
Participants 33 children from a single American centre
Interventions Temporal lobe cortical resection for children with intractable epilepsy
Outcomes Seizure outcome assessed by Engel classification at least 24 months post surgery
Notes -
Greiner 2011
Methods Retrospective case series from 2 centres in the USA
Participants 54 participants, aged 6 months to 40 years at the time of surgery, who had had a hemispherectomy
Interventions Extratemporal (i.e. all had hemispherectomy)
Outcomes Seizure freedom assessed using Engel’s classification at least 1 year post surgery
Notes -
Grivas 2006
Methods Retrospective case series
Participants 52 patients older than 50 years from1German centre were operated on for intractablemesial or combinedmesiolateral
TLE
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Grivas 2006 (Continued)
Interventions Temporal lobe resections
Outcomes Seizure outcome measured using Engel’s classification with a mean follow-up period of 33 months
Notes -
Gyimesi 2007
Methods Retrospective case series; a German/Hungarian collaboration
Participants 130 adult patients (no age range provided) who had undergone epilepsy surgery for intractable medial temporal lobe
epilepsy
Interventions Temporal lobe surgery
Outcomes Seizure freedom at 24 months after surgery compared with not seizure-free
Notes -
Hader 2004
Methods Retrospective case series from 1 centre in Canada
Participants 39 children, aged 2 months to 18.5 years, at surgery with a medically intractable epilepsy and focal cortical dysplasia
on histology
Interventions Temporal and extratemporal
Outcomes Seizure outcome measured using Engel’s classification at least 1.5 years after surgery
Notes -
Hajek 2009
Methods Retrospective case series
Participants 35 people from 1 Czech centre with mesial temporal lobe epilepsies, who had had MR spectroscopy before surgery
Interventions Temporal lobe
Outcomes Seizure outcome measured using Engel’s classification at least 24 months after surgery
Notes -
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Hallbook 2010
Methods Retrospective case series
Participants 110 children, 18 years or younger, from a single US centre, with severe refractory epilepsy
Interventions Functional hemispherectomy
Outcomes Seizure freedom at the time of follow-up, which was at least 12 months
Notes -
Hamiwka 2005
Methods Retrospective case series
Participants 38 children, with age at surgery ranging from 6 months to 18 years (mean, 9.6 years), with malformations of cortical
development
Interventions Temporal and extratemporal
Outcomes Seizure outcome at 2, 5, and 10 years measured using Engel’s classification
Notes -
Hartley 2002
Methods Retrospective case series from a single UK centre
Participants 35 children (24 females, 11 males; mean age 9.6 years; age range 11 months to 18 years) with a partial epilepsy, who
had had a SPECT scan before surgery
Interventions Temporal, extratemporal, and hemispherectomy
Outcomes Seizure outcome measured using Engel’s classification; range of follow-up since surgery was 3 to 6 years (mean 4.8
years)
Notes -
Hartzfield 2008
Methods Retrospective case series
Participants 57 patients from a single US centre operated on for post-traumatic medial temporal lobe epilepsy
Interventions Temporal lobe surgery
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Hartzfield 2008 (Continued)
Outcomes Seizure outcome measured using Engel’s classification with a mean follow-up of 4.84 years and a range of 0.5 to 9
years
Notes -
Hemb 2010
Methods Retrospective case review from a single US centre
Participants 192 children operated on before 1997 vs 397 children operated on from 1998 to 2008, all with a refractory epilepsy
Interventions Extratemporal and temporal and hemispherectomies
Outcomes Seizure freedom at time of follow-up, which was at least 12 months
Notes -
Holmes 1997
Methods Retrospective case series
Participants 44 teenagers and adults from a single American centre with bitemporal, independent, interictal epileptiform patterns
Interventions Temporal lobectomy
Outcomes Seizure outcome assessed by seizure freedom at least 12 months post surgery
Notes -
Holmes 2000
Methods Retrospective case series
Participants 126 children and adults from a single American centre with medically intractable extratemporal epilepsy
Interventions Extratemporal cortical resections
Outcomes Seizure outcome assessed by seizure freedom at least 24 months post surgery
Notes -
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Jack 1992
Methods Retrospective case series
Participants 50 teenagers and adults from a single American centre with medically intractable temporal lobe epilepsy
Interventions Anterior temporal lobectomy
Outcomes Seizure outcome assessed by seizure freedom at least 12 months post surgery
Notes -
Janszky 2003a
Methods Retrospective case series from a single German centre
Participants 133 patients (aged 16 to 59 years) with hippocampal sclerosis-associated temporal lobe epilepsy
Interventions Temporal lobe resections
Outcomes Seizure outcome at 2 years post surgery (for 84 patients) measured using Engel’s classification
Notes -
Janszky 2003b
Methods Retrospective case series from a single German centre
Participants 147 patients (range 16 to 59 years) with intractable medial temporal lobe epilepsy who underwent presurgical
evaluation including high-resolution MRI and video-EEG monitoring with seizure registration
Interventions Temporal lobe
Outcomes Seizure outcome at 2 years post surgery measured using Engel’s classification
Notes -
Jaramillo-Betancur 2009
Methods Retrospective case series; nested case-control study
Participants 89 teenagers and adults from Columbia
Interventions Temporal lobectomies
Outcomes Seizure outcome by Engel class determined at 12 and 24 months after surgery
Notes -
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Jayakar 2008
Methods Retrospective case series
Participants 102 children with non-lesional intractable partial epilepsy
Interventions Temporal and extratemporal
Outcomes Seizure outcome measured according to Engel’s classification at 2 years, 5 years, and 10 years post surgery
Notes -
Jayalakshmi 2011
Methods Retrospective case review
Participants 87 children with refractory partial epilepsy
Interventions Temporal, extratemporal, and hemispherectomy
Outcomes Seizure outcome by Engel class determined at least 12 months after surgery
Notes -
Jeha 2006
Methods Retrospective case series
Participants 371 patients who underwent anterior temporal lobectomy to treat pharmacoresistant epilepsy
Interventions Temporal lobe
Outcomes Seizure-free vs not seizure-free assessed at least 1 year after surgery
Notes -
Jehi 2012
Methods Retrospective case series from a single US centre
Participants 312 patients ranging in age from 2.5 to 74 years with an intractable temporal lobe epilepsy
Interventions Temporal resections
Outcomes Seizure freedom assessed using Engel’s classification at least 1 year post surgery
Notes -
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Jennum 1993
Methods Retrospective case series
Participants 64 children and adults from a single Danish centre with medically intractable temporal and extratemporal lobe
epilepsy
Interventions Tailored temporal or extratemporal lobe cortical resection
Outcomes Seizure outcome assessed by seizure freedom at least 12 months post surgery
Notes -
Jeong 1999
Methods Retrospective case series
Participants 93 consecutive children and adults from a single Korean centre with medically intractable mesial temporal lobe
epilepsy
Interventions Temporal lobectomy
Outcomes Seizure outcome assessed by seizure freedom at least 18 months post surgery
Notes -
Kan 2008
Methods Retrospective case series from a single US centre
Participants 58 children with an intractable localised epilepsy
Interventions Temporal and extratemporal
Outcomes Seizure outcome measured according to Engel’s classification at least 1 year post surgery
Notes -
Kang 2009
Methods Retrospective case series from a single US centre
Participants 244 adult patients with a mean age at surgery of 35 years (range 18 to 68 years) with an intractable temporal lobe
epilepsy, all of whom had BMI > 26 (i.e. overweight, obese, or morbidly obese)
Interventions Temporal lobe surgery
Outcomes Seizure outcome measured according to Engel’s classification at least 1 year post surgery
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Kang 2009 (Continued)
Notes -
Kanner 2009
Methods Retrospective case series from a single US centre
Participants 100 patients with a mean age of 31.2 years with temporal lobe epilepsy (TLE)
Interventions Temporal lobe surgery
Outcomes Seizure outcome at 2-year follow-up measured using Engel’s classification
Notes -
Kilpatrick 1997
Methods Prospective case series
Participants 75 consecutive teenagers and adults from 2 Australian centres with medically intractable temporal lobe epilepsy
Interventions Those with hippocampal sclerosis underwent a tailored anterior temporal lobectomy with en bloc excision of the
neocortical structures followed by microsurgical resection of the amygdala and en bloc excision of the hippocampal
formation and parahippocampal gyrus. On the non-dominant side, this included excision of 4 cm of the superior
temporal gyrus and the middle temporal gyrus, and the inferior temporal gyrus to the vein of Labbe or 5 to 6 cm; in
dominant lobectomy, the superior temporal gyrus was left intact, the middle temporal gyrus was excised for 4 to 5
cm or to the vein of Labbe, and the inferior temporal was excised for either 4.5 to 5.5 cm or to the vein of Labbe.
Patients with foreign tissue lesions had an anterior temporal lobectomy, lesionectomy, or neocorticectomy
Outcomes Seizure outcome assessed by Engel class at least 12 months post surgery
Notes -
Kim 2009
Methods Retrospective case series from a single Korean centre
Participants 166 patients aged 3 to 51 years with a mean age of 24.7 years with intractable epilepsy related to focal cortical
dysplasia
Interventions Temporal and extratemporal
Outcomes Seizure outcome (i.e. freedom or not at follow-up); mean length of postoperative follow-up was 7.94 years
Notes -
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Kim 2010a
Methods Retrospective case series from a single Korean centre
Participants 177 participants, between 11 and 51 years of age at the time of surgery, who had had resective surgery and intracranial
EEG monitoring
Interventions Temporal and extratemporal resections
Outcomes Seizure outcome by Engel class determined at least 12 months after surgery
Notes -
Kim 2010b
Methods Retrospective case series from a single Korean centre
Participants 40 patients, aged 4 to 51 years, with refractory epilepsy
Interventions Temporal and extratemporal surgery
Outcomes Seizure-free (as opposed to not seizure-free) measured at least 2 years postoperatively
Notes -
Kloss 2002
Methods Retrospective and prospective case series
Participants 68 participants from 1 German centre younger than 18 years of age
Interventions Types of resection included lesionectomy, lesion and corticectomy, lobectomy, and multi-lobar resection
Outcomes Seizure outcome was assessed using Engel’s classification at 2 years postoperatively
Notes -
Knowlton 2008
Methods Prospective case series from a single US centre
Participants 62 patients with mean age at surgery of 26 years (minimum age 1 year, maximum age 60 years), who required
intracranial electroencephalography (ICEEG) because epileptic focus was not sufficiently localised with scalp EEG
and MRI
Interventions Temporal and extratemporal
Outcomes Seizure outcome measured using Engel’s classification at least 1 year post surgery; range of follow-up was 1.5 to 10.
5 years, with mean time of 4.2 years, and median of 3.5 years. Patients with < 1 year follow-up were excluded
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Knowlton 2008 (Continued)
Notes -
Kral 2007
Methods Retrospective cases series from a single German centre
Participants 49 patients with mean age at surgery of 18 years (range 5 to 47 years) with focal cortical dysplasia
Interventions Temporal and extratemporal
Outcomes Seizure outcome measured using the ILAE classification with mean follow-up of 8.1 (SD 4.5) years
Notes -
Krsek 2013
Methods Retrospective case series
Participants 106 children from 1 American centre
Interventions Resection of epileptogenic zone - temporal and extratemporal
Outcomes Assessed as Engel class at 24 months post surgery
Notes Focus was outcome related retrospectively to pre-operative SPECT findings
Kuzniecky 1993
Methods Prospective case series
Participants 34 children and adults from 1 American centre with medically intractable temporal lobe epilepsy
Interventions Temporal lobectomy
Outcomes Seizure outcome assessed by modified Engel class at least 12 months post surgery
Notes Focus on MRI findings and presence of febrile seizures
Kwan 2010
Methods Retrospective cases series
Participants 41 Canadian children undergoing hemispherectomy
Interventions Hemidecortication compared with peri-insular hemispherotomy
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Kwan 2010 (Continued)
Outcomes Seizure outcome by Engel class determined at least 24 months after surgery
Notes -
Lackmayer 2013
Methods Retrospective case series
Participants 45 consecutive patients from a single Austrian centre with medically refractory unilateral mesial temporal lobe seizures
Interventions Selective amygdalohippocampectomy or anteromedial temporal lobectomy
Outcomes Assessed as seizure freedom 1, 2, or 3 years post surgery
Notes Focus of study was postoperative depression related to seizure outcome
Lee 2006
Methods Retrospective cases series from a single Korean centre
Participants 51 patients with a mean age at surgery of 31.4 years (ranging from 16 to 50 years) with pathologically proven mesial
temporal sclerosis
Interventions Temporal lobe surgery
Outcomes Seizure outcome measured using Engel’s classification at follow-up, which lasted at least 4 years
Notes -
Lee 2008
Methods Not stated
Participants 71 participants from a single Korean centre with frontal lobe epilepsy and mean age at surgery of 26.2 years (ranging
from 12 to 57 years)
Interventions Extratemporal surgery
Outcomes Seizure outcome at least 2 years after surgery with an unclassified scale
Notes -
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Lee 2010a
Methods Retrospective case series from a single Korean centre
Participants 52 people with intractable temporal lobe epilepsy; 19 patients were classified as children (≤ 18 years old), and 33
patients were classified as adults (> 18 years old)
Interventions Temporal lobe
Outcomes Whether seizure-free or not at 2 years and 4 years post surgery
Notes -
Lee 2011
Methods Retrospective cases series
Participants 40 Korean participants treated for lesional mesial temporal lobe epilepsy between 1993 and 2008
Interventions Intervention before 2006 was anterior temporal lobectomy, and from 2006, selective lesionectomy via a transsylvian-
transcisternal approach
Outcomes Seizure outcome by Engel class determined at least 12 months after surgery
Notes -
Lei 2008
Methods Retrospective case series from a single Korean centre
Participants 250 cases of epilepsy caused by cerebral schistosomiasis in patients 17 to 66 years of age (mean age 32.8 years)
Interventions Temporal and extratemporal
Outcomes Seizure outcome at follow-up 4 to 5 years after operation measured using Engel’s classification
Notes -
Li 1997
Methods Retrospective case series
Participants 51 children and adults from Canadian, UK, and American centres with medically intractable temporal and extratem-
poral lobe epilepsy
Interventions Lesionectomy, lesionectomy plus corticectomy or lobectomy, corticectomy without removal of the lesion, selective
amygdalo-hippocampectomy, selective amygdalohippocampectomy, and lesionectomy
Outcomes Seizure outcome assessed by modified Engel class at least 12 months post surgery
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Li 1997 (Continued)
Notes -
Li 1999
Methods Case series; not clear whether retrospective or prospective
Participants 38 teenagers and adults from Canadian, UK, American, and Australian centres with medically intractable epilepsy
associated with hippocampal sclerosis and an additional lesion, which could have been temporal or extratemporal
Interventions Lesionectomy (removal of the extrahippocampal lesion); mesial temporal resection (removal of the atrophic hip-
pocampus); and lesionectomy plus mesial temporal resection (removal of both the lesion and the atrophic hippocam-
pus)
Outcomes Seizure outcome assessed by modified Engel class at least 12 months post surgery
Notes -
Liang 2010
Methods Prospective study “randomly allocated” to either treatment group
Participants 60 Chinese participants with temporal lobe epilepsy and mental retardation
Interventions Half had anterior temporal lobectomy, and half anterior corpus callosotomy combined with anterior temporal
lobectomy
Outcomes Seizure outcome by Engel class determined at 24 months after surgery
Notes Study to compare the outcome of the 2 surgical approaches
Liang 2012
Methods Retrospective case series
Participants 206 children from 4 Chinese centres undergoing surgical resection for epilepsy between 2001 and 2007
Interventions Lesion resection, epileptogenic zone resection, anterior temporal lobectomy (involving resection of 3 to 3.5 cm of the
neocortex and 2 to 2.5 cm of the mesial structure of the left anterior temporal lobe, or 3.5 to 4.5 cm of the neocortex
and 2 to 3 cm of the mesial structure of the right anterior temporal lobe, and selective amygdalohippocampotomy
using a trans-Sylvian approach
Outcomes Assessed as seizure freedom at least 12 months post surgery
Notes -
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Liava 2012
Methods Retrospective case series
Participants 53 children and young adults from 2 Italian centres with extratemporal lobe epilepsy
Interventions Tailored resections with localisation: 5 frontomesial, 6 fronto-dorsolateral, 6 fronto-mesial + dorsolateral, 2 fronto-
orbital, 5 fronto-operculo-insular, 1 fronto-central, 4 frontocentro-parietal, 3 fronto-centro-temporal, 5 parietal,
2 parietotemporal, 1 centro-parietal, 1 occipital, 7 occipito-temporal, and 5 temporo-parieto-occipital. In 5 cases,
only partial excision of the EZ was performed because of its functional intersection with eloquent areas: 1 fronto-
dorsolateral, 1 fronto-mesial + dorsolateral, 1 fronto-central, 1 parietal, and1 temporo-parieto-occipital; the remaining
resections were considered as complete
Outcomes Assessed as Engel class at least 18 months post surgery
Notes -
Lopez-Gonzalez 2012
Methods Retrospective case series from a single US centre
Participants 130 children, aged 1 to 18 years at surgery, who had temporal lobe surgery
Interventions Temporal lobe resections
Outcomes Seizure outcome measured using Engel’s classification at 1, 2, 5, and 12 years post surgery
Notes -
Lorenzo 1995
Methods Retrospective case series
Participants 48 participants (age not specified) from 1 American centre with medically intractable focal frontal lobe epilepsy
Interventions Focal cortical resection (i.e. partial or complete frontal lobectomy with or without an identified mass lesion) and
stereotactic resection of a frontal lobe MRI-identified epileptogenic lesion
Outcomes Seizure outcome assessed by modified Engel class at least 12 months post surgery
Notes -
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Madhavan 2007
Methods Retrospective case series from 5 centres: 1 French, 3 American, and 1 Canadian
Participants 70 patients with tuberous sclerosis complex and epilepsy; mean age at surgery 9.9 years
Interventions Temporal and extratemporal
Outcomes Seizure outcome at follow-up (time from surgery to evaluationwas 5.2 (8.0) years)measuredusing Engel’s classification
Notes -
Mani 2006
Methods Retrospective cases series from a single US centre
Participants 132 children (< 18 years) with intractable epilepsy; mean age at surgery was 8.17 years
Interventions Extratemporal cortical resection and hemispherectomy
Outcomes Seizure outcome at 12 and 24 months post surgery assessed using Engel’s classification
Notes -
Mathern 1999
Methods Retrospective case series from a multi-centre Australian surgery for epilepsy programme
Participants 198 children from 1 American centre with medically intractable temporal and extratemporal lobe epilepsy
Interventions The most common procedures were hemispherectomies, followed by lobar resections
Outcomes Seizure outcome assessed by seizure freedom at least 12 months post surgery
Notes -
McIntosh 2012
Methods Retrospective case series from an Australian centre
Participants 81 patients - aged 4 to 60 years at the time of surgery with 12 people younger than 16 years - who had extratemporal
resection
Interventions Extratemporal resections
Outcomes Seizure freedom measured at least 2 years post surgery
Notes -
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Mihara 2004
Methods Retrospective case series from a Japanese centre
Participants 357 patients with a medically intractable epilepsy (mean age at surgery calculated as 24.7 years); temporal lobe group:
25.5 years (range 2 to 55 years); extratemporal group: 21.8 years (range 2 to 40 years)
Interventions Temporal and extratemporal
Outcomes Seizure outcome measured using Engel’s classification at least 12 months post surgery
Notes -
Miserocchi 2013
Methods Retrospective case series
Participants 68 children from a single Italian centre with temporal lobe epilepsy, operated between 2001 and 2010
Interventions Tailored microsurgical resections of epileptogenic zone
Outcomes Assessed as Engel class at least 12 months post surgery
Notes -
Morino 2009
Methods Retrospective case series
Participants 62 people with temporal lobe seizures operated on at a single Japanese centre
Interventions All participants underwent trans-sylvian selective amygdalohippocampectomy
Outcomes Seizure freedom 12 months postoperatively
Notes Study to determine effects of selective surgery on memory outcome
Morris 1998
Methods Retrospective case series from a US centre
Participants 38 children and adults from 1 American centre with medically intractable epilepsy, who had had resection of a
ganglioglioma in the temporal or extratemporal lobe over a 9-year period
Interventions Tumour resection
Outcomes Seizure outcome assessed by Engel class at least 12 months post surgery
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Morris 1998 (Continued)
Notes -
O’Brien 1996
Methods Retrospective case series from an Australian centre
Participants 46 teenagers and adults from 1 Australian centre with medically intractable temporal lobe epilepsy over a 9-year
period
Interventions Standard anterior temporal lobectomy (4.5 to 5.5 cm lateral resection) with en bloc removal of the mesial temporal
structures or lesionectomy
Outcomes Seizure outcome assessed by seizure freedom at least 12 months post surgery
Notes -
O’Brien 2000
Methods Retrospective case series from an Australian centre
Participants 36 children at 1 American centre who had peri-ictal and interictal SPECT studies and extratemporal resective epilepsy
surgery performed between June 1993 and June 1997
Interventions Resection of epileptogenic zone
Outcomes Seizure outcome assessed by seizure freedom at least 12 months post surgery
Notes Study of whether subtraction ictal SPECT co-registered with MRI (SISCOM) is predictive of outcome
Oertel 2005
Methods Prospective randomised study from a German centre
Participants 30 patients; mean age and range: waterjet group 35.5 (18 to 70), aspirator group 34.7 (20 to 57); mean age for all
patients calculated as 35.1, with an intractable epilepsy
Interventions Temporal lobe surgery
Outcomes Seizure outcome with a mean follow-up period of 2.15 years (range 1 to 3.5 years), measured as seizure-free or not
Notes -
102Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Paglioli 2006
Methods Prospective case series
Participants 161 consecutive Brazilian participants with MTLE/HS
Interventions Anterior temporal lobectomy or a selective amygdalohippocampectomy
Outcomes Seizure outcome by Engel class determined from 24 months after surgery onwards
Notes -
Paolicchi 2000
Methods Retrospective case series
Participants 75 children at 2 American centres with intractable temporal or extratemporal lobe epilepsy
Interventions Cortical resections.None of the temporal resectionswere ’standard’; all included anterior neocortical andmesial limbic
structures, tailored posteriorly according to EEG, lesional data, and location of language cortex. For seizures that
originated posteriorly, resection of the temporal convexity and the basal neocortex was extended further posteriorly,
with the vein of Labbe undercut if needed. Extratemporal resections consisted of complete removal of the lesion
combined with corticectomy tailored to the epileptogenic region. Anterior frontal epileptogenic regions were often
treated by medial or lateral wedge resections; posterior frontal, parietal, and occipital foci were more likely to be
treated by tailored corticectomy alone
Outcomes Seizure outcome assessed by seizure freedom at least 12 months post surgery
Notes -
Park 2002
Methods Retrospective case series from a US centre
Participants 148 participants younger than 18 years who underwent surgery for relief of medically intractable epilepsy, with mean
age at surgery of 13.4 years (range 5 months to 18 years)
Interventions Temporal and extratemporal
Outcomes Seizure outcome measured using Engel’s classification at least 12 months after surgery
Notes -
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Park 2006
Methods Retrospective case series from a single Korean centre
Participants 30 patients with cortical dysplasia (CD) and epilepsy (age range 1.5 to 18.3 years)
Interventions Temporal and extratemporal
Outcomes Seizure outcome measured using Engel’s classification with a mean follow-up period of 3.2 years and a minimum
follow-up period of 12 months
Notes -
Perego 2009
Methods Retrospective case series
Participants 37 adults from 1 Spanish centre
Interventions 25 participants underwent anteromedial temporal lobe resection; 5 underwent temporal complete lobectomy; 6
underwent a lesionectomy with well-demarcated lesions; and 1 underwent selective transventricular amygdalohip-
pocampectomy
Outcomes Seizure outcome was assessed using Engel’s classification at 1 and 3 years postoperatively
Notes -
Perry 2010
Methods Retrospective cases series
Participants 83 American participants younger than 18 years of age with incomplete resection (defined by intraoperative or
extraoperative subdural EEG data and postoperative MRI when a lesion was present) for epilepsy, with 2 years of
follow-up
Interventions Lesional resection - excluding those who had corpus callosotomy, vagal nerve stimulator placement, multiple subpial
transections as their sole procedure, and those who had a hemispherectomy
Outcomes Seizure outcome by Engel class determined at least 24 months after surgery
Notes Note: this is a follow-up study of participants with original incomplete resection
104Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Phi 2009
Methods Retrospective cases series
Participants 87 participants from a single Korean centre with tumour-related temporal lobe epilepsy
Interventions Temporal lobe lesionectomy with or without hippocampectomy
Outcomes Seizure outcome by Engel class determined at least 12 months after surgery
Notes -
Phi 2010
Methods Retrospective cases series
Participants 41 paediatric patients from a single Korean centre with focal cortical dysplasia
Interventions Temporal or extratemporal lobe surgery
Outcomes Seizure outcome by Engel class determined at least 12 months after surgery
Notes -
Pinheiro-Martins 2012
Methods Retrospective case series from a Brazilian centre
Participants 70 participants, aged 1 to 52 years at the time of surgery, with a refractory frontal lobe epilepsy
Interventions Extratemporal resections
Outcomes Seizure outcome measured according to Engel’s classification at time of follow-up, which was at least 4 years after
surgery
Notes -
Prevedello 2000
Methods Retrospective case series
Participants 84 adults from 1 German centre with intractable temporal lobe epilepsy
Interventions Anterior temporal lobectomy
Outcomes Seizure outcome assessed by Engel class at least 15 months post surgery
Notes -
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Raabe 2012
Methods Retrospective case series from a German centre
Participants 80 patients with drug-resistant focal epilepsy and either a cavernous angioma or an arteriovenous malformation in
underlying histology
Interventions Not stated whether temporal or extratemporal resections
Outcomes Seizure outcome measured using Engel’s classification at follow-up at least 2 years post surgery
Notes -
Radhakrishnan 1998
Methods Prospective and retrospective case series
Participants 175 children and adults from 1 American centre with intractable temporal lobe epilepsy
Interventions Anterior temporal lobectomy with amygdalohippocampectomy with resection of the lateral temporal cortex and the
mesial temporal structures, which included the amygdala, the hippocampus, and the parahippocampal gyrus
Outcomes Seizure outcome assessed by Engel class at least 24 months post surgery
Notes -
Rausch 2003
Methods Not stated - but a longitudinal study, possibly prospective
Participants 44 patients from a US centre who had a temporal lobe resection
Interventions Temporal lobe resection
Outcomes Seizure freedom at time of follow-up, which was at least 12 months
Notes -
Remi 2011
Methods Retrospective case study
Participants 154 German participants with a focal epilepsy, temporal and extratemporal
Interventions Resections were tailored so as to encompass as much epileptogenic tissue as possible and as little eloquent cortex as
possible
Outcomes Seizure outcome by Engel class determined at least 22 months after surgery
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Remi 2011 (Continued)
Notes -
Roberti 2007
Methods Retrospective case study
Participants 42 adults and children from a single US centre with non-lesional temporal lobe epilepsy
Interventions All had anteromedial temporal lobectomy
Outcomes Seizure outcome by Engel class at a median of 60 months but a minimum of 12 months of follow-up
Notes -
Rossi 1994
Methods Retrospective case series
Participants 138 children and adults from 1 Italian centre with intractable temporal and extratemporal lobe epilepsy
Interventions Surgical procedures utilised were 17 hemispherectomies (children only), 67 anterior temporal lobectomies, and 54
extratemporal resections
Outcomes Seizure outcome assessed by Engel class at least 24 months post surgery
Notes -
Russo 2003
Methods Retrospective case series from 1 Italian centre
Participants 126 participants - adults and children, with age at surgery ranging from 0 to 53 years - with intractable epilepsy and
malformation of cortical development on histology
Interventions Temporal and extratemporal resections
Outcomes Seizure outcome by Engel class determined at least 12 months after surgery
Notes -
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Sagher 2012
Methods Retrospective case series from a single US centre
Participants 96 patients with medically refractory mesial temporal lobe epilepsy
Interventions Temporal lobe resections
Outcomes Seizure outcome measured using Engel’s classification at 3 months, 1 year, 2 years, and 3 years post surgery
Notes -
Sakamoto 2009
Methods Retrospective case series from a Japanese centre
Participants 36 participants, 12 years old and over, with intractable temporal lobe epilepsy
Interventions Temporal lobe surgery - anterior temporal lobectomy with amygdalo-hippocampectomy or selective amygdalo-
hippocampectomy with or without multiple subpial transection
Outcomes Seizure outcomes evaluated according to ILAE classification at least 24 months after resection
Notes -
Salanova 1994
Methods Retrospective case series
Participants 98 children and adults from 1 American centre with intractable temporal lobe epilepsy
Interventions Temporal lobectomy
Outcomes Seizure outcome assessed by Engel class at least 12 months post surgery
Notes -
Sarkis 2012
Methods Retrospective case series from a US centre
Participants 63 participants, aged 1.6 to 56 years at time of surgery, who had a multi-lobar resection for a medically refractory
epilepsy
Interventions Multi-lobar surgical resections, classified based on the lobes involved (frontal, parietal, temporal, or occipital), then
categorised into frontotemporal (FT), temporoparietal (TP), frontoparietal (FP), and occipital plus (temporoparieto-
occipital (TPO), parieto-occipital (PO), or temporo-occipital (TO)). The occipital plus group represented extended
posterior quadrant resections as opposed to more anterior resection subsets
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Sarkis 2012 (Continued)
Outcomes Seizure outcome measured using Engel’s classification 1 year post surgery and annually thereafter
Notes -
Schramm 2011
Methods Randomised controlled trial
Participants 207 participants from 3 German centres with temporal lobe epilepsy
Interventions Randomised to an intended minimum resection length of 25 mm or 35 mm for hippocampus and parahippocampus
Outcomes Seizure outcome by Engel class determined at 12 months after surgery
Notes -
Seymour 2012
Methods Retrospective case series from a UK centre
Participants 306 adults and children operated on between 1975 and 1995
Interventions Resection of either temporal lobe
Outcomes Seizure outcome by Engel class determined at least 24 months after surgery
Notes Report on mortality, after a longer interval, in a cohort treated by temporal lobe surgery between 1975 and 1995
Sinclair 2003
Methods Retrospective case series from 1 Canadian centre
Participants 77 children with intractable epilepsy
Interventions Extratemporal operations: 8 parietal, 12 frontal, 4 occipital, and 10 multi-lobar or hemispherectomy resections. One
hypothalamic hamartoma and 4 callosotomies (reported separately), as well as 42 temporal lobectomies (method not
defined in any detail)
Outcomes Seizure outcome was assessed using Engel’s classification at 1 year postoperatively and annually thereafter
Notes -
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Sindou 2006
Methods Not stated - probably retrospective case series
Participants 100 people from a French centre with medically intractable temporo-mesial epilepsy
Interventions Tailored temporal lobe resection
Outcomes Seizure outcome was assessed using Engel’s classification at least 1 year postoperatively up to 10 years of follow-up
Notes -
Sola 2005
Methods Retrospective case series; multi-centre study from Spain
Participants 137 teenagers and adults followed for 2 years postoperatively
Interventions Temporal lobectomies
Outcomes Seizure outcome by Engel class (1 and 2 combined) determined at 24 months after surgery
Notes -
Spencer 2005
Methods Prospective observational multi-centre American study of seizures, anxiety, depression, and quality of life (QOL)
outcomes after resective epilepsy surgery
Participants 339 participants followed for at least 2 years
Interventions Resective surgery: mesial temporal resection or resection in any neocortical region including temporal lobe
Outcomes Any seizure at 12 months or 1 to 2 years postoperatively
Notes -
Sperling 1992
Methods Prospective case series
Participants 51 adults from 1 American centre with intractable temporal lobe epilepsy
Interventions Standard anterior temporal lobectomy. In the non-dominant hemisphere, the resection line ran 5.0 to 5.5 cm from
the temporal tip and 4.5 to 5.0 cm in the dominant hemisphere. The amygdala and 1.5 to 2.0 cm of the hippocampus
were removed by suction in early participants and en bloc in later participants in the series
Outcomes Seizure outcome assessed by Engel class at least 21 months post surgery
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Sperling 1992 (Continued)
Notes -
Stavrou 2008
Methods Retrospective case series
Participants 53 children and adults from a single Austrian centre with a cavernoma and epilepsy
Interventions 58 microsurgical resections; 3 participants underwent several operations for multiple cavernomas; 1 underwent a
second operation for remaining lesion 4 years after initial surgery
Outcomes Seizure outcome by ILAE classification at least 2 years after surgery
Notes -
Suppiah 2009
Methods Retrospective case series
Participants 176 children and adults from New Zealand followed up for at least 12 months
Interventions Temporal lobectomy
Outcomes Seizure outcome by Engel class determined at 12 months after surgery
Notes -
Swartz 1992
Methods Prospective case series
Participants 34 adults from 1 American centre with intractable temporal lobe epilepsy
Interventions Temporal lobe resection
Outcomes Seizure outcome assessed by seizure freedom Engel class at least 20 months post surgery
Notes -
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Tanriverdi 2010
Methods Retrospective case series
Participants 256 participants from Canada and France with mesial temporal lobe epilepsy
Interventions Corticohippocampectomy or selective amygdalohippocampectomy
Outcomes Seizure outcome by Engel class determined at 12 months after surgery
Notes Comparison of surgical approach and IQ and memory outcomes at 1-year follow-up for people with medically
refractory mesial temporal lobe epilepsy (MTLE) due to hippocampal sclerosis
Tatum 2008
Methods Retrospective case series from 2 US centres
Participants 39 adults with intractable localisation-related epilepsy and a normal MRI scan
Interventions Anterior temporal lobectomy
Outcomes Participants were classified as seizure-free or not seizure-free at follow-up, which was at least 12 months after surgery
Notes -
Terra-Bustamante 2005a
Methods Prospective study from a Brazilian centre
Participants 107 patients, 18 years of age and younger, with medically intractable epilepsy
Interventions Temporal and extratemporal resections
Outcomes Seizure outcome was classified according to Engel’s classification scheme and was assessed at least 12 months post-
operatively
Notes -
Terra-Bustamante 2005b
Methods Prospective study from a Brazilian centre
Participants 35 children, 18 years and younger, with medically intractable temporal lobe epilepsy
Interventions All had surgery on the temporal lobe
Outcomes Seizure outcome was classified according to Engel’s classification scheme and was assessed at least 12 months post-
operatively
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Terra-Bustamante 2005b (Continued)
Notes -
Tezer 2008
Methods Retrospective case series from a Turkish centre
Participants 109 adults with mesial temporal lobe epilepsy and hippocampal sclerosis
Interventions Anterior temporal lobectomy in all
Outcomes Seizure outcome assessed using Engel’s classification at least 12 months after surgery
Notes -
Theodore 2012
Methods Prospective case series
Participants 41 adults from 1 American centre
Interventions All participants underwent anterior temporal lobectomy, tailored to individual pre-resection evaluations, and intra-
operative electrocorticography. All resections included the temporal tip, a minimum of 1 cm of the anterior part
of the superior temporal gyrus, and between 3 and 5 cm of the middle and inferior temporal gyri. Resection was
extended to involve epileptogenic frontal regions identified on subdural electrode recording in 2 participants
Outcomes Seizure outcome by Engel class determined at least 12 months after surgery
Notes Objective of this study was to compare 5-hydroxytryptamine receptor 1A (5-HT1A) PET vs cerebral metabolic rate
of glucose (CMRglc) PET for temporal lobectomy planning
Tigaran 2003
Methods Retrospective case series from a US centre
Participants 65 adults who had surgery for intractable partial epilepsy
Interventions All had frontal lobe cortical resections
Outcomes Seizure outcome was classified according to Engel’s classification scheme and was assessed at least 12 months post-
operatively
Notes -
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Tripathi 2008
Methods Retrospective cases series from an Indian centre
Participants 57 children and adults (61% younger than 18 years) with intractable epilepsy secondary to cortical dysplasia
Interventions Temporal and extratemporal resections
Outcomes Seizure outcome measured at least 12 months postoperatively and classified using Engel’s scale
Notes -
Trottier 2008
Methods Retrospective case series
Participants 105 French adults (2 children) from 1 centre
Interventions Lesionectomies defined by MRI/EEG concordance or by SEEG
Outcomes Seizure outcome assessed using Engel’s classification at follow-up at 12 months after surgery and annually thereafter
Notes -
Urbach 2007
Methods Retrospective case series from a German centre
Participants 42 adults and children with drug-resistant parietal and occipital lobe epilepsies
Interventions Extratemporal surgery
Outcomes Seizure outcome at 12 months was determined using Engel’s classification
Notes -
Ure 2009
Methods Retrospective case series
Participants 77 participants from 1 Canadian centre aged 14 to 53 years with bitemporal lobe epilepsy
Interventions Target temporal lobectomies
Outcomes Seizure outcome was assessed using Engel’s classification at 1 year
Notes Study of the usefulness of intracranial electrical stimulation in identifying the temporal lobe to be targeted for resection
in bitemporal lobe epilepsy
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Velasco 2011
Methods Prospective case series from a Brazilian centre
Participants 163 patients, over 18 years of age, with refractory mesial temporal lobe epilepsy and hippocampal sclerosis
Interventions Temporal lobectomies
Outcomes Seizure outcome measured at least 14 months after surgery using Engel’s classification
Notes -
Vogt 2018
Methods Randomised controlled trial conducted at theUniversity Hospital of Bonn, Germany fromAugust 2019 toDecember
2012
Participants All participants who recommended for selective amygdalohippocampectomy (SAH) were invited to join the study
Participants had to be at least 16 years old with drug resistant mesial temporal lobe epilepsy as determined by long-
term EEG, MRI and semiology
Interventions Selective amygdalohippocampectomy (SAH) with participants randomised to a subtemporal (n = 26 randomised, n
= 22 analysed) or transsylvian approach (n = 28 randomised, n = 25 analysed)
Outcomes Primary outcome: Neuropsychological assessments at 12 months; memory, attention and executive functions, lan-
guage functions (not relevant to this review)
Freedom from seizures according to the ILAE scale at 12 months
Notes
Walz 2003
Methods Not stated whether prospective or retrospective
Participants 100 adults from a Brazilian centre with mesial temporal lobe epilepsy related to hippocampal sclerosis
Interventions Anterior or mesial temporal lobectomy
Outcomes Seizure outcome measured at least 12 months postoperatively using Engel’s scale
Notes -
Weinand 1992
Methods Retrospective case series
Participants 89 participants (age not stated) from 1 American centre with intractable temporal lobe epilepsy
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Weinand 1992 (Continued)
Interventions For participants with medial temporal lobe onset, a standardised 4.5-cm lateral resection with the posterior resection
line of the parahippocampal gyrus and hippocampus extending to at least the level of the cerebral peduncle; for
lateral onset, a more extensive and tailored ECoG-guided resection; for regional temporal lobe onset, more extensive
removal of the parahippocampal gyrus, hippocampus, and lateral cortex
Outcomes Seizure outcome assessed by seizure freedom at least 12 months post surgery
Notes -
Wellmer 2012
Methods Retrospective case series from a German centre
Participants 197 participants, between 0 and 70 years of age, with pharmacoresistant epilepsy, who had undergone invasive
monitoring before surgery
Interventions Not stated
Outcomes Seizure outcome measured at 3, 6, 12, and 24 months after surgery using Engel’s classification
Notes -
Widdess-Walsh 2007
Methods Retrospective case series from a US centre
Participants 48 participants (30 were over 16 years of age) undergoing surgery for focal cortical dysplasia guided by subdual
electrode recordings
Interventions Temporal and extratemporal resections
Outcomes Measurement of seizure freedom at follow-up at least 12 months from the time of surgery
Notes -
Wiebe 2001
Methods Randomised controlled trial conducted at 3 centres in 1 Canadian city
Participants Participants had to be at least 16 years old and must have had seizures with strong temporal lobe semiology for longer
than 1 year
Interventions Randomisation (40 in each group) to resection of a maximum of 6.0 to 6.5 cm of the anterior lateral non-dominant
temporal lobe, or 4.0 to 4.5 cm of the dominant temporal lobe. Mesial resection included the amygdala and, at a
minimum, the anterior 1.0 to 3.0 cm of the hippocampus (most commonly, 4.0 cm) OR continued antiepileptic
drugs
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Wiebe 2001 (Continued)
Outcomes Primary outcome was freedom from seizures that impair awareness of self and surroundings at 1 year
Notes -
Wieshmann 2008
Methods Retrospective case series from a UK centre
Participants 76 adults with refractory temporal lobe epilepsy
Interventions Anterior temporal lobe resections
Outcomes Seizure outcome assessed 2 years post surgery using Engel’s classification
Notes -
Wray 2012
Methods Retrospective case series from a US centre
Participants 52 children from 1 American centre; all participants had the primary motor or somatosensory cortex localised via 2
or more of the following tests: SSEP, fMRI, or high gamma electrocorticography (hgECoG)
Interventions Resection of epileptogenic zone: temporal and extratemporal
Outcomes Assessed as Engel class at least 12 months post surgery
Notes -
Wyler 1995
Methods Prospective case series
Participants 70 adults from 1 American centre with intractable temporal lobe epilepsy
Interventions The same procedure for either hemisphere and all participants: anterior lateral 4.5 cm of temporal neocortex was
removed, including superior through inferior temporal gyri, leaving hippocampus, parahippocampus, and fusiform
gyri. Fusiform gyrus was then dissected piecemeal, leaving only hippocampal and parahippocampal gyri. The hip-
pocampus was removed en bloc to the anterior margin of the cerebral peduncle (partial hippocampectomy (P)) or to
the level of the colliculi (total hippocampectomy (T))
Outcomes Seizure outcome assessed by seizure freedom at least 12 months post surgery
Notes -
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Wyllie 1998
Methods Case series (whether prospective or retrospective not stated)
Participants 136 children from 1 American centre with intractable extratemporal or temporal lobe epilepsy
Interventions Participants with hippocampal sclerosis had anteromesial temporal resection. For other temporal lesions, resection of
the lesion, surrounding cortex, and usually also the mesial temporal structures was performed. 46% of extratemporal
resections were frontal, and the rest were parietal, occipital, perirolandic, or multi-lobar (frontal and temporal,
temporal and occipital, or temporo-parietal-occipital). Functional hemispherectomies were performed as described
by Rasmussen, with resection of central regions and hemispheric disconnection by transection of white matter tracts
and corpus callosotomy
Outcomes Seizure outcome assessed by Engel class at least 12 months post surgery
Notes -
Yang 2011
Methods Retrospective case series
Participants 99 children and adults from 1 Chinese centre followed for at least 1 year
Interventions Lesion resection defined by clinical, neuroimaging, and electrophysiological results
Outcomes Seizure outcome assessed at least 12 months post surgery using modified ILAE classification
Notes -
Yeon 2009
Methods Retrospective case series from a Korean centre
Participants 60 adults with an infratentorial cavernous haemangioma and seizures
Interventions Temporal and extratemporal
Outcomes Seizure outcome measured at least 12 months postoperatively and classified using Engel’s scale
Notes -
Yu 2009
Methods Retrospective case series from a Chinese centre
Participants 43 adults and children with posterior cortex epilepsy
Interventions Extratemporal resections
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Yu 2009 (Continued)
Outcomes Seizure outcome measured at least 12 months postoperatively and classified using Engel’s scale
Notes -
Yu 2012a
Methods Prospective case series
Participants 100 adults from 1 Chinese centre with resective epilepsy surgery between 2001 and 2009
Interventions Classic anterior temporal lobotomies were performed for temporal lobe epilepsy. Tailored resection was completed
for patients with extratemporal lobe epilepsy. Resective microsurgeries were conducted with the guidance of presur-
gical localisation results and aimed to remove epileptogenic zones. Anatomical or functional hemispherectomy was
performed on some participants with hemispheric lesions. 62 with temporal lobe epilepsy had anterior temporal
lobectomies, 37 had tailored focal or lobar resections with extra temporal lobe epilepsy (6 with tumours), and 1 had
anatomical hemispherectomy
Outcomes Seizure outcome assessed at least 12 months post surgery using Engel classification
Notes Yu 2012a and Yu 2012b were treated as 2 studies in a single publication. One quality assessment was performed for
the single publication
Yu 2012b
Methods Prospective case series
Participants 222 children from 1 Chinese centre with resective epilepsy surgery between 2001 and 2009
Interventions Classic anterior temporal lobotomies were performed for temporal lobe epilepsy. Tailored resection was completed
for participants with extratemporal lobe epilepsy. Resective microsurgeries were conducted with the guidance of
presurgical localisation results and aimed to remove epileptogenic zones. Anatomical or functional hemispherectomy
was performed on some participants with hemispheric lesions. 62 with temporal lobe epilepsy had anterior temporal
lobectomies, 37 had tailored focal or lobar resections with extra temporal lobe epilepsy (6 with tumours), and 1 had
anatomical hemispherectomy
Outcomes Seizure outcome assessed at least 12 months post surgery using Engel classification
Notes Yu 2012a and Yu 2012b were treated as 2 studies in a single publication. One quality assessment was performed for
the single publication
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Zangaladze 2008
Methods Both retrospective and prospective case series from a US centre
Participants 99 participants 12 years of age and older with localisation-related epilepsy, who had obtained intracranial EEG
recordings before surgery
Interventions Temporal and extratemporal lobe resections
Outcomes Seizure freedom at follow-up, which was no less than 2 years after surgery
Notes -
Zentner 1995
Methods Retrospective case series
Participants 178 children and adults from a single German centre with intractable temporal lobe epilepsy
Interventions Procedures performed: anterior temporal lobectomy (standard or “keyhole”) with hippocampectomy, anterior tem-
poral lobectomy without hippocampectomy, extended lesionectomy with hippocampectomy, extended lesionectomy
without hippocampectomy, and selective amygdalohippocampectomy
Outcomes Seizure outcome assessed by Engel class at least 12 months post surgery
Notes -
Zentner 1996
Methods Prospective case series
Participants 60 children and adults from a single German centre with intractable extratemporal lobe epilepsy
Interventions The following surgical procedures were performed: frontal lobectomy (n = 16), frontal topectomy (n = 24), parietal
topectomy (n = 7), and occipital topectomy
Outcomes Seizure outcome assessed by Engel class at least 20 months post surgery
Notes -
ATL: anterior temporal lobectomy. |
BMI: body mass index.
CCT: corpus callosotomy.
CD: cortical dysplasia.
CMRglc: cerebral metabolic rate of glucose.
ECoG: electrocorticography.
EEG: electroencephalography.
EZ: epileptogenic zone.
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FDG: fluorodeoxyglucose.
fMRI: functional magnetic resonance imaging.
HS: hippocampal sclerosis.
ICEEG: intracranial electroencephalography.
ILAE: International League Against Epilepsy.
MEG: magnetoencephalography.
MR: magnetic resonance.
MRI: magnetic resonance imaging.
MTLE: mesial temporal lobe epilepsy.
PET: positron emission tomography.
PO: postoperative.
QOL: quality of life.
SD: standard deviation.
SEEG: stereoelectroencephalography.
SISCOM: subtraction ictal SPECT co-registered with MRI.
SPECT: single-photon emission computed tomography.
SSEP: somatosensory evoked potential.
TLE: temporal lobe epilepsy.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Acar 2008 Only 17 participants followed up for longer than 12 months
Alemany-Rosales 2011 No seizure outcome data reported
Alpherts 2008 Only 6 months of follow-up reported
Andersson-Roswall 2010 No seizure outcome data reported
Asadi-Pooya 2008 Study of postoperative antiepileptic drug treatment rather than seizure outcome of surgery
Bauer 2007 Fewer than 30 participants included
Baxendale 2005 No seizure outcome data reported
Bell 2010 No seizure outcome data reported
Binder 2009 Minimum 4 months of follow-up reported; unknown number followed up for 1 year
Bindu 2018 Fewer than 30 surgical participants included
Boesebeck 2002 Subset of participants reported in Boesebeck 2007
Boshuisen 2012 Only those with 12 postoperative months seizure-free reported
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(Continued)
Bourgeois 2007 Fewer than 30 participants included
Buckingham 2010 Only participants with postoperative seizures included in the study
Busch 2011 Only 5 to 7 months of postoperative follow-up reported
Caicoya 2007 Fewer than 30 participants included
Carne 2004 No seizure outcome data reported
Cascino 1996 Same participants reported as in Cascino 1995; more relevant information provided in Cascino 1995
Chang 2007 Unknown proportion in the study followed up for less than 1 year
Choi 2004b No follow-up period defined for the study
Cohen-Gadol 2003 Unknown proportion in the study followed up for less than 1 year
Colonnelli 2012 No follow-up period defined for the study
Coutin-Churchman 2012 No follow-up period defined for the study
CTRI/2018/07/015007 Does not randomise surgical interventions; randomises stereoencephalography or no stereoencephalog-
raphy as part of pre-surgical evaluation
Cukiert 2009 Fewer than 30 participants included
D’Angelo 2006 Unknown proportion in the study followed up for less than 1 year
D’Argenzio 2011 No seizure outcome data reported
da Costa-Neves 2012 Study follow-up 6 months
Danielsson 2009 Fewer than 30 participants included
Datta 2009 Fewer than 30 participants included
Dulay 2006 Follow-up period less than 12 months reported
Dulay 2009 Postoperative follow-up period less than 12 months reported for most participants
Elsharkawy 2008b Subset of participants from Elsharkawy 2009a reported
Elsharkawy 2009b Questionnaire follow-up study with no seizure outcome data
Elsharkawy 2011b Only children not seizure-free 6 months postoperatively reported
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(Continued)
Engel Jr 2012 Fewer than 30 surgical participants included
Fauser 2008 No seizure outcome data reported
Ferrari-Marinho 2012 No postoperative follow-up period defined for the study
Ferroli 2006 Unknown proportion of participants followed up for less than 12 months
Freitag 2005 Study follow-up defined as 6 to 12 months
Ghacibeh 2009 Study follow-up period not defined
Griffin 2007 No seizure outcome data reported
Grunert 2003 No duration of outcome; surgery not performed for epilepsy (surgery for tumours)
Haegelen 2013 Fewer than 30 participants in the study with 12-month follow-up
Harvey 2008 Study follow-up 6 months
Hellwig 2012 Follow-up less than 12 months
Helmstaedter 2004 Reported 3 months of follow-up
Helmstaedter 2011 Subset of participants from Schramm 2011 (results from a single centre of Schramm 2011) reported
Hervas-Navidad 2002 Some participants followed up for only 6months; no seizure outcome data reported for some participants
Hildebrandt 2005 No seizure outcome data reported
Hu 2012 Unknown proportion of participants followed up for less than 12 months
Jehi 2010 Only those who experienced postoperative seizures included
Junna 2013 Seizure outcome not measured at 1 year for all participants; not possible to separate analyses
Kuzniecky 1996 Same participants reported as in Kuzniecky 1993; more relevant information provided in Kuzniecky
1993
Lach 2010 Case control design (participants selected based on seizure outcome) inappropriate for this review
Lachhwani 2003 Commentary on Wiebe 2001 provided
Lee 2010 Fewer than 30 participants included
Limbrick 2009 Unknown proportion of participants followed up for less than 12 months
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(Continued)
Lodenkemper 2007 Seizure outcome data reported for fewer than 30 participants
Lutz 2004 No seizure outcome data reported
Malla 1998 Same participants reported as in Cascino 1995; more relevant information provided in Cascino 1995
McClelland 2007 No seizure outcome data reported
McClelland 2011 No seizure outcome data reported
Mikati 2004 Fewer than 30 participants included
Mohammed 2012 MRI scans obtained for less than 90%
Moien-Afshari 2009 Fewer than 30 participants included
NCT03643016 Does not randomise surgical interventions; randomises Virtual Epilepsy Patient software or no Virtual
Epilepsy Patient software as part of pre-surgical evaluation
NCT03790280 Does not randomise surgical interventions; randomises Intra-operative electrocorticography or no Intra-
operative electrocorticography as part of pre-surgical evaluation
Negishi 2011 Fewer than 30 participants included
Nikase 2007 Fewer than 30 participants included
Oertel 2004 No seizure outcome data reported
Ogiwara 2010 Unknown proportion of participants followed up for less than 12 months
Park 2010 Seizure outcome rather than outcome after surgery measured following antiepileptic drug reduction
Placantonakis 2010 Fewer than 30 participants included
Rocamora 2009 Fewer than 30 participants included
Roth 2011 Unknown proportion of participants followed up for less than 12 months
Sakuta 2005 Fewer than 30 participants included
Schatlo 2015 No seizure outcome data reported
Schwartz 2006 Data reported only for participants who were seizure-free at 12 months
Smyth 2007 Unknown proportion of participants followed up for less than 12 months
Soeder 2009 Fewer than 30 participants included
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(Continued)
Stavem 2005 No seizure outcome data reported
Stavem 2008 No seizure outcome data reported
Stefan 2004 Unknown proportion of participants followed up for less than 12 months
Stefan 2008 Case-control design (participants selected based on seizure outcome) inappropriate for this review
Teutonico 2008 Fewer than 30 participants included
Tong 2015 No seizure outcome data reported
Upchurch 2010 Fewer than 30 participants included
Vachrajani 2012 Unknown proportion of participants followed up for less than 12 months
Vadera 2012 Unknown proportion of participants followed up for less than 12 months
Vadlamudi 2004 Only seizure-free participants included in the study
Vogt 2016 No seizure outcome data reported
Wang 2016 No seizure outcome data reported
Weinand 2001 Same participants reported as in Weinand 1992; more relevant information given in Weinand 1992
Wetjen 2006 No seizure outcome data reported
Wetjen 2009 Fewer than 30 participants included
Wieser 2003a MRI scan obtained for less than 90%
Wieser 2003b MRI scan obtained for less than 90%
Yasuda 2010a No seizure outcome data reported
Yasuda 2010b Fewer than 30 participants included
Zupanc 2010 Unknown proportion of participants followed up for less than 12 months
MRI: magnetic resonance imaging.
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D A T A A N D A N A L Y S E S
Comparison 1. Surgery versus medical treatment (randomised evidence)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Proportion free from seizures at
1 year
2 196 Risk Ratio (M-H, Fixed, 95% CI) 9.78 [4.73, 20.21]
1.1 Free from seizures
impairing awareness at 1 year
1 80 Risk Ratio (M-H, Fixed, 95% CI) 7.67 [2.50, 23.51]
1.2 Free from seizures (ILAE
Class 1) at 1 year
1 116 Risk Ratio (M-H, Fixed, 95% CI) 11.39 [4.37, 29.64]
2 Proportion free from all seizures
(including auras) at 1 year
1 80 Risk Ratio (M-H, Fixed, 95% CI) 15.0 [2.08, 108.23]
Comparison 2. Comparison of surgical techniques (randomised evidence)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Parahippocampectomy (PHC)
or anterior temporal lobectomy
(ATL): Proportion free from
seizures (Engel Class Scale)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Engel Class 1 at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Engel Class 1A at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Engel Class 1 at 5 years 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Engel Class 1A at 5 years 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Parahippocampectomy
(PHC) or Selective
Amygdalohippocampectomy
(SAH): Proportion free from
seizures (Engel Class Scale)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Engel Class 1 at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Engel Class 1A at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Engel Class 1 at 5 years 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 Engel Class 1A at 5 years 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Selective
Amygdalohippocampectomy
(SAH) or Anterior Temporal
Lobectomy (ATL): Proportion
free from seizures (Engel Class
Scale)
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Engel Class 1 at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Engel Class 1A at 1 year 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Engel Class 1 at 5 years 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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3.4 Engel Class 1A at 5 years 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Stereotactic radiosurgery (SRS)
or anterior temporal lobectomy
(ATL): proportion with
remission of seizures (at least
Engel Class IB) between 25
and 36 months
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5 Resection with or without
corpus callosotomy (CCT):
Proportion free from seizures
(Engel Class 1)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Engel Class 1 at 1 year 1 43 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.76, 1.70]
5.2 Engel Class 1 at 3 years 1 43 Risk Ratio (M-H, Fixed, 95% CI) 1.19 [0.72, 1.95]
5.3 Engel Class 1 at 5 years 1 43 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.53, 2.21]
6 Anterior temporal lobectomy
(ATL) with or without
corpus callosotomy (CCT):
Proportion free from seizures
(Engel Class 1) at 2 years
1 60 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.85, 1.76]
7 Subtemporal or
transsylvian selective
amygdalohippocampectomy
(SAH): Proportion free from all
seizures (including auras, ILAE
1a) at 1 year
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8 Total or partial
hippocampectomy: Proportion
free from all seizures (including
auras) at 1 year
1 70 Risk Ratio (M-H, Fixed, 95% CI) 1.82 [1.12, 2.93]
9 Length of resection (2.5 or 3.5
cm): Proportion free from
seizures (Engel Class 1) at 1
year
1 207 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.86, 1.20]
Comparison 3. Surgery for epilepsy (randomised and non-randomised evidence)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Proportion with a good outcome
of surgery
178 Proportion (good outcome) (Fixed, 95% CI) Totals not selected
1.1 > 1 year seizure-free 42 Proportion (good outcome) (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Engel Class Scale 116 Proportion (good outcome) (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 ’Other’ scale 20 Proportion (good outcome) (Fixed, 95% CI) 0.0 [0.0, 0.0]
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Comparison 4. Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Good outcome by MRI results 43 3999 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.73, 0.83]
1.1 > 1 year seizure-free 17 1691 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.74, 0.90]
1.2 Engel Class Scale 22 2097 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.69, 0.81]
1.3 ’Other’ scale 4 211 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.53, 1.32]
2 Good outcome by use of
intracranial monitoring (IM)
21 1547 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.78, 0.93]
2.1 > 1 year seizure-free 6 634 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.76, 1.02]
2.2 Engel Class Scale 14 863 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.77, 0.94]
2.3 ’Other’ scale 1 50 Risk Ratio (M-H, Fixed, 95% CI) 0.53 [0.28, 0.98]
3 Good outcome by presence
of mesial temporal sclerosis
(MTS)
46 4430 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [1.12, 1.23]
3.1 > 1 year seizure-free 9 958 Risk Ratio (M-H, Fixed, 95% CI) 1.25 [1.13, 1.39]
3.2 Engel Class Scale 31 2949 Risk Ratio (M-H, Fixed, 95% CI) 1.13 [1.07, 1.20]
3.3 ’Other’ scale 6 523 Risk Ratio (M-H, Fixed, 95% CI) 1.31 [1.14, 1.51]
4 Good outcome by concordance
of pre-op MRI and EEG
23 1778 Risk Ratio (M-H, Fixed, 95% CI) 1.25 [1.15, 1.37]
4.1 > 1 year seizure-free 8 744 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.07, 1.37]
4.2 Engel Class Scale 12 770 Risk Ratio (M-H, Fixed, 95% CI) 1.27 [1.11, 1.46]
4.3 ’Other’ scale 3 264 Risk Ratio (M-H, Fixed, 95% CI) 1.40 [1.02, 1.93]
5 Good outcome by history of
febrile seizures (FS)
15 1368 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [1.01, 1.17]
5.1 > 1 year seizure-free 5 644 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [1.05, 1.32]
5.2 Engel Class Scale 9 631 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.92, 1.11]
5.3 ’Other’ scale 1 93 Risk Ratio (M-H, Fixed, 95% CI) 1.11 [0.90, 1.37]
6 Good outcome by history of
head injury (HI)
7 551 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.86, 1.13]
6.1 > 1 year seizure-free 2 152 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.72, 1.05]
6.2 Engel Class Scale 3 174 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [0.99, 1.37]
6.3 ’Other’ scale 2 225 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.51, 1.33]
7 Good outcome by presence of
encephalomalacia
5 317 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.52, 1.17]
7.1 Engel Class Scale 4 218 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.60, 1.33]
7.2 ’Other’ scale 1 99 Risk Ratio (M-H, Fixed, 95% CI) 0.28 [0.04, 1.87]
8 Good outcome by presence
of focal cortical dysplasia
(FCD)/malformation of
cortical development (MCD)
46 3572 Risk Ratio (M-H, Fixed, 95% CI) 0.90 [0.85, 0.95]
8.1 > 1 year seizure-free 8 784 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.84, 1.02]
8.2 Engel Class Scale 33 2386 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.82, 0.96]
8.3 ’Other’ scale 5 402 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.73, 1.13]
9 Good outcome by presence of
tumour
41 3357 Risk Ratio (M-H, Random, 95% CI) 1.23 [1.14, 1.32]
9.1 > 1 year seizure-free 7 656 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.97, 1.41]
9.2 Engel Class Scale 28 2199 Risk Ratio (M-H, Random, 95% CI) 1.23 [1.13, 1.33]
9.3 ’Other’ scale 6 502 Risk Ratio (M-H, Random, 95% CI) 1.35 [1.07, 1.70]
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10 Good outcome by presence of
vascular malformation
19 1488 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.94, 1.21]
10.1 > 1 year seizure-free 1 46 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.62, 1.79]
10.2 Engel Class Scale 13 973 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.98, 1.34]
10.3 ’Other’ scale 5 469 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.74, 1.20]
11 Good outcome by unilateral or
bilateral interictal spikes
18 1414 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [1.05, 1.24]
11.1 > 1 year seizure-free 7 521 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.94, 1.24]
11.2 Engel Class Scale 6 502 Risk Ratio (M-H, Fixed, 95% CI) 1.19 [1.04, 1.36]
11.3 ’Other’ scale 5 391 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.97, 1.39]
12 Good outcome by extent of
resection
40 3013 Risk Ratio (M-H, Fixed, 95% CI) 1.41 [1.32, 1.50]
12.1 > 1 year seizure free 9 640 Risk Ratio (M-H, Fixed, 95% CI) 2.00 [1.66, 2.41]
12.2 Engel Class Scale 28 2189 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [1.21, 1.39]
12.3 ’Other’ scale 3 184 Risk Ratio (M-H, Fixed, 95% CI) 1.59 [1.15, 2.20]
13 Good outcome by extent of
resection
39 2930 Risk Ratio (M-H, Fixed, 95% CI) 1.46 [1.37, 1.56]
13.1 Site of surgery:
extratemporal only
1 30 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.76, 5.29]
13.2 Site of surgery: temporal
only
13 1266 Risk Ratio (M-H, Fixed, 95% CI) 1.11 [1.03, 1.20]
13.3 Site of surgery: temporal
and extratemporal
25 1634 Risk Ratio (M-H, Fixed, 95% CI) 1.92 [1.72, 2.15]
14 Good outcome by side of
surgical resection
37 2976 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.91, 1.01]
14.1 > 1 year seizure-free 5 290 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.91, 1.13]
14.2 Engel Class Scale 27 2407 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.89, 1.02]
14.3 ’Other’ scale 5 279 Risk Ratio (M-H, Random, 95% CI) 0.94 [0.82, 1.07]
15 Good outcome by side of
surgical resection
36 2933 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.90, 0.98]
15.1 Site of surgery:
extratemporal only
2 123 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.76, 1.39]
15.2 Site of surgery: temporal
only
30 2592 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.89, 0.98]
15.3 Site of surgery: temporal
and extratemporal
4 218 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.84, 1.14]
16 Good outcome by presence of
postoperative discharges
6 542 Risk Ratio (M-H, Random, 95% CI) 0.91 [0.68, 1.22]
16.1 > 1 year seizure-free 2 109 Risk Ratio (M-H, Random, 95% CI) 0.97 [0.24, 3.93]
16.2 Engel Class Scale 4 433 Risk Ratio (M-H, Random, 95% CI) 0.85 [0.70, 1.03]
17 Good outcome by presence of
postoperative discharges
6 542 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.79, 1.04]
17.1 Site of surgery: temporal
only
3 381 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.70, 0.94]
17.2 Site of surgery: temporal
and extratemporal
3 161 Risk Ratio (M-H, Fixed, 95% CI) 1.20 [0.89, 1.61]
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Analysis 1.1. Comparison 1 Surgery versus medical treatment (randomised evidence), Outcome 1
Proportion free from seizures at 1 year.
Review: Surgery for epilepsy
Comparison: 1 Surgery versus medical treatment (randomised evidence)
Outcome: 1 Proportion free from seizures at 1 year
Study or subgroup Surgery Medical treatment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Free from seizures impairing awareness at 1 year
Wiebe 2001 23/40 3/40 43.3 % 7.67 [ 2.50, 23.51 ]
Subtotal (95% CI) 40 40 43.3 % 7.67 [ 2.50, 23.51 ]
Total events: 23 (Surgery), 3 (Medical treatment)
Heterogeneity: not applicable
Test for overall effect: Z = 3.56 (P = 0.00037)
2 Free from seizures (ILAE Class 1) at 1 year
Dwivedi 2017 44/57 4/59 56.7 % 11.39 [ 4.37, 29.64 ]
Subtotal (95% CI) 57 59 56.7 % 11.39 [ 4.37, 29.64 ]
Total events: 44 (Surgery), 4 (Medical treatment)
Heterogeneity: not applicable
Test for overall effect: Z = 4.98 (P < 0.00001)
Total (95% CI) 97 99 100.0 % 9.78 [ 4.73, 20.21 ]
Total events: 67 (Surgery), 7 (Medical treatment)
Heterogeneity: Chi2 = 0.28, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 6.15 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.28, df = 1 (P = 0.60), I2 =0.0%
0.01 0.1 1 10 100
Medical treatment Surgery
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Analysis 1.2. Comparison 1 Surgery versus medical treatment (randomised evidence), Outcome 2
Proportion free from all seizures (including auras) at 1 year.
Review: Surgery for epilepsy
Comparison: 1 Surgery versus medical treatment (randomised evidence)
Outcome: 2 Proportion free from all seizures (including auras) at 1 year
Study or subgroup Surgery Medical treatment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wiebe 2001 15/40 1/40 100.0 % 15.00 [ 2.08, 108.23 ]
Total (95% CI) 40 40 100.0 % 15.00 [ 2.08, 108.23 ]
Total events: 15 (Surgery), 1 (Medical treatment)
Heterogeneity: not applicable
Test for overall effect: Z = 2.69 (P = 0.0072)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Medical treatment Surgery
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Analysis 2.1. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 1
Parahippocampectomy (PHC) or anterior temporal lobectomy (ATL): Proportion free from seizures (Engel
Class Scale).
Review: Surgery for epilepsy
Comparison: 2 Comparison of surgical techniques (randomised evidence)
Outcome: 1 Parahippocampectomy (PHC) or anterior temporal lobectomy (ATL): Proportion free from seizures (Engel Class Scale)
Study or subgroup
Parahippocampectomy
(PHC)
Anterior Temporal
Lobectomy (ATL) Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Engel Class 1 at 1 year
Alonso-Vanegas 2018 11/14 13/14 0.85 [ 0.62, 1.15 ]
2 Engel Class 1A at 1 year
Alonso-Vanegas 2018 6/14 10/14 0.60 [ 0.30, 1.20 ]
3 Engel Class 1 at 5 years
Alonso-Vanegas 2018 7/14 9/14 0.78 [ 0.40, 1.49 ]
4 Engel Class 1A at 5 years
Alonso-Vanegas 2018 4/14 7/14 0.57 [ 0.21, 1.52 ]
0.01 0.1 1 10 100
Favours ATL Favours PHC
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Analysis 2.2. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 2
Parahippocampectomy (PHC) or Selective Amygdalohippocampectomy (SAH): Proportion free from seizures
(Engel Class Scale).
Review: Surgery for epilepsy
Comparison: 2 Comparison of surgical techniques (randomised evidence)
Outcome: 2 Parahippocampectomy (PHC) or Selective Amygdalohippocampectomy (SAH): Proportion free from seizures (Engel Class Scale)
Study or subgroup
Parahippocampectomy
(PHC)
Selective Amygdalo-
hippocampectomy
(SAH) Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Engel Class 1 at 1 year
Alonso-Vanegas 2018 11/14 14/15 0.84 [ 0.62, 1.14 ]
2 Engel Class 1A at 1 year
Alonso-Vanegas 2018 6/14 9/15 0.71 [ 0.34, 1.49 ]
3 Engel Class 1 at 5 years
Alonso-Vanegas 2018 7/14 10/15 0.75 [ 0.40, 1.41 ]
4 Engel Class 1A at 5 years
Alonso-Vanegas 2018 4/14 8/15 0.54 [ 0.21, 1.39 ]
0.01 0.1 1 10 100
Favours SAH Favours PHC
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Analysis 2.3. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 3
Selective Amygdalohippocampectomy (SAH) or Anterior Temporal Lobectomy (ATL): Proportion free from
seizures (Engel Class Scale).
Review: Surgery for epilepsy
Comparison: 2 Comparison of surgical techniques (randomised evidence)
Outcome: 3 Selective Amygdalohippocampectomy (SAH) or Anterior Temporal Lobectomy (ATL): Proportion free from seizures (Engel Class Scale)
Study or subgroup
Selective Amygdalo-
hippocampectomy
(SAH)
Anterior Temporal
Lobectomy (ATL) Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Engel Class 1 at 1 year
Alonso-Vanegas 2018 14/15 13/14 1.01 [ 0.82, 1.23 ]
2 Engel Class 1A at 1 year
Alonso-Vanegas 2018 9/15 10/14 0.84 [ 0.49, 1.43 ]
3 Engel Class 1 at 5 years
Alonso-Vanegas 2018 10/15 9/14 1.04 [ 0.61, 1.76 ]
4 Engel Class 1A at 5 years
Alonso-Vanegas 2018 8/15 7/14 1.07 [ 0.53, 2.16 ]
0.01 0.1 1 10 100
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Analysis 2.4. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 4
Stereotactic radiosurgery (SRS) or anterior temporal lobectomy (ATL): proportion with remission of seizures
(at least Engel Class IB) between 25 and 36 months.
Review: Surgery for epilepsy
Comparison: 2 Comparison of surgical techniques (randomised evidence)
Outcome: 4 Stereotactic radiosurgery (SRS) or anterior temporal lobectomy (ATL): proportion with remission of seizures (at least Engel Class IB) between 25 and 36
months
Study or subgroup
Stereotactic
radiosurgery
(SRS)
Anterior temporal
lobectomy (ATL) Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Barbaro 2018 16/31 21/27 0.66 [ 0.45, 0.99 ]
0.01 0.1 1 10 100
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Analysis 2.5. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 5
Resection with or without corpus callosotomy (CCT): Proportion free from seizures (Engel Class 1).
Review: Surgery for epilepsy
Comparison: 2 Comparison of surgical techniques (randomised evidence)
Outcome: 5 Resection with or without corpus callosotomy (CCT): Proportion free from seizures (Engel Class 1)
Study or subgroup Resection with CCT Resection only Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Engel Class 1 at 1 year
Ding 2016 17/23 13/20 100.0 % 1.14 [ 0.76, 1.70 ]
Subtotal (95% CI) 23 20 100.0 % 1.14 [ 0.76, 1.70 ]
Total events: 17 (Resection with CCT), 13 (Resection only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
2 Engel Class 1 at 3 years
Ding 2016 15/23 11/20 100.0 % 1.19 [ 0.72, 1.95 ]
Subtotal (95% CI) 23 20 100.0 % 1.19 [ 0.72, 1.95 ]
Total events: 15 (Resection with CCT), 11 (Resection only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
3 Engel Class 1 at 5 years
Ding 2016 10/23 8/20 100.0 % 1.09 [ 0.53, 2.21 ]
Subtotal (95% CI) 23 20 100.0 % 1.09 [ 0.53, 2.21 ]
Total events: 10 (Resection with CCT), 8 (Resection only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.23 (P = 0.82)
0.2 0.5 1 2 5
Favours Resection only Favours Resection with CCT
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Analysis 2.6. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 6
Anterior temporal lobectomy (ATL) with or without corpus callosotomy (CCT): Proportion free from seizures
(Engel Class 1) at 2 years.
Review: Surgery for epilepsy
Comparison: 2 Comparison of surgical techniques (randomised evidence)
Outcome: 6 Anterior temporal lobectomy (ATL) with or without corpus callosotomy (CCT): Proportion free from seizures (Engel Class 1) at 2 years
Study or subgroup
ATL with corpus
callosotomy
(aCCT)
Anterior temporal
lobectomy (ATL) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Liang 2010 22/30 18/30 100.0 % 1.22 [ 0.85, 1.76 ]
Total (95% CI) 30 30 100.0 % 1.22 [ 0.85, 1.76 ]
Total events: 22 (ATL with corpus callosotomy (aCCT)), 18 (Anterior temporal lobectomy (ATL))
Heterogeneity: not applicable
Test for overall effect: Z = 1.08 (P = 0.28)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ATL Favours aCCT
Analysis 2.7. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 7
Subtemporal or transsylvian selective amygdalohippocampectomy (SAH): Proportion free from all seizures
(including auras, ILAE 1a) at 1 year.
Review: Surgery for epilepsy
Comparison: 2 Comparison of surgical techniques (randomised evidence)
Outcome: 7 Subtemporal or transsylvian selective amygdalohippocampectomy (SAH): Proportion free from all seizures (including auras, ILAE 1a) at 1 year
Study or subgroup Subtemporal SAH Transsylvian SAH Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Vogt 2018 13/22 16/25 0.92 [ 0.59, 1.46 ]
0.01 0.1 1 10 100
Favours Transsylvian SAH Favours Subtemporal SAH
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Analysis 2.8. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 8 Total or
partial hippocampectomy: Proportion free from all seizures (including auras) at 1 year.
Review: Surgery for epilepsy
Comparison: 2 Comparison of surgical techniques (randomised evidence)
Outcome: 8 Total or partial hippocampectomy: Proportion free from all seizures (including auras) at 1 year
Study or subgroup
Total
hippocam-
pectomy
Partial
hippocam-
pectomy Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Wyler 1995 25/36 13/34 100.0 % 1.82 [ 1.12, 2.93 ]
Total (95% CI) 36 34 100.0 % 1.82 [ 1.12, 2.93 ]
Total events: 25 (Total hippocampectomy), 13 (Partial hippocampectomy)
Heterogeneity: not applicable
Test for overall effect: Z = 2.44 (P = 0.015)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours partial Favours total
Analysis 2.9. Comparison 2 Comparison of surgical techniques (randomised evidence), Outcome 9 Length
of resection (2.5 or 3.5 cm): Proportion free from seizures (Engel Class 1) at 1 year.
Review: Surgery for epilepsy
Comparison: 2 Comparison of surgical techniques (randomised evidence)
Outcome: 9 Length of resection (2.5 or 3.5 cm): Proportion free from seizures (Engel Class 1) at 1 year
Study or subgroup 2.5 cm resection 3.5 cm resection Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Schramm 2011 77/104 75/103 100.0 % 1.02 [ 0.86, 1.20 ]
Total (95% CI) 104 103 100.0 % 1.02 [ 0.86, 1.20 ]
Total events: 77 (2.5 cm resection), 75 (3.5 cm resection)
Heterogeneity: not applicable
Test for overall effect: Z = 0.20 (P = 0.84)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours 3.5 cm resection Favours 2.5 cm resection
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Analysis 3.1. Comparison 3 Surgery for epilepsy (randomised and non-randomised evidence), Outcome 1
Proportion with a good outcome of surgery.
Review: Surgery for epilepsy
Comparison: 3 Surgery for epilepsy (randomised and non-randomised evidence)
Outcome: 1 Proportion with a good outcome of surgery
Study or subgroup Poor outcome Good outcome
Proportion
(good outcome)
(SE)
Proportion (good
outcome)
Proportion (good
outcome)
N N IV,Fixed,95% CI IV,Fixed,95% CI
1 > 1 year seizure-free
Adelson 1992 10 23 69.7 (8.00006) 69.70 [ 54.02, 85.38 ]
Althausen 2013 16 45 73.77 (5.63211) 73.77 [ 62.73, 84.81 ]
Awad 1991 20 27 57.45 (7.21191) 57.45 [ 43.31, 71.59 ]
Bautista 2003 15 28 65.12 (7.26812) 65.12 [ 50.87, 79.37 ]
Chee 1993 10 28 73.68 (7.14338) 73.68 [ 59.68, 87.68 ]
Dagar 2011 23 89 79.46 (3.81709) 79.46 [ 71.98, 86.94 ]
Duchowny 1998 15 16 51.61 (8.97559) 51.61 [ 34.02, 69.20 ]
Erba 1992 9 37 80.43 (5.84905) 80.43 [ 68.97, 91.89 ]
Fujiwara 2012 21 23 52.27 (7.52999) 52.27 [ 37.51, 67.03 ]
Garcia 1991 20 35 63.64 (6.48642) 63.64 [ 50.93, 76.35 ]
Garcia 1994 15 36 70.59 (6.38031) 70.59 [ 58.08, 83.10 ]
Gilliam 1997a 25 53 67.95 (5.28404) 67.95 [ 57.59, 78.31 ]
Gilliam 1997b 11 22 66.67 (8.2061) 66.67 [ 50.59, 82.75 ]
Greiner 2011 12 42 77.78 (5.6575) 77.78 [ 66.69, 88.87 ]
Hallbook 2010 22 88 80 (3.81385) 80.00 [ 72.52, 87.48 ]
Hemb 2010 102 223 68.62 (2.57411) 68.62 [ 63.57, 73.67 ]
Holmes 1997 22 22 50 (7.53778) 50.00 [ 35.23, 64.77 ]
Jack 1992 16 34 68 (6.59697) 68.00 [ 55.07, 80.93 ]
Jeha 2006 140 231 62.26 (2.51657) 62.26 [ 57.33, 67.19 ]
Jehi 2012 147 165 52.88 (2.82598) 52.88 [ 47.34, 58.42 ]
Jennum 1993 22 42 65.63 (5.93699) 65.63 [ 53.99, 77.27 ]
Kim 2009 72 94 56.63 (3.84652) 56.63 [ 49.09, 64.17 ]
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Study or subgroup Poor outcome Good outcome
Proportion
(good outcome)
(SE)
Proportion (good
outcome)
Proportion (good
outcome)
N N IV,Fixed,95% CI IV,Fixed,95% CI
Kim 2010b 26 14 35 (7.54155) 35.00 [ 20.22, 49.78 ]
Lei 2008 16 180 91.84 (1.95574) 91.84 [ 88.01, 95.67 ]
Lopez-Gonzalez 2012 21 65 75.58 (4.63253) 75.58 [ 66.50, 84.66 ]
Morino 2009 7 55 88.71 (4.01923) 88.71 [ 80.83, 96.59 ]
O’Brien 1996 10 36 78.26 (6.08155) 78.26 [ 66.34, 90.18 ]
Oertel 2005 15 20 57.14 (8.36486) 57.14 [ 40.75, 73.53 ]
Paolicchi 2000 31 44 58.67 (5.68611) 58.67 [ 47.53, 69.81 ]
Rausch 2003 21 21 50 (7.71517) 50.00 [ 34.88, 65.12 ]
Spencer 2005 91 264 74.37 (2.31729) 74.37 [ 69.83, 78.91 ]
Swartz 1992 7 27 79.41 (6.93446) 79.41 [ 65.82, 93.00 ]
Tatum 2008 17 22 56.41 (7.94034) 56.41 [ 40.85, 71.97 ]
Theodore 2012 15 26 63.41 (7.5224) 63.41 [ 48.67, 78.15 ]
Walz 2003 13 85 86.73 (3.42643) 86.73 [ 80.01, 93.45 ]
Weinand 1992 32 57 64.04 (5.0866) 64.04 [ 54.07, 74.01 ]
Widdess-Walsh 2007 26 22 45.83 (7.19178) 45.83 [ 31.73, 59.93 ]
Wiebe 2001 13 23 63.89 (8.00538) 63.89 [ 48.20, 79.58 ]
Wyler 1995 32 38 54.29 (5.95415) 54.29 [ 42.62, 65.96 ]
Yu 2012a 39 61 61 (4.8775) 61.00 [ 51.44, 70.56 ]
Yu 2012b 74 148 66.67 (3.16386) 66.67 [ 60.47, 72.87 ]
Zangaladze 2008 33 66 66.67 (4.73779) 66.67 [ 57.38, 75.96 ]
2 Engel Class Scale
Aaberg 2012 24 30 55.56 (6.76201) 55.56 [ 42.31, 68.81 ]
Adam 1996 4 26 86.67 (6.20633) 86.67 [ 74.51, 98.83 ]
Alfstad 2011 23 25 52.08 (7.21061) 52.08 [ 37.95, 66.21 ]
Alonso-Vanegas 2018 5 38 88.37 (4.88848) 88.37 [ 78.79, 97.95 ]
Arruda 1996 21 53 71.62 (5.24083) 71.62 [ 61.35, 81.89 ]
Babini 2013 4 26 86.67 (6.20633) 86.67 [ 74.51, 98.83 ]
Battaglia 2006 13 32 71.11 (6.7566) 71.11 [ 57.87, 84.35 ]
Baumann 2007 50 118 70.24 (3.52746) 70.24 [ 63.33, 77.15 ]
Bell 2009 16 24 60 (7.74597) 60.00 [ 44.82, 75.18 ]
Benifla 2006 28 78 73.58 (4.28221) 73.58 [ 65.19, 81.97 ]
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Study or subgroup Poor outcome Good outcome
Proportion
(good outcome)
(SE)
Proportion (good
outcome)
Proportion (good
outcome)
N N IV,Fixed,95% CI IV,Fixed,95% CI
Berkovic 1995 61 74 54.81 (4.28332) 54.81 [ 46.41, 63.21 ]
Blount 2004 18 12 40 (8.94427) 40.00 [ 22.47, 57.53 ]
Blume 2004 44 26 37.14 (5.77519) 37.14 [ 25.82, 48.46 ]
Brainer-Lima 1996 3 29 90.63 (5.1527) 90.63 [ 80.53, 100.73 ]
Britton 1994 17 34 66.67 (6.60098) 66.67 [ 53.73, 79.61 ]
Caraballo 2011 12 33 73.33 (6.59218) 73.33 [ 60.41, 86.25 ]
Cascino 1995 52 113 68.48 (3.61672) 68.48 [ 61.39, 75.57 ]
Chabardes 2005 7 47 87.04 (4.57096) 87.04 [ 78.08, 96.00 ]
Chang 2009 12 45 78.95 (5.39989) 78.95 [ 68.37, 89.53 ]
Chkhenkeli 2007 55 12 17.91 (4.68446) 17.91 [ 8.73, 27.09 ]
Choi 2004a 8 27 77.14 (7.09782) 77.14 [ 63.23, 91.05 ]
Chung 2005 70 58 45.31 (4.39995) 45.31 [ 36.69, 53.93 ]
Cossu 2005 72 93 56.36 (3.86084) 56.36 [ 48.79, 63.93 ]
Cossu 2008 36 77 68.14 (4.38308) 68.14 [ 59.55, 76.73 ]
Costello 2009 10 32 76.19 (6.57205) 76.19 [ 63.31, 89.07 ]
Cukiert 2002 11 89 89 (3.1289) 89.00 [ 82.87, 95.13 ]
Dalmagro 2005 15 28 65.12 (7.26812) 65.12 [ 50.87, 79.37 ]
Delbeke 1996 15 23 60.53 (7.92929) 60.53 [ 44.99, 76.07 ]
Dellabadia 2002 15 20 57.14 (8.36486) 57.14 [ 40.75, 73.53 ]
Devlin 2003 16 17 51.52 (8.69989) 51.52 [ 34.47, 68.57 ]
Ding 2016 13 30 69.77 (7.00373) 69.77 [ 56.04, 83.50 ]
Donadio 2011 24 60 71.43 (4.92904) 71.43 [ 61.77, 81.09 ]
Dorward 2011 15 18 54.55 (8.66784) 54.55 [ 37.56, 71.54 ]
Dunkley 2011 22 20 47.62 (7.70642) 47.62 [ 32.52, 62.72 ]
Dunlea 2010 80 119 59.8 (3.47567) 59.80 [ 52.99, 66.61 ]
Elsharkawy 2008a 97 121 55.5 (3.36584) 55.50 [ 48.90, 62.10 ]
Elsharkawy 2009a 119 311 72.33 (2.1575) 72.33 [ 68.10, 76.56 ]
Elsharkawy 2011a 9 38 80.85 (5.7394) 80.85 [ 69.60, 92.10 ]
Erickson 2005 25 46 64.79 (5.66841) 64.79 [ 53.68, 75.90 ]
Fauser 2004 24 35 59.32 (6.39531) 59.32 [ 46.79, 71.85 ]
Gelinas 2011 15 52 77.61 (5.09255) 77.61 [ 67.63, 87.59 ]
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Study or subgroup Poor outcome Good outcome
Proportion
(good outcome)
(SE)
Proportion (good
outcome)
Proportion (good
outcome)
N N IV,Fixed,95% CI IV,Fixed,95% CI
Georgakoulias 2008 8 42 84 (5.18459) 84.00 [ 73.84, 94.16 ]
Grivas 2006 15 37 71.15 (6.28263) 71.15 [ 58.84, 83.46 ]
Hader 2004 18 21 53.85 (7.98269) 53.85 [ 38.20, 69.50 ]
Hajek 2009 10 25 71.43 (7.63604) 71.43 [ 56.46, 86.40 ]
Hamiwka 2005 21 17 44.74 (8.06601) 44.74 [ 28.93, 60.55 ]
Hartley 2002 15 20 57.14 (8.36486) 57.14 [ 40.75, 73.53 ]
Hartzfield 2008 32 24 42.86 (6.613) 42.86 [ 29.90, 55.82 ]
Janszky 2003a 24 60 71.43 (4.92904) 71.43 [ 61.77, 81.09 ]
Janszky 2003b 24 123 83.67 (3.04847) 83.67 [ 77.70, 89.64 ]
Jaramillo-Betancur 2009 24 43 64.18 (5.85771) 64.18 [ 52.70, 75.66 ]
Jayakar 2008 57 44 43.56 (4.9338) 43.56 [ 33.89, 53.23 ]
Jayalakshmi 2011 28 50 64.1 (5.43153) 64.10 [ 53.45, 74.75 ]
Kan 2008 15 43 74.14 (5.7496) 74.14 [ 62.87, 85.41 ]
Kang 2009 50 194 79.51 (2.58405) 79.51 [ 74.45, 84.57 ]
Kanner 2009 14 86 86 (3.46987) 86.00 [ 79.20, 92.80 ]
Kilpatrick 1997 11 39 78 (5.85833) 78.00 [ 66.52, 89.48 ]
Kim 2010a 102 75 42.37 (3.71425) 42.37 [ 35.09, 49.65 ]
Kloss 2002 34 34 50 (6.06339) 50.00 [ 38.12, 61.88 ]
Knowlton 2008 25 37 59.68 (6.22993) 59.68 [ 47.47, 71.89 ]
Lee 2008 33 38 53.52 (5.91918) 53.52 [ 41.92, 65.12 ]
Lee 2010a 16 36 69.23 (6.40039) 69.23 [ 56.69, 81.77 ]
Lee 2011 3 37 92.5 (4.16458) 92.50 [ 84.34, 100.66 ]
Li 1997 12 39 76.47 (5.93974) 76.47 [ 64.83, 88.11 ]
Li 1999 22 16 42.11 (8.00933) 42.11 [ 26.41, 57.81 ]
Liang 2010 20 40 66.67 (6.08581) 66.67 [ 54.74, 78.60 ]
Liang 2012 33 173 83.98 (2.55552) 83.98 [ 78.97, 88.99 ]
Liava 2012 13 39 75 (6.00481) 75.00 [ 63.23, 86.77 ]
Lorenzo 1995 31 17 35.42 (6.90309) 35.42 [ 21.89, 48.95 ]
Madhavan 2007 33 37 52.86 (5.96638) 52.86 [ 41.17, 64.55 ]
Mani 2006 36 86 70.49 (4.12915) 70.49 [ 62.40, 78.58 ]
Mihara 2004 88 269 75.35 (2.28095) 75.35 [ 70.88, 79.82 ]
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Study or subgroup Poor outcome Good outcome
Proportion
(good outcome)
(SE)
Proportion (good
outcome)
Proportion (good
outcome)
N N IV,Fixed,95% CI IV,Fixed,95% CI
Miserocchi 2013 10 58 85.29 (4.29488) 85.29 [ 76.87, 93.71 ]
Morris 1998 10 26 72.22 (7.46505) 72.22 [ 57.59, 86.85 ]
O’Brien 2000 22 14 38.89 (8.12497) 38.89 [ 22.97, 54.81 ]
Paglioli 2006 17 143 89.38 (2.4362) 89.38 [ 84.61, 94.15 ]
Park 2002 40 108 72.97 (3.65047) 72.97 [ 65.82, 80.12 ]
Park 2006 10 20 66.67 (8.60663) 66.67 [ 49.80, 83.54 ]
Perego 2009 8 29 78.38 (6.7677) 78.38 [ 65.12, 91.64 ]
Perry 2010 49 34 40.96 (5.39784) 40.96 [ 30.38, 51.54 ]
Phi 2009 7 80 91.95 (2.91619) 91.95 [ 86.23, 97.67 ]
Pinheiro-Martins 2012 37 33 47.14 (5.96638) 47.14 [ 35.45, 58.83 ]
Prevedello 2000 31 53 63.1 (5.26502) 63.10 [ 52.78, 73.42 ]
Raabe 2012 19 57 75 (4.967) 75.00 [ 65.26, 84.74 ]
Radhakrishnan 1998 41 134 76.57 (3.20175) 76.57 [ 70.29, 82.85 ]
Remi 2011 16 138 89.61 (2.45877) 89.61 [ 84.79, 94.43 ]
Roberti 2007 15 27 64.29 (7.39356) 64.29 [ 49.80, 78.78 ]
Russo 2003 37 64 63.37 (4.79412) 63.37 [ 53.97, 72.77 ]
Sagher 2012 11 85 88.54 (3.25087) 88.54 [ 82.17, 94.91 ]
Salanova 1994 36 53 59.55 (5.2024) 59.55 [ 49.35, 69.75 ]
Sarkis 2012 24 38 61.29 (6.186) 61.29 [ 49.17, 73.41 ]
Schramm 2011 55 152 73.43 (3.07007) 73.43 [ 67.41, 79.45 ]
Seymour 2012 138 153 52.58 (2.92716) 52.58 [ 46.84, 58.32 ]
Sinclair 2003 20 57 74.03 (4.99708) 74.03 [ 64.24, 83.82 ]
Sindou 2006 15 85 85 (3.57071) 85.00 [ 78.00, 92.00 ]
Sola 2005 63 74 54.01 (4.258) 54.01 [ 45.66, 62.36 ]
Sperling 1992 10 41 80.39 (5.55951) 80.39 [ 69.49, 91.29 ]
Stavrou 2008 8 45 84.91 (4.91742) 84.91 [ 75.27, 94.55 ]
Suppiah 2009 80 94 54.02 (3.7782) 54.02 [ 46.61, 61.43 ]
Tanriverdi 2010 96 160 62.5 (3.02577) 62.50 [ 56.57, 68.43 ]
Terra-Bustamante 2005a 45 62 57.94 (4.77229) 57.94 [ 48.59, 67.29 ]
Terra-Bustamante 2005b 8 27 77.14 (7.09782) 77.14 [ 63.23, 91.05 ]
Tezer 2008 19 90 82.57 (3.63378) 82.57 [ 75.45, 89.69 ]
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Study or subgroup Poor outcome Good outcome
Proportion
(good outcome)
(SE)
Proportion (good
outcome)
Proportion (good
outcome)
N N IV,Fixed,95% CI IV,Fixed,95% CI
Tigaran 2003 33 32 49.23 (6.201) 49.23 [ 37.08, 61.38 ]
Tripathi 2008 26 29 52.73 (6.73196) 52.73 [ 39.54, 65.92 ]
Trottier 2008 23 73 76.04 (4.35631) 76.04 [ 67.50, 84.58 ]
Urbach 2007 17 25 59.52 (7.57392) 59.52 [ 44.68, 74.36 ]
Velasco 2011 70 93 57.06 (3.87712) 57.06 [ 49.46, 64.66 ]
Wellmer 2012 59 106 64.24 (3.73124) 64.24 [ 56.93, 71.55 ]
Wieshmann 2008 30 46 60.53 (5.60685) 60.53 [ 49.54, 71.52 ]
Wray 2012 16 36 69.23 (6.40039) 69.23 [ 56.69, 81.77 ]
Wyllie 1998 44 92 67.65 (4.01155) 67.65 [ 59.79, 75.51 ]
Yeon 2009 10 50 83.33 (4.81125) 83.33 [ 73.90, 92.76 ]
Yu 2009 17 26 60.47 (7.45604) 60.47 [ 45.86, 75.08 ]
Zentner 1995 64 103 61.68 (3.76213) 61.68 [ 54.31, 69.05 ]
Zentner 1996 26 30 53.57 (6.66446) 53.57 [ 40.51, 66.63 ]
3 ’Other’ scale
Barbaro 2018 21 37 63.79 (7.32906) 63.79 [ 49.43, 78.15 ]
Boesebeck 2007 48 33 66.67 (4.73779) 66.67 [ 57.38, 75.96 ]
Boshuisen 2010 10 33 76.74 (6.4425) 76.74 [ 64.11, 89.37 ]
de Tisi 2011 370 245 39.84 (1.97411) 39.84 [ 35.97, 43.71 ]
Dwivedi 2017 13 44 77.19 (5.55758) 77.19 [ 66.30, 88.08 ]
Engman 2004 19 35 64.81 (6.49861) 64.81 [ 52.07, 77.55 ]
Goldstein 1996 18 15 45.45 (8.66784) 45.45 [ 28.46, 62.44 ]
Gyimesi 2007 26 74 74 (4.38634) 74.00 [ 65.40, 82.60 ]
Holmes 2000 72 54 42.86 (4.40867) 42.86 [ 34.22, 51.50 ]
Jeong 1999 15 78 83.87 (3.81389) 83.87 [ 76.39, 91.35 ]
Kral 2007 13 27 67.5 (7.40566) 67.50 [ 52.99, 82.01 ]
Lackmayer 2013 13 32 71.11 (6.7566) 71.11 [ 57.87, 84.35 ]
Lee 2006 14 37 72.55 (6.24899) 72.55 [ 60.30, 84.80 ]
Mathern 1999 120 78 39.39 (3.47248) 39.39 [ 32.58, 46.20 ]
McIntosh 2012 70 11 13.58 (3.80643) 13.58 [ 6.12, 21.04 ]
Phi 2010 21 20 48.78 (7.80637) 48.78 [ 33.48, 64.08 ]
Rossi 1994 52 86 62.32 (4.12508) 62.32 [ 54.23, 70.41 ]
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Study or subgroup Poor outcome Good outcome
Proportion
(good outcome)
(SE)
Proportion (good
outcome)
Proportion (good
outcome)
N N IV,Fixed,95% CI IV,Fixed,95% CI
Sakamoto 2009 17 19 52.78 (8.32046) 52.78 [ 36.47, 69.09 ]
Vogt 2018 18 29 61.7 (7.41316) 61.70 [ 47.17, 76.23 ]
Yang 2011 72 27 27.27 (4.47605) 27.27 [ 18.50, 36.04 ]
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Analysis 4.1. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 1 Good outcome by MRI results.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 1 Good outcome by MRI results
Study or subgroup Normal MRI Abnormal MRI Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 1 year seizure-free
Duchowny 1998 4/5 15/24 0.5 % 1.28 [ 0.75, 2.19 ]
Erba 1992 6/10 31/36 1.4 % 0.70 [ 0.41, 1.18 ]
Fujiwara 2012 6/15 16/26 1.2 % 0.65 [ 0.33, 1.30 ]
Garcia 1994 10/20 26/31 2.1 % 0.60 [ 0.37, 0.95 ]
Gilliam 1997a 11/19 42/59 2.1 % 0.81 [ 0.54, 1.23 ]
Gilliam 1997b 2/3 20/30 0.4 % 1.00 [ 0.43, 2.31 ]
Hallbook 2010 24/29 64/81 3.4 % 1.05 [ 0.86, 1.28 ]
Jehi 2012 10/33 137/279 2.9 % 0.62 [ 0.36, 1.05 ]
Kim 2009 49/96 45/70 5.2 % 0.79 [ 0.61, 1.03 ]
Kim 2010b 7/24 7/16 0.8 % 0.67 [ 0.29, 1.54 ]
Paolicchi 2000 18/35 26/40 2.4 % 0.79 [ 0.53, 1.17 ]
0.05 0.2 1 5 20
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Study or subgroup Normal MRI Abnormal MRI Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Spencer 2005 22/40 157/225 4.8 % 0.79 [ 0.59, 1.06 ]
Swartz 1992 5/5 22/29 0.8 % 1.22 [ 0.89, 1.68 ]
Theodore 2012 8/15 18/26 1.3 % 0.77 [ 0.45, 1.32 ]
Widdess-Walsh 2007 12/25 10/23 1.0 % 1.10 [ 0.59, 2.05 ]
Yu 2012a 12/21 49/79 2.1 % 0.92 [ 0.61, 1.39 ]
Yu 2012b 36/62 112/160 6.3 % 0.83 [ 0.66, 1.05 ]
Subtotal (95% CI) 457 1234 38.6 % 0.82 [ 0.74, 0.90 ]
Total events: 242 (Normal MRI), 797 (Abnormal MRI)
Heterogeneity: Chi2 = 20.10, df = 16 (P = 0.22); I2 =20%
Test for overall effect: Z = 4.02 (P = 0.000058)
2 Engel Class Scale
Adam 1996 0/1 26/29 0.3 % 0.28 [ 0.03, 3.13 ]
Alfstad 2011 5/8 20/40 0.7 % 1.25 [ 0.67, 2.32 ]
Berkovic 1995 8/24 66/111 2.4 % 0.56 [ 0.31, 1.01 ]
Chabardes 2005 7/8 34/40 1.1 % 1.03 [ 0.77, 1.38 ]
Cossu 2005 16/42 77/123 3.9 % 0.61 [ 0.40, 0.92 ]
Ding 2016 13/19 17/24 1.5 % 0.97 [ 0.65, 1.44 ]
Erickson 2005 8/16 49/63 2.0 % 0.64 [ 0.39, 1.07 ]
Hartley 2002 2/4 18/31 0.4 % 0.86 [ 0.31, 2.40 ]
Hartzfield 2008 5/15 19/41 1.0 % 0.72 [ 0.33, 1.58 ]
Kim 2010a 34/111 41/66 5.2 % 0.49 [ 0.35, 0.69 ]
Liang 2012 67/88 106/118 9.1 % 0.85 [ 0.74, 0.97 ]
Liava 2012 5/10 34/42 1.3 % 0.62 [ 0.33, 1.17 ]
Lorenzo 1995 7/26 10/22 1.1 % 0.59 [ 0.27, 1.29 ]
Mihara 2004 150/195 71/87 9.9 % 0.94 [ 0.83, 1.07 ]
O’Brien 2000 7/17 7/19 0.7 % 1.12 [ 0.49, 2.53 ]
Perego 2009 2/6 27/31 0.9 % 0.38 [ 0.12, 1.20 ]
Perry 2010 5/18 29/65 1.3 % 0.62 [ 0.28, 1.38 ]
Radhakrishnan 1998 45/71 89/104 7.3 % 0.74 [ 0.61, 0.90 ]
Sinclair 2003 5/12 52/65 1.6 % 0.52 [ 0.26, 1.03 ]
Sindou 2006 8/13 77/87 2.0 % 0.70 [ 0.45, 1.08 ]
Sola 2005 21/34 75/99 3.9 % 0.82 [ 0.61, 1.09 ]
Wray 2012 2/6 34/46 0.8 % 0.45 [ 0.14, 1.42 ]
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Study or subgroup Normal MRI Abnormal MRI Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Subtotal (95% CI) 744 1353 58.3 % 0.75 [ 0.69, 0.81 ]
Total events: 422 (Normal MRI), 978 (Abnormal MRI)
Heterogeneity: Chi2 = 39.20, df = 21 (P = 0.01); I2 =46%
Test for overall effect: Z = 7.32 (P < 0.00001)
3 ’Other’ scale
Boshuisen 2010 28/32 5/11 0.7 % 1.93 [ 0.99, 3.73 ]
Goldstein 1996 5/14 10/19 0.9 % 0.68 [ 0.30, 1.54 ]
Sakamoto 2009 0/4 19/32 0.5 % 0.17 [ 0.01, 2.38 ]
Yang 2011 3/20 24/79 1.0 % 0.49 [ 0.17, 1.48 ]
Subtotal (95% CI) 70 141 3.1 % 0.84 [ 0.53, 1.32 ]
Total events: 36 (Normal MRI), 58 (Abnormal MRI)
Heterogeneity: Chi2 = 8.65, df = 3 (P = 0.03); I2 =65%
Test for overall effect: Z = 0.76 (P = 0.45)
Total (95% CI) 1271 2728 100.0 % 0.78 [ 0.73, 0.83 ]
Total events: 700 (Normal MRI), 1833 (Abnormal MRI)
Heterogeneity: Chi2 = 68.37, df = 42 (P = 0.01); I2 =39%
Test for overall effect: Z = 8.10 (P < 0.00001)
Test for subgroup differences: Chi2 = 2.07, df = 2 (P = 0.35), I2 =4%
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Analysis 4.2. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 2 Good outcome by use of intracranial monitoring (IM).
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 2 Good outcome by use of intracranial monitoring (IM)
Study or subgroup IM used IM not used Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 1 year seizure-free
Garcia 1994 8/14 28/37 3.7 % 0.76 [ 0.46, 1.23 ]
Kim 2009 87/146 7/20 3.0 % 1.70 [ 0.92, 3.14 ]
Kim 2010b 10/33 4/7 1.6 % 0.53 [ 0.23, 1.21 ]
Spencer 2005 73/116 129/181 24.3 % 0.88 [ 0.75, 1.04 ]
Tatum 2008 4/8 18/31 1.8 % 0.86 [ 0.40, 1.83 ]
Theodore 2012 7/17 19/24 3.8 % 0.52 [ 0.28, 0.95 ]
Subtotal (95% CI) 334 300 38.1 % 0.88 [ 0.76, 1.02 ]
Total events: 189 (IM used), 205 (IM not used)
Heterogeneity: Chi2 = 9.23, df = 5 (P = 0.10); I2 =46%
Test for overall effect: Z = 1.66 (P = 0.097)
2 Engel Class Scale
Adam 1996 5/8 21/22 2.7 % 0.65 [ 0.38, 1.13 ]
Alfstad 2011 7/13 18/35 2.3 % 1.05 [ 0.58, 1.90 ]
Chang 2009 8/13 24/31 3.4 % 0.79 [ 0.50, 1.27 ]
Cossu 2008 62/96 15/17 6.1 % 0.73 [ 0.58, 0.92 ]
Gelinas 2011 27/34 25/33 6.1 % 1.05 [ 0.81, 1.36 ]
Grivas 2006 11/11 36/41 3.9 % 1.10 [ 0.93, 1.30 ]
Lee 2008 34/65 4/6 1.8 % 0.78 [ 0.43, 1.45 ]
Liava 2012 23/33 16/19 4.9 % 0.83 [ 0.61, 1.11 ]
Morris 1998 14/21 12/15 3.4 % 0.83 [ 0.56, 1.24 ]
O’Brien 2000 6/20 8/16 2.1 % 0.60 [ 0.26, 1.38 ]
Perry 2010 16/34 18/49 3.6 % 1.28 [ 0.77, 2.14 ]
Raabe 2012 15/25 42/51 6.7 % 0.73 [ 0.52, 1.03 ]
Terra-Bustamante 2005a 11/15 16/20 3.3 % 0.92 [ 0.63, 1.33 ]
Wyllie 1998 15/30 66/90 7.9 % 0.68 [ 0.47, 1.00 ]
Subtotal (95% CI) 418 445 58.2 % 0.85 [ 0.77, 0.94 ]
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Study or subgroup IM used IM not used Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 254 (IM used), 321 (IM not used)
Heterogeneity: Chi2 = 20.47, df = 13 (P = 0.08); I2 =37%
Test for overall effect: Z = 3.03 (P = 0.0024)
3 ’Other’ scale
Kan 2008 5/10 38/40 3.7 % 0.53 [ 0.28, 0.98 ]
Subtotal (95% CI) 10 40 3.7 % 0.53 [ 0.28, 0.98 ]
Total events: 5 (IM used), 38 (IM not used)
Heterogeneity: not applicable
Test for overall effect: Z = 2.02 (P = 0.044)
Total (95% CI) 762 785 100.0 % 0.85 [ 0.78, 0.93 ]
Total events: 448 (IM used), 564 (IM not used)
Heterogeneity: Chi2 = 31.89, df = 20 (P = 0.04); I2 =37%
Test for overall effect: Z = 3.70 (P = 0.00021)
Test for subgroup differences: Chi2 = 2.51, df = 2 (P = 0.29), I2 =20%
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Analysis 4.3. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 3 Good outcome by presence of mesial temporal sclerosis (MTS).
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 3 Good outcome by presence of mesial temporal sclerosis (MTS)
Study or subgroup MTS present MTS absent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 1 year seizure-free
Dagar 2011 23/26 66/86 3.0 % 1.15 [ 0.96, 1.38 ]
Erba 1992 8/9 29/37 1.1 % 1.13 [ 0.85, 1.51 ]
Gilliam 1997b 1/2 21/31 0.3 % 0.74 [ 0.18, 3.01 ]
Hemb 2010 24/27 199/298 3.3 % 1.33 [ 1.14, 1.56 ]
Jennum 1993 4/7 38/57 0.8 % 0.86 [ 0.44, 1.67 ]
O’Brien 1996 27/31 9/15 1.2 % 1.45 [ 0.94, 2.24 ]
Spencer 2005 128/171 47/86 6.2 % 1.37 [ 1.11, 1.69 ]
Swartz 1992 12/15 15/19 1.3 % 1.01 [ 0.72, 1.43 ]
Theodore 2012 16/23 10/18 1.1 % 1.25 [ 0.76, 2.05 ]
Subtotal (95% CI) 311 647 18.3 % 1.25 [ 1.13, 1.39 ]
Total events: 243 (MTS present), 434 (MTS absent)
Heterogeneity: Chi2 = 6.24, df = 8 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 4.29 (P = 0.000018)
2 Engel Class Scale
Aaberg 2012 5/7 25/48 0.6 % 1.37 [ 0.80, 2.36 ]
Alfstad 2011 12/18 13/30 1.0 % 1.54 [ 0.91, 2.60 ]
Bell 2009 4/7 20/33 0.7 % 0.94 [ 0.47, 1.89 ]
Berkovic 1995 49/85 25/50 3.1 % 1.15 [ 0.83, 1.61 ]
Chabardes 2005 23/28 18/20 2.1 % 0.91 [ 0.73, 1.14 ]
Cossu 2005 18/27 13/22 1.4 % 1.13 [ 0.73, 1.75 ]
Cossu 2008 7/11 70/102 1.3 % 0.93 [ 0.58, 1.48 ]
Delbeke 1996 16/27 7/11 1.0 % 0.93 [ 0.54, 1.61 ]
Donadio 2011 25/32 35/52 2.6 % 1.16 [ 0.89, 1.51 ]
Erickson 2005 19/22 35/55 2.0 % 1.36 [ 1.05, 1.76 ]
Georgakoulias 2008 15/21 21/23 2.0 % 0.78 [ 0.58, 1.05 ]
Grivas 2006 22/31 15/21 1.8 % 0.99 [ 0.70, 1.41 ]
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Study or subgroup MTS present MTS absent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Hartley 2002 8/13 12/22 0.9 % 1.13 [ 0.64, 2.00 ]
Hartzfield 2008 4/10 20/46 0.7 % 0.92 [ 0.40, 2.10 ]
Kanner 2009 60/63 26/37 3.2 % 1.36 [ 1.09, 1.68 ]
Kilpatrick 1997 29/34 10/16 1.3 % 1.36 [ 0.91, 2.04 ]
Li 1999 10/20 6/18 0.6 % 1.50 [ 0.68, 3.29 ]
Mihara 2004 138/172 131/185 12.5 % 1.13 [ 1.01, 1.28 ]
Miserocchi 2013 19/20 39/48 2.3 % 1.17 [ 0.99, 1.38 ]
O’Brien 2000 0/1 14/35 0.2 % 0.62 [ 0.05, 7.07 ]
Perego 2009 21/26 8/11 1.1 % 1.11 [ 0.74, 1.67 ]
Perry 2010 3/7 31/76 0.5 % 1.05 [ 0.43, 2.58 ]
Radhakrishnan 1998 63/74 71/101 5.9 % 1.21 [ 1.03, 1.42 ]
Schramm 2011 133/186 19/21 3.4 % 0.79 [ 0.67, 0.93 ]
Seymour 2012 85/158 63/143 6.5 % 1.22 [ 0.97, 1.54 ]
Sinclair 2003 12/14 45/63 1.6 % 1.20 [ 0.92, 1.56 ]
Sindou 2006 63/69 22/31 3.0 % 1.29 [ 1.02, 1.63 ]
Terra-Bustamante 2005a 12/17 50/90 1.6 % 1.27 [ 0.89, 1.82 ]
Wray 2012 5/9 31/43 1.1 % 0.77 [ 0.42, 1.42 ]
Wyllie 1998 14/21 67/99 2.3 % 0.99 [ 0.71, 1.37 ]
Zentner 1995 26/39 77/128 3.6 % 1.11 [ 0.85, 1.44 ]
Subtotal (95% CI) 1269 1680 72.0 % 1.13 [ 1.07, 1.20 ]
Total events: 920 (MTS present), 1039 (MTS absent)
Heterogeneity: Chi2 = 42.81, df = 30 (P = 0.06); I2 =30%
Test for overall effect: Z = 4.49 (P < 0.00001)
3 ’Other’ scale
Goldstein 1996 1/5 14/28 0.4 % 0.40 [ 0.07, 2.40 ]
Jeong 1999 74/85 4/8 0.7 % 1.74 [ 0.87, 3.50 ]
Kan 2008 14/16 29/42 1.6 % 1.27 [ 0.96, 1.67 ]
Mathern 1999 7/8 71/120 0.9 % 1.48 [ 1.09, 2.00 ]
Sakamoto 2009 63/74 71/101 5.9 % 1.21 [ 1.03, 1.42 ]
Yang 2011 18/28 1/8 0.2 % 5.14 [ 0.81, 32.84 ]
Subtotal (95% CI) 216 307 9.7 % 1.31 [ 1.14, 1.51 ]
Total events: 177 (MTS present), 190 (MTS absent)
Heterogeneity: Chi2 = 6.05, df = 5 (P = 0.30); I2 =17%
Test for overall effect: Z = 3.73 (P = 0.00019)
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Study or subgroup MTS present MTS absent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total (95% CI) 1796 2634 100.0 % 1.17 [ 1.12, 1.23 ]
Total events: 1340 (MTS present), 1663 (MTS absent)
Heterogeneity: Chi2 = 62.32, df = 45 (P = 0.04); I2 =28%
Test for overall effect: Z = 6.83 (P < 0.00001)
Test for subgroup differences: Chi2 = 5.49, df = 2 (P = 0.06), I2 =64%
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Analysis 4.4. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 4 Good outcome by concordance of pre-op MRI and EEG.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 4 Good outcome by concordance of pre-op MRI and EEG
Study or subgroup Concordant Discordant Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 1 year seizure-free
Garcia 1994 34/45 2/6 1.0 % 2.27 [ 0.72, 7.11 ]
Gilliam 1997a 37/48 16/30 5.5 % 1.45 [ 1.00, 2.09 ]
Gilliam 1997b 15/20 7/13 2.4 % 1.39 [ 0.79, 2.45 ]
Kim 2009 68/127 26/39 11.1 % 0.80 [ 0.61, 1.06 ]
Kim 2010b 12/29 2/11 0.8 % 2.28 [ 0.60, 8.57 ]
Spencer 2005 111/153 90/143 25.9 % 1.15 [ 0.98, 1.35 ]
Tatum 2008 20/27 2/12 0.8 % 4.44 [ 1.23, 16.06 ]
Theodore 2012 16/24 10/17 3.3 % 1.13 [ 0.70, 1.85 ]
Subtotal (95% CI) 473 271 50.7 % 1.21 [ 1.07, 1.37 ]
Total events: 313 (Concordant), 155 (Discordant)
Heterogeneity: Chi2 = 16.01, df = 7 (P = 0.03); I2 =56%
Test for overall effect: Z = 2.97 (P = 0.0030)
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Study or subgroup Concordant Discordant Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
2 Engel Class Scale
Brainer-Lima 1996 24/26 5/6 2.3 % 1.11 [ 0.76, 1.61 ]
Chang 2009 4/5 28/39 1.8 % 1.11 [ 0.69, 1.80 ]
Cukiert 2002 84/94 5/6 2.6 % 1.07 [ 0.74, 1.54 ]
Dalmagro 2005 19/28 9/16 3.2 % 1.21 [ 0.73, 1.99 ]
Janszky 2003a 47/64 13/20 5.5 % 1.13 [ 0.79, 1.61 ]
Jaramillo-Betancur 2009 43/64 0/3 0.3 % 5.35 [ 0.40, 71.97 ]
Kilpatrick 1997 37/48 2/2 1.3 % 0.92 [ 0.54, 1.56 ]
Lei 2008 17/23 20/43 3.9 % 1.59 [ 1.06, 2.38 ]
O’Brien 2000 7/18 7/18 2.0 % 1.00 [ 0.44, 2.27 ]
Perego 2009 25/32 4/5 1.9 % 0.98 [ 0.61, 1.57 ]
Sinclair 2003 45/58 12/19 5.0 % 1.23 [ 0.85, 1.78 ]
Sola 2005 77/96 20/37 8.0 % 1.48 [ 1.08, 2.03 ]
Subtotal (95% CI) 556 214 37.8 % 1.27 [ 1.11, 1.46 ]
Total events: 429 (Concordant), 125 (Discordant)
Heterogeneity: Chi2 = 8.46, df = 11 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 3.47 (P = 0.00052)
3 ’Other’ scale
Holmes 2000 33/76 21/50 7.1 % 1.03 [ 0.68, 1.57 ]
Rossi 1994 28/38 9/21 3.2 % 1.72 [ 1.01, 2.92 ]
Yang 2011 21/57 3/22 1.2 % 2.70 [ 0.89, 8.16 ]
Subtotal (95% CI) 171 93 11.5 % 1.40 [ 1.02, 1.93 ]
Total events: 82 (Concordant), 33 (Discordant)
Heterogeneity: Chi2 = 4.00, df = 2 (P = 0.14); I2 =50%
Test for overall effect: Z = 2.08 (P = 0.037)
Total (95% CI) 1200 578 100.0 % 1.25 [ 1.15, 1.37 ]
Total events: 824 (Concordant), 313 (Discordant)
Heterogeneity: Chi2 = 29.73, df = 22 (P = 0.13); I2 =26%
Test for overall effect: Z = 4.96 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.86, df = 2 (P = 0.65), I2 =0.0%
0.01 0.1 1 10 100
Favours Discordant Favours Concordant
153Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.5. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 5 Good outcome by history of febrile seizures (FS).
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 5 Good outcome by history of febrile seizures (FS)
Study or subgroup History of FS No history of FS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 1 year seizure-free
Holmes 1997 7/8 15/36 1.5 % 2.10 [ 1.32, 3.35 ]
Kim 2009 17/30 77/136 7.7 % 1.00 [ 0.71, 1.41 ]
Kim 2010b 6/11 8/29 1.2 % 1.98 [ 0.89, 4.40 ]
Spencer 2005 67/86 134/210 21.6 % 1.22 [ 1.05, 1.42 ]
Walz 2003 20/24 65/74 8.8 % 0.95 [ 0.78, 1.16 ]
Subtotal (95% CI) 159 485 40.9 % 1.18 [ 1.05, 1.32 ]
Total events: 117 (History of FS), 299 (No history of FS)
Heterogeneity: Chi2 = 13.13, df = 4 (P = 0.01); I2 =70%
Test for overall effect: Z = 2.75 (P = 0.0059)
2 Engel Class Scale
Adam 1996 14/16 12/14 3.6 % 1.02 [ 0.77, 1.35 ]
Chabardes 2005 18/22 23/26 5.9 % 0.92 [ 0.73, 1.18 ]
Grivas 2006 3/4 41/45 1.9 % 0.82 [ 0.46, 1.46 ]
Hajek 2009 14/18 11/17 3.1 % 1.20 [ 0.78, 1.85 ]
Jaramillo-Betancur 2009 10/18 33/49 4.9 % 0.82 [ 0.52, 1.30 ]
Perry 2010 3/5 31/78 1.0 % 1.51 [ 0.70, 3.25 ]
Radhakrishnan 1998 45/57 89/118 16.1 % 1.05 [ 0.88, 1.24 ]
Terra-Bustamante 2005a 6/7 21/28 2.3 % 1.14 [ 0.79, 1.66 ]
Tezer 2008 60/73 30/36 11.2 % 0.99 [ 0.82, 1.18 ]
Subtotal (95% CI) 220 411 50.0 % 1.01 [ 0.92, 1.11 ]
Total events: 173 (History of FS), 291 (No history of FS)
Heterogeneity: Chi2 = 4.12, df = 8 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 0.22 (P = 0.83)
3 ’Other’ scale
Jeong 1999 53/61 25/32 9.1 % 1.11 [ 0.90, 1.37 ]
Subtotal (95% CI) 61 32 9.1 % 1.11 [ 0.90, 1.37 ]
Total events: 53 (History of FS), 25 (No history of FS)
Heterogeneity: not applicable
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Study or subgroup History of FS No history of FS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 1.00 (P = 0.32)
Total (95% CI) 440 928 100.0 % 1.09 [ 1.01, 1.17 ]
Total events: 343 (History of FS), 615 (No history of FS)
Heterogeneity: Chi2 = 20.64, df = 14 (P = 0.11); I2 =32%
Test for overall effect: Z = 2.34 (P = 0.019)
Test for subgroup differences: Chi2 = 3.95, df = 2 (P = 0.14), I2 =49%
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Analysis 4.6. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 6 Good outcome by history of head injury (HI).
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 6 Good outcome by history of head injury (HI)
Study or subgroup History of HI No history of HI Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 1 year seizure-free
Greiner 2011 0/1 42/53 2.3 % 0.32 [ 0.03, 3.52 ]
Walz 2003 31/38 54/60 32.1 % 0.91 [ 0.76, 1.08 ]
Subtotal (95% CI) 39 113 34.4 % 0.87 [ 0.72, 1.05 ]
Total events: 31 (History of HI), 96 (No history of HI)
Heterogeneity: Chi2 = 0.93, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 1.46 (P = 0.14)
2 Engel Class Scale
Adam 1996 5/5 21/25 6.2 % 1.11 [ 0.82, 1.49 ]
Terra-Bustamante 2005a 13/14 14/21 8.6 % 1.39 [ 1.00, 1.95 ]
Tezer 2008 34/43 47/66 28.4 % 1.11 [ 0.89, 1.38 ]
Subtotal (95% CI) 62 112 43.2 % 1.17 [ 0.99, 1.37 ]
Total events: 52 (History of HI), 82 (No history of HI)
Heterogeneity: Chi2 = 1.38, df = 2 (P = 0.50); I2 =0.0%
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Study or subgroup History of HI No history of HI Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 1.85 (P = 0.064)
3 ’Other’ scale
Holmes 2000 6/24 48/102 14.0 % 0.53 [ 0.26, 1.09 ]
Yang 2011 11/34 16/65 8.4 % 1.31 [ 0.69, 2.51 ]
Subtotal (95% CI) 58 167 22.4 % 0.83 [ 0.51, 1.33 ]
Total events: 17 (History of HI), 64 (No history of HI)
Heterogeneity: Chi2 = 3.42, df = 1 (P = 0.06); I2 =71%
Test for overall effect: Z = 0.79 (P = 0.43)
Total (95% CI) 159 392 100.0 % 0.99 [ 0.86, 1.13 ]
Total events: 100 (History of HI), 242 (No history of HI)
Heterogeneity: Chi2 = 11.13, df = 6 (P = 0.08); I2 =46%
Test for overall effect: Z = 0.19 (P = 0.85)
Test for subgroup differences: Chi2 = 6.13, df = 2 (P = 0.05), I2 =67%
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Analysis 4.7. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 7 Good outcome by presence of encephalomalacia.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 7 Good outcome by presence of encephalomalacia
Study or subgroup
Encephalomalacia
present
Encephalomalacia
absent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Engel Class Scale
Ding 2016 7/10 23/33 32.0 % 1.00 [ 0.63, 1.60 ]
Hartzfield 2008 3/10 21/46 22.5 % 0.66 [ 0.24, 1.78 ]
O’Brien 2000 3/7 11/29 12.8 % 1.13 [ 0.43, 2.99 ]
Perry 2010 2/6 32/77 13.8 % 0.80 [ 0.25, 2.56 ]
Subtotal (95% CI) 33 185 81.1 % 0.89 [ 0.60, 1.33 ]
Total events: 15 (Encephalomalacia present), 87 (Encephalomalacia absent)
Heterogeneity: Chi2 = 0.86, df = 3 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.55 (P = 0.58)
2 ’Other’ scale
Yang 2011 1/12 26/87 18.9 % 0.28 [ 0.04, 1.87 ]
Subtotal (95% CI) 12 87 18.9 % 0.28 [ 0.04, 1.87 ]
Total events: 1 (Encephalomalacia present), 26 (Encephalomalacia absent)
Heterogeneity: not applicable
Test for overall effect: Z = 1.31 (P = 0.19)
Total (95% CI) 45 272 100.0 % 0.78 [ 0.52, 1.17 ]
Total events: 16 (Encephalomalacia present), 113 (Encephalomalacia absent)
Heterogeneity: Chi2 = 2.96, df = 4 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 1.21 (P = 0.23)
Test for subgroup differences: Chi2 = 1.38, df = 1 (P = 0.24), I2 =27%
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Analysis 4.8. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 8 Good outcome by presence of focal cortical dysplasia (FCD)/malformation
of cortical development (MCD).
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 8 Good outcome by presence of focal cortical dysplasia (FCD)/malformation of cortical development (MCD)
Study or subgroup FCD/MCD present FCD/MCD absent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 1 year seizure-free
Dagar 2011 13/18 76/94 2.8 % 0.89 [ 0.66, 1.21 ]
Duchowny 1998 9/21 7/10 1.1 % 0.61 [ 0.32, 1.16 ]
Fujiwara 2012 16/34 7/10 1.3 % 0.67 [ 0.39, 1.15 ]
Gilliam 1997b 5/12 17/21 1.4 % 0.51 [ 0.26, 1.04 ]
Greiner 2011 17/21 25/33 2.3 % 1.07 [ 0.80, 1.42 ]
Hallbook 2010 31/43 57/67 5.2 % 0.85 [ 0.69, 1.05 ]
Hemb 2010 86/120 137/205 11.7 % 1.07 [ 0.92, 1.24 ]
Paolicchi 2000 22/42 22/33 2.9 % 0.79 [ 0.54, 1.14 ]
Subtotal (95% CI) 311 473 28.7 % 0.92 [ 0.84, 1.02 ]
Total events: 199 (FCD/MCD present), 348 (FCD/MCD absent)
Heterogeneity: Chi2 = 11.93, df = 7 (P = 0.10); I2 =41%
Test for overall effect: Z = 1.61 (P = 0.11)
2 Engel Class Scale
Aaberg 2012 10/21 20/33 1.8 % 0.79 [ 0.46, 1.33 ]
Battaglia 2006 7/16 25/29 2.1 % 0.51 [ 0.29, 0.90 ]
Blount 2004 2/6 10/24 0.5 % 0.80 [ 0.23, 2.73 ]
Cossu 2005 41/72 52/93 5.3 % 1.02 [ 0.78, 1.33 ]
Cossu 2008 54/88 23/25 4.2 % 0.67 [ 0.54, 0.82 ]
Cukiert 2002 5/6 84/94 1.2 % 0.93 [ 0.65, 1.34 ]
Dalmagro 2005 15/22 13/21 1.5 % 1.10 [ 0.71, 1.71 ]
Ding 2016 15/22 15/21 1.8 % 0.95 [ 0.64, 1.41 ]
Donadio 2011 11/15 49/69 2.0 % 1.03 [ 0.73, 1.45 ]
Elsharkawy 2008a 28/68 93/150 6.7 % 0.66 [ 0.49, 0.91 ]
Erickson 2005 3/5 51/72 0.8 % 0.85 [ 0.41, 1.76 ]
Georgakoulias 2008 3/3 33/41 0.7 % 1.10 [ 0.73, 1.64 ]
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Study or subgroup FCD/MCD present FCD/MCD absent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Hajek 2009 9/14 16/21 1.5 % 0.84 [ 0.53, 1.33 ]
Hamiwka 2005 12/31 5/7 0.9 % 0.54 [ 0.28, 1.03 ]
Kilpatrick 1997 1/2 38/48 0.4 % 0.63 [ 0.16, 2.54 ]
Kim 2010a 43/103 32/74 4.3 % 0.97 [ 0.68, 1.37 ]
Lee 2011 8/9 29/31 1.5 % 0.95 [ 0.74, 1.22 ]
Li 1997 5/7 31/44 1.0 % 1.01 [ 0.61, 1.68 ]
Li 1999 4/9 12/29 0.7 % 1.07 [ 0.46, 2.51 ]
Liava 2012 22/28 17/24 2.1 % 1.11 [ 0.80, 1.53 ]
Miserocchi 2013 30/32 28/36 3.1 % 1.21 [ 0.99, 1.47 ]
Morris 1998 9/13 17/23 1.4 % 0.94 [ 0.61, 1.45 ]
O’Brien 2000 2/3 12/33 0.2 % 1.83 [ 0.73, 4.59 ]
Perego 2009 2/3 27/34 0.5 % 0.84 [ 0.37, 1.90 ]
Perry 2010 16/40 18/43 2.0 % 0.96 [ 0.57, 1.60 ]
Raabe 2012 2/3 55/73 0.5 % 0.88 [ 0.39, 1.99 ]
Sinclair 2003 7/12 50/65 1.8 % 0.76 [ 0.46, 1.25 ]
Sindou 2006 3/5 82/95 1.0 % 0.70 [ 0.34, 1.43 ]
Terra-Bustamante 2005a 14/27 48/80 2.8 % 0.86 [ 0.58, 1.30 ]
Tripathi 2008 16/26 13/29 1.4 % 1.37 [ 0.83, 2.28 ]
Urbach 2007 11/16 14/26 1.2 % 1.28 [ 0.79, 2.07 ]
Wray 2012 2/5 34/47 0.8 % 0.55 [ 0.19, 1.64 ]
Wyllie 1998 16/31 65/89 3.9 % 0.71 [ 0.49, 1.02 ]
Subtotal (95% CI) 763 1623 61.5 % 0.89 [ 0.82, 0.96 ]
Total events: 428 (FCD/MCD present), 1111 (FCD/MCD absent)
Heterogeneity: Chi2 = 44.27, df = 32 (P = 0.07); I2 =28%
Test for overall effect: Z = 3.02 (P = 0.0025)
3 ’Other’ scale
Boesebeck 2007 10/26 23/55 1.7 % 0.92 [ 0.52, 1.64 ]
Kan 2008 8/13 35/45 1.8 % 0.79 [ 0.50, 1.25 ]
Mathern 1999 35/54 43/74 4.2 % 1.12 [ 0.85, 1.47 ]
Sakamoto 2009 1/1 18/35 0.2 % 1.46 [ 0.62, 3.45 ]
Yang 2011 6/37 21/62 1.8 % 0.48 [ 0.21, 1.08 ]
Subtotal (95% CI) 131 271 9.8 % 0.91 [ 0.73, 1.13 ]
Total events: 60 (FCD/MCD present), 140 (FCD/MCD absent)
Heterogeneity: Chi2 = 6.01, df = 4 (P = 0.20); I2 =33%
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Study or subgroup FCD/MCD present FCD/MCD absent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 0.85 (P = 0.39)
Total (95% CI) 1205 2367 100.0 % 0.90 [ 0.85, 0.95 ]
Total events: 687 (FCD/MCD present), 1599 (FCD/MCD absent)
Heterogeneity: Chi2 = 62.49, df = 45 (P = 0.04); I2 =28%
Test for overall effect: Z = 3.50 (P = 0.00047)
Test for subgroup differences: Chi2 = 0.38, df = 2 (P = 0.83), I2 =0.0%
0.01 0.1 1 10 100
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Analysis 4.9. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 9 Good outcome by presence of tumour.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 9 Good outcome by presence of tumour
Study or subgroup Tumour present Tumour absent Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 > 1 year seizure-free
Dagar 2011 14/18 75/94 3.5 % 0.97 [ 0.75, 1.27 ]
Duchowny 1998 7/7 9/24 1.4 % 2.47 [ 1.45, 4.20 ]
Erba 1992 20/26 17/20 3.4 % 0.90 [ 0.68, 1.20 ]
Gilliam 1997b 10/13 12/20 1.8 % 1.28 [ 0.80, 2.04 ]
Hemb 2010 18/22 205/303 4.3 % 1.21 [ 0.98, 1.49 ]
Paolicchi 2000 17/25 27/50 2.4 % 1.26 [ 0.87, 1.83 ]
Swartz 1992 5/6 22/28 2.1 % 1.06 [ 0.71, 1.59 ]
Subtotal (95% CI) 117 539 18.9 % 1.17 [ 0.97, 1.41 ]
Total events: 91 (Tumour present), 367 (Tumour absent)
Heterogeneity: Tau2 = 0.03; Chi2 = 13.11, df = 6 (P = 0.04); I2 =54%
Test for overall effect: Z = 1.66 (P = 0.097)
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Study or subgroup Tumour present Tumour absent Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
2 Engel Class Scale
Aaberg 2012 1/5 29/49 0.2 % 0.34 [ 0.06, 1.98 ]
Battaglia 2006 3/12 29/33 0.5 % 0.28 [ 0.11, 0.76 ]
Cossu 2005 17/30 76/135 2.6 % 1.01 [ 0.71, 1.42 ]
Cossu 2008 31/35 46/78 4.2 % 1.50 [ 1.21, 1.87 ]
Dalmagro 2005 5/6 23/37 1.9 % 1.34 [ 0.87, 2.08 ]
Elsharkawy 2008a 50/79 71/139 4.0 % 1.24 [ 0.98, 1.57 ]
Erickson 2005 10/16 44/61 2.1 % 0.87 [ 0.57, 1.31 ]
Grivas 2006 6/7 31/45 2.5 % 1.24 [ 0.87, 1.78 ]
Hamiwka 2005 5/7 12/31 1.0 % 1.85 [ 0.97, 3.52 ]
Kilpatrick 1997 6/10 33/40 1.5 % 0.73 [ 0.43, 1.23 ]
Kim 2010a 6/10 69/167 1.4 % 1.45 [ 0.85, 2.49 ]
Lee 2011 28/30 9/10 4.1 % 1.04 [ 0.83, 1.30 ]
Li 1997 24/32 12/19 2.2 % 1.19 [ 0.80, 1.77 ]
Li 1999 5/10 11/18 0.9 % 0.82 [ 0.40, 1.68 ]
Liava 2012 10/12 29/40 2.9 % 1.15 [ 0.84, 1.58 ]
Miserocchi 2013 32/35 26/33 4.4 % 1.16 [ 0.95, 1.42 ]
O’Brien 2000 3/8 11/28 0.5 % 0.95 [ 0.35, 2.61 ]
Perego 2009 6/7 23/30 2.5 % 1.12 [ 0.78, 1.60 ]
Perry 2010 12/18 22/65 1.7 % 1.97 [ 1.23, 3.16 ]
Sinclair 2003 18/21 39/56 3.8 % 1.23 [ 0.96, 1.57 ]
Sindou 2006 9/10 76/90 4.1 % 1.07 [ 0.85, 1.33 ]
Sperling 1992 15/16 26/35 4.0 % 1.26 [ 1.00, 1.59 ]
Terra-Bustamante 2005a 15/18 47/89 3.3 % 1.58 [ 1.19, 2.10 ]
Urbach 2007 8/13 17/29 1.5 % 1.05 [ 0.62, 1.78 ]
Wray 2012 20/22 16/30 2.5 % 1.70 [ 1.19, 2.44 ]
Wyllie 1998 36/44 45/76 4.0 % 1.38 [ 1.09, 1.74 ]
Zentner 1995 50/73 53/94 3.9 % 1.21 [ 0.96, 1.54 ]
Zentner 1996 12/15 18/41 2.0 % 1.82 [ 1.19, 2.80 ]
Subtotal (95% CI) 601 1598 70.1 % 1.23 [ 1.13, 1.33 ]
Total events: 443 (Tumour present), 943 (Tumour absent)
Heterogeneity: Tau2 = 0.02; Chi2 = 44.62, df = 27 (P = 0.02); I2 =39%
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Study or subgroup Tumour present Tumour absent Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Test for overall effect: Z = 4.76 (P < 0.00001)
3 ’Other’ scale
Boesebeck 2007 11/18 22/63 1.6 % 1.75 [ 1.06, 2.88 ]
Goldstein 1996 8/11 7/22 0.9 % 2.29 [ 1.12, 4.65 ]
Kan 2008 13/16 30/42 3.1 % 1.14 [ 0.84, 1.54 ]
Mathern 1999 6/12 72/116 1.2 % 0.81 [ 0.45, 1.44 ]
Rossi 1994 20/24 47/79 3.7 % 1.40 [ 1.09, 1.81 ]
Yang 2011 3/7 24/92 0.6 % 1.64 [ 0.65, 4.13 ]
Subtotal (95% CI) 88 414 11.0 % 1.35 [ 1.07, 1.70 ]
Total events: 61 (Tumour present), 202 (Tumour absent)
Heterogeneity: Tau2 = 0.03; Chi2 = 7.62, df = 5 (P = 0.18); I2 =34%
Test for overall effect: Z = 2.55 (P = 0.011)
Total (95% CI) 806 2551 100.0 % 1.23 [ 1.14, 1.32 ]
Total events: 595 (Tumour present), 1512 (Tumour absent)
Heterogeneity: Tau2 = 0.02; Chi2 = 67.33, df = 40 (P = 0.004); I2 =41%
Test for overall effect: Z = 5.56 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.88, df = 2 (P = 0.64), I2 =0.0%
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Analysis 4.10. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 10 Good outcome by presence of vascular malformation.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 10 Good outcome by presence of vascular malformation
Study or subgroup Malformation present Malformation absent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 1 year seizure-free
Erba 1992 2/2 35/44 2.9 % 1.06 [ 0.62, 1.79 ]
Subtotal (95% CI) 2 44 2.9 % 1.06 [ 0.62, 1.79 ]
Total events: 2 (Malformation present), 35 (Malformation absent)
Heterogeneity: not applicable
Test for overall effect: Z = 0.20 (P = 0.84)
2 Engel Class Scale
Aaberg 2012 8/9 22/45 4.9 % 1.82 [ 1.25, 2.65 ]
Battaglia 2006 3/4 29/41 3.4 % 1.06 [ 0.58, 1.93 ]
Cossu 2008 3/3 74/110 3.4 % 1.30 [ 0.88, 1.93 ]
Dalmagro 2005 2/2 26/41 2.3 % 1.32 [ 0.76, 2.30 ]
Elsharkawy 2008a 15/24 106/194 15.5 % 1.14 [ 0.82, 1.60 ]
Erickson 2005 6/8 47/69 6.5 % 1.10 [ 0.72, 1.70 ]
Kilpatrick 1997 3/4 36/46 3.8 % 0.96 [ 0.53, 1.72 ]
Li 1997 5/8 31/43 6.5 % 0.87 [ 0.49, 1.53 ]
Li 1999 2/5 14/33 2.4 % 0.94 [ 0.30, 2.96 ]
Perry 2010 0/3 34/80 2.2 % 0.29 [ 0.02, 3.97 ]
Terra-Bustamante 2005a 3/4 59/103 2.9 % 1.31 [ 0.73, 2.36 ]
Urbach 2007 3/4 22/38 2.8 % 1.30 [ 0.69, 2.43 ]
Wray 2012 2/2 34/50 2.5 % 1.23 [ 0.72, 2.11 ]
Subtotal (95% CI) 80 893 59.2 % 1.14 [ 0.98, 1.34 ]
Total events: 55 (Malformation present), 534 (Malformation absent)
Heterogeneity: Chi2 = 9.41, df = 12 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 1.68 (P = 0.092)
3 ’Other’ scale
Boesebeck 2007 2/8 31/73 4.1 % 0.59 [ 0.17, 2.01 ]
Kan 2008 4/5 39/53 4.5 % 1.09 [ 0.68, 1.73 ]
Mathern 1999 12/21 66/107 14.4 % 0.93 [ 0.62, 1.38 ]
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Study or subgroup Malformation present Malformation absent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Rossi 1994 13/20 54/83 13.9 % 1.00 [ 0.70, 1.43 ]
Yang 2011 1/3 26/96 1.0 % 1.23 [ 0.24, 6.30 ]
Subtotal (95% CI) 57 412 37.9 % 0.94 [ 0.74, 1.20 ]
Total events: 32 (Malformation present), 216 (Malformation absent)
Heterogeneity: Chi2 = 1.12, df = 4 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.47 (P = 0.64)
Total (95% CI) 139 1349 100.0 % 1.07 [ 0.94, 1.21 ]
Total events: 89 (Malformation present), 785 (Malformation absent)
Heterogeneity: Chi2 = 13.73, df = 18 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 0.96 (P = 0.34)
Test for subgroup differences: Chi2 = 1.72, df = 2 (P = 0.42), I2 =0.0%
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Analysis 4.11. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 11 Good outcome by unilateral or bilateral interictal spikes.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 11 Good outcome by unilateral or bilateral interictal spikes
Study or subgroup Unilateral spikes Bilateral Spikes Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 1 year seizure-free
Chee 1993 30/33 2/5 1.0 % 2.27 [ 0.77, 6.69 ]
Greiner 2011 29/38 13/16 5.3 % 0.94 [ 0.70, 1.26 ]
Kim 2009 41/71 53/95 13.2 % 1.04 [ 0.79, 1.35 ]
Kim 2010b 10/28 4/12 1.6 % 1.07 [ 0.42, 2.75 ]
Tatum 2008 16/27 6/12 2.4 % 1.19 [ 0.62, 2.26 ]
Walz 2003 39/42 44/53 11.3 % 1.12 [ 0.96, 1.30 ]
Weinand 1992 52/82 5/7 2.7 % 0.89 [ 0.54, 1.46 ]
Subtotal (95% CI) 321 200 37.6 % 1.08 [ 0.94, 1.24 ]
Total events: 217 (Unilateral spikes), 127 (Bilateral Spikes)
Heterogeneity: Chi2 = 3.68, df = 6 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 1.12 (P = 0.26)
2 Engel Class Scale
Dalmagro 2005 15/23 13/19 4.1 % 0.95 [ 0.62, 1.46 ]
Erickson 2005 45/60 6/13 2.9 % 1.63 [ 0.89, 2.98 ]
Jayakar 2008 45/75 7/26 3.0 % 2.23 [ 1.15, 4.31 ]
Lee 2008 10/16 27/50 3.8 % 1.16 [ 0.73, 1.83 ]
Madhavan 2007 24/35 11/31 3.4 % 1.93 [ 1.14, 3.27 ]
Remi 2011 67/78 71/76 20.9 % 0.92 [ 0.83, 1.02 ]
Subtotal (95% CI) 287 215 38.2 % 1.19 [ 1.04, 1.36 ]
Total events: 206 (Unilateral spikes), 135 (Bilateral Spikes)
Heterogeneity: Chi2 = 31.24, df = 5 (P<0.00001); I2 =84%
Test for overall effect: Z = 2.60 (P = 0.0094)
3 ’Other’ scale
Boshuisen 2010 16/19 17/24 4.4 % 1.19 [ 0.86, 1.64 ]
Goldstein 1996 9/21 6/12 2.2 % 0.86 [ 0.40, 1.82 ]
Holmes 2000 20/26 34/100 4.1 % 2.26 [ 1.60, 3.19 ]
Lee 2006 23/29 14/22 4.6 % 1.25 [ 0.86, 1.80 ]
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Study or subgroup Unilateral spikes Bilateral Spikes Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Rossi 1994 13/29 73/109 8.9 % 0.67 [ 0.44, 1.02 ]
Subtotal (95% CI) 124 267 24.2 % 1.16 [ 0.97, 1.39 ]
Total events: 81 (Unilateral spikes), 144 (Bilateral Spikes)
Heterogeneity: Chi2 = 21.67, df = 4 (P = 0.00023); I2 =82%
Test for overall effect: Z = 1.59 (P = 0.11)
Total (95% CI) 732 682 100.0 % 1.14 [ 1.05, 1.24 ]
Total events: 504 (Unilateral spikes), 406 (Bilateral Spikes)
Heterogeneity: Chi2 = 52.27, df = 17 (P = 0.00002); I2 =67%
Test for overall effect: Z = 3.10 (P = 0.0020)
Test for subgroup differences: Chi2 = 1.08, df = 2 (P = 0.58), I2 =0.0%
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Analysis 4.12. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 12 Good outcome by extent of resection.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 12 Good outcome by extent of resection
Study or subgroup Complete Less Complete Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 1 year seizure free
Awad 1991 17/18 10/29 1.1 % 2.74 [ 1.64, 4.58 ]
Fujiwara 2012 15/26 8/18 1.4 % 1.30 [ 0.70, 2.39 ]
Jennum 1993 36/50 6/14 1.4 % 1.68 [ 0.90, 3.15 ]
Kim 2009 77/111 17/55 3.4 % 2.24 [ 1.48, 3.40 ]
Kim 2010b 12/24 2/16 0.4 % 4.00 [ 1.03, 15.53 ]
Paolicchi 2000 37/49 7/26 1.4 % 2.80 [ 1.46, 5.39 ]
Walz 2003 72/82 9/11 2.4 % 1.07 [ 0.80, 1.43 ]
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Study or subgroup Complete Less Complete Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Widdess-Walsh 2007 15/22 5/19 0.8 % 2.59 [ 1.16, 5.79 ]
Wyler 1995 25/36 13/34 2.0 % 1.82 [ 1.12, 2.93 ]
Subtotal (95% CI) 418 222 14.2 % 2.00 [ 1.66, 2.41 ]
Total events: 306 (Complete), 77 (Less Complete)
Heterogeneity: Chi2 = 24.17, df = 8 (P = 0.002); I2 =67%
Test for overall effect: Z = 7.27 (P < 0.00001)
2 Engel Class Scale
Arruda 1996 25/37 28/37 4.2 % 0.89 [ 0.67, 1.19 ]
Babini 2013 10/10 16/30 1.3 % 1.79 [ 1.26, 2.56 ]
Blount 2004 12/26 0/4 0.1 % 4.63 [ 0.32, 66.24 ]
Brainer-Lima 1996 25/25 4/7 1.0 % 1.74 [ 0.94, 3.22 ]
Chang 2009 32/42 0/2 0.1 % 4.53 [ 0.36, 57.27 ]
Choi 2004a 20/22 7/13 1.3 % 1.69 [ 1.00, 2.84 ]
Cossu 2005 70/115 23/50 4.8 % 1.32 [ 0.95, 1.85 ]
Cossu 2008 57/72 20/41 3.8 % 1.62 [ 1.16, 2.27 ]
Dalmagro 2005 11/18 17/25 2.1 % 0.90 [ 0.57, 1.42 ]
Hamiwka 2005 24/29 1/9 0.2 % 7.45 [ 1.16, 47.62 ]
Jayakar 2008 35/63 9/38 1.7 % 2.35 [ 1.27, 4.33 ]
Kanner 2009 23/25 63/75 4.7 % 1.10 [ 0.94, 1.28 ]
Kloss 2002 21/26 5/30 0.7 % 4.85 [ 2.13, 11.02 ]
Lee 2011 32/32 5/8 1.3 % 1.61 [ 0.96, 2.72 ]
Li 1997 35/41 4/10 1.0 % 2.13 [ 0.99, 4.61 ]
Madhavan 2007 26/39 11/31 1.8 % 1.88 [ 1.11, 3.17 ]
Miserocchi 2013 54/63 4/5 1.1 % 1.07 [ 0.68, 1.68 ]
Morris 1998 20/28 6/8 1.4 % 0.95 [ 0.60, 1.51 ]
O’Brien 2000 4/4 6/11 0.6 % 1.66 [ 0.91, 3.02 ]
Paglioli 2006 58/80 58/81 8.6 % 1.01 [ 0.84, 1.23 ]
Raabe 2012 10/26 47/50 4.8 % 0.41 [ 0.25, 0.67 ]
Sagher 2012 43/51 38/45 6.0 % 1.00 [ 0.84, 1.19 ]
Schramm 2011 62/74 84/125 9.3 % 1.25 [ 1.06, 1.46 ]
Stavrou 2008 14/18 23/35 2.3 % 1.18 [ 0.84, 1.67 ]
Tanriverdi 2010 81/123 79/133 11.3 % 1.11 [ 0.92, 1.34 ]
Terra-Bustamante 2005a 69/79 3/28 0.7 % 8.15 [ 2.79, 23.83 ]
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Study or subgroup Complete Less Complete Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Yeon 2009 21/27 29/33 3.9 % 0.89 [ 0.70, 1.12 ]
Zentner 1996 14/21 3/9 0.6 % 2.00 [ 0.76, 5.29 ]
Subtotal (95% CI) 1216 973 80.6 % 1.29 [ 1.21, 1.39 ]
Total events: 908 (Complete), 593 (Less Complete)
Heterogeneity: Chi2 = 107.28, df = 27 (P<0.00001); I2 =75%
Test for overall effect: Z = 7.17 (P < 0.00001)
3 ’Other’ scale
Lackmayer 2013 5/9 27/36 1.6 % 0.74 [ 0.40, 1.37 ]
Rossi 1994 54/63 13/40 2.4 % 2.64 [ 1.67, 4.17 ]
Sakamoto 2009 4/10 15/26 1.2 % 0.69 [ 0.30, 1.59 ]
Subtotal (95% CI) 82 102 5.2 % 1.59 [ 1.15, 2.20 ]
Total events: 63 (Complete), 55 (Less Complete)
Heterogeneity: Chi2 = 14.50, df = 2 (P = 0.00071); I2 =86%
Test for overall effect: Z = 2.80 (P = 0.0051)
Total (95% CI) 1716 1297 100.0 % 1.41 [ 1.32, 1.50 ]
Total events: 1277 (Complete), 725 (Less Complete)
Heterogeneity: Chi2 = 175.37, df = 39 (P<0.00001); I2 =78%
Test for overall effect: Z = 10.29 (P < 0.00001)
Test for subgroup differences: Chi2 = 19.07, df = 2 (P = 0.00), I2 =90%
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Analysis 4.13. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 13 Good outcome by extent of resection.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 13 Good outcome by extent of resection
Study or subgroup Complete resection
Less
complete
resection Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Site of surgery: extratemporal only
Zentner 1996 14/21 3/9 0.7 % 2.00 [ 0.76, 5.29 ]
Subtotal (95% CI) 21 9 0.7 % 2.00 [ 0.76, 5.29 ]
Total events: 14 (Complete resection), 3 (Less complete resection)
Heterogeneity: not applicable
Test for overall effect: Z = 1.40 (P = 0.16)
2 Site of surgery: temporal only
Arruda 1996 25/37 28/37 4.4 % 0.89 [ 0.67, 1.19 ]
Choi 2004a 20/22 7/13 1.4 % 1.69 [ 1.00, 2.84 ]
Kanner 2009 23/25 63/75 5.0 % 1.10 [ 0.94, 1.28 ]
Lackmayer 2013 5/9 27/36 1.7 % 0.74 [ 0.40, 1.37 ]
Miserocchi 2013 32/32 5/8 1.4 % 1.61 [ 0.96, 2.72 ]
Paglioli 2006 54/63 4/5 1.2 % 1.07 [ 0.68, 1.68 ]
Sagher 2012 58/80 58/81 9.2 % 1.01 [ 0.84, 1.23 ]
Sakamoto 2009 43/51 38/45 6.4 % 1.00 [ 0.84, 1.19 ]
Sarkis 2012 4/10 15/26 1.3 % 0.69 [ 0.30, 1.59 ]
Schramm 2011 32/53 1/10 0.3 % 6.04 [ 0.93, 39.26 ]
Tanriverdi 2010 62/74 84/125 9.9 % 1.25 [ 1.06, 1.46 ]
Walz 2003 81/123 79/133 12.1 % 1.11 [ 0.92, 1.34 ]
Wyler 1995 72/82 9/11 2.5 % 1.07 [ 0.80, 1.43 ]
Subtotal (95% CI) 661 605 56.8 % 1.11 [ 1.03, 1.20 ]
Total events: 511 (Complete resection), 418 (Less complete resection)
Heterogeneity: Chi2 = 17.28, df = 12 (P = 0.14); I2 =31%
Test for overall effect: Z = 2.74 (P = 0.0061)
3 Site of surgery: temporal and extratemporal
Awad 1991 17/18 10/29 1.2 % 2.74 [ 1.64, 4.58 ]
Babini 2013 10/10 16/30 1.4 % 1.79 [ 1.26, 2.56 ]
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(. . . Continued)
Study or subgroup Complete resection
Less
complete
resection Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Blount 2004 12/26 0/4 0.1 % 4.63 [ 0.32, 66.24 ]
Brainer-Lima 1996 25/25 4/7 1.1 % 1.74 [ 0.94, 3.22 ]
Chang 2009 32/42 0/2 0.1 % 4.53 [ 0.36, 57.27 ]
Cossu 2005 70/115 23/50 5.1 % 1.32 [ 0.95, 1.85 ]
Cossu 2008 57/72 20/41 4.0 % 1.62 [ 1.16, 2.27 ]
Ding 2016 13/20 17/23 2.5 % 0.88 [ 0.59, 1.32 ]
Fujiwara 2012 15/26 8/18 1.5 % 1.30 [ 0.70, 2.39 ]
Hamiwka 2005 24/29 1/9 0.2 % 7.45 [ 1.16, 47.62 ]
Jayakar 2008 35/63 9/38 1.8 % 2.35 [ 1.27, 4.33 ]
Jennum 1993 36/50 6/14 1.5 % 1.68 [ 0.90, 3.15 ]
Kim 2009 77/111 17/55 3.6 % 2.24 [ 1.48, 3.40 ]
Kim 2010b 12/24 2/16 0.4 % 4.00 [ 1.03, 15.53 ]
Kloss 2002 21/26 5/30 0.7 % 4.85 [ 2.13, 11.02 ]
Li 1997 35/41 4/10 1.0 % 2.13 [ 0.99, 4.61 ]
Madhavan 2007 26/39 11/31 1.9 % 1.88 [ 1.11, 3.17 ]
Morris 1998 20/28 6/8 1.5 % 0.95 [ 0.60, 1.51 ]
O’Brien 2000 4/4 6/11 0.6 % 1.66 [ 0.91, 3.02 ]
Paolicchi 2000 37/49 7/26 1.5 % 2.80 [ 1.46, 5.39 ]
Rossi 1994 54/63 13/40 2.5 % 2.64 [ 1.67, 4.17 ]
Stavrou 2008 14/18 23/35 2.5 % 1.18 [ 0.84, 1.67 ]
Terra-Bustamante 2005a 69/79 3/28 0.7 % 8.15 [ 2.79, 23.83 ]
Widdess-Walsh 2007 15/22 5/19 0.9 % 2.59 [ 1.16, 5.79 ]
Yeon 2009 21/27 29/33 4.1 % 0.89 [ 0.70, 1.12 ]
Subtotal (95% CI) 1027 607 42.6 % 1.92 [ 1.72, 2.15 ]
Total events: 751 (Complete resection), 245 (Less complete resection)
Heterogeneity: Chi2 = 101.68, df = 24 (P<0.00001); I2 =76%
Test for overall effect: Z = 11.41 (P < 0.00001)
Total (95% CI) 1709 1221 100.0 % 1.46 [ 1.37, 1.56 ]
Total events: 1276 (Complete resection), 666 (Less complete resection)
Heterogeneity: Chi2 = 168.43, df = 38 (P<0.00001); I2 =77%
Test for overall effect: Z = 11.13 (P < 0.00001)
Test for subgroup differences: Chi2 = 62.55, df = 2 (P = 0.00), I2 =97%
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Analysis 4.14. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 14 Good outcome by side of surgical resection.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 14 Good outcome by side of surgical resection
Study or subgroup Left side resection Right side resection Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 > 1 year seizure-free
Jack 1992 22/27 18/23 2.6 % 1.04 [ 0.79, 1.38 ]
Morino 2009 27/31 28/31 4.8 % 0.96 [ 0.81, 1.15 ]
Tatum 2008 12/23 10/16 0.9 % 0.83 [ 0.48, 1.44 ]
Theodore 2012 15/23 11/18 1.1 % 1.07 [ 0.66, 1.71 ]
Walz 2003 54/61 31/37 5.1 % 1.06 [ 0.89, 1.25 ]
Subtotal (95% CI) 165 125 14.4 % 1.01 [ 0.91, 1.13 ]
Total events: 130 (Left side resection), 98 (Right side resection)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.11, df = 4 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.84)
2 Engel Class Scale
Adam 1996 13/15 13/15 2.6 % 1.00 [ 0.76, 1.32 ]
Babini 2013 12/13 14/17 2.8 % 1.12 [ 0.86, 1.47 ]
Battaglia 2006 17/26 15/19 1.8 % 0.83 [ 0.58, 1.19 ]
Brainer-Lima 1996 14/15 15/17 3.7 % 1.06 [ 0.85, 1.32 ]
Cascino 1995 63/92 50/73 4.0 % 1.00 [ 0.81, 1.23 ]
Chabardes 2005 14/20 27/28 2.4 % 0.73 [ 0.54, 0.98 ]
Chang 2009 14/20 18/23 1.8 % 0.89 [ 0.62, 1.28 ]
Choi 2004a 17/22 10/13 1.7 % 1.00 [ 0.69, 1.46 ]
Cossu 2008 37/56 40/57 3.1 % 0.94 [ 0.73, 1.21 ]
Dalmagro 2005 13/21 15/22 1.3 % 0.91 [ 0.58, 1.41 ]
Georgakoulias 2008 20/23 21/26 3.2 % 1.08 [ 0.84, 1.38 ]
Grivas 2006 22/23 25/29 5.0 % 1.11 [ 0.94, 1.31 ]
Hartzfield 2008 12/23 12/27 0.8 % 1.17 [ 0.66, 2.09 ]
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Study or subgroup Left side resection Right side resection Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Janszky 2003a 23/33 20/34 1.8 % 1.18 [ 0.83, 1.70 ]
Jaramillo-Betancur 2009 28/46 32/38 2.8 % 0.72 [ 0.55, 0.95 ]
Kilpatrick 1997 19/27 20/23 2.5 % 0.81 [ 0.60, 1.08 ]
Lee 2008 22/34 16/37 1.2 % 1.50 [ 0.96, 2.33 ]
Liava 2012 11/19 28/33 1.4 % 0.68 [ 0.45, 1.03 ]
Miserocchi 2013 31/34 27/34 4.2 % 1.15 [ 0.94, 1.40 ]
Perego 2009 11/13 18/24 2.1 % 1.13 [ 0.81, 1.56 ]
Prevedello 2000 24/41 29/43 2.0 % 0.87 [ 0.62, 1.21 ]
Schramm 2011 84/110 68/97 5.1 % 1.09 [ 0.92, 1.29 ]
Seymour 2012 68/155 80/128 3.6 % 0.70 [ 0.56, 0.88 ]
Sola 2005 35/74 39/63 2.3 % 0.76 [ 0.56, 1.04 ]
Tanriverdi 2010 75/132 84/124 4.4 % 0.84 [ 0.69, 1.02 ]
Tezer 2008 40/51 50/58 4.8 % 0.91 [ 0.76, 1.09 ]
Zentner 1995 44/68 59/99 3.3 % 1.09 [ 0.85, 1.38 ]
Subtotal (95% CI) 1206 1201 75.6 % 0.96 [ 0.89, 1.02 ]
Total events: 783 (Left side resection), 845 (Right side resection)
Heterogeneity: Tau2 = 0.01; Chi2 = 45.40, df = 26 (P = 0.01); I2 =43%
Test for overall effect: Z = 1.30 (P = 0.19)
3 ’Other’ scale
Engman 2004 16/25 19/29 1.5 % 0.98 [ 0.66, 1.45 ]
Jeong 1999 35/42 43/51 4.7 % 0.99 [ 0.83, 1.18 ]
Lackmayer 2013 14/22 18/23 1.6 % 0.81 [ 0.55, 1.19 ]
Lee 2006 12/20 25/31 1.5 % 0.74 [ 0.50, 1.11 ]
Sakamoto 2009 11/20 8/16 0.7 % 1.10 [ 0.59, 2.07 ]
Subtotal (95% CI) 129 150 10.0 % 0.94 [ 0.82, 1.07 ]
Total events: 88 (Left side resection), 113 (Right side resection)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.51, df = 4 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 0.96 (P = 0.34)
Total (95% CI) 1500 1476 100.0 % 0.96 [ 0.91, 1.01 ]
Total events: 1001 (Left side resection), 1056 (Right side resection)
Heterogeneity: Tau2 = 0.01; Chi2 = 50.15, df = 36 (P = 0.06); I2 =28%
Test for overall effect: Z = 1.46 (P = 0.14)
Test for subgroup differences: Chi2 = 1.02, df = 2 (P = 0.60), I2 =0.0%
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Analysis 4.15. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 15 Good outcome by side of surgical resection.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 15 Good outcome by side of surgical resection
Study or subgroup Left side Right side Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Site of surgery: extratemporal only
Lee 2008 22/34 16/37 1.5 % 1.50 [ 0.96, 2.33 ]
Liava 2012 11/19 28/33 2.0 % 0.68 [ 0.45, 1.03 ]
Subtotal (95% CI) 53 70 3.5 % 1.03 [ 0.76, 1.39 ]
Total events: 33 (Left side), 44 (Right side)
Heterogeneity: Chi2 = 6.59, df = 1 (P = 0.01); I2 =85%
Test for overall effect: Z = 0.20 (P = 0.84)
2 Site of surgery: temporal only
Adam 1996 13/15 13/15 1.3 % 1.00 [ 0.76, 1.32 ]
Battaglia 2006 17/26 15/19 1.7 % 0.83 [ 0.58, 1.19 ]
Cascino 1995 63/92 50/73 5.4 % 1.00 [ 0.81, 1.23 ]
Chabardes 2005 14/20 27/28 2.2 % 0.73 [ 0.54, 0.98 ]
Choi 2004a 17/22 10/13 1.2 % 1.00 [ 0.69, 1.46 ]
Engman 2004 16/25 19/29 1.7 % 0.98 [ 0.66, 1.45 ]
Georgakoulias 2008 20/23 21/26 1.9 % 1.08 [ 0.84, 1.38 ]
Grivas 2006 22/23 25/29 2.1 % 1.11 [ 0.94, 1.31 ]
Hartzfield 2008 12/23 12/27 1.1 % 1.17 [ 0.66, 2.09 ]
Jack 1992 22/27 18/23 1.9 % 1.04 [ 0.79, 1.38 ]
Janszky 2003a 28/46 32/38 3.4 % 0.72 [ 0.55, 0.95 ]
Jaramillo-Betancur 2009 23/33 20/34 1.9 % 1.18 [ 0.83, 1.70 ]
Jeong 1999 35/42 43/51 3.8 % 0.99 [ 0.83, 1.18 ]
Kilpatrick 1997 19/27 20/23 2.1 % 0.81 [ 0.60, 1.08 ]
Lackmayer 2013 14/22 18/23 1.7 % 0.81 [ 0.55, 1.19 ]
Lee 2006 12/20 25/31 1.9 % 0.74 [ 0.50, 1.11 ]
Miserocchi 2013 31/34 27/34 2.6 % 1.15 [ 0.94, 1.40 ]
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Study or subgroup Left side Right side Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Morino 2009 27/31 28/31 2.7 % 0.96 [ 0.81, 1.15 ]
Perego 2009 11/13 18/24 1.2 % 1.13 [ 0.81, 1.56 ]
Prevedello 2000 24/41 29/43 2.7 % 0.87 [ 0.62, 1.21 ]
Sakamoto 2009 11/20 8/16 0.9 % 1.10 [ 0.59, 2.07 ]
Schramm 2011 84/110 68/97 7.0 % 1.09 [ 0.92, 1.29 ]
Seymour 2012 68/155 80/128 8.5 % 0.70 [ 0.56, 0.88 ]
Sola 2005 35/74 39/63 4.1 % 0.76 [ 0.56, 1.04 ]
Tanriverdi 2010 75/132 84/124 8.4 % 0.84 [ 0.69, 1.02 ]
Tatum 2008 12/23 10/16 1.1 % 0.83 [ 0.48, 1.44 ]
Tezer 2008 40/51 50/58 4.5 % 0.91 [ 0.76, 1.09 ]
Theodore 2012 15/23 11/18 1.2 % 1.07 [ 0.66, 1.71 ]
Walz 2003 54/61 31/37 3.7 % 1.06 [ 0.89, 1.25 ]
Zentner 1995 44/68 59/99 4.7 % 1.09 [ 0.85, 1.38 ]
Subtotal (95% CI) 1322 1270 88.5 % 0.93 [ 0.89, 0.98 ]
Total events: 878 (Left side), 910 (Right side)
Heterogeneity: Chi2 = 41.49, df = 29 (P = 0.06); I2 =30%
Test for overall effect: Z = 2.76 (P = 0.0058)
3 Site of surgery: temporal and extratemporal
Babini 2013 12/13 14/17 1.2 % 1.12 [ 0.86, 1.47 ]
Brainer-Lima 1996 14/15 15/17 1.4 % 1.06 [ 0.85, 1.32 ]
Chang 2009 14/20 18/23 1.6 % 0.89 [ 0.62, 1.28 ]
Cossu 2008 37/56 40/57 3.8 % 0.94 [ 0.73, 1.21 ]
Subtotal (95% CI) 104 114 8.0 % 0.98 [ 0.84, 1.14 ]
Total events: 77 (Left side), 87 (Right side)
Heterogeneity: Chi2 = 1.79, df = 3 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.29 (P = 0.77)
Total (95% CI) 1479 1454 100.0 % 0.94 [ 0.90, 0.98 ]
Total events: 988 (Left side), 1041 (Right side)
Heterogeneity: Chi2 = 50.07, df = 35 (P = 0.05); I2 =30%
Test for overall effect: Z = 2.62 (P = 0.0089)
Test for subgroup differences: Chi2 = 0.76, df = 2 (P = 0.68), I2 =0.0%
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Analysis 4.16. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 16 Good outcome by presence of postoperative discharges.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 16 Good outcome by presence of postoperative discharges
Study or subgroup Discharges present Discharges absent Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 > 1 year seizure-free
Jennum 1993 31/38 11/26 15.1 % 1.93 [ 1.20, 3.10 ]
Widdess-Walsh 2007 7/25 12/20 9.9 % 0.47 [ 0.23, 0.96 ]
Subtotal (95% CI) 63 46 25.0 % 0.97 [ 0.24, 3.93 ]
Total events: 38 (Discharges present), 23 (Discharges absent)
Heterogeneity: Tau2 = 0.92; Chi2 = 10.42, df = 1 (P = 0.001); I2 =90%
Test for overall effect: Z = 0.04 (P = 0.97)
2 Engel Class Scale
Janszky 2003b 13/22 92/116 18.1 % 0.75 [ 0.52, 1.07 ]
Miserocchi 2013 13/20 45/48 18.9 % 0.69 [ 0.50, 0.96 ]
Radhakrishnan 1998 41/58 93/117 22.5 % 0.89 [ 0.74, 1.07 ]
Wray 2012 27/37 9/15 15.5 % 1.22 [ 0.77, 1.92 ]
Subtotal (95% CI) 137 296 75.0 % 0.85 [ 0.70, 1.03 ]
Total events: 94 (Discharges present), 239 (Discharges absent)
Heterogeneity: Tau2 = 0.01; Chi2 = 4.56, df = 3 (P = 0.21); I2 =34%
Test for overall effect: Z = 1.70 (P = 0.089)
Total (95% CI) 200 342 100.0 % 0.91 [ 0.68, 1.22 ]
Total events: 132 (Discharges present), 262 (Discharges absent)
Heterogeneity: Tau2 = 0.09; Chi2 = 18.30, df = 5 (P = 0.003); I2 =73%
Test for overall effect: Z = 0.64 (P = 0.52)
Test for subgroup differences: Chi2 = 0.04, df = 1 (P = 0.84), I2 =0.0%
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Analysis 4.17. Comparison 4 Prognostic factors of a good outcome of surgery (randomised and non-
randomised evidence), Outcome 17 Good outcome by presence of postoperative discharges.
Review: Surgery for epilepsy
Comparison: 4 Prognostic factors of a good outcome of surgery (randomised and non-randomised evidence)
Outcome: 17 Good outcome by presence of postoperative discharges
Study or subgroup Discharges present Discharges absent Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Site of surgery: temporal only
Janszky 2003b 13/22 92/116 18.7 % 0.75 [ 0.52, 1.07 ]
Miserocchi 2013 41/58 93/117 39.4 % 0.89 [ 0.74, 1.07 ]
Radhakrishnan 1998 13/20 45/48 16.9 % 0.69 [ 0.50, 0.96 ]
Subtotal (95% CI) 100 281 75.0 % 0.81 [ 0.70, 0.94 ]
Total events: 67 (Discharges present), 230 (Discharges absent)
Heterogeneity: Chi2 = 2.00, df = 2 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 2.73 (P = 0.0063)
2 Site of surgery: temporal and extratemporal
Jennum 1993 27/37 9/15 8.2 % 1.22 [ 0.77, 1.92 ]
Widdess-Walsh 2007 7/25 12/20 8.5 % 0.47 [ 0.23, 0.96 ]
Wray 2012 31/38 11/26 8.3 % 1.93 [ 1.20, 3.10 ]
Subtotal (95% CI) 100 61 25.0 % 1.20 [ 0.89, 1.61 ]
Total events: 65 (Discharges present), 32 (Discharges absent)
Heterogeneity: Chi2 = 10.41, df = 2 (P = 0.01); I2 =81%
Test for overall effect: Z = 1.21 (P = 0.23)
Total (95% CI) 200 342 100.0 % 0.91 [ 0.79, 1.04 ]
Total events: 132 (Discharges present), 262 (Discharges absent)
Heterogeneity: Chi2 = 18.30, df = 5 (P = 0.003); I2 =73%
Test for overall effect: Z = 1.41 (P = 0.16)
Test for subgroup differences: Chi2 = 5.42, df = 1 (P = 0.02), I2 =82%
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Table 1. Study characteristics and participant demographics for 182 included studies
Author
(year)
Outcome
scale used
Study de-
sign
Partici-
pants
having
surgery
Good out-
come
Males Site of
surgery
Age
at surgery
(min to
max), years
a
Duration
of epilepsy
(min to
max), years
a
Follow-
up (min to
max),
monthsa
Aaberg
2012
Engel
Class Scale
Retrospec-
tive
54 30 32 Tempo-
ral and ex-
tratemporal
0.5 to 16 NA > 24
Adam
1996
Engel
Class Scale
Prospec-
tive
30 26 11 Temporal
only
18 to 44 NA 12 to 44
Adelson
1992
> 1 year
seizure-
free
Retrospec-
tive
33 23 19 Tempo-
ral and ex-
tratemporal
0 to 17 NA 18 to 72
Alfstad
2011
Engel
Class Scale
Retrospec-
tive
48 25 26 Tempo-
ral and ex-
tratemporal
24.6 (NA) 14.5 (NA) > 24
Alonso-
Vanegas
2018
Engel
Class Scale
Prospec-
tive
43 38 15 Temporal 18 to 56 NA 12 to 60
Althausen
2013
> 1 year
seizure-
free
Retrospec-
tive
61 45 29 Extratem-
poral only
14.5 (12.0) 11.9 (10.8) 13 to 233
Arruda
1996
Engel
Class Scale
Retrospec-
tive
74 53 34 Temporal
only
32.1 (10.5) NA 33.4 (13.1)
Awad
1991
> 1 year
seizure-
free
Not stated 47 27 38 Tempo-
ral and ex-
tratemporal
2 to 45 0 to 29 20 to 114
Babini
2013
Engel
Class Scale
Retrospec-
tive
30 26 20 Tempo-
ral and ex-
tratemporal
3 to 18 0 to 16 12 to 204
Barbaro
2018
’Other’
scale
Prospec-
tive
58 37 28 Temporal 40.2 (13.4) 28.6 (14.5) 12 to 36
Battaglia
2006
Engel
Class Scale
Not stated 45 32 29 Temporal
only
0 to 7 0 to 5 24 to 179
Baumann
2007
Engel
Class Scale
Retrospec-
tive
168 118 90 Tempo-
ral and ex-
1 to 71 0 to 41 12 to 39
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
tratemporal
Bautista
2003
> 1 year
seizure-
free
Retrospec-
tive
43 28 29 Tempo-
ral and ex-
tratemporal
29.6 (10.9) 2 to 48 > 12
Bell 2009 Engel
Class Scale
Retrospec-
tive
40 24 17 Temporal
only
13 to 62 1 to 36 18 to 126
Benifla
2006
Engel
Class Scale
Retrospec-
tive
106 78 65 Temporal
only
13.5 (NA) 5.9 (NA) 24 to 162
Berkovic
1995
Engel
Class Scale
Prospec-
tive
135 74 NA Temporal
only
11 to 58 NA 18 to 81
Blount
2004
Engel
Class Scale
Retrospec-
tive
30 12 13 Tempo-
ral and ex-
tratemporal
11.7 (4.4) NA > 30
Blume
2004
Engel
Class Scale
Retrospec-
tive
70 26 41 Tempo-
ral and ex-
tratemporal
6 to 65 1 to 41 24 to 144
Boesebeck
2007
’Other’
scale
Retrospec-
tive
81 33 51 Extratem-
poral only
16 to 53 2 to 43 > 24
Boshuisen
2010
’Other’
scale
Retrospec-
tive
43 33 18 Tempo-
ral and ex-
tratemporal
0 to 14 0 to 12 12 to 188
Brainer-
Lima 1996
Engel
Class Scale
Retrospec-
tive
32 29 24 Tempo-
ral and ex-
tratemporal
6 to 57 2 to 30 4 to 68
Britton
1994
Engel
Class Scale
Retrospec-
tive
51 34 NA Tempo-
ral and ex-
tratemporal
6 to 60 NA 24 to 96
Caraballo
2011
Engel
Class Scale
Retrospec-
tive
45 33 27 Not stated 0 to 18 NA 12 to 192
Cascino
1995
Engel
Class Scale
Retrospec-
tive
165 113 NA Temporal
only
32.1 (10.5) NA > 12
Chabardes
2005
Engel
Class Scale
Retrospec-
tive
54 47 24 Temporal
only
NA 2.5 to 41 48 to 100
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Chang
2009
Engel
Class Scale
Retrospec-
tive
57 45 NA Tempo-
ral and ex-
tratemporal
NA NA > 12
Chee 1993 > 1 year
seizure-
free
Retrospec-
tive
38 28 25 Temporal
only
18 to 53 3 to 36 > 12
Chkhenkeli
2007
Engel
Class Scale
Retrospec-
tive
67 12 NA Temporal
only
NA NA >24
Choi
2004a
Engel
Class Scale
Retrospec-
tive
35 27 19 Temporal
only
16 to 61 4 to 22 16 to 105
Chung
2005
Engel
Class Scale
Retrospec-
tive
128 58 85 Tempo-
ral and ex-
tratemporal
NA NA 26.9 (12)
Cossu
2005
Engel
Class Scale
Retrospec-
tive
165 93 NA Tempo-
ral and ex-
tratemporal
NA NA > 12
Cossu
2008
Engel
Class Scale
Retrospec-
tive
113 77 67 Tempo-
ral and ex-
tratemporal
1 to 15 0 to 14 24 to 115
Costello
2009
Engel
Class Scale
Retrospec-
tive
42 32 21 Tempo-
ral and ex-
tratemporal
45 to 66 0.5 to 55.5 13 to 173
Cukiert
2002
Engel
Class Scale
Prospec-
tive
100 89 43 Temporal
only
28 (9) NA 18 to 48
Dagar
2011
> 1 year
seizure-
free
Retrospec-
tive
112 89 67 Tempo-
ral and ex-
tratemporal
0 to 18 0 to 15 > 12
Dalmagro
2005
Engel
Class Scale
Retrospec-
tive
43 28 23 Not stated 22.4 (NA) 14.7 (11.5) > 12
de Tisi
2011
’Other’
scale
Retrospec-
tive
615 245 287 Tempo-
ral and ex-
tratemporal
16 to 63 20.7
(median)
12 to 228
Delbeke
1996
Engel
Class Scale
Retrospec-
tive
38 23 15 Temporal
only
15 to 59 NA 18 to 58
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Dellabadia
2002
Engel
Class Scale
Retrospec-
tive
35 20 NA Tempo-
ral and ex-
tratemporal
NA NA 22 to 48
Devlin
2003
Engel
Class Scale
Retrospec-
tive
33 17 21 Tempo-
ral and ex-
tratemporal
0 to 17 7.4
(median)
12 to 96
Ding 2016 Engel
Class Scale
Prospec-
tive
43 30 24 Tempo-
ral and Ex-
tratemporal
4 to 18 NA 12 to 60
Donadio
2011
Engel
Class Scale
Retrospec-
tive
84 60 45 Tempo-
ral and ex-
tratemporal
2 to 59 1 to 50 12 to 126
Dorward
2011
Engel
Class Scale
Retrospec-
tive
33 18 18 Extratem-
poral only
3 to 19 0.5 to 16 49.4 (NA)
Duchowny
1998
> 1 year
seizure-
free
Retrospec-
tive
31 16 16 Tempo-
ral and ex-
tratemporal
0 to 3 NA > 12
Dunkley
2011
Engel
Class Scale
Retrospec-
tive
42 20 24 Tempo-
ral and ex-
tratemporal
0 to 3 0 to 3 27 to 158
Dunlea
2010
Engel
Class Scale
Retrospec-
tive
199 119 95 Tempo-
ral and ex-
tratemporal
1 to 61 0.5 to 43 12 to 288
Dwivedi
2017
’Other’
scale
Prospec-
tive
57 44 44 Tempo-
ral and Ex-
tratemporal
0.8 to 17.0 0.4-16.3 > 12
Elsharkawy
2008a
Engel
Class Scale
Retrospec-
tive
218 121 129 Extratem-
poral only
16 to 69 1 to 65 12 to 60
Elsharkawy
2009a
Engel
Class Scale
Retrospec-
tive
430 311 220 Tempo-
ral and ex-
tratemporal
16 to 61 1 to 57 > 24
Elsharkawy
2011a
Engel
Class Scale
Retrospec-
tive
47 38 33 Temporal
only
32 (12) 11.8 (8.8) 6 to 72
Engman
2004
’Other’
scale
Retrospec-
tive
54 35 NA Temporal
only
34 (median) NA 33.6
(median)
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Erba 1992 > 1 year
seizure-
free
Retrospec-
tive
46 37 28 Temporal
only
4 to 34 1 to 31 38 to 216
Erickson
2005
Engel
Class Scale
Retrospec-
tive
71 46 27 Temporal
only
5 to 64 0 to 46 > 12
Fauser
2004
Engel
Class Scale
Retrospec-
tive
59 35 34 Temporal
only
2 to 66 NA 6 to 48
Fujiwara
2012
> 1 year
seizure-
free
Retrospec-
tive
44 23 0 Tempo-
ral and ex-
tratemporal
NA NA 12 to 26
Garcia
1991
> 1 year
seizure-
free
Retrospec-
tive
55 35 NA Temporal
only
9 to 47 NA 12 to 48
Garcia
1994
> 1 year
seizure-
free
Prospec-
tive
51 36 NA Temporal
only
NA NA 12 to 48
Gelinas
2011
Engel
Class Scale
Retrospec-
tive
67 52 39 Tempo-
ral and ex-
tratemporal
0 to 16 2.7 (NA) 75.6 (NA)
Georgak-
oulias
2008
Engel
Class Scale
Retrospec-
tive
50 42 25 Temporal
only
14 to 62 NA 60 to 120
Gilliam
1997a
> 1 year
seizure-
free
Retrospec-
tive
78 53 18 Tempo-
ral and ex-
tratemporal
1 to 12 1 to 11 7 to 72
Gilliam
1997b
> 1 year
seizure-
free
Retrospec-
tive
33 22 40 Temporal
only
9 to 50 NA > 12
Goldstein
1996
’Other’
scale
Retrospec-
tive
33 15 17 Temporal
only
0 to 15 0 to 12 24 to 120
Greiner
2011
> 1 year
seizure-
free
Retrospec-
tive
54 42 NA Tempo-
ral and ex-
tratemporal
0.5 to 40 7.6
(median)
> 12
Grivas
2006
Engel
Class Scale
Retrospec-
tive
52 37 22 Temporal
only
50 to 71 1 to 62 12 to 84
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Gyimesi
2007
’Other’
scale
Retrospec-
tive
100 74 NA Temporal
only
NA NA > 24
Hader
2004
Engel
Class Scale
Retrospec-
tive
39 21 16 Tempo-
ral and ex-
tratemporal
0 to 18.5 0.19 > 18
Hajek
2009
Engel
Class Scale
Retrospec-
tive
35 25 15 Temporal
only
10 to 58 5 to 47 24 to 91
Hallbook
2010
> 1 year
seizure-
free
Retrospec-
tive
110 88 71 Tempo-
ral and ex-
tratemporal
0 to 18 NA 12 to 84
Hamiwka
2005
Engel
Class Scale
Retrospec-
tive
38 17 NA Tempo-
ral and ex-
tratemporal
0.5 to 18 NA > 24
Hartley
2002
Engel
Class Scale
Retrospec-
tive
35 20 11 Tempo-
ral and ex-
tratemporal
1 to 18 1 to 17 36 to 72
Hartzfield
2008
Engel
Class Scale
Retrospec-
tive
56 24 35 Temporal
only
8 to 70 4.5 to 41 6 to 108
Hemb
2010
> 1 year
seizure-
free
Retrospec-
tive
325 223 229 Tempo-
ral and ex-
tratemporal
7.7(6.3) 4.9 (4.6) > 24
Holmes
1997
> 1 year
seizure-
free
Retrospec-
tive
44 22 17 Temporal
only
14 to 55 3 to 46 12 to 48
Holmes
2000
’Other’
scale
Retrospec-
tive
126 54 71 Tempo-
ral and ex-
tratemporal
6 to 69 1 to 46 24 to 72
Jack 1992 > 1 year
seizure-
free
Retrospec-
tive
50 34 27 Temporal
only
14 to 51 2 to 37 12 to 34
Janszky
2003a
Engel
Class Scale
Retrospec-
tive
84 60 NA Temporal
only
NA NA > 24
Janszky
2003b
Engel
Class Scale
Retrospec-
tive
147 123 NA Temporal
only
NA NA > 6
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Jaramillo-
Betancur
2009
Engel
Class Scale
Retrospec-
tive
67 43 52 Temporal
only
27 (11) 20 (10) > 24
Jayakar
2008
Engel
Class Scale
Retrospec-
tive
101 44 60 Tempo-
ral and ex-
tratemporal
1.5 to 21 NA > 24
Jayalak-
shmi
2011
Engel
Class Scale
Retrospec-
tive
78 50 44 Tempo-
ral and ex-
tratemporal
2 to 16 1 to 16 12 to 58
Jeha 2006 > 1 year
seizure-
free
Retrospec-
tive
371 231 NA Temporal
only
NA NA > 12
Jehi 2012 > 1 year
seizure-
free
Retrospec-
tive
312 165 149 Temporal
only
2.5 to 74 1 to 64 42 (20.4)
Jennum
1993
> 1 year
seizure-
free
Retrospec-
tive
64 42 45 Tempo-
ral and ex-
tratemporal
8 to 52 1 to 38 > 12
Jeong
1999
’Other’
scale
Not stated 93 78 54 Temporal
only
9 to 51 NA 18 to 33
Kan 2008 Engel
Class Scale
Retrospec-
tive
58 43 34 Tempo-
ral and ex-
tratemporal
2 to 21 0.5 to 15 12 to 96
Kang 2009 Engel
Class Scale
Retrospec-
tive
244 194 108 Temporal
only
18 to 68 NA 12 to 204
Kanner
2009
Engel
Class Scale
Retrospec-
tive
100 86 60 Temporal
only
31.2 (10.7) 12.7 (NA) 24 to 168
Kilpatrick
1997
Engel
Class Scale
Prospec-
tive
50 39 28 Temporal
only
16 to 57 NA 12 to 38
Kim 2009 > 1 year
seizure-
free
Retrospec-
tive
166 94 102 Tempo-
ral and ex-
tratemporal
3 to 51 0.5 to 37 95.3 (NA)
Kim2010a Engel
Class Scale
Retrospec-
tive
177 75 121 Tempo-
ral and ex-
tratemporal
11 to 51 1 to 50 24 to 180
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Kim
2010b
> 1 year
seizure-
free
Retrospec-
tive
40 14 26 Tempo-
ral and ex-
tratemporal
4 to 51 1 to 48 > 24
Kloss 2002 Engel
Class Scale
Combina-
tion
68 34 30 Tempo-
ral and ex-
tratemporal
0 to 16 NA 12 to 108
Knowlton
2008
Engel
Class Scale
Prospec-
tive
62 37 33 Tempo-
ral and ex-
tratemporal
1 to 60 NA > 12
Kral 2007 ’Other’
scale
Retrospec-
tive
40 27 23 Tempo-
ral and ex-
tratemporal
5 to 47 1 to 45 97 (54)
Krsek
2013
Engel
Class Scale
Retrospec-
tive
106 64 49 Not stated 0 to 30 NA > 24
Kuzniecky
1993
’Other’
scale
Prospec-
tive
34 23 14 Temporal
only
7 to 38 > 2 12 to 30
Kwan
2010
Engel
Class Scale
Retrospec-
tive
41 27 22 Extratem-
poral only
0 to 17.5 0 to 16 72 (NA)
Lackmayer
2013
’Other’
scale
Retrospec-
tive
45 32 21 Temporal
only
40.8 (10.2) 13.0 (10.1) > 12
Lee 2006 ’Other’
scale
Retrospec-
tive
51 37 29 Temporal
only
16 to 50 4 to 38 > 24
Lee 2008 Engel
Class Scale
Not stated 71 38 44 Extratem-
poral only
12 to 57 3 to 34 > 24
Lee 2010 Engel
Class Scale
Retrospec-
tive
52 36 31 Temporal
only
9 to 54 1 to 33 14 to 42
Lee 2011 Engel
Class Scale
Retrospec-
tive
40 37 23 Temporal
only
1 to 15 0 to 14 11 to 151
Lei 2008 > 1 year
seizure-
free
Retrospec-
tive
196 180 210 Tempo-
ral and ex-
tratemporal
17 to 66 NA > 48
Li 1997 Engel
Class Scale
Retrospec-
tive
51 39 23 Tempo-
ral and ex-
tratemporal
8 to 73 NA 12 to 157
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Li 1999 Engel
Class Scale
Not stated 38 16 23 Tempo-
ral and ex-
tratemporal
14 to 63 NA 12 to 180
Liang
2010
Engel
Class Scale
Prospec-
tive
60 40 34 Tempo-
ral and ex-
tratemporal
16.7 (NA) NA > 24
Liang
2012
Engel
Class Scale
Retrospec-
tive
206 173 94 Tempo-
ral and ex-
tratemporal
6 to 14 2 to 14 > 12
Liava 2012 Engel
Class Scale
Retrospec-
tive
52 39 NA Extratem-
poral only
1 to 26 7.9 (NA) 18 to 162
Lopez-
Gonzalez
2012
> 1 year
seizure-
free
Retrospec-
tive
86 65 63 Temporal
only
1 to 18 1 to 17 > 12
Lorenzo
1995
Engel
Class Scale
Retrospec-
tive
48 17 NA Extratem-
poral only
NA NA > 12
Madhavan
2007
Engel
Class Scale
Retrospec-
tive
70 37 39 Tempo-
ral and ex-
tratemporal
9.9 (10.2) NA
Mani 2006 Engel
Class Scale
Retrospec-
tive
122 86 72 Tempo-
ral and ex-
tratemporal
8.2 (5.5) 5.2 (4.6) > 6
Mathern
1999
’Other’
scale
Retrospec-
tive
198 78 111 Tempo-
ral and ex-
tratemporal
0 to 37 0 to 31 6 to 120
McIntosh
2012
’Other’
scale
Retrospec-
tive
81 11 38 Extratem-
poral only
4 to 60 16 (median) 12 to 212
Mihara
2004
Engel
Class Scale
Retrospec-
tive
357 269 NA Tempo-
ral and ex-
tratemporal
2 to 55 1 to 40 24 to 196
Miserocchi
2013
Engel
Class Scale
Retrospec-
tive
68 58 43 Temporal
only
1 to 15 0.5 to 14 > 12
Morino
2009
> 1 year
seizure-
free
Retrospec-
tive
62 55 24 Temporal
only
34.4 (NA) NA > 12
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Morris
1998
Engel
Class Scale
Retrospec-
tive
36 26 22 Tempo-
ral and ex-
tratemporal
2 to 56 1 to 29 6 to 41
O’Brien
1996
> 1 year
seizure-
free
Retrospec-
tive
46 36 24 Temporal
only
16 to 58 2 to 43 12 to 33
O’Brien
2000
Engel
Class Scale
Retrospec-
tive
36 14 23 Tempo-
ral and ex-
tratemporal
1 to 56 NA 12 to 40
Oertel
2005
> 1 year
seizure-
free
Prospec-
tive
35 20 11 Temporal
only
35.1 (NA) NA 12 to 42
Paglioli
2006
Engel
Class Scale
Prospec-
tive
160 143 88 Temporal
only
8 to 62 3 to 60 24 to 132
Paolicchi
2000
> 1 year
seizure-
free
Retrospec-
tive
75 44 40 Tempo-
ral and ex-
tratemporal
0 to 12 NA 12 to 120
Park 2002 Engel
Class Scale
Retrospec-
tive
148 108 76 Tempo-
ral and ex-
tratemporal
0.5 to 18 0 to 19 0 to 166
Park 2006 Engel
Class Scale
Retrospec-
tive
30 20 19 Tempo-
ral and ex-
tratemporal
0 to 13 1 to 18 12 to 64
Perego
2009
Engel
Class Scale
Retrospec-
tive
37 29 19 Temporal
only
33 (10) 19 (NA) > 36
Perry 2010 Engel
Class Scale
Retrospec-
tive
83 34 50 Tempo-
ral and ex-
tratemporal
NA 0 to 17 > 24
Phi 2009 Engel
Class Scale
Retrospec-
tive
87 80 49 Temporal
only
1 to 62 0 to 48 12 to 128
Phi 2010 ’Other’
scale
Retrospec-
tive
41 20 20 Tempo-
ral and ex-
tratemporal
1 to 17 1 to 11 24 to 153
Pinheiro-
Martins
2012
Engel
Class Scale
Retrospec-
tive
70 33 27 Extratem-
poral only
1 to 52 1 to 36 59.1 (30.5)
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Prevedello
2000
Engel
Class Scale
Retrospec-
tive
84 53 48 Temporal
only
19 to 43 10 to 33 15 to 44
Raabe
2012
Engel
Class Scale
Retrospec-
tive
76 57 55 Not stated 6 to 67 0 to 53 24 to 200
Radhakr-
ishnan
1998
Engel
Class Scale
Combina-
tion
175 134 77 Temporal
only
7 to 86 0 to 81 24 to 68
Rausch
2003
> 1 year
seizure-
free
Not stated 42 21 21 Temporal
only
NA NA 109 to 228
Remi 2011 Engel
Class Scale
Retrospec-
tive
154 138 NA Tempo-
ral and ex-
tratemporal
NA NA 22 to 228
Roberti
2007
Engel
Class Scale
Retrospec-
tive
42 27 17 Temporal
only
10 to 52 3 to 51 44 to 121
Rossi 1994 ’Other’
scale
Retrospec-
tive
138 86 100 Tempo-
ral and ex-
tratemporal
1 to 46 > 3 > 36
Russo
2003
Engel
Class Scale
Retrospec-
tive
101 64 67 Tempo-
ral and ex-
tratemporal
0 to 53 0 to 46 > 12
Sagher
2012
Engel
Class Scale
Retrospec-
tive
96 85 46 Temporal
only
17 to 59 1 to 57 > 12
Sakamoto
2009
’Other’
scale
Retrospec-
tive
36 19 16 Temporal
only
12 to 58 4 to 49 24 to 63
Salanova
1994
Engel
Class Scale
Retrospec-
tive
89 53 46 Temporal
only
8 to 53 1 to 43 12 to 96
Sarkis
2012
Engel
Class Scale
Retrospec-
tive
62 38 34 Temporal
only
1 to 56 NA 6 to 170
Schramm
2011
Engel
Class Scale
Prospec-
tive
207 152 100 Temporal
only
39.7 (13.2) 22 (median) > 12
Seymour
2012
Engel
Class Scale
Retrospec-
tive
291 153 159 Temporal
only
3 to 59 NA 28 to 144
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Sinclair
2003
Engel
Class Scale
Retrospec-
tive
77 57 39 Tempo-
ral and ex-
tratemporal
0 to 16 0 to 15 12 to 144
Sindou
2006
Engel
Class Scale
Not stated 100 85 42 Temporal
only
18 to 58 NA 12 to 120
Sola 2005 Engel
Class Scale
Retrospec-
tive
137 74 63 Temporal
only
12 to 69 1 to 44 24 to 138
Spencer
2005
> 1 year
seizure-
free
Prospec-
tive
355 264 174 Tempo-
ral and ex-
tratemporal
NA NA > 12
Sperling
1992
Engel
Class Scale
Prospec-
tive
51 41 31 Temporal
only
17 to 59 NA 21 to 64
Stavrou
2008
Engel
Class Scale
Retrospec-
tive
53 45 31 Tempo-
ral and ex-
tratemporal
NA 3.4 (0.8) > 24
Suppiah
2009
Engel
Class Scale
Retrospec-
tive
174 94 75 Temporal
only
10 to 61 NA 57 (32)
Swartz
1992
> 1 year
seizure-
free
Prospec-
tive
34 27 NA Temporal
only
29 (NA) NA 20 to 71
Tanriverdi
2010
Engel
Class Scale
Retrospec-
tive
256 160 123 Temporal
only
30.3 (10.5) 20.6 (10.7) > 12
Tatum
2008
> 1 year
seizure-
free
Retrospec-
tive
39 22 15 Temporal
only
33.8 (10.9) 14.5 (NA) 30.8
Terra-
Busta-
mante
2005a
Engel
Class Scale
Prospec-
tive
107 62 55 Tempo-
ral and ex-
tratemporal
10.2 (5.4) 6.4 (4.8) 12 to 108
Terra-
Busta-
mante
2005b
Engel
Class Scale
Prospec-
tive
35 27 11 Temporal
only
1 to 18 0 to 15 12 to 84
Tezer 2008 Engel
Class Scale
Retrospec-
tive
109 90 42 Temporal
only
15 to 52 18.5 (7.8) 57.4 (30.6)
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Theodore
2012
> 1 year
seizure-
free
Prospec-
tive
41 26 19 Temporal
only
34.2 (9.5) 25 (12) 12 to 132
Tigaran
2003
Engel
Class Scale
Retrospec-
tive
65 32 41 Extratem-
poral only
4 to 50 1 to 40 12 to 144
Tripathi
2008
Engel
Class Scale
Retrospec-
tive
55 29 33 Tempo-
ral and ex-
tratemporal
1 to 45 NA 60 to 120
Trottier
2008
Engel
Class Scale
Retrospec-
tive
96 73 69 Extratem-
poral only
0.5 to 52 16 (NA) > 12
Urbach
2007
Engel
Class Scale
Retrospec-
tive
42 25 20 Extratem-
poral only
7 to 50 2 to 42 > 12
Ure 2009 Engel
Class Scale
Retrospec-
tive
74 28 0 Not stated 14 to 53 NA 12 to 336
Velasco
2011
Engel
Class Scale
Prospec-
tive
163 93 NA Not stated NA NA 14 to 73
Vogt 2018 ’Other’
scale
Prospec-
tive
47 29 22 Temporal 19 to 77 4 to 71 >12
Walz 2003 > 1 year
seizure-
free
Not stated 98 85 44 Temporal
only
36.2 (10.7) 25.2 (10.5) 12 to 90
Weinand
1992
> 1 year
seizure-
free
Retrospec-
tive
89 57 NA Temporal
only
6 to 52 2 to 42 12 to 54
Wellmer
2012
Engel
Class Scale
Retrospec-
tive
165 106 NA Not stated NA NA 24 to 103
Widdess-
Walsh
2007
> 1 year
seizure-
free
Retrospec-
tive
48 22 26 Tempo-
ral and ex-
tratemporal
2 to 56 0 to 27 32.4
(median)
Wiebe
2001
> 1 year
seizure-
free
Prospec-
tive
36 23 NA Temporal
only
NA NA > 12
Wiesh-
mann
2008
Engel
Class Scale
Retrospec-
tive
76 46 32 Not stated NA NA > 12
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Table 1. Study characteristics and participant demographics for 182 included studies (Continued)
Wray 2012 Engel
Class Scale
Retrospec-
tive
52 36 24 Tempo-
ral and ex-
tratemporal
0 to 17 NA > 12
Wyler
1995
> 1 year
seizure-
free
Prospec-
tive
70 38 33 Temporal
only
NA NA > 12
Wyllie
1998
Engel
Class Scale
Not stated 136 92 78 Tempo-
ral and ex-
tratemporal
13 to 20 NA 12 to 88
Yang 2011 ’Other’
scale
Retrospec-
tive
99 27 63 Not stated 8 to 59 NA 12 to 72
Yeon 2009 Engel
Class Scale
Retrospec-
tive
60 50 37 Tempo-
ral and ex-
tratemporal
NA 1 to 26 34.9 (22.5)
Yu 2009 Engel
Class Scale
Retrospec-
tive
43 26 28 Extratem-
poral only
4 to 43 1 to 30 33.6 (16.8)
Yu 2012a > 1 year
seizure-
free
Retrospec-
tive
100 61 NA Tempo-
ral and ex-
tratemporal
26.8 (7.6) 14.3 (8.3) 12 to 108
Yu 2012b > 1 year
seizure-
free
Retrospec-
tive
222 148 NA Tempo-
ral and ex-
tratemporal
12.5 (8.1) 6.6 (4.3) 12 to 108
Zangal-
adze
2008
> 1 year
seizure-
free
Combina-
tion
99 66 NA Tempo-
ral and ex-
tratemporal
NA NA > 24
Zentner
1995
Engel
Class Scale
Retrospec-
tive
167 103 82 Temporal
only
3 to 64 2 to 52 12 to 72
Zentner
1996
Engel
Class Scale
Prospec-
tive
56 30 39 Extratem-
poral only
1 to 49 2 to 35 20 to 85
aAge at surgery (years), duration of epilepsy (years), and duration of follow-up (months) expressed as minimum and maximum years
or months when reported. If minimum and maximum not available, reported as mean (standard deviation (SD)) or median (noted
in table). Follow-up expressed as minimum only (e.g. > 12 months) for 59 studies.
NA: not available.
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Table 2. Quality assessment of 182 included studies according to EPHPP tool
Author Design Study de-
sign
Selection
bias rating
Study
design rat-
ing
Con-
founders
rating
Blinding
rating
Data col-
lection
rating
With-
drawals
rating
Global
rating
Aaberg
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Adam
1996
Prospec-
tive
Cohort Moderate Moderate Strong Weak Weak Strong Weak
Adelson
1992
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Alfstad
2011
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Alonso-
Vanegas
2018
Prospec-
tive
Ran-
domised
controlled
trial
Strong Strong Strong Weak Strong Strong Moderate
Althausen
2013
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Arruda
1996
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Awad
1991
Not stated Cohort Moderate Moderate Strong Weak Strong Weak Weak
Babini
2013
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
Barbaro
2018
Prospec-
tive
Ran-
domised
controlled
trial
Moderate Strong Strong Strong Strong Strong Strong
Battaglia
2006
Not stated Cohort Moderate Moderate Strong Weak Weak Weak Weak
Baumann
2007
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Bautista
2003
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
Bell 2009 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Benifla
2006
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Berkovic
1995
Prospec-
tive
Cohort Moderate Moderate Strong Weak Weak Strong Weak
Blount
2004
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
Blume
2004
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Boesebeck
2007
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
Boshuisen
2010
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Brainer-
Lima 1996
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Britton
1994
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Caraballo
2011
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
Cascino
1995
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Chabardes
2005
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Chang
2009
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Chee 1993 Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Chkhenkeli
2007
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Choi
2004a
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Chung
2005
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Cossu
2005
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Cossu
2008
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Costello
2009
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Cukiert
2002
Prospec-
tive
Cohort Moderate Moderate Strong Weak Weak Strong Weak
Dagar
2011
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Dalmagro
2005
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
de Tisi
2011
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Delbeke
1996
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Dellabadia
2002
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Devlin
2003
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Ding 2016 Prospec-
tive
Ran-
domised
controlled
trial
Moderate Strong Strong Weak Strong Strong Moderate
Donadio
2011
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Dorward
2011
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Duchowny
1998
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Dunkley
2011
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Dunlea
2010
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Dwivedi
2017
Prospec-
tive
Ran-
domised
controlled
trial
Strong Strong Strong Strong Strong Strong Strong
Elsharkawy
2008a
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Elsharkawy
2009a
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Elsharkawy
2011a
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Engman
2004
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Weak
Erba 1992 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Erickson
2005
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Fauser
2004
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Fujiwara
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Garcia
1991
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
Garcia
1994
Prospec-
tive
Cohort Moderate Moderate Strong Weak Strong Weak Weak
Gelinas
2011
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Georgak-
oulias
2008
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Gilliam
1997a
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Gilliam
1997b
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Goldstein
1996
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Greiner
2011
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Grivas
2006
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
Gyimesi
2007
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Hader
2004
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Hajek
2009
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Hallbook
2010
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Hamiwka
2005
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Hartley
2002
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
Hartzfield
2008
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Hemb
2010
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Holmes
1997
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Holmes
2000
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Jack 1992 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Janszky
2003a
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Janszky
2003b
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Jaramillo-
Betancur
2009
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Jayakar
2008
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
Jayalak-
shmi
2011
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Jeha 2006 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Jehi 2012 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Jennum
1993
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Jeong
1999
Not stated Cohort Moderate Moderate Strong Weak Strong Weak Weak
Kan 2008 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Kang 2009 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Kanner
2009
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Kilpatrick
1997
Prospec-
tive
Cohort Moderate Moderate Strong Weak Weak Weak Weak
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Kim 2009 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Kim2010a Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Kim
2010b
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Kloss 2002 Combina-
tion
Cohort Moderate Moderate Strong Weak Weak Weak Weak
Knowlton
2008
Prospec-
tive
Cohort Moderate Moderate Strong Weak Strong Weak Weak
Kral 2007 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Krsek
2013
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Kuzniecky
1993
Prospec-
tive
Cohort Moderate Moderate Strong Weak Weak Strong Weak
Kwan
2010
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Lackmayer
2013
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Weak
Lee 2006 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Lee 2008 Not stated Cohort Moderate Moderate Strong Weak Weak Weak Weak
Lee 2010 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Lee 2011 Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Lei 2008 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Li 1997 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Li 1999 Not stated Cohort Moderate Moderate Strong Weak Weak Weak Weak
Liang
2010
Prospec-
tive
Ran-
domised
controlled
trial
Moderate Strong Strong Moderate Strong Strong Strong
Liang
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Liava 2012 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Lopez-
Gonzalez
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Lorenzo
1995
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Madhavan
2007
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Mani 2006 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Mathern
1999
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
McIntosh
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Mihara
2004
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Miserocchi
2013
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Morino
2009
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Morris
1998
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
O’Brien
1996
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
O’Brien
2000
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Oertel
2005
Prospec-
tive
Cohort an-
alytic
Moderate Strong Moderate Weak Weak Weak Weak
Paglioli
2006
Prospec-
tive
Cohort Moderate Moderate Strong Weak Strong Strong Moderate
Paolicchi
2000
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Park 2002 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Park 2006 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Perego
2009
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Perry 2010 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Phi 2009 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Phi 2010 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Pinheiro-
Martins
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Prevedello
2000
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Raabe
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Radhakr-
ishnan
1998
Combina-
tion
Cohort Moderate Moderate Strong Weak Strong Weak Weak
Rausch
2003
Not stated Cohort Moderate Moderate Strong Weak Strong Weak Weak
Remi 2011 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Roberti
2007
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Rossi 1994 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Russo
2003
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Sagher
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Sakamoto
2009
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Salanova
1994
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Sarkis
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Schramm
2011
Prospec-
tive
Ran-
domised
controlled
trial
Moderate Strong Strong Strong Weak Strong Moderate
Seymour
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Sinclair
2003
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Sindou
2006
Not stated Cohort Moderate Moderate Strong Weak Weak Weak Weak
Sola 2005 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Spencer
2005
Prospec-
tive
Cohort Moderate Moderate Strong Weak Strong Weak Weak
Sperling
1992
Prospec-
tive
Cohort Moderate Moderate Strong Weak Strong Strong Moderate
Stavrou
2008
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Suppiah
2009
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Swartz
1992
Prospec-
tive
Cohort Moderate Moderate Strong Weak Weak Weak Weak
Tanriverdi
2010
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Tatum
2008
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Terra-
Busta-
mante
2005a
Prospec-
tive
Cohort Moderate Moderate Strong Weak Strong Weak Weak
Terra-
Busta-
mante
2005b
Prospec-
tive
Cohort Moderate Moderate Strong Weak Strong Weak Weak
Tezer 2008 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Theodore
2012
Prospec-
tive
Cohort Moderate Moderate Strong Weak Weak Weak Weak
Tigaran
2003
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Tripathi
2008
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Trottier
2008
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Urbach
2007
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Ure 2009 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Velasco
2011
Prospec-
tive
Cohort an-
alytic
Strong Strong Strong Weak Weak Strong Weak
Vogt 2018 Prospec-
tive
Ran-
domised
controlled
trial
Strong Strong Strong Moderate Strong Strong Strong
Walz 2003 Not stated Cohort Moderate Moderate Strong Weak Weak Weak Weak
Weinand
1992
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Wellmer
2012
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Widdess-
Walsh
2007
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Wiebe
2001
Prospec-
tive
Ran-
domised
controlled
trial
Strong Strong Strong Weak Strong Strong Moderate
Wiesh-
mann
2008
Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Weak Not appli-
cable
Weak
Wray 2012 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Wyler
1995
Prospec-
tive
Ran-
domised
controlled
trial
Moderate Strong Strong Strong Strong Strong Strong
Wyllie
1998
Not stated Cohort Strong Moderate Strong Weak Strong Weak Weak
Yang 2011 Retrospec-
tive
Retrospec-
tive case se-
ries
Moderate Moderate Strong Weak Strong Not appli-
cable
Moderate
Yeon 2009 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Strong Not appli-
cable
Moderate
Yu 2009 Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Yu 2012a Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Yu 2012b Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
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Table 2. Quality assessment of 182 included studies according to EPHPP tool (Continued)
Zangal-
adze
2008
Combina-
tion
Cohort Moderate Moderate Strong Weak Weak Weak Weak
Zentner
1995
Retrospec-
tive
Retrospec-
tive case se-
ries
Strong Moderate Strong Weak Weak Not appli-
cable
Weak
Zentner
1996
Prospec-
tive
Cohort Strong Moderate Strong Weak Weak Strong Weak
EPHPP: Effective Public Health Practice Project.
Table 3. Summary of EPHPP tool quality assessment component ratings
Quality assessment criteria Number and proportion of studies
Method of identifying participants Retrospective 144 (79%)
Prospective 26 (14%)
Combination 3 (2%)
Not stated 9 (5%)
A. Selection bias
(Q1) Are the individuals selected to partic-
ipate in the study likely to
be representative of the target population?
Very likely 129 (71%)
Somewhat likely 53 (29%)
(Q2) What percentage of selected individ-
uals agreed to participate?
80% to 100% 9 (5%)
less than 60% 1 (1%)
Can’t tell 28 (15%)
Not applicable 144 (79%)
Selection bias rating Moderate 64 (35%)
Strong 118 (65%)
B. Study design Retrospective case series 144 (79%)
Cohort 27 (15%)
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Table 3. Summary of EPHPP tool quality assessment component ratings (Continued)
Cohort analytic 2 (1%)
Randomised controlled trial 9 (5%)
Study design rating Moderate 171 (94%)
Strong 11 (6%)
C. Confounders
(Q1) Were there important differences be-
tween groups before the intervention?
No 181 (99%)
Unclear/Can’t tell 1 (1%)
(Q2) If yes, indicate the percentage of rel-
evant confounders that were controlled
(either in the design (e.g. stratification,
matching) or in the analysis)?
Unclear/Can’t tell 1 (1%)
Not applicable 181 (99%)
Confounders rating Strong 181 (99%)
Moderate 1 (1%)
D. Blinding
(Q1) Was (were) the outcome assessor(s)
aware of the intervention
or exposure status of participants?
Yes 176 (97%)
No 4 (2%)
Can’t tell 2 (1%)
(Q2) Were the study participants aware of
the research question?
Yes 176 (97%)
No 4 (1%)
Can’t tell 2 (1%)
Blinding rating Strong 4 (2%)
Moderate 2 (1%)
Weak 176 (97%)
E. Data collection methods
(Q1) Were data collection tools shown to
be valid?
Yes 95 (52%)
Unclear/Can’t tell 87 (48%)
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Table 3. Summary of EPHPP tool quality assessment component ratings (Continued)
(Q2) Were data collection tools shown to
be reliable?
Yes 95 (52%)
Unclear/Can’t tell 87 (48%)
Data collection rating Strong 95 (52%)
Weak 87 (48%)
F. Withdrawals and dropouts
(Q1) Were withdrawals and dropouts re-
ported in terms of numbers
and/or reasons per group?
Yes 17 (9%)
No 21 (12%)
Not applicable 144 (79%)
(Q2) Indicate the percentage of partici-
pants completing the study
80% to 100% 17 (9%)
Can’t tell 21 (12%)
Not applicable 144 (79%)
Withdrawals rating Strong 17 (9%)
Weak 21 (12%)
Not applicable 144 (79%)
G. Intervention integrity
(Q1) What percentage of participants re-
ceived the allocated
intervention or exposure of interest?
80% to 100% 182 (100%)
(Q2) Was the consistency of the interven-
tion measured?
Yes 164 (90%)
No 18 (10%)
(Q3) Is it likely that participants received an
unintended intervention (contamination
or co-intervention) that may have influ-
enced the results?
No 182 (100%)
H. Analyses
(Q1) Unit of allocation Individual 182 (100%)
(Q2) Unit of analysis Individual 182 (100%)
207Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 3. Summary of EPHPP tool quality assessment component ratings (Continued)
(Q3) Are the statistical methods appropri-
ate for the study design?
Yes 159 (87%)
No stats 23 (13%)
(Q4) Is the analysis performed by interven-
tion allocation status
(i.e. intention-to-treat) rather than by the
actual intervention received?
Yes 182 (100%)
Global rating Strong 5 (3%)
Moderate 79 (43%)
Weak 98 (54%)
EPHPP: Effective Public Health Practice Project.
Table 4. Risk of bias assessment of six randomised controlled trials
Study Random
sequence gener-
ation (selection
bias)
Allocation con-
cealment (selec-
tion bias)
Blinding of par-
ticipants, per-
sonnel, andout-
come as-
sessors (perfor-
mance and de-
tection bias)
Incomplete
outcome data
(attrition bias)
Selective re-
porting (report-
ing bias)
Other bias
Alonso-
Vanegas 2018:
judgement
Low Unclear High Low Low Low
Support for
judgement
Computer gen-
erated randomi-
sation list
No information
provided
Not blinded No exclusions or
withdrawals
stated, all ran-
domised patients
seem to be in-
cluded
Seizure outcome
and safety out-
comes described
in the methods
section well re-
ported in the re-
sults. No proto-
col available
to assess planned
outcomes a pri-
ori
No other bias de-
tected
Barbaro 2018:
judgement
Unclear Unclear Low Low Low Low
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Table 4. Risk of bias assessment of six randomised controlled trials (Continued)
Support for
judgement
Described as ran-
domised but
no further details
provided
No information
provided
Sin-
gle-blinded, out-
come assessors
were blinded
Attri-
tion rates clearly
stated, all partic-
ipants included
in seizure remis-
sion analysis up
to 36 months
Seizure
outcome, cogni-
tion and quality
of life outcomes
described in the
methods section
well reported in
the results. No
protocol
available to as-
sess planned out-
comes a priori
No other bias de-
tected
Ding 2016 :
judgement
High High Unclear Low Low Low
Support for
judgement
Quasi-randomi-
sation based on
odd or even pa-
tient ID num-
ber; not an ade-
quate method of
randomisation
Quasi-
randomisation
meaning that al-
location was not
concealed
No information
provided
All
participants fol-
lowed for 3 years
and included in
the outcome at 3
years; attrition at
5 years clearly re-
ported
Seizure out-
come, complica-
tions, and intel-
ligence /quality
of life changes
described in the
methods section
well reported in
the results. No
protocol avail-
able for assess-
ment of planned
outcomes a pri-
ori
No other bias de-
tected
Dwivedi 2017 :
judgement
Low Low Low Low Low Low
Support for
judgement
Computer-gen-
erated non-strat-
ified randomisa-
tion
Allocation con-
cealed with
sealed opaque
envelopes
Primary out-
come measure of
freedom
from seizures as-
sessed in a
blinded manner
All participants
followed for 12
months and in-
cluded
in the outcome
at 12 months
Pro-
tocol available as
an online supple-
ment to the pub-
lication. All pre-
specified out-
comes reported
Noother bias de-
tected
Liang 2012:
judgement
High High Unclear Low Low Low
Support for
judgement
Quasi-randomi-
sation based on
odd or even pa-
tient ID num-
Quasi-
randomisation
meaning that al-
No information
provided
All
participants fol-
lowed for 2 years
Seizure out-
come, complica-
tions,
No other bias de-
tected
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Table 4. Risk of bias assessment of six randomised controlled trials (Continued)
ber; not an ade-
quate method of
randomisation
location was not
concealed
and included in
the outcome at 2
years
and behavioural
changes
described in the
methods section
well reported in
the results. No
protocol avail-
able for assess-
ment of planned
outcomes a pri-
ori
Schramm 2011:
judgement
Low Low Low Low Low Low
Support for
judgement
Computer-gen-
erated blocked
randomisation
list prepared
Each centre re-
ceived the ran-
domisation
codes in num-
bered and sealed
envelopes, with
each envelope al-
locating the ex-
tent of resection
for 1 particu-
lar participant at
that centre. En-
velopes were to
be used in the
given sequence
for participants
as they were in-
cluded into the
study. Envelopes
had to be opened
in the OR not
before the morn-
ing of surgery.
Thus, the type of
surgery (selective
amygdalohip-
pocampec-
tomy or lobec-
tomy) was de-
termined before
the envelope was
opened, but the
content of the
Neither study
partici-
pants nor epilep-
tologists as-
sessing outcomes
were told of the
result of the ran-
domisation (i.e.
they were not
aware whether a
short or
a long resection
had been done)
; the only per-
son who knew
this was the sur-
geon. OR notes
did not mention
the planned re-
section extent. In
par-
ticular, persons
performing MRI
volumetry were
blinded to group
assignment
No losses to fol-
low-up; all par-
ticipants in-
cluded in analy-
sis of outcome at
1 year
Seizure
outcome, extent
of resection, and
compli-
cations described
in the methods
section well re-
ported in the re-
sults. No proto-
col available for
assessment
of planned out-
comes a priori
No other bias de-
tected
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Table 4. Risk of bias assessment of six randomised controlled trials (Continued)
envelope deter-
mined the mesial
extent of resec-
tion
Vogt 2018:
judgement
Low Low Unclear High Low Low
Support for
judgement
Computer gen-
erated randomi-
sation list
Allocation com-
municated to the
surgeon after the
patient was
brought into the
operating theatre
No information
provided
Seven
out of 54 (13%)
randomised
participants who
did not complete
neuropsycholog-
ical assessments
at 1 year were ex-
cluded from all
analyses
Seizure outcome
and neuropsy-
chological out-
comes described
in the methods
section well re-
ported in the re-
sults. No proto-
col available
to assess planned
outcomes a pri-
ori
No other bias de-
tected
Wiebe 2001:
judgement
Unclear Low Unclear Low Low Low
Support for
judgement
Partici-
pants “randomly
assigned…after
stratification ac-
cording to the
presence or ab-
sence of general-
ized motor
seizures”; no fur-
ther information
given
Random assign-
ments prepared
outside the study
centre and de-
livered in sealed,
opaque, sequen-
tially numbered
envelopes
Blinding
not possible for
anyone involved
(surgical vs med-
ical treatment);
unclear whether
outcome was in-
fluenced by this
Full details of at-
tri-
tion given: “No
patients were lost
to follow-
up. There were
no crossovers
from themedical
group to the sur-
gical group. One
pa-
tient in the med-
ical group died
(a sudden, un-
explained death)
7.5 months into
the study. No
deaths occurred
in the surgical
group.” Inten-
tion-to-treat ap-
proach taken
Seizure outcome
and quality
of life described
in the methods
section well re-
ported in the re-
sults. No proto-
col available for
assessment
of planned out-
comes a priori
No other bias de-
tected
Wyler 1995:
judgement
Unclear Unclear Low Low Low Low
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Table 4. Risk of bias assessment of six randomised controlled trials (Continued)
Support for
judgement
Study
described as ran-
domised; no fur-
ther information
given
No information
provided
Participants and
outcome asses-
sors blinded; not
possible to blind
surgeons by de-
sign
All participants
in-
cluded in assess-
ment of outcome
at 1 year; inten-
tion-to-treat ap-
proach taken
Seizure outcome
and neuropsy-
chological out-
comes described
in the methods
section well re-
ported in the re-
sults. No proto-
col available for
assessment
of planned out-
comes a priori
No other bias de-
tected
ID: identification.
MRI: magnetic resonance imaging.
OR: operating room.
Table 5. Risk of bias in prognostic studies according to QUIPS tool
Author 1. Study partici-
pation
2. Study attrition 3. Prognostic fac-
tor measurement
4. Outcome mea-
surement
5. Study
confounding
6. Sta-
tistical
analy-
sis
and re-
porting
Judge-
ment
Risk of
bias
Judge-
ment
Risk of
bias
Judge-
ment
Risk of
bias
Judge-
ment
Risk of
bias
Judge-
ment
Risk of
bias
Judge-
ment
Risk of
bias
Al-
thausen
2013
Popula-
tion of
interest
well de-
scribed
and
sample
re-
cruited
seems
to
match
this;
how-
ever
sample
re-
stricted
moder-
ate
Retro-
spec-
tive, so
NA
NA Most
vari-
ables
well de-
fined,
some
not;
unclear
how
data
were
col-
lected
and
whether
data
were
moder-
ate
Out-
come
patient-
re-
ported,
there-
fore
likely
to be
highly
subjec-
tive;
also
unclear
when
out-
come
high Most
vari-
ables
well de-
fined,
some
not;
unclear
how
data
were
col-
lected
and
whether
data
moder-
ate
Insuf-
ficient
infor-
mation
pro-
vided
in the
meth-
ods;
some
vari-
ables
in-
cluded
in the
model
high
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
to those
who re-
turned
postop-
erative
ques-
tion-
naires;
may
exclude
some of
those
with
poorer
intel-
lectual/
seizure
out-
comes?
com-
plete
was
mea-
sured
and if
addi-
tional
medical
records
were
used for
some/
all
partici-
pants
were
com-
plete;
some
adjust-
ment
seems
to have
been
done
but not
for all
relevant
vari-
ables
without
pre-
specifi-
cation
and no
defini-
tions;
results
selec-
tively
re-
ported
Boese-
beck
2007
Popula-
tion of
interest
well de-
scribed
and
sample
seems
to
match
this,
but
unclear
on
recruit-
ment
meth-
ods and
inclu-
sion
criteria
moder-
ate
Retro-
spec-
tive, so
NA
NA Prog-
nostic
factors
enter-
ing the
model
well de-
scribed,
but not
much
infor-
mation
given
on how
these
data
were
col-
lected
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way,
but
out-
come
defini-
tion is
clear
and the
same
for all
partic-
ipants;
method
of col-
lecting
out-
come
data
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Model
well de-
scribed
and
based
on
clinical
value
rather
than
statis-
tical
signifi-
cance;
how-
ever not
all P
values
re-
ported
and re-
gression
coeffi-
cients
re-
moder-
ate
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
not
speci-
fied
ported
rather
than
mean-
ingful
effect
sizes
Cossu
2008
Popula-
tion of
interest
well de-
scribed;
sample
well de-
scribed;
sam-
ple rep-
resen-
tative of
the
source
popula-
tion
low Retro-
spec-
tive, so
NA
NA All vari-
ables
well de-
scribed;
mea-
sure-
ment
tech-
niques
speci-
fied and
patients
all came
from a
single
centre,
so likely
fol-
lowed
the
same
proto-
col
low Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
mea-
sured
on a
known
scale;
last
follow-
up
mean-
ing
vari-
ability
across
mea-
sure-
ment
times
moder-
ate
Age at
surgery
and
pathol-
ogy
seem
to have
been
consid-
ered as
con-
founders;
unclear
what
are con-
founders
and
what
are
prog-
nostic
factors
moder-
ate
Analy-
sis de-
scribed
clearly,
but
vari-
ables
in the
model
based
on sta-
tistical
signifi-
cance;
results
pre-
sented
only for
statis-
tically
signif-
icant
vari-
ables
high
Cossu
2005
Popula-
tion of
interest
well de-
scribed
and
original
sample
matches
this
popu-
lation;
how-
moder-
ate
Retro-
spec-
tive, so
NA
NA Vari-
ables
well de-
fined,
but
very
little
infor-
mation
pro-
vided
on how
data
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
infor-
mation
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Meth-
ods
well de-
scribed
on the
model
and
vari-
ables,
but
report-
ing of
moder-
ate
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
ever not
all from
original
sample
in-
cluded
in final
analy-
ses, and
charac-
teristics
not de-
scribed
for the
sub-
group
of
interest
who
did un-
dergo
surgery
were
col-
lected
and
anal-
ysed
pro-
vided
on out-
come
classifi-
cation,
but
not on
when
out-
come
was
mea-
sured
and
how
out-
come
was
mea-
sured
results
highly
selec-
tive,
with no
useful
infor-
mation
pro-
vided at
all
Elsharkawy
2008a
Popula-
tion
of inter-
est and
sample
well de-
scribed;
seem to
match
low Retro-
spec-
tive, so
NA
NA All vari-
ables
well de-
fined,
pre-op-
erative
workup
seems
the
same
but
data
col-
lected
retro-
spec-
tively
in a
variety
of ways,
which
could
have
led to
moder-
ate
Dif-
ficult
variable
to mea-
sure in
a valid
and
reliable
way;
out-
come
well
defined
overall,
but un-
clear at
which
time
point
mod-
elling
was
con-
ducted
moder-
ate
Al-
though
all
results
pre-
sented
accord-
ing to
“Group”,
differ-
ences
be-
tween
these
groups
do not
seem to
be con-
sidered;
unclear
if any
vari-
ables
moder-
ate
Model
appro-
priate
for the
data,
but
vari-
ables
in-
cluded
based
on sta-
tistical
signif-
icance
and
results
selec-
tively
re-
ported
high
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
vari-
ability
across
partici-
pants
and po-
tential
vari-
ability
in data
collec-
tion
across
partici-
pants
are
being
treated
as con-
founders
or as
prog-
nostic
vari-
ables
Elsharkawy
2009a
Popula-
tion of
interest
well de-
fined,
and
sample
re-
cruited
seems
to
match
this;
very
clear
how
sample
was re-
cruited;
large
sample
size
low Retro-
spec-
tive, so
NA
NA Most
vari-
ables
well de-
fined,
and
data
recorded
and col-
lected
follow-
ing the
same
pro-
tocol;
how-
ever
defini-
tions of
some
vari-
ables
unclear
due to
variable
termi-
nology,
which
makes
it un-
clear
which
vari-
ables
have
been
anal-
ysed
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way,
but
meth-
ods
seem
satis-
factory
(same
time
points,
single
pro-
tocol,
multi-
ple data
sources)
low NA for
studies
of a sin-
gle-
group
design
NA Model
appro-
priate
for the
data
but
vari-
ables
in-
cluded
based
on sta-
tistical
signifi-
cance;
some
variable
defini-
tions
unclear
and
results
selec-
tively
re-
ported
high
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
Gelinas
2011
Popula-
tion of
interest
and
sample
re-
cruited
well de-
scribed
and
seem
com-
patible;
uncer-
tainty
only
around
the def-
inition
of “pae-
diatric”
moder-
ate
Retro-
spec-
tive, so
NA
NA All vari-
ables
well
defined
and
method
of mea-
sure-
ment
seems
valid
and
consis-
tent for
most;
some
vari-
ability
possible
for one
of the
most
impor-
tant
vari-
ables
in the
study
- sub-
jective
choice
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
mea-
sured at
a single
time
point
for
analysis
and
judged
by an
expert,
so
seems
reason-
able
low Po-
tential
“con-
founder”;
type of
surgery
well
defined
but
choice
was
subjec-
tive and
likely
to vary
across
partic-
ipants;
differ-
ences
be-
tween
groups
consid-
ered,
and this
variable
in-
cluded
in re-
gression
analysis
moder-
ate
Results
well re-
ported,
but un-
clear ex-
actly
how
many
vari-
ables
went
into the
model
moder-
ate
Janszky
2003a
Popula-
tion of
interest
well de-
scribed;
how-
ever
given
the
clinical
ques-
tion of
inter-
est, the
sample
seems
high Retro-
spec-
tive, so
NA
NA Prog-
nostic
factors
well
defined
includ-
ing def-
initions
of key
vari-
ables
(IEDs,
CFCs);
unclear
whether
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
out-
come
recorded
accord-
moder-
ate
All ap-
parent
relevant
con-
founders
exam-
ined,
well de-
fined,
and ad-
justed
for in
analysis
of prog-
moder-
ate
Meth-
ods de-
scribe
models
quite
well;
unclear
how
it was
decided
which
vari-
ables
went
high
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
quite
selec-
tive
partic-
ipants
were
submit-
ted to
1 or 2
centres,
so
unclear
if data
collec-
tion
meth-
ods
are the
same
ing to a
known
scale,
but
unclear
when
out-
come
was
mea-
sured
(pos-
sibly
variable
across
partic-
ipants)
; little
detail
given
about
how
data
were
col-
lected
nostic
factors,
but
unclear
whether
partic-
ipants
were
submit-
ted to
1 or 2
centres,
so
unclear
if data
collec-
tion
meth-
ods
are the
same
into the
prog-
nostic
model;
results
selec-
tively
re-
ported
Jennum
1993
Popula-
tion of
interest
well de-
scribed,
and
sample
seems
to
match
this,
but
unclear
on
recruit-
ment
meth-
ods and
inclu-
sion
criteria
moder-
ate
Retro-
spec-
tive, so
NA
NA Prog-
nostic
factors
enter-
ing the
model
mostly
well de-
scribed
(except
for
extent
of re-
section)
, but
not
much
infor-
mation
given
on how
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
how-
ever
out-
come
data
col-
lected
in the
same
way
low NA for
studies
of a sin-
gle-
group
design
NA Very
little in-
forma-
tion
given
about
the
model;
only
signif-
icant P
val-
ues re-
ported
high
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
these
data
were
col-
lected
for all
partic-
ipants
and
mea-
sured
at the
same
time
Kim
2009
Popula-
tion of
interest
well de-
scribed;
sample
well de-
scribed;
seem to
match
low Retro-
spec-
tive, so
NA
NA Defini-
tions
and
mea-
sure-
ments
of some
factors
unclear
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
not
defined
accord-
ing to
a scale
such as
Engel
Class;
no
infor-
mation
on
when
out-
come
is mea-
sured
high NA for
studies
of a sin-
gle-
group
design
NA Meth-
ods
well de-
scribed,
but
vari-
ables
entered
into the
model
based
on sta-
tistical
signif-
icance
and
results
selec-
tively
re-
ported
high
Kim
2010a
Popula-
tion of
interest
and
sample
well de-
fined,
but
unclear
whether
patients
were re-
moder-
ate
Retro-
spec-
tive, so
NA
NA Most
vari-
ables
well de-
scribed
but
techni-
cal; not
clear if
partic-
ipants
moder-
ate
Seizure
out-
come
de-
fined,
but
not the
time
point
mea-
sured;
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Unclear
which
vari-
ables
went
into the
model;
results
selec-
tively
moder-
ate
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
cruited
from a
single
centre
or from
mul-
tiple
centres,
and
if the
type of
epilepsy
in the
sample
matches
the
popula-
tion
came
from a
single
centre,
so dif-
ferent
pro-
tocols
may
have
been
fol-
lowed
unclear
how
data
were
col-
lected
re-
ported
Lopez-
Gonza-
lez
2012
Popula-
tion of
interest
well de-
fined,
and
sample
re-
cruited
seems
to
match
this;
very
clear
how
sample
was re-
cruited
low Retro-
spec-
tive, so
NA
NA Vari-
ables
well de-
scribed;
pre-op-
erative
evalu-
ations
carried
out in
stan-
dard-
ised
fashion,
but
unclear
how
retro-
spective
analysis
was
carried
out
(patient
records
ex-
tracted,
etc.)?
moder-
ate
Out-
come
briefly
defined
but no
further
infor-
mation
pro-
vided;
unclear
how
out-
come
data
were
col-
lected;
mul-
tiple
time
points
for the
analysis
ac-
counted
for in
the
analysis
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Statis-
tical
meth-
ods
well de-
scribed;
vari-
ables
well
defined
(but
based
on sta-
tistical
signifi-
cance)
and
results
clearly
tabu-
lated
(un-
clear
why
RRs
were re-
ported)
moder-
ate
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
Madha-
van
2007
De-
scrip-
tions of
popula-
tion of
interest
and
sample
re-
cruited
not
quite
the
same;
inclu-
sion
criteria
brief
moder-
ate
Retro-
spec-
tive, so
NA
NA Likely
that
mea-
sure-
ment
of vari-
ables
was dif-
ferent
across
centres;
unclear
how
some
vari-
ables
have
been
defined
and
choice
for
analysis
high Seizure
out-
come
defined
accord-
ing to a
known
scale;
time
point
not
stated
and
unclear
how
out-
come
data
were
col-
lected
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Unclear
what
kind
of sta-
tistical
model
had
been
fitted;
only
signif-
icant
vari-
ables
entered
into the
model
high
McIn-
tosh
2012
Popula-
tion of
interest
well de-
scribed;
study
sample
matches
popula-
tion for
charac-
teristics
of in-
terest;
all in-
cluded
in
analysis
low Retro-
spec-
tive, so
NA
NA Prog-
nostic
vari-
ables
well de-
fined; a
lot of
effort
made
to accu-
rately
collect
data
for all
partic-
ipants;
partic-
ipants
came
from a
single
centre
low Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way,
but a
lot of
effort
made
to cor-
rectly
classify
partic-
ipants;
out-
come
mea-
low NA for
studies
of a sin-
gle-
group
design
NA Meth-
ods
well de-
scribed
and
results
well re-
ported;
how-
ever,
choice
of vari-
ables
and cat-
egories
based
on data
and sta-
tistical
signifi-
cance
moder-
ate
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
sured at
1 time
point in
primary
analysis
O’Brien
2000
Popula-
tion of
interest
well
defined
and
sample
re-
cruited
seems
to
match
this;
very
clear
how
sample
was re-
cruited
low Retro-
spec-
tive, so
NA
NA Poten-
tial for
mis-
classifi-
cation
due
to the
nature
of the
prog-
nostic
factors,
but
efforts
made to
reduce
risk;
defini-
tions
well de-
scribed
but
unclear
why
some
partic-
ipants
were
not in-
cluded
in some
analyses
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
mea-
sured
accord-
ing to a
known
scale;
could
have
been
differ-
ent if
a dif-
ferent
time of
mea-
sure-
ment
was
chosen
due to
vari-
ability
of out-
come
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Statisti-
cal
anal-
ysis de-
scribed
very
well,
with no
selec-
tive re-
porting
of
results
low
Paolic-
chi
2000
Popula-
tion of
interest
clear
and
sample
seems
to
moder-
ate
Retro-
spec-
tive, so
NA
NA All def-
initions
of vari-
ables
seem
clear;
little to
no vari-
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Unclear
which
vari-
ables
have
actually
gone
high
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match
this;
how-
ever
insuf-
ficient
infor-
mation
given
regard-
ing
meth-
ods of
recruit-
ment
ation
in col-
lection/
mea-
sure-
ment
meth-
ods
seems
to have
oc-
curred
across
partic-
ipants,
but un-
clear if
partic-
ipants
came
from a
single
centre
reliable
way;
unclear
when
the out-
come
was
mea-
sured -
prob-
ably
variable
across
partic-
ipants,
who
may
have
come
from
mul-
tiple
centres
into the
model,
what
“uni-
variate
condi-
tions”
means,
and
whether
results
are
selec-
tively
re-
ported
Phi
2009
Popula-
tion of
interest
well de-
fined,
and
sample
re-
cruited
seems
to
match
this;
very
clear
how
sample
was re-
cruited
low Retro-
spec-
tive, so
NA
NA Most
vari-
ables
well de-
fined;
some
uncer-
tainty
on
method
of mea-
sure-
ment
for
some
vari-
ables
and
meth-
ods of
analysis
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
unclear
when
the out-
come
was
mea-
sured -
prob-
ably
variable
across
partici-
pants
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Meth-
ods
section
seems
clear on
meth-
ods and
factor
list, but
unclear
from
the
results
exactly
what
has
gone
into the
model
moder-
ate
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Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
Rad-
hakr-
ishnan
1998
Sample
re-
cruited
well de-
scribed
and
seems
repre-
sen-
tative
of the
popu-
lation
of in-
terest;
how-
ever
unclear
whether
partic-
ipants
were re-
cruited
prospec-
tively
or ret-
rospec-
tively,
and
how
com-
plete
follow-
up
infor-
mation
was
moder-
ate
Unclear
whether
partic-
ipants
were re-
cruited
prospec-
tively
or ret-
rospec-
tively
(or
both)
. 15
partic-
ipants
ex-
cluded
for less
than 2
years of
follow-
up, or
missing
data
from all
consec-
utive
partic-
ipants;
no
with-
drawals
men-
tioned
(but
im-
plied),
and no
fixed
study
dura-
tion, so
whether
partic-
ipants
high Vari-
ables
seem to
be mea-
sured
in the
same
way
for all
partic-
ipants
and
defined
clearly;
some
vari-
ables
subjec-
tive and
taken
from
partic-
ipant
surveys
by
defini-
tion, so
could
induce
bias;
quan-
tity of
missing
data
unclear,
as is
how
this was
han-
dled in
analysis
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
could
have
been
differ-
ent if
a dif-
ferent
time of
mea-
sure-
ment
was
chosen
due to
vari-
ability
of out-
come
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Appro-
priate
model,
well de-
scribed;
how-
ever,
unclear
which
vari-
ables
had
been
entered
into the
multi-
variate
model
(based
on uni-
variate
anal-
yses?
) and
if all
results
have
been re-
ported
moder-
ate
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com-
pleted
the
study
is NA;
unclear
how
com-
plete
follow-
up
infor-
mation
was,
and if
this im-
pacted
analysis
Rossi
1994
Popula-
tion of
interest
vague
and
unclear,
so un-
certain
if the
sample
repre-
sents
this;
little
infor-
mation
about
how the
sample
was re-
cruited;
analysis
per-
formed
on a
subset
of this
sample
high Retro-
spec-
tive, so
NA
NA Vari-
ables
well
defined
and
meth-
ods/
setting
de-
scribed
in some
detail,
but
unclear
how the
retro-
spective
review
was
carried
out;
large
propor-
tion of
missing
data
likely
to have
high Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
out-
come
mea-
sured
at the
same
time
point
by a
well-
defined
scale,
but no
details
pro-
vided
regard-
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Some
uncer-
tainty
over
exactly
what
has
been
done in
terms
of mod-
elling;
vari-
ables
entered
based
on sta-
tistical
signifi-
cance;
only P
values
re-
ported
without
inter-
high
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im-
pacted
the
general-
isability
of
analyses
ing data
collec-
tion
preta-
tion
Sagher
2012
Popula-
tion of
interest
well de-
scribed;
sam-
ple re-
cruited
well de-
scribed;
seem to
match
low Retro-
spec-
tive, so
NA
NA All vari-
ables
well de-
scribed;
mul-
tiple
study
authors
clas-
sified
some
vari-
ables,
and
data
likely
to have
been
col-
lected
in the
same
way for
partic-
ipants
from a
single
centre
low Seizure
out-
come
mea-
sured
accord-
ing to a
known
scale at
specific
time
points;
model
builds
in all
follow-
up of
partic-
ipants
and
data
col-
lected
in the
same
way;
partic-
ipants
from a
single
centre
low Vari-
ables
well
defined
and
sepa-
rated
by the 2
types of
surgery;
differ-
ences
be-
tween
vari-
ables
mostly
not
tested;
type of
surgery
in-
cluded
in GEE
model
moder-
ate
Statis-
tical
meth-
ods
well de-
scribed,
but
unclear
which
vari-
ables
went
into the
model
and
how
effect
sizes
should
be
inter-
preted
moder-
ate
Sarkis
2012
Popula-
tion of
interest
well de-
scribed;
sam-
ple re-
cruited
well de-
low Retro-
spec-
tive, so
NA
NA All vari-
ables
well de-
scribed;
data
likely
to have
been
col-
low Seizure
out-
come
defined
accord-
ing to a
known
scale;
not
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Statis-
tical
meth-
ods
well de-
scribed;
how-
ever
high
226Surgery for epilepsy (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 5. Risk of bias in prognostic studies according to QUIPS tool (Continued)
scribed;
seem to
match
lected
in the
same
way,
with
partic-
ipants
from a
single
centre
com-
pletely
clear
how
out-
come
data
were
col-
lected;
statis-
tical
model
will
account
for
variable
follow-
up
length
vari-
ables
selected
based
on sta-
tistical
signif-
icance
and
results
selec-
tively
re-
ported
Schramm
2011
Large
sample
re-
cruited;
seems
repre-
sen-
tative
of the
popu-
lation
of in-
terest;
how-
ever
35% of
poten-
tially
eligible
indi-
viduals
not in-
cluded
for
varying
reasons
moder-
ate
All
partic-
ipants
in the
study
con-
tributed
data
from
1 year
and
were in-
cluded
in an
inten-
tion-
to-treat
analy-
sis; sec-
ondary
analysis
was
planned
in the
case of
drop-
outs
low Clin-
ical/
demo-
graphic
data
seem
to have
been
col-
lected
in a
reliable
and
valid
way
under
the
same
proto-
col for
all pa-
tients;
how-
ever
unclear
what
moder-
ate
Dif-
ficult
out-
come
to mea-
sure
in a
reliable
and
valid
way but
seems
satis-
factory;
mea-
sured
by a
known
scale at
a single
time
point
in the
same
way
for all
low Clin-
ical/
demo-
graphic
data
seem
to have
been
col-
lected
in a
reliable
and
valid
way
under
the
same
pro-
tocol
for all
partic-
ipants;
how-
ever
moder-
ate
Unclear
which
vari-
ables
have
been
in-
cluded
in the
model,
exactly
what
type of
analysis
has
been
per-
formed,
and
whether
all
results
have
been re-
moder-
ate
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are
prog-
nostic
vari-
ables
and
what
are con-
found-
ing
factors
partici-
pants
unclear
what
are
prog-
nostic
vari-
ables
and
what
are con-
found-
ing
factors;
“con-
founders”
do not
appear
to be
ac-
counted
for in
the
design,
and
unclear
what
type of
analysis
(if any)
was
done
ported
Spencer
2005
Large
sample
size,
which
is rep-
resen-
tative
of the
popula-
tion of
inter-
est, but
unclear
how
many
other
eligible
moder-
ate
Not
enough
infor-
mation
in the
publi-
cations
on
partic-
ipants
lost to
follow-
up and
those
in-
cluded
in the
moder-
ate
Com-
plete
data
col-
lected
under
the
same
pro-
tocol;
some
scope
for vari-
ation
be-
tween
moder-
ate
Dif-
ficult
out-
come
to mea-
sure
in a
reliable
and
valid
way;
relies
on
patient
report-
ing and
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Unclear
whether
the
analysis
was
appro-
priate,
which
vari-
ables
were
entered
into the
model,
and
high
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individ-
uals de-
clined
to take
part or
were
ex-
cluded
from
analyses
analyses
unclear
partic-
ipants;
not all
PF defi-
nitions
are
com-
pletely
clear
does
not
use a
known
scale
whether
results
were
selec-
tively
re-
ported
Tezer
2008
Popula-
tion
of inter-
est and
sample
well de-
scribed;
sample
seems
to
match
popula-
tion of
interest
low Retro-
spec-
tive, so
NA
NA Most
vari-
ables
well de-
fined;
unclear
how
some
vari-
ables
defined
and
anal-
ysed; a
lot of
effort
made
to avoid
mis-
classifi-
cation
in data
collec-
tion;
partic-
ipants
came
from a
single
centre
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way,
but a
lot of
effort
made
to cor-
rectly
classify
partic-
ipants
accord-
ing to a
known
scale;
how-
ever,
out-
come
mea-
sured at
variable
time
points
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Unclear
which
vari-
ables
went
into the
model,
what
the out-
come
variable
was,
and
results
were
selec-
tively
re-
ported
high
Theodore
2012
Study
sample
seems
to be
repre-
moder-
ate Prospec-
tive
study
with
moder-
ate
Exact
prog-
nostic
factors
of inter-
moder-
ate
Dif-
ficult
out-
come
to mea-
moder-
ate
NA for
studies
of a sin-
gle-
group
NA Unclear
how
vari-
ables
high
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sen-
tative
of the
popu-
lation
of in-
terest;
how-
ever not
clear
on how
this
sample
was re-
cruited,
how
many
eligible
partic-
ipants
de-
clined
to take
part,
whether
any
with-
drawals
oc-
curred,
etc
41 in-
cluded
partic-
ipants;
no fixed
study
length
(dura-
tion of
follow-
up
speci-
fied), so
com-
pleting
the
study
is not
applica-
ble; no
drop-
outs/
with-
drawals/
losses to
follow-
up
men-
tioned,
and
unclear
if any
oc-
curred
est from
the
PET
scans
unclear
sure in
a valid
and
reliable
way;
could
have
been
differ-
ent if
a dif-
ferent
time of
mea-
sure-
ment
was
chosen
due to
vari-
ability
of out-
come;
not
mea-
sured
accord-
ing to a
known
scale
design are
being
anal-
ysed
in the
model
and
results
selec-
tively
pre-
sented
(no nu-
merical
results
at all)
Walz
2003
Sample
re-
cruited
well de-
scribed
and
seems
repre-
sen-
tative
of the
popu-
lation
of in-
moder-
ate
No
losses to
follow-
up
men-
tioned;
reasons
for ex-
clusion
from
analysis
given;
not
clear
moder-
ate
Data
seem
to have
been
col-
lected
the
same
way
for all
partic-
ipants,
in a way
that
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way;
could
have
been
moder-
ate
NA for
studies
of a sin-
gle-
group
design
NA Statis-
tical
analysis
appro-
priate
and all
results
pre-
sented;
how-
ever
choice
moder-
ate
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terest;
how-
ever
unclear
whether
partic-
ipants
were re-
cruited
prospec-
tively
or ret-
rospec-
tively
if the
study
is of a
prospec-
tive or
retro-
spective
design,
so diffi-
cult to
judge
with-
drawals
and
drop-
outs
should
min-
imise
bias.
Some
vari-
ables
by def-
inition
could
be
prone
to
recall/
mis-
classifi-
cation
biases,
but
clear
defini-
tions
given
(except
di-
chotomised
vari-
ables)
differ-
ent if
a dif-
ferent
time of
mea-
sure-
ment
was
chosen
due to
vari-
ability
of out-
come;
all
partic-
ipants
from a
single
centre,
and
out-
come
mea-
sured
accord-
ing to a
known
scale
of vari-
ables
for the
multi-
variate
model
based
on uni-
variate
results
Wyler
1995
Popula-
tion of
interest
not
well de-
fined;
intro-
duction
refers
more to
surgical
tech-
nique
than
to the
popula-
tion it
is being
moder-
ate
Out-
come
assess-
ment at
1 year
recorded
for all
partic-
ipants;
no
drop-
outs
nor
missing
data
low Vari-
ables
entered
into the
logistic
regres-
sion
model
well
defined
and
seem
to have
been
col-
lected
reliably,
moder-
ate
Dif-
ficult
out-
come
to mea-
sure in
a valid
and
reliable
way,
but
every
effort
seems
to have
been
made to
low Ran-
domi-
sation
has bal-
anced
groups
in
terms
of any
con-
found-
ing
factors;
there-
fore
logistic
low No sta-
tistical
analysis
de-
scribed
in the
meth-
ods,
only
in the
results;
unclear
exactly
what
has
been
moder-
ate
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applied
to
but
unclear
if all
partic-
ipants
were
from
the
sample
centre
and
were
follow-
ing the
same
proto-
col
verify
seizure
out-
comes
of
partic-
ipants,
and all
out-
comes
mea-
sured
at the
same
time
regres-
sion
should
allow
for
identi-
fication
of prog-
nostic
factors
without
con-
found-
ing
done
and
whether
selec-
tive
report-
ing oc-
curred
Yang
2011
Study
sam-
ple ap-
peared
to
be rep-
resen-
tative of
the
popula-
tion
of inter-
est, but
infor-
mation
is lim-
ited
moder-
ate
Retro-
spec-
tive, so
NA
NA Defini-
tions
and
mea-
sure-
ments
of some
factors
unclear
moder-
ate
Dif-
ficult
out-
come
to mea-
sure
in a
reliable
and
valid
way but
seems
satis-
factory
and
mea-
sured
accord-
ing to a
known
scale;
vari-
ability
in
follow-
up time
han-
dled in
analysis
low NA for
studies
of a sin-
gle-
group
design
NA Statisti-
cal
meth-
ods un-
clear
moder-
ate
CFC: complex febrile convulsion.
GEE: generalised estimating equation.
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